The Genetic Profiles of TIF1 and TIF2 Duplicate Genes by Venturi, Veronica
  
 
 
 
 
 
 
 
THE GENETIC PROFILES OF TIF1 AND TIF2 DUPLICATE GENES 
 
 
 
 
 
BY 
 
 
 
VERONICA VENTURI 
 
 
 
 
 
 
 
 
 
A thesis 
Submitted to the Victoria University of Wellington 
in fulfilment of the requirements for the degree of 
Doctor of Philosophy in  
Cell and Molecular Bioscience 
 
 
 
 
 
 
 
 
Victoria University of Wellington 
2012 
 
2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 
 
Abstract 
 
 
As one of the key steps in protein synthesis, translation initiation is 
subjected to multi-level regulation which is achieved via diverse mechanisms. 
The cell adjusts protein synthesis accordingly to its status and environment. The 
degree of contribution of the processes involved in the regulation of translation 
initiation is still poorly understood.  
The first part of this study focuses on identifying mechanisms of 
regulation in a translationally deficient yeast system, impaired by the loss of one 
or the other of the TIF1/2 duplicate genes, which together code for the 
eukaryotic initiation factor 4A (eIF4A). A major finding of this research is related 
to the functional competences associated with the two duplicate members of the 
gene pair. Although the genetic profile associated with TIF1 highlights a 
connection with transcriptional process, the majority of transcription-translation 
inter-talk is allocated with TIF2, along with a dense network of genetic 
interactions surrounding the SAGA complex. TIF2 is also the only paralog 
devoted to interactions with a substantial group of functionally related genes 
involved in early meiotic gene expression.  Protein degradation in the global 
control of protein synthesis represents a fundamental process and accounts for 
diverse points of control, in particular through ubiquitination/deubiquitination. 
This research concludes that functional turnover of proteins and the 
translation/transcription inter-talk emerges as the most significant contributors 
to the sophistically regulated translational regulation,  
The second part of this study aims to determine the extent of similarity 
and divergence between the TIF1 and TIF2 paralogs. Growth of their individual 
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deletion strains was challenged under different chemical and environmental 
conditions with the intent to explore the relative contributions of each duplicate 
in response to an extend range of perturbations. The pair of duplicates appeared 
convincingly robust in coping with these adversities under disparate cellular 
contexts, thus suggesting a highly conserved and backed-up genetic network.  
One of the primary treatments made use of lithium, a condition which was 
hoped to help, along with furthering our understanding of the TIF1 and TIF2 
networks, in formulating an explanation on how augmented translation initiation 
overcomes lithium toxicity. Although this approach did not return results that 
could be used to address this unresolved topic, evaluation of genetic inhibition 
and suppression was highly instructive regarding the mechanisms of response 
triggered upon lithium/galactose stress. Regulation and synchronization of basic 
cellular processes were affected: emphasis brought on aspects of cell 
communication highlighted mechanisms articulated by kinase enzymes and the 
importance of repression of cell cycle progression in control of protein synthesis. 
Data from the screen also indicated the stress that combined lithium/galactose 
treatment places on central metabolic pathways, for instance those between the 
Leloir, gluconeogenesis, and trehalose pathways. 
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1. Chapter 1 
 
1.1. Introduction 
 
 
The capability of a biological system to successfully respond and adapt to 
a range of environmental challenges represents the key to success for survival 
and is manifested through new variation and evolutionary novelty. The genome 
can be subjected to a number of mutations that could potentially affect it, 
including gene duplication. Differently from a point mutation or a chromosome 
rearrangement, the duplication process displays the unique characteristic of 
affecting genomic functionality while concurrently enhancing mutational 
robustness. 
The Japanese scientist S. Ohno has made a major contribution to the 
subject of gene duplication. His ahead-of-time views and landmark statements 
gained him a place of honour in the field of genome evolution. The legacy of his 
contribution still lives on, with scientists occasionally referring to duplicated 
genes derived by genome duplication as “ohnologs” (Wolfe, 2000). Nevertheless, 
discussion of the significance and implications of genome duplication events had 
previously been addressed and has an extensive, if often neglected, history, as 
discussed below.  
At the beginning of the past century, studies on meiosis in pollen 
conducted by Y. Kuwada revealed that maize was an ancient tetraploid. This was 
recognised on the basis of the observation of two set of paralogous chromosomes 
in the Zea mays karyotype (Kuwada, 1911). Almost two decades later, L. Stadler 
reported that polyploids of some species of cereal grains, such barley and oats, 
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are less prone to irradiation than their related diploids (Stadler, 1929). This 
latter piece of scientific work is frequently underestimated; undoubtedly, it is 
deserving of recognition for the novel connection suggested between stress, 
environmental circumstances, and adaptability of the system, especially in 
relation to the benefits of gene duplication. Further speculation on the advantage 
of duplication events came with the publication of The Causes of Evolution 
(Haldane, 1932); in this book, emphasis was given to the potential malleability of 
the genome as being a source of genes capable of bearing mutations without 
harmful consequences for the organism. As a corollary of this consideration, 
organisms that display various copies of genes should be less prone to lethal 
mutations.  
Additional instances of underrated contributions are also works from: A. 
Serebrovsky (1938), who pioneered an argument nowadays known as the 
subfunctionalization model (section 1.3) by envisioning a pre-duplication multi-
task gene whose functions may become reallocated; C. Metz (1947) and his 
acknowledgement of the duplication of chromosome sections as a key feature in 
evolution and S. Stephens (1951), who asserted that increments in the number of 
genetic loci provides an ideal pathway for a system to evolutionarily progress. 
Although containing elements of imprecision, these and other considerations 
fuelled interest for further investigation into gene duplication. 
Only occasionally diverted by a passionate period of militancy in the 
Communist Party, J. Haldane, by this time better known in the scientific 
community as one of the founders of the discipline of population genetics, 
marked his return to evolutionary studies in 1957 with The cost of natural 
selection (Haldane, 1957). In this publication the author re-evaluated the subject 
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of gene duplication closely, although in different terms. His contribution resulted 
in crucial reflections on the so-called “cost of substitution”, referring to a 
scenario in which an advantageous mutation needs to be fixed in the genome and 
its contribution increased in terms of number of copies, driven by evolutionary 
progression. Following this principle, newly mutated genes take the place of 
some pre-existent ones, which will end up being lost. However, remarks Haldane, 
there is a limit to the speed at which this process can occur and this is what 
would intrigue him for his lifetime. Whilst not addressing the theme of gene 
duplication directly, Haldane’s intuition provided inspirational scientific ground 
for scientists to come, as attested by further interpretations of his popular and 
well accredited theory that turned into a “dilemma” (Van Valen, 1963).  
Almost concurrently, the evolutionary biologist M. Kimura referred to the 
loss of pre-existent genes in favour of new ones generated by duplication and 
successive up-take of non-lethal mutations as the “substitutional load” (Kimura, 
1960). Together with colleague T. Maruyama, he introduced models for the study 
of genetic drift, contributing amply to the controversy over genetic load (the cost 
in genetic deaths to the population of replacing one allele by another -a 
mutation- in the course of evolutionary change) throughout the 1960s. 
Attributed to Kimura is also the neutral theory of molecular evolution (Kimura, 
1983) that ascribes a predominant role to mutational pressure and genetic drift 
in terms of contribution to evolutionary changes, focussing on molecular rather 
than phenotypic level. This controversial model was received by some as an 
argument aimed at diminishing the role attributed to natural selection by 
Darwin's theory of evolution. Although the neutral model acknowledges a 
predominant role to random drift, most evolutionary biologists agree that the 
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two hypothesis are compatible, as Kimura feverishly defended in his 1986 
publication: "The theory does not deny the role of natural selection in 
determining the course of adaptive evolution”, (Kimura, 1986). 
It was not until the publication of Evolution by Gene Duplication (Ohno, 
1970), that the concept of gene duplication was no longer confined to theoretical 
speculations among evolutionists but saw its contribution broadly acknowledged 
in biology. S. Ohno (1928–2000) was a scientist of multifaceted capacities and 
indeed the image of Ohno emerging from this monograph is of a sharply minded 
man and a scientist of visionary talent. In the preface of his book Evolution by 
Gene Duplication he wrote: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Had evolution been entirely dependent upon 
natural selection, from a bacterium only 
numerous forms of bacteria would have 
emerged. The creation of metazoans, vertebrates, 
and finally mammals from unicellular 
organisms would have been quite impossible, for 
such big leaps in evolution required the creation 
of new gene loci with previously nonexistent 
function. Only the cistron that became 
redundant was able to escape from the relentless 
pressure of natural selection. By escaping, it 
accumulated formerly forbidden mutations to 
emerge as a new gene locus. 
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At this stage Ohno was persuaded by the potential of raw genomic 
material as forceful means and proposed it as the source through which new 
functions or new genes could be generated. The time had come for scientists to 
combine molecular genetics tools with modern biology theories and thereby to 
explore the critical contribution of duplication to evolution. 
 
1.2. Duplication of the Saccharomyces cerevisiae genome 
 
1.2.1. Yeast taxonomy 
The number of species of fungi described so far amounts to approximately 
80,000, however existing fungal species are estimated to be in the order of 
millions (Hedges, 2002).  The ordinary classification based on morphology 
divides fungi into five phyla:  Ascomycota represents the largest phylum and is 
characterized by the presence of the ascus, a specific structure that surrounds 
the spores (James, 2006), a product of the mitotic event. Within the Ascomycota 
two prominent subphyla are identified: Pezizomycotina (to which the hyphal 
fungus Neurospora crassa belongs) and Saccharomycotina (accounting yeast 
such Candida albicans and Saccharomyces cerevisiae). Genomes of all the species 
belonging to Saccharomycotina are ascribable to four main clusters; the most 
well known and extensively investigated in terms of genome sequencing is 
referred to as the “Saccharomyces complex” (Kurtzman & Robnett, 2003) and 
comprises almost exclusively species from the genera Saccharomyces and 
Kluyveromyces (Figure 1-1).  
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Figure 1-1. Section of a phylogenetic tree showing relationships among the sequenced fungal 
genomes. Saccharomyces complex - the group of species sharing duplication of the whole genome 
(WGD) - clade and Saccharomyces sensu stricto (van der Walt, 1970) are annotated. The numbers 
indicated the bootstrap values associated to each node. Adapted from Fitzpatrick (2006). 
 
 
Contemporary yeast classification accounts for an extensive variety of 
approaches, depending on whether the categorization is pheno- or genotypically 
determined.  
 
1.2.2. Evidence for duplication  
Gene duplication can take place as a single-gene phenomenon or be 
limited to duplication of short chromosomal segments (SSD, short segment 
duplication); cases of aneuploidy also occur with duplication of entire 
chromosomes up to the more drastic case of whole genome duplication (WGD). 
Given the ubiquity of duplication events among different species, scientists 
attempted to express how often such a phenomenon takes place: the probability 
of gene duplication during evolution has been described in terms of gene 
duplicability intended as the rate of mutation producing duplicate genes and the 
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probability that the duplicates are fixed and retained in the genome (He & Zhang, 
2005a). In recent times gene duplication has also been annotated as continuing 
(Lynch & Conery, 2000; Friedman & Hughes, 2003), highlighting how this 
process incessantly happens in the genomes of all cellular organisms. 
The credit for advancing the hypothesis of the polyploid origin of the 
yeast genome goes to M. Smith during his study on S. cerevisiae histone gene loci 
(Smith, 1987). The outcome of his research pointed to a diploidization or fusion 
of two ancient fungi as the probable origin of the modern yeast S. cerevisiae 
genome. With the most plausible scenarios likely to be either subsequent 
duplications or a single in toto genome duplication followed by translocations. 
Genetic sequencing studies and comparative genomics have assessed these 
possibilities. Over time, significant contributions echoed with the model 
proposed by Ohno, lending credibility to the WGD hypothesis. Results of a 
BLASTP analysis conducted by Wolfe and Shields (1997) using a spatial map-
based approach on the baker’s yeast genome revealed 55 segments of duplicated 
regions: 50 out of the 55 so-called blocks displayed the same orientation with 
respect to the centromere. 
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Figure 1-2. Duplicate regions (blocks) of chromosomes X and XI. Adapted from Wolfe & Shields 
(1997). 
 
 
 
 
As an example, three defined duplicate regions on chromosomes X and XI 
are represented as diagonal clusters of genes in Figure 1-2; as a result of random 
post-WGD individual gene deletions and/or reciprocal translocations, singletons 
are scattered in between the duplicate pairs. The authors interpreted this result 
as proof that these genome segments were generated in a single duplication 
process, followed by translocations among duplicate chromosomes as, if each 
single region was the product of an independent duplication event, their 
orientation would be expected to be random. A similar model in which most, but 
not all, of the original chromosomes were duplicated (aneuploidy) seems less 
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likely but cannot be ruled out entirely. The investigators concluded that baker’s 
yeast is the outcome of the WGD event that occurred after divergence of S. 
cerevisiae from Kluyveromyces lactis about 100 million years ago (mya). The 
duplication of many genomic regions both intrachromosomally and 
interchromosomally -including genes and nongenic segments- suggests that 
duplication is a major attribute of S. cerevisiae genome evolution. 
Supporting evidence (Kellis, 2004) confirms a WGD, believed to have 
taken place 8 to 10 mya, as the most accredited hypothesis. As a result of this 
event, the number of genes of S. cerevisiae genome doubled from a diploid 
number of 5,000 to a tetraploid of 10,000. WGD is regarded as a cataclysmic 
event in which an enormous amount of genetic material became available for 
evolution to forge, followed by a massive gene loss (85% of the copies were 
deleted). Subsequent chromosomal rearrangements and translocations in the 
genome progressively shaped the obvious outcome of the duplication event, 
leaving behind a faint genomic footprint. The existing S. cerevisiae genome, 
accounting for about 5,800 genes, still encloses many conserved paralogs as the 
inheritance of that gene duplication. 
 
 
1.3. Different fates of duplicated genes 
In general, a eukaryote duplicate gene has a half life of just several million 
years (Lynch & Conery, 2000) and a chance of being lost varying from 50% to 
92% (Wagner, 2001).  A number of models have been proposed to account for 
the functional divergence and retention of duplicate genes, mechanisms of which 
are still partially unknown.  
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Four possible fates await a duplicated gene: 
i. Both copies persist  
ii. One copy is deleted  
iii. One copy functionally diverges 
iv. One copy becomes a pseudogene 
 
 
i. Both copies persist 
 
Since complete redundancy is not favoured by evolution (Kitano, 2004), 
retention of two gene copies over evolutionary periods strongly depends on the 
degree of redundant function(s). This may apply to the case of two perfectly 
redundant gene copies, where any damaging mutational effects on one copy can 
be extensively buffered by activity of the other gene copy (Fisher, 1935). It has 
also been suggested that a gene may be maintained not because it is intrinsically 
useful, but simply as this deletion would result in a dosage imbalance, relative to 
key partner genes, which may also be held in duplication. Such impairment of the 
dosage equilibrium would eventually trigger the engagement of very expensive 
cellular processes, like alleviating mechanisms of dosage-compensation. These 
considerations represent the rationale behind the gene dosage hypothesis 
(deVries, 1901) and a possible explanation for the preservation of two copies of 
the same gene. Safeguarding of both duplicates has additionally been postulated 
in the case of protein products needed in significant amounts and/or those that 
are essential for survival of an organism (e.g., increased dosage can be beneficial 
for ribosomal RNA and histone genes). 
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ii. One copy is deleted 
 
The most likely outcome of duplication sees one copy of the gene being 
lost. One of the mechanisms accounting for such a tendency is referred to as non-
functionalization, a process in which one paralog is deprived of its function and is 
eventually lost. Such a mechanism appears not to contribute in terms of adding 
novelty and variation for evolution as it leads to the restoration of both pre-
duplication genotype and phenotype. 
 
iii. One copy functionally diverges 
 
If a gene pair undergoes either neofunctionalization or 
subfunctionalization, then both duplicates will be maintained by selection; the 
presence of partial redundancy, however, may result in one or both genes 
experiencing an altered selective regime relative to the ancestral single-copy 
state. 
 
iiia. Neofunctionalization  
 
S. Ohno proposed that after duplication one copy of the gene becomes 
functionally redundant and free to accumulate mutations without any lethal 
phenotypical consequence. Occasionally, such mutations can by chance pre-
adapt the gene product for a new function, allowing it to “emerge” as a new gene 
(Ohno, 1973). Neofunctionalization means the retention of both gene copies and 
confers an advantage as both genotype and phenotype can be altered. 
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iiib. Subfunctionalization 
 
 R. Jensen (1976) first introduced the hypothesis that two genes with 
separate functions may evolve, after duplication events, if the original functions 
are subdivided among the duplicate pairs. According to his theory, the gene’s 
ancestral functions are partitioned between the two daughter genes, resulting in 
a re-establishment of the original phenotype accompanied by a variation in the 
genotype. This model was introduced by L. Orgel (1977), who proposed sharing 
of an original function as the way diversification takes place in multigene 
families. This proposal attracted the interest of scientists over decades, with 
notable further investigations by R. Jensen and G. Byng (1981) and A. Hughes 
(1994). Re-allocation of pre-duplication functions among paralogs after 
duplication has been referred to as “subfunctionalization” and took shape in the 
duplication-degeneration-complementation (DDC) mathematical model 
proposed by Force and colleagues (Force, 1999, Lynch & Force, 2000). DDC 
attributes complementary degenerative mutations in regulatory elements for 
controlling the expression of duplicated genes, leading to portioning of ancestral 
gene functions. If any selective pressure acts on this mechanism, the 
evolutionary advantage of subfunctionalization is presumably to allow individual 
optimisation of the newly separated functions, although it could simply 
represent the most likely outcome for complexly regulated genes. 
 
iiic. Sub-neo-functionalization 
 
As both neofunctionalization and subfunctionalization have failed to 
satisfactorily describe genome configuration of genetic interactions singularly, a 
more complex scenario known as “sub-neo-functionalization” has also been 
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theorized (He & Zhang, 2005). Elements of previously proposed models are 
combined: in addition to changes at the amino acid sequence level, an important 
aspect of subfunctionalization of duplicate genes is likely to involve differences 
in expression patterns. The two paralogs’ expression patterns will diverge as a 
result of modifications in cis-regulatory elements, which allow them to bind 
different sets of transcription factors. According to this theory, a conspicuous 
number of paralogs have endured rapid subfunctionalization followed by 
prolonged neofunctionalization (He & Zhang, 2005). More recent work done by 
Hittinger and Carroll on duplication and divergence of GAL genes and their 
contribution to genetic novelty (Hittinger & Carroll, 2007) provided 
experimental evidence in support of this model. 
 
iv. One copy becomes a pseudo-gene (Pseudogenization)  
 
After duplication the most likely gene fate is loss, with the majority of the 
duplicates degenerating into pseudogenes (Jacq, 1977), DNA sequences 
displaying all characteristics of ordinary genes, including exon structures and 
promoter sequences. Although generally believed to execute no function, several 
pseudogenes have been described since their discovery and some of them have 
been surprisingly reported to affect other functions (e.g., the courtship behaviour 
of flies, Kaessmann, 2009). Where duplication has arisen through retroposition 
or retroduplication (Kaessmann, 2009), the duplicate is particularly susceptible 
to decay mechanisms and their fate is often to become a pseudogene. 
A possible scenario may involve a copy of a functional gene acquiring 
mutations that cause it to become non-functional. Nevertheless, pseudogenes 
may have previously held a prior role: some duplicate pairs have been retained 
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in the functional genome for a time, before being turned into pseudogenes. 
Pseudogenization may be triggered by changes in genetic background and/or 
environment variation, in this latter case it would be more appropriate to refer 
to pseudogenization by neutral selection. This process renders a formerly 
functional gene into one that is no longer operating, leading to an easing of the 
negative selection exercised on the gene itself; as a consequence, mutations 
disrupting the gene are fixed by genetic drift, and the gene can assume the 
appearance of a pseudogene.  
 
1.4. Post-duplication evolutionary-driven functional 
divergence and retention  
 
Not all duplicate genes survive in an organism, nor have they the same 
probability to be retained; the forces addressing their process of 
functionalization and eventual retention in the genome are still largely unknown. 
Natural selection represents a key element, according to Ohno’s view.  Over an 
early period following the duplication event, one of the paralogs would benefit 
from the absence of selective pressure, leaving the duplicate free to accumulate 
mutational events with no disruptive phonotypical consequences for the 
organism. It is through such a mechanism that acquisition of new function(s) 
takes place.  Studies of molecular evolution also suggest that during this period 
of less selective pressure, shortly after duplication, “new” duplicates can bear 
accumulation of changes, with around 10-fold more amino acid variations than 
paralogs duplicated in more remote times, and are more tolerant to nucleotide 
changes than their single copy counterparts (Lynch & Conery, 2000). However, 
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the assumption that the duplicate will benefit from a “genetic drift free” status 
for the rest of its lifetime should be discarded in consideration of the purifying 
selection that operates on the gene copy, as long as it is expressed. This 
argument leads to the consideration that paralogs are not entirely freed from 
constraint (Hughes, 1994). Whilst Ohno’s hypothesis permits 
neofunctionalization as the only mechanism through which duplicates can 
escape being lost and are thus enduringly retained, this model has nowadays 
revealed its inadequacy in representing the entirety of duplicate gene pairs. 
Alternative mechanisms are additionally proposed to take place, as reviewed in 
section 1.3. In referring to yeast duplicate gene pairs, paralogs are often implied 
as arising from WGD, however SSD paralogs deserve a further elucidation as 
their divergence and eventual retention is underpinned by distinctive selective 
constraints. For this reason, differences are present between WGD and SSD in the 
post-duplication time period. Following the dosage balance hypothesis, WGD-
derived duplicate genes are preferentially maintained whilst SSD paralogs, 
perceived as a perturbation of the stoichiometric balance of the system, are 
rarely retained (Papp, 2003a). 
 
1.4.1. What if Ohno was wrong? 
Over the past two decades, although inspiring and very popular, Ohno’s 
theory has been surrounded by raising doubts, leading evolutionist biologists to 
formulate alternative hypotheses. J. Piatigorsky and G. Wistow are likely to have 
inspired most of them, by pioneering the concept of gene sharing (Piatigorsky & 
Wistow, 1989), a scenario in which a protein displays at least two distinct 
functions. Shortly after, the duo of scientists emphasized their view in the iconic 
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paper The recruitment of crystallins: new functions precede gene duplication 
(Piatigorsky & Wistow, 1991). The notion of gene sharing was here refined and 
the idea that duplication was not an essential pre-requisite to gain a new 
function authenticated as theory. 
Over time, a persuasive body of research ended up contradicting Ohno’s 
paradigm when considered in stricto sensu and the mutation during non-
functionality (MDN) model, a scenario in which post-duplication gene copy is 
redundant and free to accumulate mutations (substitutions) at random, began 
inexorably to loose followers. The downfalls of Ohno’s theory can be perceived 
from work published by A. Hughes, who underlined how duplicate pairs are 
inexorably under the pressure of purifying selection and so are far from being 
free to accumulate random mutations (Hughes, 1994). This outspoken scientist 
also embraced the theory of gene sharing and laid emphasis on how studies on 
multi-gene families (Piatigorsky & Wistow, 1991) were pointing at positive 
(Darwinian) selection as a possible mechanism underlying the existence of 
related proteins with distinct functions. Hughes was simply fuelling an already 
emergent current of thought which was persuaded that gene sharing could 
indeed precede duplication events. All together these considerations questioned 
the importance of duplicate genes’ contribution as prerequisite for formation of 
new proteins and, by the beginning of the 21st century, Ohno’s view had acquired 
an unexpected anachronistic connotation. 
Disregarding the dispute, interrogatives of critical importance for 
understanding the functioning and impact of gene duplication have not yet been 
answered: “which copy evolves a new function?” and “which forces influence or 
drive this process?”. Ohno postulated that mutations arising during the period of 
38 
 
relaxed selection pressure drive the duplicate gene to either non -or neo-
functionalization.  
1.4.2. Contemporary knowledge 
Several years of exciting research has gone past since Ohno’s first 
proposals; significant theoretical and empirical advancements have been 
achieved, revolutionizing the meaning of what we call a “gene”. Innovative 
approaches and methodologies, such as combined efforts of genome sequencing, 
comparative genomics and studies on chromosome morphology, have been 
crucial in the acquisition of knowledge surrounding the factors that influence 
paralogs’ outcomes. Their destiny has been shown to be affected by genetic 
aspects including redundancy (Piskur, 2007) and expression dosage (Conant & 
Wolfe, 2006). It is nowadays extensively accepted that the characteristics 
associated with retention of a duplicate can be quite diverse, including the 
modality the modality through which the gene has ended up in the genome. For 
example, a WGD-derived duplicated copy may be preferentially retained on the 
basis of the gene dosage balance hypothesis (Lynch & Conery, 2000), as it is 
essential for the dosage equilibrium to be preserved. Gene function also plays a 
role. For example, cyclins, myosins, protein kinases, pheromones and 
transcription factors are annotated as the preferentially retained pairs of genes 
in S. cerevisiae (Wolfe & Shields, 1997). 
Outside of WGD events, a number of additional factors which affect the 
tendency for duplication to occur are now recognised: 
 1) The species to which the gene of interest belongs. The duplication rate 
is different between species with humans and worms being faster than yeast and 
other species (Gregory, 2005);  
39 
 
2) the gene evolutional rate. Rapidly evolving genes undergo duplication 
less often than those with low rate of evolution: the more slowly evolving copy 
may be under stronger selective constraint, whilst the faster evolving copy may 
be under more relaxed selective constraint (Conant & Wagner 2003; Zhang, 
2003). Several recent studies have shown that duplicate genes in general tend to 
evolve more slowly (Davis & Petrov 2004; Jordan, 2004), indicating strong 
purifying selection on duplicate proteins, presumably to conserve its ancestral 
sequence and function;  
3) the length and structure of the gene. Long genes appear to be 
duplicated less often than short genes (Gregory, 2005). 
Contemporary knowledge has deepened our understanding of gene 
duplication, enhancing comprehension of the advantage of such an apparently 
expensive phenomenon. Little is known, though, about the rules that govern 
post-duplication modifications of gene interactions or whether these latter affect 
the fate of duplicate genes. Fascinating questions regarding how two copies 
initially identical and affected by the same mutational forces embark on different 
evolutionary pathways remain yet to be answered. Whilst we are left yearning 
for enlightenment about the evolutionary impact of duplicated genes, it seems 
likely that participation of short-term mechanisms may be required to guarantee 
the long-term advantages granted by the retention of both paralogs (Lynch & 
Katju, 2004). 
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1.5. Genetic and systemic robustness 
 
The phenomenon through which malfunction in one component of the 
organism does not result into a failure of the whole system, thanks to the 
intervention of another constituent, is known as robustness. The genome of the 
yeast S. cerevisiae genome displays a high degree of gene dispensability with the 
organism able to bear a deletion of a predominant fraction of Open Reading 
Frames (ORFs) with no evident phenotypical consequences on the system under 
laboratory conditions.  Only 18% of the genes have been found to be essential 
under experimental conditions in rich glucose-containing medium (Giaever, 
2002), aligning findings in yeast with similar ones in bacteria (Kobayashi, 2003) 
and worms (Kamath, 2003). However, this does not mean that only such a small 
percentage of genes are involved in essential process but it represents the extent 
of robustness inherent in the system. Some of the so-called non-essential genes 
are believed to play roles in essential processes, with a portion of non-essential 
genes defined essential under specific conditions. 
The high level of redundancy in the genome has for a long time been 
ascribed to the presence of duplicate genes, where a direct backup compensation 
from one of the paralogs assists the counterpart when this latter is impaired. In 
other words, functional redundancy between paralogs may lead to genetic 
robustness. This characteristic makes baker’s yeast an appropriated organism 
for studying this topic.  
Investigations into the biological properties and contribution to 
robustness of duplicates have been conducted with different approaches. So far, 
the most informative attempts have resulted in examinations based on physical 
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interactions (Baudot, 2004; Musso, 2007), metabolic networks (Papp, 2004) and 
single-gene deletion phenotypes (Gu, 2003). This congruent body of studies has 
given evidence for functional similarities among WGD and SSD pairs of 
duplicates, supporting the hypothesis that there is an advantage in preserving a 
functional overlap, disregarding the nature of the duplication event. However, 
yeast duplicate pairs derived from WGD appear to be more dispensable (with the 
exception of ribosomal protein genes) than duplicates generated through other 
mechanisms (Lin, 2007). The contribution of paralogs to genetic robustness has 
been estimated and WGD pairs appeared more likely to buffer each other than 
SSD pairs -39% versus 18%- (Li, 2010), showing indeed a more pronounced 
buffering strength. This observation may have implications in the case of a 
duplicate under strong functional constraint, which reduces the rate of functional 
divergence between WGD paralogs.  
Redundancy caused by duplication is not the only source of robustness 
against mutations: an important contribution comes from the network system 
that arises from metabolic pathways, regulatory and feed-back networks 
(Wagner, 2000). Such coordinated effort is better known as system robustness, 
where networks of interactions display a certain degree of back up, even if their 
elements and elementary processes themselves do not.   
 
1.5.1. Robustness and Evolution  
It is interesting to consider how evolution contributes to the robustness 
of a biological system and how robustness and function interrelate. Is cellular 
robustness a well articulated strategy that the organism engages to avoid the 
detrimental effects of deleterious mutations (e.g., genetic robustness) or does it 
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arise from such mutations? Currently, there is uncertainty about whether there 
is pressure to maintain robustness or whether it is simply a random event. The 
robustness expressed as the ability of a system to formulate novel and effective 
solutions, it is currently viewed as facilitating evolutionary innovations or, at the 
very least, a chance for their occurrence. Phenotypic diversity, which provides 
options to be tested against stressors, can be summarized in the form of 
evolutionary innovation that goes under the name of “evolvability” (Kirschner & 
Gerhart, 1998). Gene duplication causes robustness that, in turn facilitates 
evolvability. The requirement for variation that results in non-lethal phenotypes 
hints at an intimate link between evolvability and mutational robustness 
(Wagner, 2008).  The survival of the system seems to be correlated with its 
capacity to find a compromise between robustness and adaptability; this key 
requirement has to be met to allow long- term survival in an environment that 
presents incessant new challenges. Approaching the topic from a population’s 
perspective, the outcome of a highly robust system will guarantee that fewer 
mutations have deleterious effects, leading to a disfavoured phenotype. As a 
result of that, a greater diversity of genotypes will arise in a population of robust 
individuals and such diversity, although itself not always accompanied by 
phenotypical change, may facilitate the emergence of new phenotypes (Ciliberti, 
2007; Wagner, 2008). 
 
1.5.2. Do duplicates genes really play a role in genetic robustness?  
The contribution of paralogs to mechanisms of genetic robustness has 
been established by an exhaustive investigation from Gu and colleagues (Gu, 
2003), with later studies showing direct backup compensation accounting only 
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for a quarter of the system robustness (Ihmels, 2007). Duplicates have been 
shown to possess significantly higher probability of functional compensation 
than singletons and a higher probability of having a severe fitness defect when 
the copy with higher expression level is deleted. Finding that a less severe fitness 
consequence is associated with deletion of a duplicate gene rather than a 
singleton gene has been challenged by studies done by He & Zhang (2006), which 
suggest that it could partially be traced back to the fact that duplicates are 
intrinsically less important than singletons, suggesting thus an overvaluation of 
the duplicate genes’ contribution to mechanisms of genetic robustness. 
Furthermore, a high correlation between the frequency of compensation and the 
similarity in sequence of two duplicates has also been reported: duplicated genes 
that are highly similar in sequences perform better at compensating for each 
other than duplicates whose sequences (and presumably functions) have 
diverged further (Gu, 2003).  
Whilst recent studies confirmed that functional overlap between 
duplicate genes is supported by genetic redundancy (DeLuna, 2008, Li, 2010), a 
number of paralogs still fail to display backup capacity. In many cases, the 
buffering ability of the duplicates, the strength of which is strictly tied to the 
extent of mutations in their background and proportional to their divergence 
time (Li, 2010), appears to have partially been lost. The observation that 
duplicate pairs often fail to genuinely back up for each other is confirmed by the 
lack of similarity between interactions profiles of the paralogs (Ihmels, 2007). 
Such a transitory status profile of functional compensation between duplicated 
pairs indicates that they do not contribute heavily towards functional 
redundancy, as might be expected from reliable mechanisms of cellular 
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robustness. Overall, it seems that gene duplication does not represent the major 
route to robustness; instead interactions among ‘unrelated’ genes provide 
robustness against mutations by participation in regulatory networks (Wagner, 
2000). 
 
1.6. The TIF1 and TIF2 genes 
S. cerevisiae gene TIF1 (Translation Initiation Factor) was isolated as a 
suppressor of a missense mutation in the mitochondrial gene oxi2 (Linder & 
Slonimski, 1988) and described to code for a 395 amino acid protein. In 
association with this discovery, a second gene -TIF2- almost identical to TIF1, 
except for five silent substitutions within the ORF was also reported (Linder & 
Slonimski, 1988). TIF1 and TIF2 genes, respectively located on chromosome XI 
and X (Muller, 1989), are functionally redundant under normal growth 
conditions (Linder & Slonimski, 1989); protein sequence comparison showed 
they both specify for the same protein (Linder & Slonimski, 1989) which shares 
81% of homology with the mouse eukaryotic initiation factor 4A (eIF4A). The 
role of the TIF1 gene is confirmed by the presence of two sequences resembling 
the upstream activating sequence UASrpg -upstream activation sequence of 
ribosome protein genes- (Teem, 1984) in its 5’ region. Such a feature is 
characteristic of the promoter regions of yeast genes coding for elements of the 
protein synthesis machinery. Interestingly, although the coding regions of the 
two TIF genes are almost identical, no homology can be found in regions 
surrounding the two ORFs, as their 5’ and 3’ untranslated regions are completely 
different. This is also the case with other duplicated genes involved in translation 
and may serve to regulate their expression.  Intriguingly, TIF1 and TIF2 duplicate 
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pair retained absolute protein product identity. Both genes are characterized by 
high expression and similar mRNA size, with TIF2, however, showing the greater 
abundance of both mRNA and protein (Prat, 1990).  
 
 
1.7. The promoter regions 
 
Promoter regions appear to be of particular interest in the study of 
duplicate genes and have been addressed in several investigations. Regulatory 
regions of paralogs have been reported able to diverge, allowing expansion of 
functionality as well as changes in expression levels (Louis, 2007). As a result of 
these changes, novel or complementary organism functions could arise from 
differential regulatory mutations (Hellsten, 2007).  
The ability of a paralog to undergo transcriptional reprogramming upon 
deletion or mutation of its counter-part has been shown to be crucial when it 
comes to compensation (Kafri, 2005). Thus, it is not important whether two 
genes are co-expressed under normal conditions but rather that one of the 
paralogs can be expressed at a satisfactory level, should a functional copy of its 
counterpart to be no longer available (Kafri, 2005). The same study revealed that 
dispensable paralogs have highly correlated expression in a few conditions only 
(Kafri, 2005), while a congruent body of evidence (Zhang, 2004; Gu, 2005) 
corroborated the belief that coding sequence divergence and expression 
divergence are correlated, although this correlation is generally weak.  A later 
investigation led by Hughes and Friedman, highlighted that sharing of 
transcription factors tends to decrease with increased divergence in coding 
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sequence. Their data also showed significantly higher condivision of 
transcription factors by paralogs arising from duplicated genomic blocks than in 
other duplicated gene pairs. In addition, genes in duplicated regions also showed 
significantly greater conservation when coding sequences were compared 
(Hughes & Friedman, 2007).  
The promoter regions of TIF1 and TIF2 genes bind to the same and 
different transcription factors, possibly as a result of diverse acquired mutations 
and/or changes induced by adaptation to challenges. The TIF1 gene has been 
annotated as having eight documented transcription factors, while the number 
rises to thirty-one, if the potential ones are also taken into account; the TIF2 gene 
displays five documented and thirty-one potential transcription factors 
respectively (yeastract.com). The two duplicate genes appear to share just two of 
the documented transcription factors Met4p and Sfp1p. Such differentiated use 
of promoters provides a crucial contribution to the functions of duplicated genes 
and is regarded as one of the mechanisms by which diversity at the gene 
expression level is achieved. The resultant flexibility of both qualitative and 
quantitative gene expression regulation may represent the outcome of a post-
duplication event in which genes have become functionally differentiated in a 
multi-dimensional process, with different paralogs enduring differentiation in 
different ways (Hughes & Friedman, 2007).  
 
1.8. eIF4A and the  DEAD-box helicases family 
 
The DEAD-box family of proteins owe its name to the occurrence of a D-E-
A-D (Asp-Glu-Ala-Asp) motif, extensively conserved among helicases (Linder, 
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1989); this motif is required for ATP binding and hydrolysis and is found in the 
archetypal family of RNA helicases eIF4A. RNA helicases are crucial for 
translation initiation and in general for translational control. Their involvement 
is reported in almost every step of RNA metabolism, such as transcription, pre-
mRNA splicing, nuclear export, RNA transport, mRNA decay, ribosome 
biogenesis, and translation initiation. (Hernandez & Vazquez-Pianzola, 2005). 
DEAD-box proteins are ATP-dependant RNA helicases and RNA-dependant 
ATPases, able to transfer the energy generated from hydrolysis of ATP into 
unwinding activity on RNA secondary structure or to separate RNA strands 
(Linder & Lasko, 2006).  
The eukaryotic translation Initiation Factor 4A (eIF4A) was originally 
purified from rabbit reticulocyte lysate (Grifo, 1982); the same study also 
revealed the interaction between eIF4A and ATP, mediated through an ATP-
stimulated binding of mRNA. The interaction between eIF4A and RNA binding 
was confirmed by Abramson (1987). Whilst isolated eIF4A is a non-processive 
bi-directional RNA helicase, when part of the eIF4F complex it becomes 
processive and 5` - 3` uni-directional (Rogers, 2001) and its weak helicase 
function increased by eIF4B, an RNA binding protein (Altmann, 1995). eIF4A is 
recruited at the mRNA 5`-untranslated region (5`-UTR) by eIF4G, a scaffolding 
protein, which directly interacts with both the 5`-UTR and eIF4E, the eukaryote 
initiation translation initiation factor 4E. mRNA secondary structures in the 5`-
UTR are resolved by eIF4A, facilitating the formation of the 43S pre-initiation 
complex and ultimately ribosome recruitment and scanning to an AUG start 
codon (Sonenberg & Hinnebush, 2009). Translation of mRNAs that display a 
greater degree of secondary structures has a higher requirement for eIF4A, both 
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in vivo and in vitro (Svitkin, 2001). Interestingly, mRNAs as short as 8 nucleotides 
have been shown to be still dependent on eIF4A activity, suggesting an additional 
role(s) for this complex protein (Blum, 1992). 
Translation is a key step in the processes that leads from the genetic code 
to the synthesis of a functioning protein and ultimately to life; for this reason it 
does not come as a surprise that proteins involved in its regulation and 
performance are extensively conserved. The eIF4A family is critical for the 
process of translation to initiate in human (Gingras, 1999) as in yeast (Linder & 
Slonimski, 1989), being the most abundant translation initiation factor in both 
species (von der Haar & McCarthy, 2002). In humans it is referred to as eIF4AI/II 
while in yeast it is known as Tif1p and Tif2p. A third form, eIF4AIII, is annotated 
in humans, although unable to compensate for the eIF4AI/II activity in vitro or in 
vivo (Ferraiuolo, 2004). Instead it plays a key role in non-sense mediated decay 
(NMD). An rRNA processing (Fal1p) is found in yeast (Kressler, 1997), which has 
a similar homology to Tif1/2p as eIF4AIII does to eIF4AI/II in humans. However, 
the two proteins do not appear to be functional homologues despite the acronym 
FAL standing for “Four A Like”. While the process of translation initiation is 
highly conserved in both humans and yeast, there are minor divergences. The 
process of translation initiation is overviewed in the next section. 
 
1.8.1. Eukaryotic Translation Initiation  
Translation initiation is a conserved mechanism that occurs in most cells 
primarily through the cap-dependant mechanism, which functions through the 
5`-methyl guanine cap, a structure that marks mRNAs. Extensive studies done in 
S. cerevisiae have revealed how complexly regulated this process is (Hinnebusch 
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& Liebman, 1991). Recognition and recruitment of the G5’ppp5’N structure is 
done by eIF4E (7-methyl guanine cap-binding protein) which, in association with 
eIF4G and eIF4A, form the eIF4F complex. While the process of translation 
initiation is highly conserved in both humans and yeast, there are minor 
differences. One of these is that human eIF4G1 displays two binding sites for 
eIF4A (Korneeva, 2001), whilst yeast eIF4G contains only one (Li, 2001). The 
cap-dependent translation process involves the engagement of numerous 
eukaryotic initiation factors (eIFs) and is dependent on eIF4A, as secondary 
structures in the 5’ UTR require RNA-helicase activity for the initiation process to 
begin (de la Cruz, 1999). After recruitment, the 40S subunit scans the mRNA for 
the initiation codon, association with the 60S subunit eventually takes place, and 
translation begins.  
The major point of control for cap-dependent translation seems to be the 
association of the 40S subunit with the eIF2•GTP•Met-tRNAi ternary complex, 
which ultimately permits successful scanning. It has been shown that Gcn2p. a 
kinase activated under particular conditions of stress, phosphorylates eIF2 and 
mediates the inhibition of translation via a complex interchange of AUG 
recognition and eIF2-GTP status (Hinnebusch, 1996). A further point of 
regulation is the level of interaction of the small ribosomal subunit to the 5’ end 
of the mRNA: in this case, control is mainly achieved through modulation of 
eIF4E affinity for the cap structure by phosphorylation (Scheper & Proud, 2002) 
and inhibition of the eIF4E-eIF4G interaction (Lin, 1994; Gingras, 1999). 
Ultimately, an important mode of control has to be ascribed to the presence of 
secondary structures in the 5’ UTR, as these are inhibitory for translation both in 
vivo and in vitro (Pelletier & Sonenberg, 1985; Baim & Sherman, 1988). In this 
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context, RNA helicases, specifically eIF4A, function by smoothening the landing 
path for the translation-competent small ribosome subunit and thereby 
achieving a form of control on the translation process. 
A second mechanism, known as cap-independent translation initiation, 
does not require the ribosome to start scanning from the 5' end of the mRNA cap 
to the start codon. It relies instead on the presence of an Internal Ribosome Entry 
Site (IRES), often distant from the cap structure. The intervention of IRES trans-
acting factors permits the ribosome to bypass the need for the scanning process: 
the ribosome is loaded onto the transcript, independent of the 5`-UTR and cap 
structure, and finally trafficked to the start site. There is a variable requirement 
for an eIF4A contribution in this process (Jackson, 2010). In yeast, IRES-
containing transcripts are not particularly ubiquitous but have been reported in 
genes involved in filamentous growth induced in response to nutrient starvation 
(Fernandez, 2001). In eukaryotes, cap-independent translation has also been 
revealed to be important in conditions of apoptosis and stress-induced 
responses (López-Lastra, 2005).  
In summary, there are a number of important questions that remain 
unanswered about the role of the duplicate genes TIF1 and TIF2 in yeast, and 
why these have been evolutionarily restrained to provide an identical protein. A 
number of complementary techniques will be required to address these 
questions. 
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1.9. Aims and objectives 
The aim of this research is to develop an understanding of the 
evolutionary benefits underlying the conservation of a single protein product 
(eIF4A, referred to below as Tifp, the protein product of the TIF1 and TIF2 genes) 
formed from a whole genome duplication event. 
 To achieve this, different complementary approaches have been 
employed to understand the different roles of TIF1 and TIF2 in the context of 
translation initiation in yeast: 
 The first part of the study is an exhaustive analysis of the genetic 
surroundings of the TIF1 and TIF2 genes, by using deletions of identified 
genes as a probe in a wide-scale gene-to-function oriented approach.  
 The second part of this research utilizes chemicals and environmental 
challenges to complement TIF1 and TIF2 genome-wide screen results, 
specifically to formulate an explanation on how augmented translation 
initiation overcomes Li+ toxicity. 
 A global interpretative picture of wide-scale information is finally 
assembled in a network context, where the duplicate nature of TIF1 and 
TIF2 genes is analysed to unveil the evolutionary path they have gone 
through as paralogs. 
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2. Chapter 2 
 
This chapter describes a detailed analysis of a robustly replicated and 
validated synthetic genetic array (SGA) analysis of the genetic network of the 
TIF1 and TIF2 genes.  Analysis of the results should provide evidence towards 
the global aim of understanding evolutionary benefits underlying conservation of 
a single protein product (eIF4A, referred to below as Tifp, the protein product of 
the TIF1 and TIF2 genes) from the two genes. 
 
2.1. Introduction  
Yeast has played a significant role in human civilization for a very long 
time as an essential component for domestic activities such as baking, brewing 
and wine-making. The use of this resourceful organism for human purposes has 
been dated to 7400-7000 years ago, with the earliest evidence ascribed to the 
Neolithic Era: traces of the calcium salt of tartaric acid and the resin of the 
Pistacia (terebinth) tree identified on narrow-necked pottery specimens hint to 
these findings as the first evidence of wine making. Tartaric acid is found in great 
amounts only in grapes and it is believed that the Pistacia resin was included as 
antibacterial preservative.  Man’s first experience with yeast possibly arose from 
a process that did not require an inoculum of the organism, as yeast is present in 
the fruit and able to carry out fermentation. 
Archaeological and chemical records from lower Mesopotamia unveiled 
how Sumerian tribes, who ruled the region around 4000 to 3000 B.C., were also 
engaged in production of beer and wine. A mounting body of evidence such as 
pictograms, a seal representing Ninkasi (the goddess of brewing), beer recipes, 
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and the presence of calcium oxalate on manufactured vessels of specific shape 
strongly suggests that Sumerians were the first civilized culture carrying on 
brewing and wine-making, as a constitutive part of their customs. Analysis on a 
DNA sample isolated from a presumptive wine jug found in Abydos (Egypt) and 
dated around 3150 B.C., showed a close sequence match for the modern yeast S. 
cerevisiae (Cavalieri, 1988). 
Historians and scientists have also contemplated the hypothesis that 
around 1000 B.C., Ancient Egyptians were able to “isolate” the active yeast, 
culture it and directly introduce it into their dough, designating it as the first 
form of the domesticated organism. Once again, speculation has been raised on 
whether yeast present in the air as a natural contaminant may have triggered the 
fermentation process, causing the mix of flour and water to leaven.  
Studies on the genus Saccharomyces date back to 1837, when German 
physiologist T. Schwann experimentally showed that alcoholic fermentation is 
dependent on the presence of a bubble-giving living organism, yeast. He correctly 
annotated it as a fungus, and called it in German “Zuckerpilz”: sugar fungus. The 
following year, S. cerevisiae became the first yeast species to be described: Julius 
Meyen translated the German “Zuckerpilz” into Latin Saccharomyces, assigning to 
the organism its biological name. He named it after Saccharomyces meaning 
sugar moulds and cerevisiae meaning beer from the Gaelic word kerevigia or the 
old French word cervoise. 
In more recent times, yeast boasts a history of successful applications 
while technological advancements and research have given rise to its extensive 
use in different industrial fields such alcoholic beverages, baked goods and food 
additives. Following Pasteur’s work and the development of microbiological 
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techniques, specialized strains were introduced and evolution partially 
interrupted, as such strains are separated out from the evolutionary pool on 
which natural selection acts on. Industrial usage of yeast relies on specialized 
strains of S. cerevisiae that have been selected for a specific process and are not 
easily interchangeable. 
Yeast metabolism is of particular interest and its energetic cost is covered 
through the employment of different substrates, primarily sugars, while the 
presence or absence of oxygen in the environment generates two types of 
metabolism: in the condition of aerobiosis, oxygen is used to oxidise glucose with 
release of carbon dioxide, water and energy; this route, known as a respiration, 
allows for the whole potential energy in glucose to be released. In the absence of 
oxygen (anaerobiosis), yeast is still able to utilize sugars for the production of 
energy necessary for its survival, however with a compromised efficiency. This 
metabolic process, described by L. Pasteur as fermentation, is dramatically less 
resource-efficient in terms of releasing potential biochemical energy, as only a 
partial oxidation of glucose into alcohol and carbon dioxide is completed.  This 
ability to grow under anaerobic conditions is unlike the majority of other fungi, 
which display an exclusively aerobic metabolism. As gene duplication took place 
prior to the WGD, it can be hypothesised that such an event facilitated the 
acquiring of novel and distinctive competences, including the ability to survive in 
anaerobic environmental conditions. 
 
Fermentation denotes a characteristic ability of members of 
Saccharomyces yeast and is represented in their ability to convert sugar into 
alcohol. There is a great variety in the landscape of production of beer, wine, and 
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distilled spirits which reflects the use of different sub-strains of S. cerevisiae, 
however all those different sub-strains can be ascribed to one, S. cerevisiae. 
Whilst alcohol production for recreational use embodies the most popular 
application of the fermentation process, fermentation is not just about 
hangovers! Distinctive metabolic features of members of the Fungi kingdom have 
shown potential for application in the degradation of hazardous and organic 
waste, mainly through the construction of genetically engineered yeasts (Loper, 
1988). The use of S. cerevisiae as a biocatalyst to generate electricity in microbial 
fuel cells has also been explored: in a recent publication, Raghavulu and 
colleagues presented encouraging data for a yeast-based fuel cell to be developed 
as a remedy for high strength wastewaters with coupled generation of power 
(Raghavulu, 2011). The yeast fermentation derived ethanol represents, together 
with the transesterification derived biodiesel, one of the so-called first 
generation biofuels used to produce ethanol for the biofuel industry. The 
construction of novel genetically modified yeast strains, less sensitive to the ill-
effects of their own produced alcohol, has been accomplished by 
Stephanopoulos’ lab (Alper, 2006); the implications of this revolutionary 
methodology are considered to be enormous as the process could lead to 
boosting the efficiency of generating ethanol-based fuels from corn and plant 
wastes. Furthermore, of particular appeal for the pharmaceutical industry, S. 
cerevisiae can also be employed in the manufacture of steroids: a patent 
deposited by R. Spagnoli and others in 2010 is based upon genetically modified 
yeast strains able to carry out steroid synthesis, through their own fermentation 
process (Spagnoli, 2010). 
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2.2. Yeast as a model organism 
The yeast Saccharomyces cerevisiae is a round-ovoid single-celled 
organism of 5–10 µm in diameter, belonging to the family of Saccharomycetaceae 
(phylum Ascomycota, kingdom Fungi). It contains 16 characterized 
chromosomes that range in sizes between 200 to 2,200 Kb and its completed 
sequence was determined in 1996 (Goffeau, 1996), uncovering a 12,068 Kb 
genome, with 5885 ORFs encoding for potential proteins. Unlike other 
unicellular organisms, the yeast genome is quite compact, with genes 
representing 72% of the total sequence. Easy to manipulate, a short life cycle 
with a doubling time of 90 minutes, assessed tractability and a relatively small 
genome, represent only few of the characteristics featured by this powerful 
organism. Baker’s yeast is historically remembered as the first eukaryotic 
genome to be fully sequenced (Goffeau, 1996) and transformed by plasmids 
(Beggs, 1978). It also holds a high rate of homologous recombination that allows 
precise manipulation of the genome for the construction of gene disruptions and 
allele-specific replacements; its stability both in haploid and diploid state 
renders it suitable for limitless experimental approaches. Its maintenance and 
growth are also inexpensive and it holds a designation GRAS (Generally 
Recognized As Safe) assigned by the American Food and Drug Administration 
(FDA). In addition, broad shared knowledge in annotated information about 
ORFs and their protein products is available via regularly updated public 
databases such Saccharomyces genome Database (SGD) 
(www.yeastgenome.org/), Yeast Search for Transcriptional Regulators And 
Consensus Tracking (YEASTRACT) (www.yeastract.com/), YeastMine 
(yeastmine.yeastgenome.org/) and MIPS Comprehensive Yeast Genome 
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Database (CYGD) (mips.helmholtz-muenchen.de/genre/proj/yeast/). With the 
genome sequence completed, nowadays the challenge is pairing yeast genes with 
their function(s) and potential human homologs; elucidated knowledge on this 
topic would allow more ambitious approaches to genetic therapies and drug 
discovery and treatment strategies and overall enhance our comprehension of 
disease states etiology. 
 
2.3. Yeast as a model for human diseases 
Research on genetic diseases has undeniably benefited from the 
availability of diverse experimental organisms: S. cerevisiae contributes 
remarkably to the understanding of genes linked to human disease, while 
displaying the potential for further groundbreaking discoveries. 
 
“Each time I have identified an intriguing 
aspect of the cancer problem, I have found 
that it could be approached more effectively 
in the simpler eukaryotic cell, 
Saccharomyces cerevisiae, than the human 
cell.” 
 
L. Hartwell, 2001 Nobel Prize in Physiology or Medicine, Nobel lecture. 
 
Prof. Hartwell who conducted pioneering studies on the mechanisms of 
cancer biology in S. cerevisiae (Hartwell, 2002) emphasizes a concept already 
quite popular among his colleagues: the beauty of yeast lies in its simplicity.  
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The life cycle of this resourceful organism reflects an ordinary eukaryotic 
one, characterized by a cell cycle that undergoes G1, S, G2, and M phases 
(Williamson, 1965) and fundamental checkpoints for damaged DNA have also 
been reported (Harrison & Haber, 2006). Baker’s yeast reproduces by budding, 
with the bud growing in size during the cell cycle (Hartwell, 1970), an element 
which provides an indication of the progression of the cycle. The high degree of 
conservation between yeast and higher eukaryotes is not confined to basic 
elements of cell structure but it is also extended to molecular pathways (signal 
transduction and life span, for example), making S. cerevisiae a valuable model 
organism for studying human disorders. At least 31% of proteins encoded by 
yeast genes have human homologues and conversely nearly 50% of human genes 
implicated in heritable disease display yeast homologues (Hartwell, 2004).  
Today’s efforts are concentrated around potentially modulatable conserved 
biomolecular pathways, motivated by the vision to better understand, prevent or 
delay diseases such cancer, diabetes, cardiovascular and neurodegenerative 
disorders. 
 
2.4. Yeast in the investigation of translation initiation  
The yeast S. cerevisiae has proved an appropriate organism in which to 
study translation initiation. For the past three decades genetic analyses have 
largely contributed to the identification of genes involved in this process. 
Although eIF4A was first reported in mammals (Grifo, 1982) and plants (Seal, 
1985), it was through work done in yeast that P. Linder and colleagues (Linder & 
Slonimski, 1989) encouraged further investigations. Yeast eIF4A mutants were 
latterly employed in experiments aimed to confirm the ATPase dependence of 
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the eIF4A function (Blum, 1989) and the finding that yeast eIF4E cap-binding 
protein can be complemented by the same protein sourced from other 
organisms, such as the fruit fly (Drosophila melanogaster) or mouse (Mus 
musculus), (Altmann, 1989; Hernandez, 2005) represented a milestone in 
recognizing the “authenticity” of yeast in the study of translation initiation.  
Discovery of yeast eIF4B was also done in S. cerevisiae by screening cDNA 
libraries with anti-cap binding complex antibodies (Altmann, 1993) and 
performing  genetic screens (Coppolecchia, 1993); yeast eIF4B RNA-annealing 
activity was further elucidated (Altmann, 1995). Studies of proteomics and 
genetic analysis done in S. cerevisiae also highlighted the engagement of Ded1p in 
the splicing process, as a component of the spliceosome (Stevens, 2002) and 
established its role as initiation factor (de La Cruz, 1997) respectively. Finally, 
elucidation of the ribosome–associated scanning mechanism has been 
successfully pioneered in yeast by F. Sherman, whose studies showed that the 
first AUG is used as start codon to initiate translation (Sherman , 1980), while T. 
Donahue’s group later identified genes required for initiator codon selection 
(Cigan, 1988). Several translation factors discoveries have been achieved 
through analysis of suppressor genes: eIF2α (Cigan, 1989), eIF4β (Donahue, 
1988), eIF2γ and eIF5 (Huang, 1997) and eIF1 (Yoon & Donahue, 1992) were all 
found playing a major role in the scanning and AUG recognition processes; once 
again, yeast was the organism of choice. 
 
2.5. Overview of studies in yeast  
Studies on protein-protein interactions such as two-hybrid screens 
(Young, 1998) and Tandem Affinity Purification (TAP) (Puig, 2001) have seen 
60 
 
yeast utilized successfully, often paired with mass spectrometry (Gavin, 2002). 
The first global protein localization analysis was also achieved though 
fluorescent labelling applications in S. cerevisiae (Huh, 2003). Informative 
analyses on RNA levels have been conducted through microarrays (reviewed in 
Schulze & Downward, 2011) and Serial Analysis of Gene Expression (SAGE) 
(Velculescu, 1997) and transcription factor-dependent gene regulation was 
pioneered in ChiP-chip -chromatin immunoprecipitation (ChIP) coupled with 
microarray (chip)- experiments by Lee and colleagues (Lee, 2002). A multiplicity 
of approaches have been developed for investigations at the gene level, ranging 
from footprinting (Densmore, 1991), random mutagenesis (Ernst & Richman, 
1989), targeted gene deletions, including Synthetic Genetic Array (SGA) (Tong, 
2001) to Synthetic Lethality Analysis by Microarray (SLAM) (Ooi, 2006).  
Yeast’s features offer potential that was recognized by a group of 
scientists as an opportunity to apply functional genomics approaches in a 
comprehensive, genome-wide fashion. Such innovation initiated the way for a 
range of straightforward, but at the same time sophisticated, applications and 
was followed by opened availability and commercialization of several yeast 
libraries. The S. cerevisiae variety of collections, such as knock-out, over 
expression, modulatable promoters, green fluorescent protein (GFP), etc has 
been received with enormous enthusiasm by the scientific community, endorsing 
the ascent of yeast in the study of genetics. 
 
2.6. The Yeast Deletion Set   
Among the aforementioned libraries, the Yeast Deletion Set (YDS) is one 
of the most successful and vastly used. The most utilized YDS features 4,800 S. 
61 
 
cerevisiae non-essential single deletion strains conveniently arranged in a format 
designed to undergo high throughput screening. The essential feature of this 
array, containing deletions of almost the entirety of non essential ORFs, is the 
replacement of each single gene with a KanR gene cassette which confers 
resistance to the aminoglycoside antibiotic Geneticin (G418) (Winzeler, 1999).  
A bonus feature was introduced into the yeast collection through elegant 
work done by R. Davis’s laboratory with the creation of a molecular barcode that 
is introduced along with the resistance cassette and enables an unambiguous 
identification of the specific deletion strain. Each deleted ORF is flanked by a pair 
of 20-nucleotide TAGs (UPTAG and DOWNTAG) edged by sites amplifiable by 
universal primers; the advancement achieved in micro-array analyses thanks to 
this is incommensurable. 
The YDS, also known as Yeast Knock Out (YKO) set, is available in 
different formats covering combinations of both Mata and Matα mating types 
and homo and heterozygous conditions (Winzeler, 1999). Essential genes are 
only available in Mata and Matα heterozygous diploid sets. The haploid state has 
proven useful for identifying recessive deletions as they are easily recovered; on 
the other hand, a diploid state allows genetic analysis, including tests of 
complementation, recombination and epistasis. The Mata haploid YDS collection, 
a kind gift from C. Boone’s lab (University of Toronto, Canada), was employed in 
this research thesis as an investigative tool in ‘classic’ SGA studies (Tong, 2001), 
while the homozygous diploid library purchased from Thermo Scientific-Open 
Biosystems represented the YKO set of choice in chemical genetic screens and 
assays for scoring fitness defects in response to a broad spectrum of growth 
conditions, environmental challenges and drug treatments. 
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As phenotypic investigation resulting from gene deletions has become 
increasingly regarded as one of the most powerful ways to determine gene 
functions, the YDS has found applications in a wide range of research approaches 
to address this topic: synthetic genetic array, chemical genomic screening, 
dosage synthetic lethality, genetic suppression of lethality, synthetic haplo-
insufficiency, and physiological stress screening are among the most popular. 
 
2.7. Generation and understanding of a genetic network 
The availability of resources embodied by genome-wide arrays became 
translated into a valuable opportunity to investigate deletions in an extensive 
range of high throughput assays (Tong, 2001; Jasnon & Korona, 2007), which 
ultimately generated such large data sets that a new method for representing the 
great collection of annotated interactions was required. The task was not an easy 
one as the approach was required to represent a simplified portrait of the 
connections, while maintaining the essential complexity of the information 
revealed. Networks proved to be a valuable means in representing gene 
interactions and promptly made data analysis more accessible, unlocking a novel 
way of thinking about genetic interactions. Our understanding of such 
connections greatly benefited from network representations and their 
consequential impact from a biological point of view has gradually been unveiled 
(Merico, 2009). 
 
2.7.1. Genetic Interactions  
In organisms, gene functions appear coordinated in a cellular 
environment rather than through isolated one-to-one interactions. When 
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simultaneous perturbation of at least two genes results in a deviation from the 
expected neutral phenotype, a genetic interaction is observed. Such connections 
are extremely important when it comes to identifying relationships of a 
functional nature among genes (or their encoded protein products), as they 
suggest an associated function between the interacting genes. Genetic 
interactions tend to occur between genes involved in functionally related 
pathways, with the nature of the interactions strongly indicative of the type of 
interaction (Boone, 2007), and are therefore highly informative of how cellular 
processes are conducted. 
Genetic interactions can extensively be interpreted through the study of 
epistasis, described as the interaction between two or more genes to control a 
single phenotype. Fitness, and specifically “growth”, represents the phenotype 
considered in the majority of investigations, including research presented here.  
In the context of duplicated genes, epistasis can be considered as the capacity of 
a gene to buffer the phenotypic consequences of mutation of its sister gene; 
epistatic evidence has also successfully been processed with the aim of 
recapitulating the interactions lying behind genes that share a common function. 
(St Onge, 2007). A relationship of positive epistasis between two genes suggests 
the two genes lie inside the same pathway and possess a suppression (or within-
pathway) connection.  A diminishing (or alleviating) interaction is reported 
when the fitness defect of the double mutant phenotype is less severe than 
expected. On the other hand, negative genetic interactions are displayed by 
double mutants whose fitness is lower than expected for the joint effect of the 
single mutant growth phenotypes; negative epistasis is described as aggravating 
when it decreases the fitness and underlines the involvement of separate 
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pathways that feed into a common output. While positive epistasis would seem 
an always-winning response in overcoming inconvenient conditions, natural 
selection favours removing deleterious mutations, thereby increasing the overall 
fitness of a population. Thus, positive epistasis needs to be used parsimoniously 
in a biological system context.  
Nowadays we define as synthetic (or synergistic) interaction the case of a 
double mutant displaying a more severe growth phenotype than expected from 
the two deletions on their own and synthetic lethality (SL), an acute 
representation of it. The process later called SL was initially described by 
geneticist C. Bridges in his The origin of variation (Bridges, 1922), during his 
studies on D. melanogaster. T. Dobzhansky (1946) appears to have first utilized 
the term, where the choice of the word ‘synthetic’ sought the specific intent to 
evocate its Greek meaning, as the combination of two “entities” to form 
something new. SL represents a severe case of genetic interaction corresponding 
to two single mutations that, whilst viable on their own, result in a lethal 
phenotype when deleted in combination. What do these interactions mean in the 
context of biological systemic connections? When two genes show a SL 
interaction, it often indicates that the genes products impinge on the same 
essential function, such that under dual deletion one pathway can no longer 
functionally compensate for the defects in the other. This phenomenon is also 
known as buffering and accounts for the functional redundancy that 
characterizes biological systems. Similarly, if a combination of deletions results 
in a not-lethal growth impaired phenotype, we call this genetic interaction 
synthetic sickness; this type of synthetic fitness interaction underlies an 
important, although non-essential, genetic interaction. 
65 
 
Although particularly popular in the context of loss of function mutants, 
SL can also be mimicked by other types of genetic interactions such those 
generated by exposure to different environmental conditions and chemicals. This 
research thesis covers both typical (SGA, chapter 2) and less conventional 
(environmental challenges and chemicals, chapter 3) SL-like interactions. 
 
2.7.2. Synthetic Genetic Analysis (SGA) 
One of the most effective ways of investigating a biological system is 
indeed a “controlled”, guided perturbation, complemented by observation of the 
differences between perturbed versus native state. Making a gene non functional 
by deleting it and studying the consequence of the deletion is one way of 
achieving this. An equally informative approach involves inactivation of two 
genes at the same time and analysis of their genetic interactions with the 
purpose of uncovering phenotypes otherwise hidden by alternative mechanisms 
(e.g., robustness) (Tong, 2001). This scenario may include the case of a knockout 
(KO) gene displaying a relatively weak phenotype, but for other reasons the gene 
is assumed to affect the process of interest. A redundant gene or pathway 
backing up the system may exist, as suggested by the extent of functional 
redundancy that characterizes the yeast genome (Hartman, 2001). One way to 
overcome this redundancy is looking for a second-site mutation that alters 
somehow the phenotype of interest, either enhancing or suppressing it. 
Synthetic Genetic Analysis (SGA) represents an effective solution for the 
systematic construction of double KOs (or double mutants) and enables a 
comprehensive analysis of SS/SL interactions. A typical SGA screen consists of 
mating of the yeast deletion library (section 2.6) with a query mutation of 
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interest to the investigation. Taking advantage of the mating type specificity of a 
promoter carried by the query strain, consecutive selection steps are 
undertaken, ultimately generating the meiotic progeny carrying both mutations 
(Figure 2-1). 
 
 
Figure 2-1. SGA methodology. a. A MATα strain carries a query mutation linked to a dominant 
selectable marker (represented as a filled black circle), such as the nourseothricin-resistance 
marker natMX, and the SGA reporter can1Δ::MFA1pr–HIS3 (in which MFA1pr–HIS3 is integrated 
into the genome such that it deletes the ORF of the CAN1 gene, which normally confers sensitivity 
to canavanine). b. This query strain is crossed to an ordered array of MATa deletion mutants 
(xxxΔ). In each of these deletion strains, a single gene is disrupted by the insertion of a dominant 
selectable marker, such as the kanamycin-resistance (kanR) module (the disrupted gene is 
represented as a filled blue circle). b. The resultant heterozygous diploids are transferred to a 
medium with reduced carbon and nitrogen to induce sporulation and the formation of haploid 
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meiotic spore progeny. c. Spores are transferred to a synthetic medium that lacks histidine, which 
allows for selective germination of MATa meiotic progeny because these cells express the SGA 
reporter can1Δ:: MFA1pr–HIS3. To improve this selection, canavanine, which selects for can1Δ 
and kills CAN1 cells, is included in the selection medium. d. The MATa meiotic progeny are 
transferred to a medium that contains kanamycin, which selects for single mutants, equivalent to 
the original array mutants and double mutants. e. An array of double mutants is selected on a 
medium that contains both nourseothricin and kanamycin. Adapted from Boone (2007). 
 
 
SGA is conveniently accompanied by a scoring system and valuable 
information is revealed through the study of synthetic lethal/sick interactions 
and positive growth effects. All together, these features make SGA a quick assay 
for capturing an authentic, although blurred, picture of the kind of processes the 
gene of interest is involved in.  
If both mutations are null alleles and occur in non-essential genes, the 
ordinary interpretation is that these genes function in parallel cellular pathways 
that impinge on a shared essential function. This model is often referred to as the 
“between-pathway” model and usually reflects some bidirectionality in their 
genetic redundancy, as that each pathway compensates for defects in the other. 
Further insights on cellular mechanisms can be gained from an adequate 
knowledge of the gene function and/or the pathway the gene’s product is 
involved. This is for instance the case of a synthetic-lethal interaction that 
underlies a unidirectional compensation: one pathway normally prevents a 
potentially harmful cellular event that can be corrected by another pathway, but 
not vice versa (Boone, 2007). Data generated through this experimental 
approach are likely to highlight genes encoding components of a functionally 
related pathway or interacting protein complexes. As basic processes are 
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frequently associated with viability, which is intrinsically tied to fitness, the SGA 
methodology offers the opportunity for a wide variety of biological processes to 
be assessed.  Whereas the activity of a given pathway is required for cellular 
fitness when a gene is functionally compromised, components of this pathway 
are expected to be identified in the SGA, as shown in Figure 2-2.  
 
 
 
Figure 2-2. An example of relationship between pathways identifiable through an SGA; the 
potential genetic interactions are represented by lines. Adapted from Boone (2007). 
 
 
The identification and better characterization of several biochemical 
pathways has been substantially contributed to by the SGA experimental 
approach: extensive mapping of genetic interactions in S. cerevisiae was made 
possible through the identification of mutations in genes that either enhance or 
suppress the phenotype of mutation in a known gene (Tong, 2004). 
As negative genetic interactions are often taken as evidence of a 
relationship of a functional nature, their interpretation can help in estimating the 
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extent of redundancy between genes.  In the specific case of genes holding a 
duplicate counterpart, SGA-generated interactions offer an additional means to 
assess functional associations and differences between duplicate pairs as the 
number of negative interactions is often indicative of functional similarities 
and/or relationships between paralogs. 
The SGA approach does have limitations, as inter-laboratory variability 
and the occurrence of mechanisms of compensation (e.g., functional 
redundancy), which might affect the screen’s results and cause only a fraction of 
the genetic interactions which characterized the query gene network to be 
revealed. These are discussed more fully in section 2.42.3. 
 
2.7.3. Genetic Networks  
The intricate bundle of genetic interactions generated through genome-
wide studies is readily displayed in network representations, where cellular 
mechanisms can be investigated thanks to efficient visualization and regularly 
updated databases of known orthologues and interactions. A network is 
generally described as a system in which a set of elements can be represented by 
nodes and relationships between the elements by edges (or links), indicating 
coupling or relationships of some nature. In a genetic network context, a gene is 
represented as an entity characterized by its interactions; the neighbourhood of 
genes surrounding it (Figure 2-3). The potential to be uncovered is enormous as 
a full investigation can be covered spacing from the small scale (single KO or 
specific gene subsets) to the big picture (network of networks), in which the 
gene and its associated role(s) is/are considered as constituent of a more 
complex system.  
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Such a comprehensive representation of biological systems aligns with 
the current awareness of genetic diseases. Testimony to such complexity exists 
in the occurrence of disease states caused by rare combinations of genetic 
defects, despite the existence of different alleles within the human population. 
Partial contribution of several genes, often acting in unrelated biochemical 
pathways, has been acknowledged as a crucial component of such complexity. As 
emerged from an increasing numbers of quantitative trait loci (QTL) 
investigations (Schadt, 2003), there is a  burning need to achieve a higher 
resolution of genetic interaction mapping, motivated by the intent to understand 
disease states at the genetic level. 
Interpretation of networks appears crucial as it frequently offers a view 
into the functional organization of the organism of interest. Dilemmas such as the 
influence of genotypes over phenotypes in biological systems can be investigated 
in their entirety through the interpretation of genetic networks and the valuable 
information underlying them. A gene network appears like a “small world” 
surrounded by condensed local neighbourhoods (Tong, 2004) where a positive 
correlation is held between gene’s centrality in interaction networks and the 
severity of KO effects (Jeong, 2001). 
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Figure 2-3. A network representation of synthetic lethal interactions associated with yeast 
chromosome instability (CIN) genes found having human homologs mutated in cancer Adapted 
from Yuen (2007). 
 
 
 
Although these types of interactions have extensively been investigated 
through the use of baker’s yeast, the concept of genetic interaction itself is still 
being developed, as it remains to be resolved which degree of comparability we 
can assign to protein-protein interactions versus genetic interactions. The 
majority of protein products display a promiscuous nature and engage in 
physical interactions with several other proteins. Two proteins in the same 
region of the genetic network are likely to share a physical interaction (Tong 
2001; 2004) and proteins with many physical interactions are also highly 
connected from a genetic point of view (Ozier, 2003). 
Data generated via SGA analysis can be effectively represented via 
networks. In studies such as the one to be presented below, a SL genetic 
interaction between a gene deletion of interest and a knock-out library gene is 
represented as an edge in the network, as the condition that the phenotype 
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generated by the combined perturbation is greater than the sum of the two 
individual perturbations (Lehner, 2006). 
 
2.7.3.1. The network inside the network 
Although our understanding of the mechanisms of evolution among post-
duplication genetic interactions is still limited, we are at least now able to predict 
complex network topologies based on underpinning experimental observations. 
This is an advance from earlier basic network characterized by a limited set of 
components (Presser, 2008). The plasticity and adaptability of a network is 
partially thought to be supported by duplication events, where new components 
provide evolutionary capacity within the network system (Aury, 2006). Such 
features render genetic networks valuable sources of information, with some 
power to predict function: clustering networks of an uncharacterized gene with 
known genes’ ones of for example, is a very useful way to inform speculation 
about functional associations (Tong, 2004). Furthermore, the potential for 
merging networks generated through different data sets, approaches, and 
organisms in a high-throughput fashion is regarded as highly enlightening for the 
understanding of cellular and evolutionary processes. Integration of physical 
interactions maps with networks representative of genetic connections has been 
proven a validated investigative approach to reveal pathways (Kelley & Ideker, 
2005). 
As genes functions are extensively conserved among organisms, it is a fair 
expectation for their genetic interactions to be conserved as well, This has 
turned out not to be the case: it emerged instead that networks, and not single 
gene connections, tend to be conserved in their topology as well in their 
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organization, and then only to a limited extent. Such a scenario, in which the 
network system is partially conserved whilst the specific genetic interactions are 
not, points towards the extent of system robustness. 
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2.8. Aims and objectives 
To understand fundamental characteristics of the TIF1 and TIF2 duplicate 
genes (e.g., functional divergences) and the reason behind the retention of their 
identical protein product. In order to achieve this, a phenotypic investigation will 
be achieved through SGA analysis. 
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2.9. Methods 
 
2.9.1. Yeast  
All strains of S. cerevisiae used in this study were kindly gifted from C. 
Boone (University of Toronto, Canada) or purchased from Thermo Scientific-
Open Biosystems (Huntsville, AL, USA) as part of the YKO MATa or YKO MATα 
Strain Collection (Winzeler, 1999).  The yeast strains are derived from parental 
strain SC118 and bear a genotype of his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 in a BY4741 
background (Brachmann, 1998). 
2.9.1.1. SGA 
tif1Δ::natR and tif2Δ::natR query strains construction were constructed 
via a non-essential gene switching method (method 2.18). Starting strains 
tif1Δ::kanR and tif2Δ::kanR (Boone’s Mata library) underwent replacement of the 
kanR cassette with the natR cassette, amplified from p4339 plasmid MX4-natR 
switcher cassette. 
Y8205, the SGA starting strain into which query mutations can be 
introduced by switching protocol, was provided by the C. Boone laboratory 
(University of Toronto, Canada) as part of an SGA kit. It bears an α mating type 
and a genotype can1Δ:STE2pr-Sp_HIS5 lyp1Δ:STE3pr-LEU2 his3Δ1 leu2Δ0 ura3Δ0 
and was mated to tif1Δ::natR and tif2Δ::natR Mata to provide the query strain 
with the genetic background necessary for SGA selection.  
The control (or surrogate “wild-type”) strain of choice for this study was 
the his3Δ::kanR strain, where the HIS3 gene has been replaced with the cassette 
conferring resistance to the antibiotic G418. This is believed to have no impact 
on growth, given that BY4741 display histidine autotrophy. 
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2.9.1.2. tetO promoter 
tif1Δ::natR tetTIF2 and tif2Δ::natR tetTIF1 strains were constructed 
utilizing tif1Δ::natR and tif2Δ::natR as starting strains, in which generated tetO2 
PCR (method 2.15.2) product was inserted via transformation (method 2.18.3). 
Regulation of activity of the tetO2 promoter is achieved through addition of 
doxycycline to the medium in concentration higher than 10 µg/ml (Belli, 1998b). 
2.9.1.3. GAL over-expression promoter  
tif1Δ::URA GAL1pr-TIF2, tif2Δ::URA GAL1pr-TIF1, tif1Δ::URA GALLpr-TIF2, 
tif2Δ::URA GALLpr-TIF1, tif1Δ::URA GALSpr-TIF2,  tif2Δ::URA GALSpr-TIF1 over-
expression strains were generated utilizing tif1Δ::natR and tif2Δ::natR as starting 
strains by marker switching (method 2.13.1) with the use of the CaURA3MX4 
cassette amplified by plasmid pAG60; this was followed by insertion of GAL 
derived PCR products via transformation (method 2.13.2).  
 
All the aforementioned S. cerevisiae yeast strains were stored at -80 °C in 
YPD containing 20% glycerol. 
 
2.9.2. Bacteria 
Escherichia coli DH5α (Maximum Efficiency DH5α Competent cells, 
Invitrogen, Carlsbad, CA) were used for transformation by yeast plasmid DNA. 
Bacteria strains were grown at 37 °C in LB (Luria-Bertani) or YT (Yeast 
exctract/Tryptone) media (see method 2.9.4.1 for media composition) and 
stored at -80 °C in one of the above media containing 20% glycerol. 
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2.9.2.1. Plasmids  
Plasmid p4339, constructed by amplifying natMX with primers (5'-
ACATGGAGGCCCAGAATACCC-3' and 5'-CAGTATAGCGACCAGCATTCAC-3') 
followed by insertion of the product into pCRII-TOPO (Invitrogen) at the unique 
EcoRI site, was gifted from C. Boone’s laboratory (University of Toronto, Canada) 
as part of the SGA kit. This plasmid can be used to switch kanMX4 deletion alleles 
to natMX4 alleles by cutting with EcoRI. 
Plasmid pCM224, bearing a tetO2 (Belli, 1998) promoter-substitution 
cassette with associated kanMX4 selectable marker, was purchased from 
Euroscarf (Frankfurt, Germany) as part of the three sets of plasmids for 
tetracycline dependent expression of gene products.  pCM224 allows promoter 
cassette substitution of  the promoter of the native chromosomal ORF of interest 
via one-step PCR integration and regulation of the expression of the promoter by 
tetracycline in the medium.  
Plasmid pAG60, bearing a C. albicans URA3 ORF that confers uracil 
prototrophy to transform auxotrophic yeasts (Goldstein, 1999), was purchased 
from Euroscarf (Frankfurt, Germany) as part of the DEL-MARKER-SET. The 
pAG60 plasmid allows the substitution of selective resistance cassettes via 
marker switching. 
Galactose driven over-expression plasmids pYM-N23, pYM-N27, pYM-N31 
(respectively carrying GAL1, GALL, and GALS cassettes with associated natNT2 
selectable marker) were purchased from Euroscarf (Frankfurt, Germany) as part 
of a tool-box (Janke, 2001). 
 
All the aforementioned plasmids were stored at –20 °C. 
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2.9.3. Stock solutions  
Antibiotics stock solutions were prepared as following: 
Ampicillin (Sigma-Aldrich, Auckland, New Zealand) was dissolved in 
water at concentration of 100 mg/ml, filter-sterilized, stored in aliquots at 4 °C 
and added to the medium to a final concentration of 100 µg/ml. 
G418 (Geneticin, Invitrogen, Carlsbad, CA, USA) was dissolved in water at 
200 mg/ml, filter-sterilized, stored in aliquots at 4 °C and added to the medium 
to a final concentration of 200 µg/ml. 
clonNAT (nourseothricin, Werner BioAgents, Jena, Germany) was 
dissolved in water at 100 mg/ml, filter-sterilized, stored in aliquots at 4 °C and 
added to the medium to a final concentration of 100 µg/ml. 
Canavanine (L-canavanine sulfate salt, Sigma-Aldrich, Auckland, New 
Zealand) was dissolved in water at 100 mg/ml, filter-sterilized, stored in aliquots 
at 4 °C and added to the medium to a final concentration of 50 mg/l. 
Thialysine (S-(2-aminoethyl)-L-cysteine hydrochloride, Sigma-Aldrich, 
Auckland, New Zealand) was dissolved in water at 100 mg/ml, filter-sterilized, 
stored in aliquots at 4 °C and added to the medium to a final concentration of 
50mg/l. 
Doxycycline (Sigma-Aldrich, Auckland, New Zealand) was dissolved in 
distilled, autoclaved water at final concentration of 10 mM, filter-sterilized, 
stored in aliquots at –20 °C in dark tubes, and added to the medium at 
appropriate concentration, as listed in method 2.21.1. 
 Carbon source stock solutions were prepared as following: 
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Glucose (Dextrose, Fisher Scientific, Auckland, New Zealand) was 
dissolved in water at concentration of 40% (w/v). The solution was autoclaved 
and stored at room temperature and added to the medium to a final 
concentration of 2% (w/v). 
Galactose (Fisher Scientific, Auckland, New Zealand) was dissolved in 
water at concentration of 20% (w/v). The solution was filter-sterilized and 
stored at 4°C and added to the medium to a final concentration of 2% (w/v). 
 
2.9.4. Growth media 
The amino acids and monosodium glutamate (MSG, L-glutamic acid sodium 
salt hydrate) were purchase from Sigma-Aldrich (Auckland, New Zealand); Bacto 
Peptone, Bacto Triptone, Bacto Yeast Extract, and Bacto Yeast Nitrogen Base 
were purchase from DIFCO (Detroit, MI, USA). 
2.9.4.1. Bacteria 
All bacteria were cultured at 37 °C overnight in one of the following media 
supplemented with 100 µg/ml of ampicillin. 
Luria-Bertani (LB) 
LB medium was prepared according to the following recipe: 10 g Bacto 
Tryptone, 5 g Bacto Yeast Extract, and 10 g NaCl were mixed into 800 ml of dd 
water and the pH adjusted to 7.5 with 1 M NaOH solution. The volume was finally 
adjusted to 1 l with dd water, the medium sterilized by autoclaving and stored at 
room temperature. 
Yeast exctract/Tryptone (YT) 
YT medium was prepared according to the following recipe: 16 g Bacto 
Tryptone. 10 g Bacto Yeast Extract, and 5 g NaCl were mixed in 900 ml of dd 
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water. The pH was adjusted to 7.0 with NaOH 1 M solution and taken to a final 
volume of 1 l with dd water. The solution was then sterilized by autoclaving and 
stored at room temperature. 
2.9.4.2. Yeast 
All yeast strains were cultured according to standard yeast methods 
(Amberg, 2005) in one of the following media: 
Yeast Peptone Dextrose (YPD) 
YP medium was prepared according the following recipe: 8 g yeast 
extract, 16 g Bacto Peptone, and 0.096 g adenine were mixed into 760 ml of dd 
water and sterilized by autoclaving; 40 ml of 40% glucose solution was added 
and antibiotics at appropriate concentrations when required. 
 Synthetic Complete (SC) 
“Amino acids” supplement powder mixture for Synthetic Complete (SC) 
media contains: 3 g adenine, 2 g uracil, 2 g inositol, 0.2 g para-aminobenzoic acid, 
2 g alanine, 2 g arginine, 2 g asparagine, 2 g aspartic acid, 2 g cysteine, 2 g 
glutamic acid, 2 g glutamine, 2 g glycine, 2 g histidine, 2 g isoleucine, 10 g leucine, 
2 g lysine, 2 g methionine, 2 g phenylalanine, 2 g proline, 2 g serine, 2 g 
threonine, 2 g tyrosine, 2 g tryptophan, and 2 g valine.  
Drop-out (DO) powder mixture is a combination of the above listed 
ingredients minus the appropriate supplement; 2 g of the DO powder mixture is 
used per litre of medium. 
Synthetic Complete (SC) medium was prepared as follows: 1.7 g of Bacto 
Yeast Nitrogen Base (without amino acids or ammonium sulphate), 1 g of MSG, 
and 2 g of “amino acid supplement power mix” (DO – His/Arg/Lys) were mixed 
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into 760 ml of dd water and sterilized by autoclaving; 40 ml of 40% glucose 
solution was added and antibiotics at appropriate concentrations if required.  
If galactose was used instead of glucose, the same amounts of  ingredients 
were mixed into 720 ml of dd water and sterilized by autoclaving; 80 ml of 
galactose 20% solution was added and antibiotics at appropriate concentrations 
if required. 
Synthetic Dropout (SD) 
SD –URA (synthetic dropout missing uracil): as for SC medium but 
without uracil in the “amino acid mix”; glucose or galactose was added at final 
concentration of 2% (w/v). 
SGal –URA: as for SD-URA with the following modifications  
Sporulation medium 
For efficient sporulation yeast diploids were brought into sporulation in 
the following medium: 8 g potassium acetate, 0.8 g Bacto Yeast Extract, glucose 
0.4 g, and 0.08 g amino acid sporulation mix, were mixed into 800 ml of dd water 
and sterilized by autoclaving. 
 
2.9.5. Growth Conditions 
2.9.5.1. Liquid growth  
Deletion strains from Boone and Open Biosystems libraries  
All xxxΔ::kanR yeast strains sourced from one of the arrays were cultured 
in YPD medium supplemented with G418 at a final concentration of 200 µg /ml. 
Query strains 
tif1Δ::natR and tif2Δ::natR queries strains were cultured in YPD medium 
supplemented with clonNAT at a final concentration of 100 µg /ml. 
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Tet-promoter strains 
tif1Δ::natR tetTIF2 and tif2Δ::natR tetTIF1 strains were cultured in YPD 
medium supplemented with G418 and with or without doxycycline. 
GAL promoter strains  
tif1Δ::URA and tif2Δ::URA strains were cultured in SD –Ura ; tif1Δ::URA GAL1TIF2 
and tif2Δ::URA GAL1TIF1 over-expression strains were cultured in SD  -URA or 
SGal -URA supplemented with clonNAT at a final concentration of 100 µg /ml. 
2.9.5.2. Solid growth media 
YPD 
As for liquid medium with addition of 16 g of agar. Approximately 15 ml 
poured onto Petri dishes or 35 ml poured onto PlusPlates (Singer Instruments, 
Somerset, UK). 
SC 
As for liquid medium with addition of 16 g of agar.  Approximately 15 ml 
poured onto Petri dishes or 35 ml poured onto PlusPlates (Singer Instruments, 
Somerset, UK). 
SD - xxx amino acid 
 As for liquid medium with addition of 16 g of agar. Approximately 15 ml 
poured onto Petri dishes or 35 ml poured onto PlusPlates (Singer Instruments, 
Somerset, UK). 
 
Glucose Nutrient Agar (GNA) pre-sporulation medium 
GNA was prepared as following: 3 g of Bacto Peptone, 3 g of Bacto Yeast, 
and 20 g of agar were added to 750 ml of dd water and mixed together; 250 ml of 
40% glucose were added after autoclaving and approximately 15 ml of medium 
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poured onto Petri dishes. Storing of GNA medium is not advised due to the 
particularly high concentration of sugar that makes it prone to contamination. 
Sporulation medium 
As for liquid sporulation medium with addition of 16 gr of agar. 
Approximately 15 ml poured onto Petri dishes or 35 ml poured onto PlusPlates. 
 
2.10. Instruments  
2.10.1. Robotic pinning system 
SGA experiments were performed with the use of RoToR HDA (Singer 
Instruments, Somerset, UK), a compact bench top robot for manipulation of high 
density arrays of yeast (or bacteria). It allows reagents sets such as a deletion 
mutant collection to be utilised for large-scale, synthetic genetic array, 
phenotypic and chemical-genetic analysis. 
The Singer RoToR uses plastic replica plating RePads HDA (Singer 
Instruments, Somerset, UK) and supports liquid pinning to and from 96 and 384 
well microtiter plates and agar pinning at densities of 96, 384, 768, and 1536. 
RePads were cleaned and sterilized following a cycle of 1) soaking in 
detergent and water, for 2 h, 2) water rinsing, 3) bleach solution soaking for 45 
min, 4) water rinsing, and 5) sterilization with 80% ethanol. 
 
2.11. Bacterial transformation  
DH5α E. coli competent cells were purchased by Invitrogen and bacterial 
transformation performed according to the manufacturer’s general guidelines 
with minor modifications. A 1.5 ml microcentrifuge tube containing competent 
cells was allowed to thaw on ice, and then the cells gently mixed with a pipette 
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tip. From this, 25 µl aliquots were taken out for each intended transformation 
and transferred into a 1.5 ml microcentrifuge tube. One to 5 µl (1-10 ng) of DNA 
of interest was added to the cells and gently mixed (making sure to not pipette 
up and down) followed by incubation on ice for 30 min and heat shock for 20 s in 
a 42 °C water bath without shaking. Tubes were then placed in ice for 2 min and 
475 µl of 30 °C pre-warmed LB medium added to each tube. Final incubation of 
the tubes was conduced at 37 °C for 1 h in a shaking incubator at 225 rpm. 
Aliquots of 20, 100 and 200 µl (it is recommended to plate different volumes of 
the transformation mix to ensure that at least one plate will have well-spaced 
colonies) of transformation mix were plated onto selective plates (LB containing 
100 µg/ml of ampicillin) pre-warmed to 37 °C to select for the transformants 
containing the DNA of interest, followed by incubation of the plates at 37°C 
overnight. 
 
2.12. E. coli plasmid preparation 
Isolation and purification of plasmid DNA from DH5α E. coli competent 
cells was performed at room temperature with Zyppy™ Plasmid Miniprep kit 
(Zymo Research, Orange, CA, USA). Following the manufacture instructions, 600 
µl of bacterial culture grown in LB medium overnight was transferred to a 1.5 ml 
centrifuge tube together with 100 μl of 7X Lysis Buffer (blue) and mixed by 
inverting the tube 4-6 times. Within 2 min, 350 μl of cold Neutralization Buffer 
was added and mixed thoroughly (the sample turned yellow when the 
neutralization was complete and a yellowish precipitate formed). The sample 
was inverted an additional 2-3 times to ensure complete neutralization and 
centrifuged at 11,000-16,000 xg for 2-4 min. About 900 μl of supernatant was 
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then transferred into the provided Zymo-spin TM column, paying attention to 
avoid disturbing the cell debris pellet. The column was placed into a collection 
tube and centrifuged at 11,000-16,000 xg for 15 s, the flow-through discarded 
and the column placed back into the same collection tube. Two hundred μl of 
Endo-Wash buffer was utilized to wash the column, followed by centrifugation at 
11,000-16,000 xg for 15 s. A second washing was performed by adding 400 μl of 
Zippy Wash Buffer to the column, followed by centrifugation at 11,000-16,000 xg 
for 30 s. The column was then transferred into a clean 1.5 ml centrifuge tube and 
30 μl of dd water, added directly to the column matrix and let stand for 1 min. 
Finally, the sample underwent centrifugation at 11,000-16,000 xg for 30 s to 
elute the plasmid DNA. 
 
2.13. Transformation of yeast Saccharomyces cerevisiae  
Transformation of S. cerevisiae strains was performed using one of the 
two following methods: 
2.13.1. Transformation of intact yeast cells treated with 
lithium ions 
The following protocol, adjusted from H. Ito (1983), was kindly provided 
by Dr. D. Maass (Chemical Genetics Laboratory, Victoria University of Wellington, 
New Zealand; personal communication). 
Single yeast colonies were inoculated in 50 ml of YPD medium containing 
the appropriate antibiotic and incubated overnight at 30 ˚C in a shaking 
incubator. Once the cells reached an OD600 in 0.8 and 1, they were spun for 5 min 
at 2500 rpm in a microcentrifuge. The supernatant was then discarded and the 
cells washed twice with 10 ml 0.1 M LiAc and resuspended in 500 µl of 0.1 M 
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LiAc. Single stranded salmon sperm DNA (90 mg/ml in dd water) was boiled for 
ten minutes and consequently placed on ice. Ninety µl of cells, 10 µl of the 
prepared salmon sperm DNA and 20 µL of natR PCR product were added to a 
microcentrifuge tube and mixed, then incubated at 30 ˚C for 15 min. Six hundred 
µl Li-PEG solution (1.2 ml 90% PEG, 0.15 ml of dd water and 0.15 ml 1 M LiAc) 
was added and the cells were incubated at 30 ˚C for 30 min, at which time 68 µl 
DMSO was added and the mixture was incubated at 42 ˚C for 15 min with the 
intent of causing heat shock. The cells were centrifuged at 1000 rpm for 2 min in 
a microcentrifuge, the supernatant removed and the pellet resuspended in 800 
µL of YPD medium and incubated at 30 ˚C for 4 h. Finally, the tube was 
centrifuged at 2000 rpm, the supernatant was removed and the pellet 
resuspended in 200 µl of YPD medium. Different amounts of cell suspension (50, 
100, 200 μl) were plated onto YPD Petri dishes containing clonNAT (100 µg/ml) 
to select for the resistant transformants. 
 
2.13.2. High efficiency transformation 
Transformation of S. cerevisiae was performed using the LiAc/single 
stranded carrier DNA/PEG method (Gietz & Schiestl, 2007) with minor 
modifications.  
Prior to transformation, a single colony of each strain to be transformed 
was inoculated into 5 ml of YPD media and incubated overnight at 30 °C in a 
shaking incubator at 200 rpm. The next day the culture was diluted to an OD600 
of 0.05 in YPD media and returned to the incubator until the OD600 had reached 
0.8–1. A volume of culture corresponding to 1 x 108 cells was removed; the cells 
recovered by centrifugation at 3000 xg, washed three times with dd water and 
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resuspended in 360 µl of transformation mix (240 µl PEG 50% (w/v), 36 µl 1 M 
LiAc, 50 µl single stranded salmon sperm DNA (2 mg/ml), 34 µl dd water 
containing approximately 1 µg of plasmid DNA). This was incubated at 42 °C for 
40 min, followed by micro-centrifugation at 13,000 xg for 1 min, after which the 
transformation mix was removed. The cells were washed with 1 ml of warm YPD 
and aliquots of two, 20, and 200 µl spread onto Petri dishes containing SD agar 
supplemented with clonNAT (100 µg/ml), or G418 (200 µg/ml) and clonNAT 
(100 µg/ml), depending on the strain, to select for successful transformants.  
 
2.14. Genomic DNA purification and extraction  
2.14.1. Purification  
Purification of DNA was carried out using the MasterPureTM Yeast DNA 
Purification Kit (Epicenter Biotechnologies, Madison, WI, USA) according to the 
manufacturer’s instructions. Yeast cells were pelleted from a saturated 1.5 ml 
culture by centrifugation in a microcentrifuge at 10,000 rpm for 2-5 min. Three 
hundred µl of Yeast Cell Lysis Solution was added to the aforementioned 
microcentrifuge tube and suspended by pipetting repeatedly. The suspended 
cells were incubated at 65 °C for 15 min. The sample was kept on ice for 5 min, 
followed by addition of 150 µl of MPC Protein Precipitation Reagent and 
vortexed for 10 s. The cellular debris was pelleted by centrifugation in a 
microcentrifuge for 10 min at ≥10,000 rpm. The supernatant was then removed 
by pipetting and discarding and the pellet containing the DNA washed with 0.5 
ml of 70% isopropanol. The ethanol was carefully removed by pipetting and 
discarding and the DNA pellet briefly centrifuged to remove any remaining 
ethanol. Each DNA sample was dissolved in 35 µl of TE buffer (1 mM EDTA, 10 
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mM Tris-HCl pH 7.5) and maintained at 60 °C on a heat block for 10 min to make 
sure it reached dissolution and then stored at 4 °C. 
 
2.14.2. RNA degradation 
One µl of 5 µg/µl RNase A (from MasterPureTM Yeast DNA Purification Kit, 
Epicenter Biotechnologies, Madison, WI, USA) was added, followed by incubation 
at 37 °C for 30 min. 
 
2.14.3. DNA extraction with 
phenol/chloroform/isoamylalcohol 
The sample was made up to 500 µl with dd water; in the fume hood, 500 
µl of phenol/chloroform/isoamylalcohol (25:24:1) was added to the sample, 
vortexed for 30 s, followed by microcentrifugation at 16000 xg for 10 min. The 
upper aqueous layer (containing DNA) was then removed and 1 volume (500 µl) 
of chloroform was added to it, then vortexed and microcentrifuged at 16000 xg 
for 10 min. Finally, the upper aqueous layer was removed (approx 400 µl) and 
conserved for ethanol precipitation. 
 
2.14.4. Ethanol precipitation  
Ethanol precipitation of DNA was performed by adding 1 ml of 96% 
ethanol and 40 µl of 3 M sodium acetate (pH 5.3), followed by inversion to mix 
(making sure to not pipette) and stored at -20 °C. After 25 min the tube was spun 
for 10 min at 16000 xg, the supernatant removed and washed with 70% ethanol. 
The resulting pellet was then re-dissolved in 35 µl of TE buffer and incubated a 
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65 °C for 10 min to allow complete dissolution. This sample of DNA was 
employed as a pure genomic template in PCR reactions and/or stored at 4 °C. 
 
2.15. Polymerase chain reaction (PCR)  
2.15.1. Enzymes and cycle conditions 
All the oligonucleotides used in this study were purchased from 
Invitrogen, diluted in dd water to a concentration in the order of picomolar and 
stored at 4 °C. 
 
All the PCRs performed were run with the use of one of the following 
polymerase enzymes: 
 
HotStartTaq polymerase enzyme 
The HotStartTaq DNA polymerase kit (Qiagen) was utilized in 
conventional PCRs as it reduces the generation of non-specific products and 
primer artefacts. In this method the polymerase enzyme is chemically modified 
and made afunctional; the enzyme is reactivated by preheating the reaction mix 
at 94–95 °C for 9–12 min. This can be problematic, as high temperature 
reactivation can result in depurination of the DNA template (Lindahl & Nyberg, 
1972), reducing the quality of the products produced. In addition, the long 
reactivation time increases the length of the PCR reaction and lowers 
throughput.  
For a 25 μl reaction, the PCR mix was set up as following: 2.5 μl of 10X 
buffer, 0.5 μl of dNTP (20 mM), 0.5 μl forward primer, 0.5 μl reverse primer, 1 μl 
of 1:50 dd water dilution of DNA template,  HotStartTaq DNA polymerase 0.25 μl, 
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19.75 μl of dd water.  In case of a PCR product with a high CG content, 10% DMSO 
supplemented the reaction. 
The following cycling conditions were used, unless differently stated: 15 
min initial denaturation at 94 °C (as required for initial activation of the 
HotStartTaq DNA polymerase), followed by 30 cycles of 1 min at 94 °C 
(denaturation), 1 min at 52 °C (annealing), 1 min/Kb 72°C (extension), and 5 min 
final extension at 72 °C. 
 
Platinum High Fidelity polymerase enzymes 
Whenever a PCR reaction proved troublesome, a high fidelity (or low 
error rate) PCR was undertaken using the Platinum® Taq DNA Polymerase High 
Fidelity. 
For a 25 μl reaction, the PCR mix was set up as following: 2.5 μl of 10X 
buffer, 1 μl of 50 mM MgCl2, 2.5 mM dNTP, forward primer 10 µM 0.5 μl, reverse 
primer 10µM 0.5 μl, 1 μl of DNA template, Platinum Taq 0.1 μl, dd water 17.5 μl.  
The following conditions were utilized: initial denaturation 2 min at 94 °C, 
followed by 30-40 cycles of denaturation at 94 °C for 30 s, annealing for 30 s, and 
extension at 68 °C for 1 min/Kb, followed by a final extension at 68 °C for 15 min. 
 
2.15.2. Amplification of selective marker cassettes  
PCR amplification of selective marker cassettes from plasmids was performed 
using the Quiagen HotStartTaq DNA polymerase kit according to Methods in 
Yeast Genetics 2005 (Laboratory Course Manual, Edition Cold Spring Harbour). 
Cycling conditions are stated in method 2.15.1. 
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2.15.3. Confirmation PCR  
The correct genomic integration of DNA of interest was confirmed by PCR 
diagnosis using two pairs of primers. One of the two following techniques was 
utilized: 
2.15.3.1. Yeast colony PCR 
A 2-day streaked single colony was picked and treated with 50 μl of 
1mg/ml Zymolase (Zymo Research, Irvine, CA, USA) in water and incubated at 37 
°C for 30 min. The product of the lysis was used as template for the confirmation 
PCR, following the HotStartTaq DNA polymerase PCR conditions modified as 
follows: 35 cycles of denaturation and final extension was conducted for 10 min. 
2.15.3.2. PCR on genomic DNA (gDNA) 
Purified gDNA obtained according to method 2.14 was employed as 
template in a diagnosis PCR using the HotStartTaq DNA polymerase conditions 
modified as follows: 15 minutes at 95 °C, 9 cycles of 95 °C for 30 s, 54 °C for 30 s, 
68 °C 2 min followed by 25 cycles of 95 °C 30 s, 54 °C 30 s, 68 °C 2 min plus 10 s 
each cycle. A final 10 minute extension at 68 °C was also performed to complete 
any partially extended primers. 
 
2.16. DNA electrophoresis 
All DNA electrophoresis was performed according to standard molecular 
biology methods (Ausubel, 1987). Electrophoresis was performed in 1% or 2% 
agarose gel according to the sizes of the expected product, and run in TBE buffer 
(89 mM Boric Acid, 2 mM EDTA disodium dihydrate, 89 mM Tris Base pH 8.3) to 
which 0.5 µg/ml ethidium bromide was added. All samples were dissolved and 
mixed in a 5:1 ratio with 5x sample loading buffer (30% glycerol (v/v), 0.25% 
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(w/v) bromophenol blue, 0.25% (w/v) cyanol xylene) prior to loading onto the 
gel. Electrophoresis was performed at a constant 100 V, and agarose gels were 
visualized on a transilluminator (UVItec Limited, Cambridge, United Kingdom) 
under UV light at 365 nm. 
 
2.17. Serial spot dilution assay  
Yeast strains were inoculated into YPD or SD medium with the 
appropriate antibiotic or drug and grown overnight under shaking at 30 °C. The 
overnight culture was diluted to an OD600 of approximately 0.05, returned to the 
shaking incubator and grown to an OD600 of 1. The culture was transferred to a 
sterile 96-well plate and serially diluted ten-fold with the same medium used for 
culturing at least 6 times. A multi-channel pipette was used to apply 3 µl of each 
dilution of the culture onto YPD or SD agar plates containing the appropriate 
antibiotic or drug of interest; after absorption by the agar the plate was 
incubated at 30 °C (Parsons, 2004). Photographic records were obtained every 
24 h for 5 d. 
 
2.18. Query strain construction - Non-essential gene 
switching method 
SGA requires the mating of deletion mutant array (DMA), available 
commercially, to a query strain that needs to be constructed. The non-essential 
singular nature of TIF1 and TIF2 genes made them suitable for undergoing SGA 
investigation with the final intent of generating TIF1 and TIF2 null mutants as 
query strains. Since SGA depends on successful mating, the DMA and the query 
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strains must harbour different selectable markers. The antibiotic cassette in the 
query strains was swapped from the kanMX4 of DMA to the marker natMX4 via a 
non-essential gene switching method following an established protocol (Boone & 
Tong, 2006) with minor modifications as follows: 
 
2.18.1. Bacterial growth and plasmid purification 
E. coli bacterium containing p4339 natMX4 switcher was cultured into 3 
ml of YT supplemented with ampicillin (1/1000) of at 37 °C overnight and 
purified according to method 2.12. 
 
2.18.2. Restriction enzyme digestion 
A 30 µl aliquot of p4339 plasmid was digested in a mix containing 4 µl of 
10x buffer, 1 µl of bovine serum albumin (BSA) buffer 100x, 2 µl of EcoRI enzyme 
and 3 µl of dd water. Digestion was carried out overnight at 37 °C. 
2.18.3. Transformation 
 MATa tif1Δ::KanR and tif2Δ::KanR strains, belonging to Boone’s haploid 
deletion library, were transformed according to method 2.13.1, using EcoRI-cut 
p4339 as a template. EcoRI sites flank the MX4 cassette, and these enable 
switching of kanMX4 cassette (selection associated to original strain) with 
natMX4 obtained from the p4339 plasmid. Transformation mix was plated onto 
YPD supplemented with clonNAT and grown at 30 °C for 2 d to select for growth 
of meiotic progeny carrying the gene deletion mutation (xxxΔ::natR). Colonies 
were then re-streaked onto dishes containing medium supplemented with either 
clonNAT or G418 to ensure authenticity of the resistance towards nourseothricin 
and loss of resistance to geneticin, respectively. A pair of such verified tif1Δ::natR 
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and tif2Δ::natR transformants: 1) underwent DNA Yeast genomic DNA 
purification (method 2.14) and was utilized as template in diagnosis PCR 
(method 2.15.3.2) and 2) was then employed in the construction of diploids. 
 
2.18.4. Confirmation PCR  
Correct integration of the NAT cassette in the tif1Δ and tif2Δ query strains 
was confirmed via PCR (method 2.15.3). Yeast colony PCR (method 2.15.3.1) 
was first followed but, due to unsatisfactory gel electrophoresis, PCR on genomic 
DNA (method 2.15.3.2) was utilized instead. The transformed genomic DNA 
(gDNA) obtained according to method 2.14 was used as template in 
combination with two pairs of primers with homology for either TIF1 (#26 and 
#27) or TIF2 sequences (#28 and #29) which flank each integration site and an 
internal (#3 and #4) natR cassette primers (appendix 5.5 table A-1). The 
resulting PCR product was assessed following method 2.16. 
 
2.18.5. Diploids constructions - Micromanipulation  
Construction of diploids was achieved via dissection microscopy by 
individually crossing tif1Δ::natR and tif2Δ::natR Mata newly-generated strains to 
Y8205 Matα, a starting strain which confers the genetic background for SGA. 
Both tif1Δ::kanR and Y8205 inocula were placed parallel to each other on an YPD 
Petri dish and single haploid cells picked up from both sample strips and mated 
on the plate. Following an identical procedure, mating was separately repeated 
for tif2Δ::natR X Y8205 strains. Plates containing the products of the mating 
processes (tif1Δ::natR X Y8205 and tif2Δ::natR X Y8205) were incubated at 30 °C 
for 48 h. 
95 
 
 
2.18.6. Assay for pheromone production 
An assay for pheromone production was conducted in order to assess the 
veracity of the diploids constructed via micromanipulation. The two tester 
strains of choice for this assay were SY2014 (MATα ste3Δ306::LEU2 sst2Δ) and 
SY2625, (MATa bar1Δ) (Sprague & Herskowitz, 1981; Chan & Otte, 1982). A 
small number of cells were picked using an autoclaved fire wooden splint from 
12 diploid colonies grown on each mating plate generated via method 2.18.5 
and dissolved in 100 μl of dd water into a 96 well plate. Liquid to agar transfer 
was done via Singer robot in 96 pin format; liquid diploid cultures were pinned 
onto PlusPlates (Singer Instruments, Somerset, UK) containing the following 
solid media: 
 
1. YPD (control) 
2. YPD supplemented with clonNat 
3. YPD “blue” plate with layer of SY-2014  
4. YPD “blue” plat e with a layer of SY-2625 
 
Plates 3 and 4 were obtained as follows:  
i. “Blue” testing plates were prepared adding citrate to a final 
concentration of 0.1 M and methylene blue 0.03% (w/v) to autoclaved YPD agar 
medium, which was then pH adjusted to 4.5.  
ii. 800 μl aliquots of 1:5 and 1:10 dilutions of SY2014 and SY2625 
overnight cultures were transferred onto the plates and a layer (”lawn”) of yeast 
was created with the help of plating beads. 
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Plating beads were then washed and kept in 70% ethanol at 4 °C. 
 
Plates 1 and 2 were incubated at 30 °C for 36 h, whilst plates 3 and 4 were 
grown at room temperature for the same length of time, as incubation at the 
lower temperature has shown to give larger halos. 
Strains were scored through visual inspection by two independent 
investigators and annotated as genuine diploids if satisfying all 4 the following 
conditions: 
1. Growth in YPD 
2. Growth in YPD plus clonNAT 
3. No growth in YPD “blue” plate with layer of SY 2014 
4. No growth in YPD “blue” plat e with a layer of SY 2625 
 
2.18.7. Sporulation and Mating type selection 
Confirmed diploids were then induced to sporulate by transferring them 
onto solid medium with low level of carbon and nitrogen (method 2.9.4.2). After 
5 days, a small amount of spores was suspended in 50 μl of dd water; this latter 
sample and a further 1:10 dilution were plated onto plates containing SD –(Leu, 
Lys, Arg) medium supplemented with canavanine and thialysine, which selects 
for MATα a mating type.  The MATα meiotic progeny were then replicated onto 
plates contains clonNAT, which selects for growth of meiotic progeny that carries 
the gene deletion mutation (xxxΔ::natR). Successful colonies were picked, grown 
overnight, stored at -80 °C in YPD medium containing glycerol 20% and utilized 
as “query” strains. 
 
97 
 
2.18.8. Synthetic Genetic Array (SGA) Analysis 
The ability of budding yeast to exist in a haploid form makes it usable in 
genetic investigations, such as identification of synthetic lethal interactions. We 
performed a Synthetic Genetic Array (SGA) analysis, an approach that enables 
mass-mating construction of double mutants with the purpose of investigating 
the effects of a deletion by growth phenotype assessment (Figure 2-4). 
 
i. Deletion Mutant Array (DMA) 
The Yeast Deletion Set (YDS) utilized in this study is the Boone’s YKO 
MATa haploid strain collection, which features 5,800 S. cerevisiae single deletion 
strains conveniently arrayed in 14 plates designed to undergo high-throughput 
screening. Each plate contains 56 genes represented as quadruplicate, framed by 
a border of controls and a number of auxotrophic mutants as key indicators of 
correct performance of the SGA process. The entire knock out array has a MATa 
mating type in a BY4741 background and a genotype of his3Δ1 leu2Δ0 met15Δ0 
ura3Δ0. Each non essential gene target is represented by a MATa haploid strain 
that undergoes mating with MATα query strain tif1Δ or tif2Δ generating an 
extensive array of diploids that will be sporulated and then selected using a ‘SGA 
reporter’ that allows selection only for progeny bearing a MATa mating type. 
Double mutants are then selected and scored.  
 
           i-b. Construction and maintenance of Deletion Mutant Array (DMA) 
  
The entire collection of haploid MATa yeast deletion strains or DMA was 
grown on plates containing solid YPD medium in 384 colony type formats and 
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subsequently arrayed onto 14 YPD plates in a final 1536 colonies reproducing a 
quadruplet format of 384 source strains, using the Singer RoToR robot 
(Somerset, UK). G418 antibiotic was always present in the YPD medium at a 
concentration of 200 µg/ml to ensure the selective pressure on the DMA strains. 
The DMA can be stored at 4 °C for up to two months and utilized several times. 
 
ii. Query strains 
 tif1Δ::natR and tif2Δ::natR query strains were streaked out from glycerol 
frozen stock and after two days a single colony was picked and cultured in 5 ml 
liquid YPD overnight supplemented with clonNAT at 100 µg/ml. The saturated 
cultures were poured over YPD plates with the intent to form a lawn from which 
the Singer RoToR (Somerset, UK) would pin to array into 384 colony format. The 
query strain set was grown for two days at 30 °C, robotically re-arrayed into a 
1536 colony format onto plates containing solid YPD plus clonNAT (100 µg/ml). 
The re-formatted yeast deletion query strains were grown for two additional 
days at 30 °C. 
 
iii. Mating of haploid query strain with DMA 
The tif1Δ::natR and tif2Δ::natR query strains were first pinned onto 14 
fresh 1536 colony on YPD agar plates.  Next, the DMA was pinned on top of each 
colony of the 1536 query strain colonies, using the mating program on the Singer 
RoToR (Somerset, UK). The cells were incubated at 30 °C overnight for 2 d to 
allow for diploid formation. 
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iv. MATa/α diploid selection 
The progenies resulting from the mating were pinned onto YPD plus 
G418/clonNAT agar plates to allow for selection of diploid colonies carrying both 
the query and DMA gene deletions and incubated for 2 d at 30 °C. 
 
v. Sporulation of double mutant diploid 
Diploids were pinned onto sporulation medium which has low carbon and 
nitrogen source. Plates were incubated for 5 to 7 d at 22 °C to allow cells to 
undergo efficient sporulation. 
 
vi. MATa haploid selection 
MATa haploid spores were selected by pinning the resulting progeny onto 
SD – (His/Arg/Lys) plus canavanine (50 mg/l)/thialysine (50 mg/l). The progeny 
were incubated at 30 °C for 2 d. Plates were pinned for a second round on the 
same medium as above and incubated at 30 °C for 1 d to reduce the possibility of 
MATa/a diploid cells resulting in a false positive. 
In order to carry out SGA, it was necessary to ensure that parental haploid 
and MATa/a diploids were not selected using specific reporters that allow the 
carrying strain to grow in the following selective steps. 
 
vii. MATa-kanR meiotic progeny selection 
MATa progeny carrying the kanR marker were selected for by pinning the 
plates onto SD-(His/Arg/Lys) plus canavanine (50 mg/l)/thialysine (50 mg/l), 
followed by incubation at 30°C for 2 d.  
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viii. MATa-kanR-natR meiotic progeny selection 
Both DMA and query gene were selected for by pinning the progenies 
resulting from vii onto SD–(His/Arg/Lys) supplemented with 
canavanine/thialysine/G418 (200 µg /ml)/clonNAT (100 µg /ml), followed by 
incubation at 30 °C for 2 d. The final selected progenies correspond to a haploid 
MATa double mutant containing both the query gene deletion and one of the 
~5000 non-essential gene deletions featured in the DMA. 
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Figure 2-4. Summary diagram of SGA methodology. Query strain and YDS, both carrying a 
different antibiotic marker, undergo mating followed by sporulation. Taking advantage of the 
promoter carried by the query strain, meiotic progenies selected trough consecutive steps to 
identified double mutants, (Tong, 2001). 
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2.19. Scoring genetic interactions  
Genetic interactions were inferred from reduced (or increased) colony 
growth in which double mutants grew less (or more) than the expected 
combination of parental phenotypes. Images of 1536-colony plates were 
analysed by subsequential steps including gridding, segmenting and digitizing. 
Colony sizes were recorded using ColonyHT software (Collins, 2006) and then 
uploaded into a MySQL database, containing the standardised known colony 
position of each gene in the yeast DMA.  
The fitness of each double deletion mutant strain was determined by 
SESA (SGA Experiment Set Analyser; developed by C. Jack, Chemical Genetics 
VUW), software which analyses the images of the final MATa double mutant SGA 
plates. The SGA results were compared against a control set of other SGA results, 
ura3Δ::natR (MATα ura3Δ::natR can1Δ:: STE2pr-HIS5 lyp1Δ), acting as a control 
screen. The genetic background of tif1Δ::natR and tif2Δ::natR query strains 
included a URA3 deletion, therefore the deletion of TIF1 or TIF2 represents the 
only variable in genetic background accountable between the query strain and 
control. Comparison of tif1Δ or tif2Δ SGA results to the ura3Δ SGA results allows 
for the filtering of non-specific genetic interactions (so-called “frequent flyers”). 
Additionally, any hits that have appeared in 3 or more previous independent SGA 
screens in the VUW laboratory are deemed to be frequent flyers and are 
discounted from the results. The frequent flyer hits are usually genes involved in 
mating or in the sporulation process and therefore not particularly informative 
to the assay. Finally, the linkage genes (the genes that are in close physical 
proximity to the query gene locus) are also discounted as the genes around the 
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query locus are expected to show no growth due to the decreased ability of 
genetic recombination to occur between these loci. This pattern of no growth of 
loci flanking the query gene was used as circumstantial confirmation of the query 
gene. 
Fitness is regarded as a key element in the interpretation of an SGA 
experiment and factors potentially affecting growth should be taken into 
consideration. Yeast colonies surrounding empty spots or occupying lateral 
positions in the array plate show the tendency to grow bigger and faster than 
deletion strain colonies spotted in the middle of the plate, almost certainly due to 
an increased access to nutrients in the medium. To ensure that there are no dual 
deletion mutant strains that experience growth advantages from positioning at 
the plate edge, a two colony wide border of his3Δ::kanR was added into the 
original array.  
A robust statistical algorithm was used to score interactions in high – 
throughput fashion, utilising colony sizes as element for assessing epistatic 
interactions using the SESA software analysis. This combines replicate 
experiment and control data sets that were performed under the same growth 
conditions. Plate-to-plate variation was controlled through calculation of relative 
colony growth by taking the ratio of a mutant colony area to the median control 
colony internal borded area on each plate, where each plate contained 144 his3Δ 
mutants as controls (border strain). Experimental colony growth ratios were 
then compared to control plates where 1536-colony plates of the DMA as an SGA 
using ura3Δ as a query gene (Tong, 2001). Controls comprised 8 independent 
ura3Δ SGAs and experimental SGAs comprised 4 independent experiments. To 
improve statistical robustness against pinning errors and random growth 
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defects, robust statistics of the form median ± 3*MAD (median absolute 
deviation) were used. In SESA, confidence intervals were compared as per the 
(directional) standard method, forming each confidence interval by smoothed 
bootstrapping (two-tailed, α < 0.01, r = 1500), where the bandwidth of the 
smoothing function (Epanechnikov kernel) (Silverman, 1990) was inversely 
proportional to the number of independent replicates (Schenker, 2001). Such 
bootstrapping data were sampled from all available data from either control or 
experimental sets to better resolve the true distribution function (Cameron Jack, 
personal communication). 
 Overall, SESA software identified synthetic sick and lethal mutants as 
well as enhancers, assigning a degree of reliability based on comparison to the 
set of controls. A text file  list of significant results was outputted  and 
interactions classified in three different types of ‘hit’ groups: possible (indicating 
the lowest index of reliability, sometimes due to unreliability of the control set), 
probable, and definitive (deletions whose genetic interaction with the query 
strain has been determined with the highest degree of probability). Results were 
ultimately manually audited to confirm software reliability. 
 
2.19.1. Gene ontology  
Gene Ontology (GO) is a controlled vocabulary used to describe the 
biology of a gene product in any organism. GO annotations allows comparison of 
functional, process or cellular localisation associations between gene products 
(Ashburner, 2000; Gene Ontology Consortium, 2004). Statistically significant 
changes in GO term distribution within a set of hits compared to that of the non-
essential genome suggests enrichment in the number of genes involved in that 
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particular process. BiNGO (Maere, 2005), a plug-in ideated for Cytoscape (Cline, 
2007) and the yeast GO Slim Mapper (Cherry, 1998) were used for functional 
analysis of SGA and chemical genetic hit genes. The fold change differences in 
distribution of GO terms for the genes representing the deletions of interest were 
compared to the one of the whole non-essential genome. 
 
2.20. Validation of putative interactions 
A number of criteria were applied to diminish the noise in the SGA 
screens. Gene deletion strains that are annotated as “wild-type SL” in Boone’s 
array were removed from the final list of interactions as these deletions appear 
to generate a growth defect phenotype independently from the deletions they 
are paired with. Dubious ORFs were also removed, unless they overlapped 
partially or totally with an ORF of annotated function.  Deletions that appear in 
more than 3 SGA experiments based on unrelated query strains performed in our 
laboratory were excluded as well. Linkage groups surrounding the deletion of 
TIF1 or TIF2 genes are fully reported in sections 2.25 and 2.26 and underwent 
the filtering process as well. 
 
2.20.1. Tetrad analysis 
Tetrad analysis (Rizet & Engelmann, 1949) allows the unambiguous 
identification of individual meiotic products and it was the technique of choice 
for the validation of tif1Δ and tif2Δ SGA generated interactions. The tetrad 
analysis technique was applied to confirm synthetic lethal interactions identified 
by SESA as “definitive” hits between the deletion strain of interest and other 
deletions featured into the array. 
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Δxxx::kanR strains indicated by SESA as “definite” or “probable” hits were 
streaked out from the Boone library frozen glycerol stock onto Petri dishes 
containing YPD supplemented with G418 (200 µg/ml). Two-day single 
Δxxx::kanR colony were picked and mated with the query strain Y8205 
tif1Δ::natR and/or tif2Δ::natR onto YPD plates in a chevron shape and incubated 
at 30 °C for 2 days. The plates were then replicated onto YPD plates 
supplemented with clonNAT (100 µg/ml), G418 (200 µg/ml) or clonNAT/G418 
plates to select for diploid cells. The diploids resulting from the mating were 
replicated onto plates containing rich pre-sporulation GNA medium.  
2.20.1.1. Random Spore Analysis (RSA) 
Deletion strains reported by SESA as “probable” initially underwent 
Random Spore Analysis (RSA), a technique invented by G. Magni (1963) which 
allows many more spores to be examined than in tetrad analysis; however, a 
relatively high transformation efficiency is recommended (> 50%) when 
carrying out RSA. 
After 2 days of growth on solid GNA plates generated as method 2.20.1 
were patched onto SPO solid media and grown for 5 d. A small amount of spores 
(~ the size of a pinprick) was inoculated in 1 ml of sterile water,  mixed well and 
incubated at 30 °C for 30 min, after being treated with 50 μl of Zymolase (0.5% in 
1 M sorbitol), with the intent of weakening the asci and promoting  the release of 
the spores. 
The product of the lysis was plated as following: 20 μl on SD – 
His/Arg/Lys + canavanine/thialysine; 40 μl on SD–His/Arg/Lys + 
canavanine/thialysine/G418; 40 μl on SD–His/Arg/Lys + 
canavanine/thialysine/clonNAT; 80 μl on SD–His/Arg/Lys + 
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canavanine/thialysine/G418/clonNAT and incubated at 30 °C for 2 days. The 
number of colonies on the double-drug selection was scored against the single-
drug selections.  
2.20.1.2. Tetrad dissection 
Optimal conditions for sporulation are no more than 18 h in GNA, a cell 
concentration around 3x107 cell/ml (but not less) and cultures’ growth at 25 °C 
for 5-7 d. 
After approximately 16 h of growth on GNA solid medium, ¾ of the yeast 
patch generated through method 2.20.1 was scraped and inoculated into 2.5 ml 
of sporulation rich medium (as for methods 2.9.4.2 liquid sporulation medium) 
at a concentration of at least  3x107 cells/ml. Spore germination was induced at 
25 °C under rotation for 5 to 7 d, period after which samples were 
microscopically examined for tetrads and eventually returned to the incubator 
for few more days whenever the sporulation efficiency was not satisfactory. 
After a period of incubation at 25 °C variable from 5 to 8 d, a 50 μl aliquot 
of the cultures containing spores was spun down in a microcentrifuge and the 
supernatant removed. The pelleted cells were then treated with 50 μl of 
Zymolase (0.5% in 1 M sorbitol) and incubated at 30 °C for 10 min, with the 
intent of weakening the asci for the upcoming tetrad dissection. 
Approximately 15 mm from the edge of the Petri dish containing a thin 
YPD solid medium slab, a line was drawn and 15 μl of the sporulated cells were 
spread along the line on the plate in such a way that the inoculum would be in 
the field of a dissection microscope (Singer Instruments, Somerset, UK) and over 
the micro-manipulation needle. 
108 
 
With the use of a dissection microscope (Singer Instruments, Somerset, 
UK), the spores underwent dissection on the surface of a Petri dish using a 
dissecting needle which enables the separation of the 4 spores. Each ascus was 
micromanipulated to give a line of four isolated spores, separated by about 3-5 
mm. The spores were incubated until full formation of the colonies at 30 °C for 
two days. After this period of time pictures were taken and plates were 
replicated onto YPD clonNAT and YPD G418 plates for two days followed by 
interpretation of the type of interaction. 
 
2.20.2. Small scale SGA independent examination 
Open Biosystems MATa deletion strains of interest (xxxΔ::kanR) were 
streaked out from array glycerol frozen stock onto Petri dishes containing YPD 
solid medium supplemented with G418. Single colonies were picked and 
manually arrayed in 96-well plate containing YPD liquid medium plus G418 and 
grown at 30 °C. Saturated strains were manually arrayed creating an external 
border of his3Δ::kanR and robotically pinned onto YPD medium supplemented 
with G418, followed by 2-d incubation at 30 °C.  A standard SGA (method 
2.18.8) was conducted utilizing tif1Δ::natR and tif2Δ::natR as query strains 
against the newly generated array. Scoring of sick or lethal mutants was carried 
out by visual inspections of two independent investigators. 
 
2.21. Modulable promoter  
Insertion of tetO2 “off” promoter cassette -associated to a G418 resistance 
cassette- was carried out in tif1Δ::natR and tif2Δ::natR strains. The “tet” 
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modulable promoter system was developed in the group of E. Herrero (Lleida, 
Spain) and continued in Manchester (Yen, 2003). 
 
2.21.1. PCR amplification of “tet” promoter cassette 
The plasmid pCM224 was purified according to method 2.12 and utilized 
as template in PCR (method 2.15.2) to amplify PCR products with primers that 
have flanking regions overlapping with TIF1 (#79;#80) or TIF2 (primers 
#81;#82) as listed in appendix 5.5 table A-2.  PCR products were verified based 
on size following method 2.16. 
2.21.2. Transformation 
Transformation of tif1Δ::natR and tif2Δ::natR strains was carried on 
utilizing the tetO2 promoter (and KanR associated cassette) PCR products 
following method 2.18.3. Selection was done on plates containing both clonNAT 
and G418 antibiotics to ensure for presence of both NatR cassette (query strain) 
and KanR cassette (tetO2 promoter); successful colonies were velvet transferred 
onto Petri dishes containing clonNAT, G418, and doxycycline at concentrations of  
50/100/150/200 µg/ml to assess for repressibility. 
2.21.3. Assessment of repression (tetrability) 
Serial spot dilution assays were conducted according to method 2.17. 
Yeast strains were inoculated into YPD or SD medium supplemented with 
200 µg/ml G418 and 100 µg/ml clonNAT. Strains were serially diluted into a 96 
well plate and spotted onto YPD or SD agar plates containing 200 µg/ml G418 
and 100 µg/ml clonNAT, with or without doxycycline at concentration of 200 µM. 
Eventual repression of growth due to the inhibition of the off promoter in the 
presence of doxycycline was monitored over a period of 5 d. 
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2.22.  Over expression promoter 
Insertion of GAL over expression promoter –associated to NatR cassette- 
was conducted in tif1Δ::URA and tif2Δ::URA strains.  
 
2.22.1. Generation of tif1Δ::URA and tif2Δ::URA strains 
Plasmid pAG60 was purified according to method 2.12 and utilized in 
PCR (method 2.15.2) to amplify PCR products with primers (#83; #84) that 
have flanking regions overlapping with the universal MX4 cassette (appendix 
5.5 table A-4). 
2.22.1.1. Marker switching 
Transformation of tif1Δ::natR and tif2Δ::natR strains was carried on with 
URA3MX4 PCR products amplified from pAG60, following method 2.13.1 to 
generate tif1Δ::URA and tif2Δ::URA.  Final selection was done on plates containing 
SD-URA medium to ensure for acquired auxotrophy. Successful colonies were re-
tested in clonNAT containing medium to confirm the loss of the NatR cassette 
present in the starting strain. 
 
2.22.2. PCR amplification of  GAL over expression cassette 
The plasmids pYM-N23, pYM-N27, pYM-N31 (respectively carrying GAL1, 
GALL, and GALS cassettes) were purified according to method 2.12 and utilized 
as template in PCR (method  2.15.2) to amplify PCR products with primers that 
have flanking regions overlapping with TIF1 (#40;#41) and TIF2 (#42;#43) 
(appendix 5.5 table A-3). PCR products were verified based on size following 
method 2.16. 
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2.22.3. Transformation 
Colonies obtained through marker switching (method 2.22.1.1) were 
transformed according to method 2.13.2 utilizing the PCR products generated in 
method 2.22.2. Final selection was done on plates containing SGal–URA medium 
supplemented with clonNAT. 
 
2.22.4. Assessment of  over expression 
Yeast strains generated through method 2.22.2 were tested for 
repression of growth in both liquid and solid glucose containing media: a small 
number of cells were i) streaked out on SD-URA medium supplemented with 
clonNAT and ii) inoculated in SD-URA medium supplemented with clonNAT. 
Growth was monitored for 5 d. 
 
 
 
 
112 
 
2.23. Results 
To understand similarity and diversity between TIF1 and TIF2 paralogs 
and investigate the contribution of their respective promoter regions, a study on 
the genetic surrounding of the duplicate genes TIF1 and TIF2 has been 
undertaken. The genetic interactions of TIF1 and TIF2 genes were established 
using the SGA technique which has been described in section 2.18.8. This 
chapter reports the construction of the query strains tif1Δ::natR and tif2Δ::natR 
and the epistatic genetic interactions which characterize them.  
 
2.24. Query strain construction via non-essential gene 
switching method 
The strains MATα tif1Δ::natR and tif2Δ::natR were constructed according 
to method 2.18 as summarized in Figure 2-5. 
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Figure 2-5. Construction of tif1Δ::natR query strain via switching method for non-essential 
genes. p4339 plasmid carries the natMX4 cassette utilized for marker switched MATa tif1::kanR 
into MATa tif1::natR. This strain is mated with SGA starting strain Y8025, sporulated and finally 
tested in the appropriate selection media to select for the query strain MATα tif1Δ::natR. Adapted 
from Tong & Boone (2005). 
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2.24.1. PCR Diagnosis 
The correct insertion of the natMX4 cassette into the Y8205 SGA starting 
strain was confirmed using genomic tif1Δ::natR and tif2Δ::natR DNA in 
combination with flanking primers to generate diagnostic PCR products as 
shown in Figure 2-6. Hot Start was the polymerase of choice: this PCR method 
reduces the generation of non-specific products and primer artefacts. This 
chemically modified afunctional polymerase is reactivated by preheating the 
reaction mix at 94–95 °C for 9–12 min. Confirmation PCR products of the 
expected size were obtained for tif1Δ::natR and tif2Δ::natR, as shown in Figure 
2-6.  
 
 
 
Figure 2-6. tif1Δ::natR and tif2Δ::natR query strains diagnosis PCR. 1% agarose gel showing 
corrected integration of the natMX4 cassette, replacing TIF1 and TIF2 ORFs. Lane 1: tif1Δ:natR, 
confirmation forward (control), lane 2: tif1Δ::natR confirmation reverse (control), lane 3: 
tif1Δ::natR confirmation forward (~600 bp), lane 4: tif1Δ::natR confirmation reverse (~750 bp), 
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lane  5: tif2Δ::natR confirmation forward (control), lane 6: tif2Δ::natR confirmation reverse 
(control), lane 7: tif2Δ::natR conf forward (~650 bp), lane 8: tif2Δ::natR confirmation reverse 
(~800 bp), lane 9: 1 Kb plus ladder. 
 
                             
2.24.2. Assay for pheromone production  
To ensure the authenticity of the diploids constructed through 
micromanipulation, the halo assay for pheromone production (Sprague & 
Herskowitz, 1981) was used.  This assay relies on the use of special pheromone 
tester strains (SY2014 and SY2625) that are hypersensitive to pheromones. A 
strain secreting pheromone will inhibit growth of a tester strain resulting in a 
clear area of no-growth surrounding the strain grown as patch (halo).  
Diploids generated via micromanipulation following method 2.18.5 are 
not expected to mate with either SY2014 or SY2625 and were considered 
genuine, if fulfilling all three the following requirements: 
 
1. No halo in plate with layer of SY2014 (MATα). 
2. No halo in plate with a layer of SY2625 (MATa). 
3. Growth in plate supplemented with clonNAT. 
 
Out of the 12 diploid liquid cultures examined for each TIF gene, 4 were 
identified as genuine for tif1ΔxY8205 and 4 for tif2ΔxY8205; 2 out of the 4 
diploid clones were chosen for each of the TIF genes to be utilized in the next 
section.  
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2.24.3. Mating type selection and haploid status selection 
Diploid strains were selected for the appropriate mating type (MATα) and 
haploid status by plating spore onto synthetic medium: 
1. Lacking –Leu, which allows for selective germination of MATα meiotic 
progeny as only these cells express the MFα1pr-LEU2 reporter; 
2. Containing canavanine and thialysine, which allow for selective 
germination of meiotic progeny that carry the can1Δ (can1Δ::MFA1pr-HIS3) and 
lyp1Δ markers. 
Two recessive markers conferring drug resistance, can1 and lyp1, were 
introduced, into the query strain.  The CAN1 gene encodes an arginine permease 
that allows canavanine, a toxic analog for arginine, to enter and kill cells 
(Kitagawa & Tomiyama, 1929; Sychrova & Chevallier, 1993).  Similarly, the LYP1 
gene encodes a lysine permease that allows thialysine, a toxic analog for lysine, 
to enter and kill cells (Kitagawa, 1929; Sychrova & Chevallier, 1993).  Including 
can1 and lyp1 into the query strain ensures that MATa/a diploid cells that could 
be present due to mitotic crossover events (Tong & Boone, 2006) are killed by 
canavanine and thialysine, because they carry a wild type copy of the CAN1 and 
LYP1 genes.   
The MATα meiotic progeny were then tested for resistance to clonNAT to 
ensure tif1Δ::natR and tif2Δ::natR strains clones had been generated. 
 
2.25. tif1Δ SGA 
The tif1Δ query strain underwent SGA analysis and was mass mated with 
other deletion strains of the non-essential set as described in method 2.18.8 
generating a genome-wide set of interactions. SESA software identified 65 
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probable genetic interactions (62 negative and 3 positive interactions) and 47 
definitive (42 negative and 5 positive) as shown in sections 5.1 and 5.2 of the 
appendix.  
A typical SGA fingerprint pattern was observed in tif1Δ SGA data analysis 
and displayed in Figure 2-7. Chromosomally contiguous sets of genes form 
linkage groups (LG) (Figure 2-8), having a reduced tendency towards crossover 
during meiosis. When a KanR marked deletion is close to the NatR marked query 
gene (YKR059W, TIF1 locus), genetic linkage means that progeny will carry one 
or other of the selection marker but not both. Under the dual nat/kan selection 
these strains are lost, the appearance of synthetic lethality (SL). Whilst not 
representing SL they do represent a useful indication that the SGA worked 
correctly being centred around the locus of the selection marker. The LG for 
tif1Δ::natR appeared in all 4 SGA screens, further confirmation that TIF1 gene 
was the one replaced with the natMX4 cassette (tif1Δ::natR) (Table 2-1). 
 
 
Figure 2-7. An example of a tif1Δ::natR SGA plate (plate 8), where the linkage group pattern of 
TIF1 gene (indicated by the green arrow) is present. A section of the his3Δ::kanR border is also 
shown in yellow. 
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            A his3Δ::kanR border frames the array plate inside which deletion of a 
given gene is represented as quartets of replicates. The alternating pattern of 
growing/not growing quartets arises as a result of our library array pattern in 
which contiguous genes from one chromosome are interspersed in alternating 
fashion with those from another chromosome (Figure 2-7). 
 
 
Figure 2-8. Linkage genes for TIF1 gene on chromosome XI. 
 
 
ORF Gene 
YKR047W   
YKR051W   
YKR052C MRS4 
YKR053C YSR3 
YKR054C DYN1 
YKR055W RHO4 
YKR056W TRM2 
YKR057W RPS21A 
YKR058W GLG1 
YKR059W TIF1 
YKR060W UTP30 
YKR061W KTR2 
YKR064W   
YKR065C FMP18 
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YKR066C CCP1 
YKR067W GPT2 
YKR078W   
YKR082W NUP133 
YKR096W   
Table 2-1. List of linkage genes surrounding 
TIF1 (YKR059W). 
 
 
As further confirmation that the SGA worked correctly, the LG of the CAN1 
and LYP1 genes (method 2.24.3) were also identified in all 4 screens (Figure 
2-9 and Figure 2-12). 
 
 
Figure 2-9. Linkage groups. Left: plate 11 of tif1Δ::natR SGA, where the linkage group pattern of 
LYP1 gene is present. Right: plate 4 of tif1Δ::natR SGA, where the linkage group pattern of CAN1 
gene is present.  
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2.26. tif2 Δ SGA 
 The tif2Δ SGA resulted in 52 probable genetic interactions (49 negative 
and 3 positive) and 58 definitive (51 positive and 7 positive) as reported in 
tables 5.3 and 5.4 of the appendix. 
 
As for tif1Δ, the typical SGA fingerprint pattern was observed in tif2Δ SGA. 
In the case of the TIF2 gene (Figure 2-11), the LG is quite extended (Table 2-2) 
and only a section of the region is highlighted in Figure 2-10.  
 
 
 
Figure 2-10. An example of tif2::natR SGA plate (plate 7), where the linkage group pattern of 
TIF2 gene (indicated by the green arrow) is present. The pattern is quite extended; the region 
immediately surrounding the TIF2 locus is bordered. 
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Figure 2-11. Linkage genes for TIF2 gene on chromosome X. 
 
 
ORF Gene 
YJL119C 
 
YJL126W NIT2 
YJL128C PBS2 
YJL130C URA2 
YJL132W 
 
YJL133W MRS3 
YJL134W LCB3 
YJL135W 
 
YJL136C RPS21B 
YJL137C GLG2 
YJL138C TIF2 
YJL139C YUR1 
YJL141C YAK1 
YJL142C 
 
YJL144W 
 
YJL145W SFH5 
YJL146W IDS2 
YJL147C 
 
YJL157C FAR1 
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As for tif1Δ::nat SGA, the LG of the CAN1 and LYP1 genes (method 2.24.3) 
were also identified in all 4 tif2Δ::nat SGA screens (Figure 2-12). 
 
 
Figure 2-12. LYP1 and CAN1 linkage groups. Left: plate 11 of tif2Δ::natR SGA, where the linkage 
group pattern of LYP1 gene is present; Right: plate 4 of tif2Δ::natR SGA, where the linkage group 
pattern of CAN1 gene is present. 
 
2.27.  Genetic interactions 
The filtering process described in section method 2.20 narrowed down 
the lists of genes that genetically interact with TIF1 and/or TIF2 to a number of 
fifteen negative genetic interactions for TIF1 gene, 14 (13 and 1 positive) for 
YJL159W HSP150 
YJL160C 
 
YJL162C JJJ2 
YJL164C TPK1 
YJL170C ASG7 
YJL175W 
 
YJL204C RCY1 
Table 2-2.  List of linkage genes surrounding 
TIF2 (YJL138C) 
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TIF2 gene, and 15 (14 and 1 positive) interactions common to both paralogs. 
Complete lists of SESA-generated definitive and probable genetic interactions for 
TIF1 and TIF2 genes are reported in sections 5.1, 5.2, 5.3, and 5.4 of the 
appendix; here below are annotated only the deletions of genes from the 
“probable” and “definitive” SESA-generated hits that resulted from the filtering 
process described in method 2.19.  
When the query strain (tif1Δ::natR or tif2Δ::natR, in this study) is crossed 
to an identical one (tif1Δ::kanR or tif2Δ::kanR) in the array, the formation of 
double mutant cannot occur as the haploid cells carry a single copy of each allele; 
therefore, tif1Δ and tif2Δ appear to be synthetic lethal with themselves as well as 
being synthetic lethal with each other and for this reason they do not appear in 
the results. 
 
ORF Gene Biological process 
YOR355W GDS1 aerobic respiration 
YJR075W HOC1 
cell wall mannoprotein biosynthetic 
process 
YGL168W HUR1 DNA replication 
YGL253W HXK2 glycolysis 
YGL016W KAP122 protein import into nucleus 
YOR221C MCT1 
aerobic respiration, fatty acid 
metabolism 
YLL006W MMM1 
mitochondrial genome maintenance, 
protein import into mitochondrial 
outer membrane, phospholipid 
transport 
YMR080C NAM7 
ATP-dependent RNA helicase 
activity, RNA-dependent ATPase 
activity 
YER162C RAD4 
nucleotide-excision repair, 
proteasomal ubiquitin-dependent 
protein catabolic process 
YLR448W RPL6B ribosomal large subunit assembly 
YGR118W RPS23A regulation of translational fidelity 
YLL039C UBI4 protein ubiquitination 
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ORF Gene Biological process 
YNR006W VPS27 
protein targeting to vacuole, late 
endosome to vacuole transport 
YDR080W VPS41 vacuolar protein processing 
YFL013W-A YFL013W-A 
dubious ORF which overlaps with 
IES1/YFL013C 
Table 2-3. Genes genetically interacting with TIF1. 
 
 
ORF Gene Biological process 
YGR097W ASK10 cellular response to oxidative stress 
YER164W CHD1 
regulation of transcription by 
chromatin organization 
YOR030W DFG16 protein processing 
YNL255C GIS2 positive regulation of translation 
YOR358W HAP5 
carbon catabolite activation of 
transcription from RNA polymerase 
II promoter 
YHL027W RIM101 
fungal-type cell wall biogenesis, 
response to pH  
YBL027W RPL19B cytoplasmic translation 
YGL244W RTF1 
histone H2B ubiquitination, 
regulation of transcription for RNA 
polymerase II promoter 
YPL047W SGF11 
histone deubiquitination, regulation 
of transcription for RNA polymerase 
II promoter 
YNL257C SIP3 
positive regulation of transcription 
from RNA polymerase II promoter 
YEL065W SIT1 cellular iron ion homeostasis 
YMR223W UBP8 histone deubiquitination 
YEL057C YEL057C unknown 
YGL024W YGL024W 
dubious ORF which overlaps with 
PGD1/YGL025C  
YGR122W YGR122W 
negative regulation of transcription 
from RNA polymerase II promoter 
YPR044c YPR044c 
unknown; dubious ORF which 
overlaps with RPL43A/YPR043W 
Table 2-4. Genes genetically interacting with TIF2. 
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ORF Gene Biological process 
YDL074C BRE1 histone monoubiquitination 
YLR062C BUD28 
dubious ORF which overlaps with 
RPL22A, cellular bud site selection 
YER061C CEM1 fatty acid biosynthetic process 
YER092W IES5 unknown 
YGL219C MDM34 
mitochondrion organization, 
phospholipid transport 
YDL002C NHP10 double-strand break repair 
YMR154C RIM13 protein processing 
YOR275C RIM20 
invasive growth in response to 
glucose limitation, proteolysis, 
response to pH 
YGL045W RIM8 
invasive growth in response to 
glucose limitation , ubiquitin-
dependent endocytosis 
YGL147C RPL9A cytoplasmic translation 
YCL010C SGF29 
positive regulation of transcription 
from RNA polymerase II promoter 
YOL052C SPE2 
spermine/spermidine biosynthetic 
process 
YKL081W TEF4 translational elongation 
YGL212W VAM7 
vesicle fusion, vacuole fusion, non-
autophagic 
YGL046W YGL046W 
merged ORF, does not encode a 
discrete protein; it was merged with 
an adjacent ORF into a single reading 
frame, designated YGL045W 
 Table 2-5. Genes genetically interacting with both TIF1 and TIF2. 
 
 
2.28. Gene Ontology analysis 
Analysis of GO terms, describing the molecular function, biological 
process, and cellular component of gene products, was applied to the three 
following set of data: tif1Δ SGA hits, SGA tif2Δ hits, and hits common to tif1Δ  and 
tif2Δ SGA. 
Significant interactions were reported for tif1Δ in only one of the GO 
categories; the process GO term associated to cell organization and biogenesis 
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returned a p-value of 0.042 for the following group of genes: YJR075W, YGL168W, 
YGL253W, YGL016W, YLL006W, YMR080C, YER162C, YLR448W, YGR118W, 
YNR006W, and YDR080W. Information on further processes mediated by the 
protein products encoded by genes showing genetic interactions with TIF1 ORF 
will be revised in the next section with the use of a different analysis. 
A manual analysis revealed a number of mitochondria-related hits 
(YOR358W, YGL253W, YOR355W, YOR221C, and YLL006W) among the groups of 
genes interacting with TIF1. Further research showed however, that both mct1Δ 
(YOR221C) and mmm1Δ (YLL006W) are annotated as “petite” and thus have the 
tendency to harbour slow growing and/or small colonies, and so their 
appearance in the SESA interpretation of growth phenotype is likely to relate to 
this, rather than any genuine genetic interaction. 
Genes populating the genetic surrounding of TIF2 encode proteins that 
function in transcription regulator activity (YGR097W, YER164W, YOR358W, 
YHL027W, YGL244W, and YNL257C (p-value 0.002)), RNA Pol II transcription 
elongation factor activity (YER164W and YGL244W (p-value 0.004)), and 
transcription regulation regulator activity (YER164W and YGL244W (p-value 
0.016)). Genes populating the genetic surrounding of TIF2 encode proteins that 
function in processes such as regulation of transcription from RNA Pol II 
promoter, transcription, DNA-dependent, and RNA biosynthetic process as 
reported in Table 2-6. As is common for such analyses, many of the processes 
reported as significant are actually nested terms, with both global and more 
detailed GO terms reported.  For example, both transcription, DNA-dependent 
and the more global term RNA biosynthetic process are reported for the same set 
of genes. 
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Biological process p-value ORF 
transcription 5.2E-04 
YGR097W, YER164W, YOR358W, 
YHL027W, YGL244W, YPL047W, 
YNL257C, YGR122W 
transcription from RNA 
polymerase II promoter 
0.002 
YER164W, YHL027W, YGL244W, 
YPL047W, YNL257C, YGR122W 
RNA biosynthetic process 0.032 
YER164W, YHL027W, YGL244W, 
YPL047W, YNL257C, YGR122W 
transcription, DNA-
dependent 
0.032 
YER164W, YHL027W, YGL244W, 
YPL047W, YNL257C, YGR122W 
Table 2-6. GO term enriched for biological processes in genes interacting with TIF2. 
 
Protein products of genes which hold a SL with TIF2 display preferential 
localization in the SAGA complex and nucleosome, as reported in Error! 
eference source not found.. 
 
Component p-value ORF 
SAGA complex 0.6E-04 YER164W, YPL047W, YMR223W 
nucleoplasm part 1.2E-04 
YGR097W, YER164W, YOR358W, 
YGL244W, YPL047W, YMR223W 
nucleoplasm 1.7E-04 
YGR097W, YER164W, YOR358W, 
YGL244W, YPL047W, YMR223W 
nuclear lumen 0.001 
YGR097W, YER164W, YOR358W, 
YGL244W, YPL047W, YMR223W 
histone acetyltransferase 
complex 
0.001 YER164W, YPL047W, YMR223W 
transcription factor complex 0.002 
YER164W, YOR358W, YPL047W, 
YMR223W 
membrane-enclosed lumen 0.013 
YGR097W, YER164W, YOR358W, 
YGL244W, YPL047W, YMR223W 
organelle lumen 0.013 
YGR097W, YER164W, YOR358W, 
YGL244W, YPL047W, YMR223W 
DNA-directed RNA polymerase 
II, holoenzyme 
0.02 YGR097W, YGL244W 
transcription elongation factor 
complex 
0.03 YER164W, YGL244W 
Table 2-7. GO term enriched for components in genes interacting with TIF2. 
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For what concerns hits common to both tif1Δ and tif2Δ SGA, only the GO 
process term associated with protein processing returned a statistically 
significant enrichment with an associated p-value of 0.006 for the following 
genes: YMR154C, YOR275C, and YGL045W. 
 
2.29. The Biological Networks Gene Ontology  
The Biological Networks Gene Ontology (BiNGO) tool is an open-source 
Java application used to determine which GO terms are significantly over-
represented in a set of genes (Maere, 2005), and it was used for further analysis,  
graphic representation and determination of associated statistics on the full GO 
terms data set generated. Over-representation of these terms is reported with 
associated statistical significance generated according to the hypergeometric 
test; the most significant GO clusters for genes interacting with one of the 
paralogs only will be discussed in this section. 
 As anticipated by the GO component analysis, a substantial fraction of 
genes whose deletion leads to SL with tif2Δ are confirmed to be involved in 
nuclear activities: this takes place via participation in the (Spt-Ada-Gcn5-
Acetyltransferase) SAGA complex (SGF11, UBP8, CHD1 and, SGF29) and histone 
acetyltransferase (SAGA-like) SLIK complex, as UBP8 and CHD1 genes play an 
ambivalent role in both complexes (Figure 2-13). 
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Figure 2-13. BiNGO-generated tif2Δ GO components. BiNGO-generated tif2Δ GO components 
showing preferential localization of genes interacting with TIF2 for the SAGA and SLIK 
complexes, histone acetyltransferase and nucleoplasm (hypergeometric test). 
 
When analysed through BiNGO, a main cluster among TIF1 interacting 
genes (RIM8, YGL046W, RIM20, RIM13, and VPS41) corresponded to an 
overrepresentation for protein processing and maturation. A minor contribution 
also came from RPS23A, RPL6B, and NAM7 in regulation of translation and HXK2, 
RPS23A and, NAM7 in RNA metabolic process, as shown in Figure 2-14. 
 
 
Figure 2-14: BiNGO-generated tif1Δ GO processes. BiNGO-generated tif1Δ GO processes showing 
processes over-represented for genes interacting with TIF1: protein maturation and processing 
and post-transcriptional regulation of gene expression, regulation of translation and cellular 
protein metabolic processes (hypergeometric test). Colours shown reflect p-values and follow the 
colour coding shown in Figure 2.13. 
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Differently, tif2Δ hits displayed a number of gene subsets significantly 
over-represented for transcription (SGF11, BRE1, UBP8, ASK10, RTF1, CHD1, 
SGF29, HAP5, RIM101, and, NHP10) and gene expression, (RIM8, SIT1, YGL046W, 
BRE1, ASK10, RIM101, DFG16, NHP10, RPL9A, SGF11, TEF4, RIM20, UBP8, RTF1, 
TIF1, RIM13, CHD1, SGF29, HAP5 and, RPL19B), regulation of both the above (in 
particular in DNA- and RNA Pol II polymerase-dependent), along with processing 
and maturation of proteins (RIM8, YGL046W, RIM20, RIM13, RIM101, and DFG16) 
(Figure 2-15). A robust group of genes annotated as functioning in histone 
modifications (SGF11, BRE1, UBP8, RTF1 and, SGF29) -in particular 
ubiquitination-deubiquitination- and chromatin modification/organization 
(SGF11, IES5, BRE1, UBP8, RTF1, CHD1, SGF29 and, NHP10) and remodelling 
(SIP3, YGR122W, SGF11, BRE1, CHD1, RIM101, and NHP10) was also annotated 
(Figure 2-16).  
 
 
Figure 2-15. BiNGO-generated tif2Δ processes. BiNGO-generated tif2Δ processes showing 
processes over-represented for genes interacting with TIF2: gene expression and transcription 
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and regulation of the above, protein processing and maturation, and regulation of transcription 
from RNA Pol II promoter (hypergeometric test). 
 
 
 
Figure 2-16. BiNGO-generated tif2Δ processes. BiNGO-generated tif2Δ processes showing 
processes over-represented for genes interacting with TIF2: chromatin organization, 
modification, and remodelling, histone mono/ubiquitination and deubiquitination, protein 
monoubiquitination and deubiquitination, and  histone modification (hypergeometric test). 
 
 
2.30. Scoring genetic interactions  
This study confirmed 2 genetic interactions annotated in the literature for 
TIF1 (GDS1 and NAM7) and 2 for TIF2 (SGF11 and UBP8) respectively; it also 
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endorsed a previously reported physical interaction for TIF2 with GIS2, as shown 
in Table 2-8. 
 
 
Gene 
name This study 
Other 
studies References 
  tif1Δ tif2Δ tif1Δ tif2Δ   
ASK10 
 
√ 
    
BRE1 √ √ 
    
BUD28 √ √ 
    
CEM1 √ √ 
    
CHD1 
 
√ 
    
DFG16 
 
√ 
    
GDS1 √ 
 
√ √ 
Costanzo, 2010 
(genetic 
interaction) 
GIS2 
 
√ √ √ 
Sammons, 2011  
(physical 
interaction) 
HAP5 
 
√ 
    
HOC1 √ 
     
HUR1 √ 
     
HXK2 √ 
     
IES5 √ √ 
    
KAP122 √ 
     
MCT1 √ 
     
MDM34 √ √ 
    
MMM1 √ 
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Gene 
name This study 
Other 
studies References 
NAM7 √ 
 
√ √ 
Wilmes, 2008 
(genetic 
interaction) 
NHP10 √ √ 
    
RAD4 √ 
     
RIM101 
 
√ 
    
RIM13 √ √ 
    
RIM20 √ √ 
    
RIM8 √ √ 
    
RPL19B 
 
√ 
    
RPL6B √ 
     
RPL9A √ √ 
    
RPS23A √ 
     
RTF1 
 
√ 
    
SGF11 
 
√ 
 
√ 
Costanzo, 2010 
(genetic 
interaction) 
SGF29 √ √ 
    
SIP3 
 
√ 
    
SIT1 
 
√ 
    
SPE2 √ √ 
    
TEF4 √ √ 
    
UBI4 √ 
  
√ 
Peng, 2003 
(physical 
interaction) 
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Gene 
name This study 
Other 
studies References 
UBP8 
 
√ √ √ 
Lee, 2011 (physical 
interaction); 
Costanzo, 2010 
(genetic 
interaction),tif1Δ; 
Costanzo, 2010 
(genetic 
interaction);tif2Δ 
VAM7 √ √ 
     
VPS27 √ 
      
VPS41 √ 
      
YEL057C 
 
√ 
     
YFL013W-
A 
√ 
      
YGL024W 
 
√ 
     
YGL046W √ √ 
     
YGR122W 
 
√ 
     
YPR044C 
 
√ 
     
Table 2-8. Genetic interactions revealed by this study reported 
against the ones annotated in the existent literature. 
 
 
The results obtained from this study suggest a very high level of noise 
exists among genome-wide screens and a scrupulous follow-up analysis is 
advised to confirm extended data sets generated from these experiments. The 
variability observed among laboratories also represents a further element of 
variability that is hard to manage.  Rigorous confirmation of SL hits has been 
undertaken in this study as described below. 
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2.31. Validation of Putative Interactions 
 
2.31.1. Tetrad analysis 
2.31.1.1. Random Spore Analysis (RSA) 
Random Spore Analysis (RSA) (Dixon, 2008) was performed on yeast 
strains identified as synthetic lethal or sick or suppressors by SESA; however, 
independent visual examination by two different investigators lead to 
inconclusive assessment of sensitivity in the tested strains.  
2.31.1.2. Tetrad dissection 
As the large majority of genetic interactions could not be recapitulated via 
RSA, double mutants of interest were tested through tetrad dissection, as a more 
reliable and precise technique to assess genuine genetic relationships. The 
patterns of growth of the tetrads allow determination of the segregation type: 
examples of linkage types – parental ditype (PD), non-parental ditype (NPD) and 
tetratype (T) – are illustrated in Figure 2-17.  
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Figure 2-17. A schematic representation of a tetrad dissection. Diploids cells are induced in 
sporulation and the product of their meiotic progeny dissected with a micromanipulator 
microscope. Single spores are replicate plated on selective media and spore viability is then 
assessed. Different growth patterns reflecting PD, NPD, and T linkage types are observed for the 
dissected tetrads; an example tetratype is shown framed by the green box. 
 
 
 
Two interactions were confirmed through this analysis for tif1Δ, 7 for 
tif2Δ and 7 for both paralogs. A number of strains (8) could not be confirmed due 
to low sporulation process or to spores failing to grow even in the non selective 
medium. 
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Hits verified 
RSA 
Hits verified tetrad 
dissection 
Hits not verified Hits not tested 
NHP10, VPS27 VPS27, ASK10, RIM101, RTF1, 
SGF11, UBP8, YGR122W, 
CEM1, IES5, NHP10, SPE2, 
SGF29, VAM7, RIM20, CHD1, 
HXK2 
KAP122, SIP3, SIT1, 
BRE1, GIS2, UBI4, 
VPS41, DFG16 
GDS1, HOC1, HUR1, 
MCT1, MMM1, NAM7, 
RAD4, RPL6B, RPS23A, 
YFL013W-A, HAP5, 
RPL19B, YEL057C, 
YGL024W, BUD28, TEF4, 
YGL046W, RPL9A, 
MDM34, RIM13, RIM8, 
YPR044C 
Table 2-9. Filtered hits from the primary screen were further confirmed via RSA and tetrad dissection. 
A group of hits could not be verified due to difficulties with sporulation efficiency or slow/no growth 
of the dissected spores and a further group was not tested, including the petite strains shown in bold.  
 
 
2.31.2. Open Biosystems library small scale SGA 
An independent evaluation of the SGA hits generated through Boone’s 
array was carried on utilizing Open Biosystems deletion set, which features the 
same deletion strains arrayed in Boone’s collection. This study investigated the 
phenotypic interactions between the query strains of interest and any deletion 
identified by SESA in the previously SGA screens.  
Independent visual inspection carried out by two investigators identified 
12 deletions as SL for tif1Δ and 14 for tif2Δ, and 17 SS for tif1Δ and 14 for tif2Δ 
respectively among the 188 tested separately against both tif1Δ::natR and 
tif2Δ::natR. While a large fraction of them had been previously identified by using 
Boone’s array, it has to be noticed that a few deletions identified in this screen 
were not available in the original library.  
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tif1Δ SGA 
SL Boone's SS Boone's 
ARP8 √ BUD31 √ 
CSE2 √ CAF1 n/a  
INO4   CPA2 √ 
PRS3 n/a GRE3   
RIM13 √ HAP5   
RPL37B   HIS2 √ 
SRB8 √ HOC1 √ 
STE20 √ LYS5 √ 
TSR2   RAD4 √ 
UBP3   RCY1 √ 
UTH1 √ RIM21 √ 
YJL175W   SIT1   
  
SNF5 √ 
    TIF1 √ 
    TIF2 √ 
    TIF4631 n/a 
    UTP30 √ 
Table 2-10. Genetic interactions for TIF1 utilizing the 
Open Biosystem library. SL (bold) and SS (green) 
interactions shared by the two paralogs. The 
interactions common to the two genes although with 
different degrees of impairment on growth are also 
indicated (red), along with the deletion strains not 
available (n/a) in the primary screen. 
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tif2Δ SGA 
SL Boone's SS Boone's 
ARP8 √ BUD31 √ 
ASE1   CAF1 n/a 
DHH1   CPA2 √ 
GRE3   CSE2   
HOC1   HAP5 √ 
INO4   HIS2 √ 
PRS3 n/a LYS5 √ 
RIM13 √ RAD4   
RPL37B   RCY √ 
SRP8 √ SIT1 √ 
STE20 √ TIF1 √ 
TSR2 
 
TIF2 √ 
UTH1   TIF4631 n/a 
YJL175W √ YKR070W √ 
Table 2-11. Genetic interactions for TIF2 utilizing 
the Open Biosystem library. SL (bold) and SS (green) 
interactions shared by the two paralogs. The 
interactions common to the two genes although with 
different degrees of impairment on growth are also 
indicated (red), along with the deletion strains not 
available (n/a) in the primary screen. 
 
A general trend among the genetic interactions within the Open 
Biosystem confirmation assay was observed, with combinations of double 
mutants harbouring synthetic sick progeny rather than aggravated SL. Strikingly, 
even the combination of tif1Δ tif2Δ dual deletion mutant, which by nature should 
be a non-viable double mutant, appeared only partially impaired in growth, and 
so were the linkage groups flanking the deletions of interest and previously 
reported interactions. A certain degree of confidence in this small scale SGA is 
provided by “control” interactions included in the array that, as expected, 
harboured defecting growth double mutants. The growth defect arising from the 
combination of tif2Δ with tif4631Δ (a homolog of human eIF4G) or m-RNA 
decapping stimulator dhh1Δ, is shown in Figure 2-18. 
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Figure 2-18. Small scale SGA plate. SGA plate showing SL dhh1Δ tif2Δ (framed in blue) and SS 
tif4631Δ tif2Δ (framed in orange).  
 
 
2.32. Tetracycline modulable promoter  
Amplification of the tetO2-“off” promoter cassette from plasmid pCM24 
was conducted in a temperature gradient PCR with primers designed to have 
flanking regions to the TIF1 or TIF2 genome sequence (#79;#80, #81;#82, listed 
in appendix 5.5 table A-2). A PCR fragment of expected size was obtained as 
shown in Figure 2-19.  
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2.32.1. Transformation and assessment of repression-
tetrability 
The tetO2-“off” promoter cassette, with its associated KanR marker, was 
then transformed into tif1Δ::natR and tif2Δ::natR strains and the transformant 
mixture selected onto Petri dishes containing YPD supplemented with clonNAT 
and G418 to test for the presence of both resistance markers. Colonies which 
successfully grow will have the genome modified as illustrated in Figure 2-20. 
 
 
 
Figure 2-19. TetO2-“off” promoter cassette. 1% agarose gel showing PCR products tetO2 
promoter cassette -with associated kanR cassette- amplified from pCM224 of expected size 4,000 
bp (~3,800 bp plus ~ 80 bp of primer flanking on each side). Lane 1: 56.7°C, lane 2: 59.1 °C, lane 
3: 60.4 °C, lane 4: 61.7 °C, lane 5: 62.9°C , lane 6: ladder1 Kb plus.  
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Figure 2-20. tetO2 promoter associated to a selective marker (kanMX4). tetO2 promoter 
associated to a selective marker (kanMX4) was integrated in the genome to drive expression of 
the TIF2  gene in a tif1Δ::natR strain. 
 
 
The clonNAT-kan resistant colonies were then tested for doxycycline-
induced repression on YPD and SD plates containing 50, 100, 150 and 200 µg/ml 
of doxycycline. No repression was observed for strains streaked out onto low 
and medium concentrations of doxycycline, whilst an effect on growth was seen 
at the highest concentration. Out of 12 successful transformant colonies tested, 
only one (clone #2) appeared to have integrated the tetO2-“off” cassette in a way 
that makes the strain modulable in the expression of TIF2 in tif1Δ background, at 
least in SD medium (Figure 2-21). While clone #4 seemed to display a growth 
defect as well, it should be noticed that it appears to be a “slow grower” even in 
plain SD medium. No repression was observed for any of the 9 tif2Δ::natR tetO2-
tif1 transformants colonies tested. 
 
 
143 
 
 
Figure 2-21. Assessment of repression of the titrable tetO2-“off” promoter in tif1Δ::natR tetO2-tif2 
strains. Clones #1-4 were streaked out on SD (b) and YPD (d) media containing 200 µg of 
doxycycline and on correspondent control dishes. Clones #1 and #4 showed repressed growth in 
the presence of the drug, but in SD medium only. 
  
 
2.32.2. Spot dilution assay 
Sensitive strains were 1 in 10 serially diluted in a 96-well plate and 
spotted both manually (Figure 2-22) and robotically (not shown) onto YPD or 
SD media containing 200 µg/ml of doxycycline. 
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Figure 2-22. Manual spot assay. Lines 1-4: Δtif1Δ::natR tetO2-tif2 clones #2-a, #2-b, #2-c, #2-d; 
line 5: tif1Δ::natR ire1Δ::kanR (control) in A) SD containing clonNAT and G418 and B) SD 
clonNAT, G418, and doxycycline 200 µg/ml. 
 
 
 
2.33.  GAL over-expression promoter 
 
2.33.1. Plasmid purification and amplification PCR 
Amplification of the GAL promoter cassettes from plasmid pYM-N23, 
pYM-N27, pYM-N31, was conducted in a PCR with primers designed to have 
flanking regions to the TIF1 or TIF2 genome sequence (#40;#41, #42;#43 listed 
in appendix 5.5 table A-3); PCR fragments of expected size were obtained as 
shown in Figure 2-23.  
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Figure 2-23. GAL cassette 1% agarose gel showing in lane 1) pYM-N23, 2) pYM-N27, 3) pYM-N31 
purified plasmids (~4,000 bp), GALI from pYM-N23 with primers for TIF1 promoter, 5) GALI 
from pYM-N23with primers for TIF2 region, 6) GALL from pYM-N27 with primers for TIF1 
promoter, 7) GALL from pYM-N27 with primers for TIF2 promoter, 8) GALS from pYM-N31with 
primers for TIF1 promoter, 9) GALS from pYM-N31with primers for TIF2 promoter (~ 1,800 bp). 
The three GAL cassette plasmids were from a toolbox (Janke, 2004). Choice of polymerase was 
based on your product based on the fidelity, specificity, and target length for required 
application. 
 
 
 
2.33.2. Transformation 
 
A GAL over-expression promoter cassette, with its associated KanR 
marker, was then transformed into tif1Δ::URA and tif2Δ::URA strains and the 
transformant mixture selected onto Petri dishes containing SGal –URA 
supplemented with clonNAT and G418 to test for the presence of both resistance 
markers which select for the construct illustrated in Figure 2-24.  No successful 
transformants were harboured through this approach. 
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Figure 2-24. Hypotethical genotype of a successful transformant strain with insertion of GAL 
over-expression promoter. Hypotethical genotype of a successful transformant strain in which 
GAL over-expression promoter associated to a selective marker (natNT2) was integrated in the 
genome to drive expression of one TIF2 gene in a tif1Δ::URA strain. 
 
A further attempt to generate a strain for the over-expression of TIF1 or 
TIF2 genes was undertaken via construction of diploids strains that could 
possibly better cope with the initial drastic adjustment required by the 
transformation conditions. For reasons which are strain-dependent however, the 
mating of diploids was not achievable due to an unusual, but not unprecedented, 
case in which the yeast behaves as an opposite mating type and hence does not 
mate with the expected opposite mating type as it recognizes as its own.  
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2.34. Discussion 
An investigation into aspects of gene duplication will also be addressed 
through enquiry into TIF1 and TIF2 genetic interactions, revealing insights on the 
degree of buffering existent between this pair of duplicates and the degree of 
functional differences between these closely related genes. 
The genetic networks surrounding the TIF1 and TIF2 paralogs have 
shown to represent several aspects into the organization of a cellular system in 
which biological processes are coordinated by gene regulation and signal 
transductions along with physical protein interactions.   
A crucial characteristic of a networked system is related to its ability of 
remodelling upon perturbations, in a process known as plasticity. To be able to 
re-draw the network connections, even if only to a limited extend, is one of the 
key for survival for biological systems, which through this re-wiring are able to 
deal with variations that challenge the stability of some nodes in the network.  
 
 
 
2.35. The biology behind the interactions 
 
The current study presents two highly challenging features: firstly that 
the duplicate genes under investigation (TIF1 and TIF2) encode an identical 
common protein and secondly this protein is involved in a fundamental cellular 
process (translation). As seen in studies of duplicate genes in metabolic 
pathways (Harrison, 2007; Szappanos, 2011), the protein product encoded by 
one or both paralogs can be tracked and its involvement in cellular processes 
straightforwardly revealed. There are a few classes of duplicates, such 
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mitochondrial-related genes and other ORFs involved in processes for which a 
promptly measurable metabolic outcome is not readily available. Finally, always 
to be considered is the possibility that interactions may often be masked by 
functional and/or systemic redundancy. 
TIF1 and TIF2 are indeed two atypical genes: their common encoded 
protein plays a role in the limiting step of protein synthesis, participating in a 
broad variety of processes as availability of nutrients, glucose-signalling, mTOR 
pathway (Montero-Lomeli, 2002; Proud, 2002), to cite some and the equivalent 
genes in mammalian systems are involved with the cellular dysregulation 
associated with cancer (Mamane, 2006). The identical protein product encoded 
by the TIF1 and TIF2 paralogs is an element that further complicates the study of 
their duplicate nature and compels for an articulated and systematic genetic 
approach, with the intent to satisfactorily fulfil the gaps that protein focussed 
studies were unable to.  In a SGA, interactions are probed through mating of a 
strain harbouring deletion of a query gene (in this case either tif1Δ or tif2Δ) with 
other deletion strains. In the investigation of SGA-generated genetic interactions, 
the primary focus is on synthetic sick and lethal phenotypes, as the most severe 
display of genetic interaction. Deviation from an expected wild-type phenotype 
reflects a common involvement of the two genes in a functional process. 
Interaction can be rationalized as: 1) A direct effect on the production of a 
required protein; 2) A redundancy associated with regulation of a certain 
function in which contribution of either one of the two genes is essential (Tong, 
2001). 
Representation of data via a Cytoscape diagram (Figure 2-25) showed a 
common involvement for the two paralogs in response to stress and translation-
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related processes. Genes holding a genetic interaction with TIF1 only function in 
vesicular trafficking and mitochondrial activities, while transcription-related 
processes as regulation of RNA Pol II enzyme and 
ubiquitination/deubiquitination of the histone structure appear to govern TIF2 
genetic network.  
 
 
 
Figure 2-25: Cytoscape generated genetic network surrounding the deletions of TIF1 and TIF2 
genes.  
 
 
2.36.  TIF1 genetic profile 
Pathways critical for the fitness of yeast following deletion of TIF1 gene 
were revealed by interactions with genes involved in the up keeping and 
regulation of the vesicular trafficking (VPS27) and  vacuolar sorting (VPS41), 
processes that hold a certain degree of coordination with the ubiquitination-
deubiquination pathway (RAD4 and UBI4). Some elements of chromatin 
remodelling (YFL013W-A) and transcription progression and regulation (KAP122 
150 
 
and BRE1) were also identified, along with a genetic link (NAM7) to the NMD 
machinery. 
 
As trafficking of lipids and proteins among cellular organelles is critically 
dependent on vesicular transport (Rothman & Orci, 1992), any alteration of this 
pathway can potentially act as prompt trigger for cellular stress, mainly as a 
result of altered membrane lipid composition and pile up of unusual amounts of 
mislocalized proteins (Nelson & Lemmon, 1993). Rapid and specific attenuation 
of translation initiation in vesicular deficient strains has been studied by an 
extensive work done by Deloche and colleagues, that reported unexpected 
genetic interactions between Tif3 (yeast eIF4B ortholog) and proteins involved 
in different aspects of vesicular trafficking. As Tif3p/eIF4B promotes the 
functions of Tifp/eIF4A (Hernández, 2005) so that KO of TIF3 could reasonably 
be expected to somewhat mimic KO of one of TIF1 or TIF2. The authors first 
raised the question whether a link in between the initiation step of protein 
synthesis and vesicular transport, two apparently remotely distant processes, 
might exist. Polysome profiling of a collection of temperature sensitive mutants 
showed that initiation of translation is rapidly inhibited by a deficient vesicular 
transport along the secretory and vesicular pathway, whilst it is unaffected by a 
transport defect in the biosynthetic pathway (Deloche, 2004).  
Efficient transport, aimed to dynamically fulfil cellular requests with a 
prompt delivery of proteins and lipids to subcellular organelles, is not the only 
task that vesicular mediated trafficking undertakes in eukaryotes. Prior sorting 
into vesicles is also required for delivery of membrane proteins to proteolytic 
structures, where sorting of membrane proteins is triggered by mono-
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ubiquitination and subsequent delivery of cargoes to Multivesicular Bodies 
(MVBs) vesicles. Upon fusion of MVBs with the vacuole (commonly referred to as 
lysosome) and consequent lysis of the cargo, the membrane proteins excluded 
from the MVBs can potentially be recycled, mainly via the trans-Golgi. 
The vacuolar membrane protein Vps41p is a subunit of the homotypic 
vacuole fusion and vacuole protein sorting (HOPS) complex and its contribution 
is essential for membrane docking and fusion at the Golgi-to-endosome and 
endosome-to-vacuole stages of protein transport (Figure 2-26). The cellular 
environment seems to rapidly adapt to such a block in vesicular transport at the 
plasma membrane level, by controlling protein synthesis with a rate of inhibition 
that has been measured at 30% (Deloche, 2004). Speculation could be made on 
whether translational control in response to vesicular impairment in the case of 
vps41Δ takes place via TIF1 network and when TIF2 is the only functional 
paralog, translation initiation cannot be properly tuned. Moreover, as endosomal 
structures represent the hub where proteins can be redirected to the plasma 
membrane saving them from degradation, the unavailability of the retro-Golgi 
transport may impair recycling of components directed to proteolytic structures, 
such as MVBs and lysosomes. As precursors of lysosomal enzymes are 
transported via vesicles as well, missed delivery of such components to the 
degradative structure may result in inefficient proteolytic activity.  Cellular death 
may occur as result of an anomalous trafficking that involves, for example, 
membrane proteins being wrongly conducted to the lysosome compartment to 
undergo degradation. In the case of the viable vps41Δ strain, however, this loss in 
trafficking must be aggravated by disruption of translation. Furthermore, MVBs, 
also known as multivesicular endosomal (MVE), are endocytic intermediates that 
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contain molecules previously internalised through endocytosis. Given that MVBs 
also receive cargo from the trans-Golgi, it is understandable how intraluminal 
vesicles have an important task as storage vehicles for transmembrane proteins 
that are meant to be released from the cell in a regulated manner. 
Along with vps41Δ, an additional gene deletion related to vesicular 
trafficking was identified in this SGA, VPS27, the gene encoding for Vps27p 
membrane-associated protein, holds a negative genetic interaction with TIF1 
which could be rationalized following the same reasoning as for vps41. A further 
mechanism, although, may implicate VPS27 gene, in virtue of its recently 
established role in the endosomal sorting complex required for transport 
(ESCRT) complex. As with the majority of vacuolar protein sorting (Vps) 
proteins, Vps27p is important for endosomal maturation and transport of 
proteins to the lysosome (Raymond, 1992). The categorization of Vps27p as 
component of the ESCRT-0 complex, along with Hse1, is quite recent (Williams & 
Urbe, 2007), following biochemical and genetic studies that suggested this 
complex recruits the previously characterized ESCRT-I (Bilodeau, 2003). ESCRT 
complexes are recruited from the cytoplasm to the endosomal membrane to 
engage in a widely connected network of interactions. As the first member of 
ESCRT pathway, ESCRT-0 mediates the recognition of mono-ubiquinated 
proteins and their entry in the pathway. Both monoubiquitinated cargo and the 
ESCRT-I complex are recruited by Vps27p and this interaction appears to 
facilitate transferring of ubiquinated cargo to ESCRT-I (Bilodeau, 2003) from 
which it is transferred to ESCRT-II and finally to ESCRT-III. At this last step 
deubiquination of loaded proteins is required (Amerik, 2000) for their 
deposition into intralumenal vesicles formed by the invagination and budding off 
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of endosomal membranes to form MVBs (Gruenberg & Stenmark, 2004, for 
review) (Figure 2-26). 
 
 
Figure 2-26. Vacuolar protein sorting. Deletion strains found sensitive to lithium/galactose 
treatment correspond to genes coding Vps27p and Vps41p respectively, as shown. EE: early 
endosome; LE: late endosome; MVB: multivesicular body; ER: endoplasmatic reticulum. 
(Reviewed in Hurley, 2010). 
 
A link between trafficking and ubiquitin has been established since the 
discovery that many ESCRT components display Ubiquitin Binding Domains 
(UBDs) that contribute to their ability to sort ubiquinated membrane proteins. 
Chains of ubiquitin appear to constitute the operative sorting signal recognized 
by ESCRT UBDs (Paiva, 2009) that activates the transport of ubiquinated 
proteins into the MVBs pathway (Babst, 2005). Specifically, Vps27p contains an 
ubiquitin-interacting motif (UIM) identified in several regulators of endocytosis 
as well as of MVBs (Hofmann & Falquet, 2001) and is required for binding of a 
single ubiquitin molecule and internalization of proteins (Shih, 2002). The 
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human Vps27p hortolog Hrs is also required for sorting of a transferrin-receptor-
ubiquitin fusion protein to degradative pathway (Raiborg, 2003).  
The ESCRT machinery does not appear to be required either for 
coordination in the early step of endocytosis of ubiquitinated receptors nor in 
the processing at the early endosome level. Whilst ESCRT involvement has often 
been narrowed to MVBs formation, this study results may suggest a revised role 
for its component Vps27p. Intriguing findings that UIM-containing proteins 
might interact with ubiquinated cargo at the plasma or early endosome 
membrane (Shih, 2002) and thereby mediate its sorting into endocytic or 
intraluminar vesicles endorse this scenario. UIM-Ub interaction is, however, 
characterized by a low affinity binding and the Kd associated with this 
interaction is in the micromolar order, presumably strong enough to mediate 
recognition for sorting but weak enough to allow dissociation for future 
processing. Additionally, as the VPS27 human ortholog has been shown to be 
able to engage other UIM-containing proteins into complexes with potential 
sorting function, a model in which such large conformations bind to multi-
ubiquinated containing receptor complexes has been proposed (Raiborg, 2003). 
Under this scenario, VPS27 presence is required for the formation of the UIM-
containing proteins or multi-ubiquinated-containing complexes as they 
aggravate the cellular phenotype, already challenged by the translation initiation 
diminution driven by the UPR response and/or stress. A further issue of spatial 
nature is also imaginable in which equilibrium and activity of the 
aforementioned complexes are perturbed by the loss of sterical control on 
interaction with cargoes and/or sorting components. Finally, although not 
entirely excludible, a model in which Vps27p-UIMs act as a powerful trigger for 
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monoubiquitination instead as a sorting “decision-maker” seems less likely: as 
monoubiquitination is also invocated by other independent signals, the role of 
VPS27 in such context is expected to be non-essential. 
Additionally, in virtue of their UBDs, ESCRT complexes can also be 
ubiquinated themselves by a process termed “coupled ubiquitination” (Haglund 
& Stenamrk, 2006); such an event has been proposed to drive critical aspects of 
ESCRT function by altering intermolecular interactions between ESCRT proteins 
that bear UBDs, or triggering cargo release. Such ability is quite remarkable as 
ESCRT-0 and -I regulate ESCRT complex activity by modulating its own 
ubiquitination thanks to their ability to associate with ubiquitin-ligase and 
deubiquitinating enzymes (Ren, 2007). This specific task might be particularly 
prominent in the ESCRT-0 complex component VPS27; a characteristic that 
renders the encoding gene essential under specific conditions, such as when 
associated with defects in translation. 
Very recent work from Stringer and Piper (2011) showed that strains 
harbouring VPS27 genes encoding Vps27p lacking ubiquitinatable lysine 
residues are not ubiquitinated however still functional in MVBs cargo sorting 
(Stringer & Piper, 2011) suggesting that ubiquitination of the ESCRT apparatus is 
not required for its ability to sort monoubiquitinated cargo into the MVBs 
(Stringer & Piper, 2011). Questions should be raised as to whether the role of 
ESCRT-0 has been appropriately annotated and on what kind of regulation 
allows MVBs formation and functioning if ubiquitination is not the focal one. 
Interestingly, Vps27p is enriched at the endosomal membrane by virtue of its 
interaction with phosphatidylinositol-3-phosphate (PtdIns3P) lipid-binding 
domain (Katzmann, 2002) and is the only member of a list of protein candidates 
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for ubiquitin-binding receptors (Shih, 2002) that contains a zinc finger FYVE 
motif. In consideration of this, it is tempting to speculate that such PtdIns3P 
binding motif might be needed to regulate or be regulated by interactions with 
other proteins or lipids. 
In situations of stress, UPR represents the cellular workhorse for coping 
with misfolded proteins in the ER (Schroder & Kaufam, 2005): this response is 
accountable for the up-regulation of the expression of certain genes that are 
needed for eukaryotic cells’ survival. These upregulated genes are involved in 
folding, mainly chaperones and folding factors, and in ubiquitin/proteasome 
degradation. Transcriptional activation of the aforementioned genes appears 
quite demanding and, while the cell equips for such event, a temporary arrest in 
translation initiation takes place during early stages of UPR, mediated by 
phosphorylation of eukaryotic initiation factor 2alpha (eIF2alpha). It is inferred 
that continued synthesis and accumulation of misfolded proteins are in this way 
prevented. Decreased translation is coupled with an arrest in 
ubiquitin/proteasomal degradation with the intent to avoid a fast depletion of 
essential proteins through degradation (Shenkman, 2007). Short-lived E3 
ubiquitin ligases are believed to be among the multiple factors that govern the 
ubiquitin/proteasomal pathway (Glickman & Ciechanover, 2002) as these 
enzymes become depleted upon the inhibition of protein synthesis. This 
abrogates ubiquitination, as has been shown for p53 (Shenkman, 2007). The 
ubiquitination step has been proposed as the most affected stage in 
ubiquitin/proteasomal degradation occurring after a block in protein synthesis 
and it is likely to be the only affected step (Shenkman, 2007), based on the 
observation that the protein synthesis inhibitor cycloheximide leads to a 
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depression of ubiquinated proteins, but achieve this through inhibition or 
degradation of ubiquitin conjugates (Hershko, 1982). Once E3 ligases are 
depleted, their substrates become stabilized and this may apply to a vast number 
of cellular substrates (Shenmkman, 2007). Interestingly, ubiquitination, of the 
ESCRT-0 complex, largely mediated by the E3 Ub ligase Rsp5p, has been 
proposed as a means of assessing the role of ESCRT ubiquitination. (Stringer & 
Piper, 2011). The specificity of Rsp5p as ligase is, however, quite broad, as 
required for ubiquitination of a variety of membrane proteins at multiple 
compartments. No genetic interactions between RSP5 and either VPS27 or HSE1 
genes are reported in the literature; Vps27p does not appear to hold any 
interaction of physical nature with Rsp5p either, whilst physical interactions of 
Rsp5p with Hse1p have been independently reported by two different research 
groups (Bowers, 2004; Ren, 2007). This network arrangement (Figure 2-27) 
suggests that the physical interaction that Vps27p holds with Hse1p (Bilodeau, 
2003; Gavin, 2006) may be sufficient for Rsp5p to control ESCRT-0 as a complex 
via indirect control on Hse1p, whilst translation initiation exhibits control on 
VPS27. It is hard to state whether this happens with or without the involvement 
of the ESCRT-I component Vps23p, which both Vps27p and Hse1p share a 
physical interaction with (Bilodeau, 2003; Bowers, 2004). Results reported in 
Table 2-3  show a genetic interaction of TIF1 gene with VPS27 that is not mutual 
to HSE1. Altogether, this set of interactions suggests that, although sharing 
functional duties in the ESCRT-0 complex, Vps27p and Hse1p may have different 
roles and significance on their own. This results further open to question 
whether ESCRT complex function does require both elements of the complex to 
perform the sorting of ubiquitinated cargo into endosomal membrane 
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invaginations and the degree of competences assigned between the two complex 
subunits. A genetic interaction of TIF1 with E3 ligase, NAM7, will be discussed 
later in this chapter. 
 
 
 
Figure 2-27. Partial representation of ESCRT machinery components’ subset of interactions. 
TIF1-VPS27 (this study), Vps23p-Hse1p (Bowers, 2004), Vps27p-Hse1p (Gavin, 2002), Vps27p-
Vps23p (Bowers, 2004), and Hse1p-Rps5p (Bowers, 2004). 
 
 
Strikingly, deletion mutants of no other ESCRT encoding genes appeared 
in our screen as SL in combination with either tif1Δ or tif2Δ query strains. This 
result could find an explanation in the described role of VPS27 as gatekeeper for 
the pathway. The role of ESCRT-0 in first recruiting both mono-ubiquitinated 
cargo and the ESCRT-I may be accompanied by activation of the signal that 
ultimately leads to the formation of MVBs. The input that triggers the 
invagination and budding off of endosomal membranes could be sent, among 
other locations, from the start of the pathway and be under the expertise of 
VPS27. As a result of the cellular stress generated by the vesicular trafficking 
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disequilibrium, Tifp -encoded by TIF2 gene only - becomes target of more intense 
ubiquitination and an increasing number of Tif proteins undergo degradation, in 
a mechanism of response masterminded by the system to slow down protein 
synthesis via translation initiation and regulation of its own factors. An 
alternative scenario may have to do with Vps27p sorting of mono-ubiquitinated 
proteins and the impaired functionality which arises from the aforementioned 
proteins not being able to be loaded on ESCRT complex.  
The lack of proper sorting has an undoubted impact on degradation and 
recycling, leading to some protein products and/or ubiquitin tags no longer 
being available in physiologically required concentrations. Such a situation may 
be somewhat overcome by an increase in the rate of protein synthesis, using the 
higher throughput of protein production to provide sufficient copies of required 
proteins to overcome inefficiencies in protein handling processes. This type of 
response would represent an extreme cellular attempt to overcome stress and it 
is likely to be tolerated by the organism for a limited time only, as not all the 
recycling can be processed through the proteasome structure and the cell will 
end up dying due to lack of fundamental components derived from recycling and 
possibly by inefficient ubiquitination of mislocalized and/or unfolded proteins. 
In other words, such scenario not only would trigger the UPR but it would be also 
accompanied by a great number of unfolded proteins in need to be degraded, as 
result of a paucity of ubiquitin tags. In the case of vps27Δ tif1Δ double mutant 
strain, the translational rate, which is dependent on the amount of Tif protein 
encoded (Hilbert, 2011), may not be adequate to successfully process such 
request as the translational process is already weakened by the absence of one of 
the paralogs.  
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Finally, the role of the ESCRT complex in vesicle formation from 
endosomal membranes and biogenesis of MVBs impacts indirectly on cell 
signalling through membrane receptors which would normally be regulated 
through endocytosis. It is inferred that ESCRT complex function in modulating 
such signals is highly important, as identified by several studies that show the 
deregulation of cell signalling in ESCRT impaired strains (Michelet, 2010). This 
link with cell communication is supported by data relating to D. melanogaster 
Vps proteins that hints at different functions for vesicular proteins beside MVBs 
formation (Herz, 2009).  Although not confirmed in a mouse model, studies in 
fruit fly suggest that mammalian ESCRT members may have tumor-suppressor 
properties (Herz & Bergmann, 2009). This is of particular interest given that 
dysregulation of translational events has been associated with carcinogenesis 
(Zimmer, 2000) and an increased effort is directed towards tumor-suppressor 
strategies during the early stages of carcinogenesis (Tani, 2000). 
 
As indicated above, dysregulation of ubiquitination is one reasonable 
explanation of the SL of the vps27Δ tif1Δ double mutant. The possibility of given 
further credit since accessibility of ubiquitin precursors and ubiquitinated 
protein turnover appears also to be essential for proper cellular fitness as 
combinations of mutants lacking genes as UBI4 or RAD4 lead to SL in a 
background lacking TIF1 gene. 
UBI4 encodes for ubiquitin, a 76 aminoacid protein that conjugated to 
proteins, labelling them for selective degradation via the ubiquitin-26S 
proteasome system. While the lethal phenotype recorded in absence of UBI4 
contribution may simply reflects its essential role in the cellular stress response, 
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it might also indicate how crucial ubiquitination of the cargo is, as it triggers for 
its endocytic internalization (Kolling, 1994). Although internalization of proteins 
is a selective and complex process that relies on both ubiquitin dependent and 
independent circuit signals, it may be possible that the ubiquitin-dependent 
holds a contribution of greater importance and the lethal phenotype is likely to 
occur due to a missing or confusing internalization signal. In response to stress, 
Tifp becomes ubiquinated (Tagwerker, 2006) leading to its degradation so the 
cell can decrease protein synthesis. For Tif2p to be ubiquitinated though, the cell 
needs the ubiquitin tag that, in stress conditions, may see its output increased 
following UBI4 over expression. The SL phenotype observed for ubi4Δtif2Δ is 
likely to be ascribed to the fine balance that governs essential biological 
processes, as the synthesis of proteins is needed to produce ubiquitin, which 
subsequently can label Tifp to decrease protein synthesis itself. It is understood 
that a source of non-ubiquinated Tifp can be found in stress granule formations, 
with the purpose to restart translation after relief of stress. 
RAD4 encodes for Rad4p, a protein which works with Rad23p in 
recognizing and binding damaged DNA during nucleotide excision repair (NER), 
a major pathway deputy to repair an extensive range of DNA lesions. Specifically, 
Rad4p binds to the damaged double helix, where it makes the location available 
for other DNA repair enzymes, when encountering a helical distortion. Error-free 
DNA represents a pre-requisite for the cell to accurately transcribe genes and, 
whilst DNA damage occurs at a relatively low rate in the human genome, lesions 
in critical genes (e.g., tumor-suppressor genes) can impair cellular functionality 
and such dysregulation is associated with a predisposition to cancer. The 
underlying principle beneath rad4Δ tif1Δ synthetic lethality can be rationalized 
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in consideration of the unambiguous link established between DNA damage and 
protein synthesis: global inhibition of protein synthesis, accompanied by re-
programming of translation, follows UV radiation initiated DNA damage (Deng, 
2002; Wu, 2002). A reduction of the global rate of protein synthesis induced by 
UV DNA damage is accompanied by an increase in phosphorylation of the 
translation initiation factor eukaryotic initiation factor α (eIF2α).  
Mutations of XPC (the human homologue of yeast RAD4) or impaired NER 
activity lead to genomic instability and carcinogenesis, as established for 
Xerodrema pigmentosum, a hereditary disease that exhibits a strong 
susceptibility for skin cancer (Hanawalt, 2003).  Until recent and ground-
breaking work from Li and colleagues (2010) suggested a role for Rad4p in 
ubiquitin/proteasome-mediated protein turnover, the cellular function of Rad4p 
was believed to be restricted to DNA repair. Substrates that accumulate in rad4Δ 
mutants are found to be ubiquinated, suggesting that Rad4p acts as a regulator of 
a post-ubiquitination step via its binding to the proteasome structure and 
ubiquitin conjugates, while these unfavourable phenotypes associated with XPC 
mutations were previously exclusively attributed to their incapability of 
repairing DNA.  
Finally, together with Rad23p, Rad4p has also been annotated to play a 
role in the proteolytic process; this aspect of RAD4 regulatory contribution, 
however, is suspected to be accessorial as several proteasomal substrates 
maintained their normal degradation in rad4Δ mutant strains. For this reason, no 
SL interaction should be expected in cells lacking this particular aspect of RAD4 
regulation. It is of interest to report that, although Rad4p and Rad23p are 
believed to work together and share common substrates, only deletion of RAD4 
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was identified as SL in combination with tif1Δ. Moreover, the rad23Δ strain 
displayed a suppression-like phenotype in both TIF1 and TIF2 KO screens, 
however statistically not significant enough to be trusted. If this was true, it 
would further suggest a different role and regulation for the two genes, although 
sharing a common function.  
 
Among the tif1Δ SGA SL hits, deletions of genes functioning in the 
translation initiation process were also identified. NAM7 encodes for Nam7p 
(Upf1p), part of the triad of Upf proteins involved in NMD and functioning in a 
complex as core of the NMD machinery. Specifically, Upf1p is a cytoplasmic ATP-
dependent RNA helicase which is required for functional NMD (Czaplinki, 1995), 
a surveillance system that eliminates transcripts with premature termination 
codons (PTC) (Chang, 2007). Ubf proteins assemble on polysomes for 
recognition of aberrant mRNAs; as transcripts are housed during their 
transcription on the ribosomal structure that helps processing them, the 
ribosome stalling on a PTC is a sufficient trigger for the NMD response to be 
activated with consequent destruction of the mRNA (Brogna & Wen, 2009). At 
least two surveillance steps have been suggested during the NMD process: the 
first involves Upf1p to be docked to polysomes, independently of Upf2p; the 
second takes place via Upf2p-dependent association of Upf3p with polysomes 
(Atkin, 1997). Interpretation of this SGA data makes it tempting to speculate that 
translational initiation control is linked to Upf1p exclusively.  
Alongside its established function as an Upf2p binding protein, Upf1p 
exploits an additional role by virtue of its RING domain that mediates an 
interaction with E2 Ubc3p. It was inferred that Upf1p contains an E3 ligase 
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activity, and Upf1p-mediated ubiquitin modifications may be involved in the 
signalling pathway from the recognition of PTC to NMD (Takahashi, 2008). This 
additional feature of Upf1p can be related to the previously discussed 
mechanism that affects ubiquitin/proteasomal degradation upon a block in 
protein synthesis in concern to vesicular damage.  
Very recent work from Z. Zhang (2010) reported that mRNAs targeted by 
NMD are also suppressed at the translational level. The low translational 
efficiency is reported as the result of multiple features acting in concert, 
including the translational initiation rate, 5’ secondary structures, weak initiation 
sites and low translational elongation speed It is currently unknown, however, 
whether this low translational efficiency is a feature evolved by the cell to allow 
suppression of translation or whether transcripts with low transcriptional 
efficiency are simply more prone to be targeted by NMD. ORFs bound by more 
Upf1p have been reported as more translationally repressed, although not 
significantly (Zhang, 2010) and it was discovered that Upf1p can target normal 
mRNAs to cytoplasmic foci known as P-bodies (Sheth & Parker, 2006) suggesting 
an attempt to defer translation. Given the potential involvement of NMD factors 
in translational repression, NMD control may be considered as a part of a more 
expanded system that coordinates with delay or impediment of the translational 
process. This system has to hold a certain degree of connection and plasticity, 
since the effectiveness of NMD degradation activity has been shown to be limited 
and highly condition-dependent (Zetoune, 2008), for instance NMD is largely 
absent when ribosomal movement across mRNA is slow, as seen during 
starvation (Mendell & Sharifi, 2004). It is also conceivable that inefficient 
translation could prompt for transcripts to attract the NMD machinery.  
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Finally, a reflection should be made on the extent of post-transcriptional 
regulation in yeast in comparison to other higher organisms in consideration of 
the fact that yeast displays a paucity of introns that limits the option of 
alternative splicing. Although still worthwhile a comparison, yeast presents 
dissimilarities in the organization of mRNA surveillance compared to other 
higher organisms, perhaps the most significant being NMD: in yeast this process 
occurs both during export and inside the cytoplasm and it is not constrained to 
the pioneer round of translation (Johansson, 2007).  
 
A few genes, deletions of which were reported as SL with tif1Δ, have 
protein products that act as structural constituent of the ribosomal structure. 
RPS23a, for example, encodes for the ribosomal protein 28 (rp28) of the small 
(40S) ribosomal subunit and its connection with translational accuracy has been 
established (Synetos, 1996). An almost identical protein product to Rsp23ap, 
Rps23b, exists, however it does only appear as a “possible” hit in either tif1Δ or 
tif2Δ SGA. This result makes difficult to state whether the accurateness 
associated to translation is highly detailed and RSP23a and RSP23b undergo 
different regulation or the different severity in their growth is principally to be 
ascribed to specific strain differences. Other ribosome-related hits were: 1) 
RPL6b which encodes for a protein component of the large (60S) ribosomal 
subunit and binds to the 5.8S rRNA, one of the four ribosomal RNAs and 2) 
BUD28 which associated open reading frame is believed to be dubious; however, 
is 98% overlapping with the verified gene RPL22A is involved in ribosome 
biosynthesis/biogenesis falls in with work from Linder’s laboratory which 
showed how rapid repression of translation is not governed by repression of 
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ribosome biosynthesis (Deloche, 2004). It is interesting to notice that RPL22B 
has far fewer associated interactions, at least for high throughput screens, than 
RPL22A:  nearly all RPL22B’s physical interactions are also found with RPL22A. 
 
As cellular stress evokes the UPR, an imbalance in Ca2+ equilibrium takes 
place in the cell and it may have consequences on diverse cellular compartments, 
from Golgi-ER to endosomes and lysosome structures. Cellular Ca2+ signalling is 
tightly regulated and Ca2+ has a number of intracellular stores, such as the ER, 
where Ca2+ is stored in high quantities compared to the cytosol, which is 
characterized by a low Ca2+ concentration.  It is conceivable that genes involved 
into transport of Ca2+ into Golgi structures could then be essential under certain 
conditions. This may be the case of HUR1 gene, deletion of which generated SL 
phenotype when paired with tif1Δ query strain, which has not annotated 
function. The overlap of its ORF with PMR1, however, may help in elucidating its 
cellular task as PMR1 encodes for a high affinity Ca2+/Mn2+ P-type ATPase 
required for Ca2+ and Mn2+ transport into the Golgi compartment. PMR1 
involvement has been annotated in Ca2+ dependent protein sorting and 
processing, with mutations in human homolog ATP2C1 reported to trigger 
acantholytic skin condition Hailey-Hailey disease (Hu, 2000).  
Also ascribable to the Golgi context is the assessment of SL between tif1Δ 
and hoc1Δ, this latter gene encoding for an α-1,6-mannosyltransferase involved 
in cell wall mannan biosynthesis. Once again, a genetic interaction has been 
reported for HOC1 only, among the five components of the Golgi-localized 
complex Hoc1p is part of.  The observed SL for hoc1Δ tif1Δ double mutant can be 
rationalized as caused by a general impairment of protein synthesis. However, 
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being the remaining components of the complex verified “misses”, it seems 
appropriate to avoid over-interpretation of this result. 
  
A small subset of mitochondrial-related hits was also identified: the first, 
MTC1, encodes for a predicted malonyl-CoA ACP transferase, a putative 
component of a type-II mitochondrial fatty acid synthase that produces 
intermediates for phospholipid remodelling. mct1 mutant strains display 
respiratory-deficiency and are characterized by an inability to utilize non-
fermentable substrates (e.g., glycerol) for growth (Torkko, 2001). Such impaired 
strains, also known as ‘petite’, have the tendency to harbour smaller colonies 
compared to cells equipped with a fully functional respiratory system. The gene 
MMM1 encodes for the ER-resident protein Mmm1p (Maintenance of 
mitochondrial morphology). This latter protein is part of the ER-mitochondria 
encounter structure (ERMES) complex and its deletion leads to respiratory 
impairment. Discussion on its involvement with the translational initiation 
process will be extensively discussed in section 2.38 along with MMM2, another 
constituent of the same complex. The third SGA hit, GDS1, encodes for a protein 
of unknown function, required for growth on glycerol and is detected in highly 
purified mitochondria (Reinders, 2006). Interestingly, gds1 strains exhibit an 
abnormal cell cycle progression in G1 phase (Sopko, 2006). The genetic 
connection between TIF1 and GDS1 genes could be rationalized in consideration 
of the G1 block on the cell cycle that under stress conditions can be triggered by 
inhibition of protein synthesis (Zetterberger, 1995) and the UPR. There is 
convincing evidence, that protein synthesis is required to complete some 
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regulatory steps in the cell cycle as, for example, initiation of DNA synthesis and 
mitosis are particularly sensitive to protein synthesis inhibitors. 
 
KAP122 gene, previously known as PDR6, mediates a nuclear import 
pathway. Kap122p is responsible for transporting the Toa1p-Toa2p complex 
(large and small subunit of the transcription factor IIA (TFIIA)) into the nucleus, 
where Kap122p shuttles its substrate by binding to nucleoporins Nup1p and 
Nup2p (Titov & Blobel, 1999). Whilst not affected in their cell viability, kap122Δ 
strains show a preferential cytoplasmic localization of both large (Toa1p) and 
small (Toa2p) subunits of the complex, indicating that Kap122p activity is 
required for shuttling of such components into the nucleus compartment, 
however alternative mechanisms must exist to back up for either Kap122p or 
TFIIA function (Titov & Blobel, 1999). Transcription factor TFIIA is a nuclear 
protein involved in the RNA polymerase II-dependent transcription of DNA and 
required for all transcription events that use RNA polymerase II. The genetic 
connections among RNA polymerase II, DNA transcription and translation 
initiation will be more extensively discussed in section 2.37, however the 
importance of this interaction deserves a mention as it gives evidence for a direct 
control on gene activation, that proceeds directly on the transport of Toa1p and 
Toa2p TFIIA subunits. Finally, although Kap122p role is established, ambiguity 
remains about the exact order and modality through which Kap122p joins its 
interacting components and subsequently shuttle into the nucleus. Although this 
research study is unable to provide clarification, speculation can be made in 
based on the observation that deletions of genes encoding for other associated 
components (i.e., Wtm1p and Wtm2p) did not lead to SL in this SGA screen.  
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Finally, HXK2 encodes for a hexokinase isoenzyme 2 that catalyzes 
phosphorylation of glucose in the cytosolic compartment. During the initial 
irreversible step in the cellular metabolism of glucose, the action of the three 
enzymes Hxk1p, Hxk2p and Glk1p is required for the phosphorylation of glucose 
molecules at carbon C6 (Walsh, 1983). Whilst all three enzymes participate in 
the uptake of glucose (Bisson & Fraenkel, 1983), a major role is attributed to 
Hxk2p, at least during glucose phosphorylation in vivo, where it works as the 
predominant isoenzyme during growth on glucose (Walsh, 1983). The HXK2 
gene is expressed when yeast cells are grown on a medium containing a 
fermentable carbon source as glucose, fructose or mannose. Upon shift of the cell 
to a non-fermentable carbon source, HXK2 gene is repressed and HXK1 and GLK1 
de-repressed (Rodriguez, 2001). The genetic interaction that characterized HXK2 
and TIF1 genes could be related to the response triggered by glucose limitation 
in mammalian cells, where an increase in the phosphorylation of eIF2α occurs 
leading to a decrease in translation initiation (Vazquez de Aldana & Hinnebusch, 
1994). 
 
2.37. TIF2 genetic profile 
TIF2 genetic profile revealed an explicit involvement of this paralog in the 
regulation at different stages along the transcriptional process. TIF2 
participation takes place via a highly interconnected genetic network of SAGA 
components (CHD1, UBP8 and SGF11) via interactions that involve histone H2B 
ubiquitination/deubiquitination cycles (UBP8 and BRE1), the chromatin 
remodelling process and assembly and regulation of RNA Pol II (ASK10, RTF1, 
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SIP3 and YGL024W). Regulation of early meiotic gene expression (DFG16, 
RIM101, YEL057C, and YGR122W) is a further influential element. 
The SAGA complex mediates histone modification of gene promoters to 
enhance transcriptional activation and facilitate elongation by deubiquitinating 
histones downstream of RNA Pol II. The most critical among transcriptional-
related steps appears to be the ubiquitination-deubiquitination status of H2B 
histone, governed to an extent by SAGA interactions. SAGA (Spt-Ada-Gcn5 
acetyltransferase), a chromatin-modifying complex, acts as transcriptional co-
activator of a number of cellular processes (Baker & Grant, 2007); its 
coordination is known to happen through histone post-translational 
modifications, as SAGA takes part in processes such as acetylation, and 
deubiquitination, thereby controlling gene activation and repression (Vikki, 
2008). While ubiquitination-related processes have been extensively studied, an 
increasing interest has arisen around regulation of chromatin dynamics and gene 
expression articulated via counteracting of ubiquitination enzymatic activity on 
specific targets. As part of the SAGA deubiquination module (DUBm), crucial 
players in the ubiquitin-proteasome system as well as in autophagy are the 
DeUBiquitinating enzymes (DUBs), one of the largest classes of proteases. Among 
them, Ubp8p is localized to sites of interaction with other SAGA components and 
together with Bre1p watches over the detailed dynamic of 
ubiquitination/deubiquitination of H2B histone. Genetic interactions of an 
opposite nature are associated with deletions of UBP8 (negative interaction) and 
BRE1 (positive interaction) in tif2Δ SGA: this results is likely to reflect the genes’ 
respective roles: Ubp8 SAGA-associated protein is required for deubiquination 
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(Henry, 2003) of H2B, while Bre1p, an E3 ubiquitin ligase for Rad6p, coordinates 
the ubiquitination of H2B, contributing in this way to optimal gene activation.  
In case of cellular stress, with the aim to decrease the biosynthetic 
workload on the ER, the UPR inhibits the initial stages protein synthesis, for 
example, via degradation of protein products, among them even Tifp (Tagwerker, 
2006). As more proteins are processed through the proteasome an increased 
need for ubiquitin tags arises and there is pressure on the other structures to 
release ubiquitin tags. This suggests that under certain cellular circumstances, 
ubiquitin associated to histonic structures can be targeted for recycicling and 
made available for other processes. When the cellular system functions with a 
faulting production of proteins, the ubiquitin itself becomes scarce because of 
lack of newly synthesised ubiquitin, exacerbating the tags’ availability issue. 
Furthermore, there is a possibility that with a shortfall in protein synthesis the 
protein products with short half lives (including those prone to ubiquitination) 
become lost. Although purely speculative, different scenarios could be conceived: 
As the protein products with short half lives (including those prone to 
ubiquitination) become lost there is the possibility that proteins associated with 
the histones become degraded because of their ubiquitination but then cannot be 
replaced. Alternatively, due to the general lack of cellular ubiquitin, once the 
ubiquitination process has taken place, it cannot be re-established. Following 
this reasoning, the loss of histone ubiquitination might ultimately lead to changes 
in expression that allowed a cell to cope with the stress of depleted protein 
synthesis: this is the rationale behind the issue with loss of UBP8 gene. A cross-
talk between translational and transcriptional processes can be envisioned and 
when translation is delayed by UPR, transcription of some genes may have to be 
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adjusted accordantly. This may be actuated, among other mechanisms, by 
affecting Ubp8p, which established function in deubiquination of H2B is likely to 
be one of the most critical in managing and maintaining of transcriptional 
processes, as it is ultimately necessary for transcriptional elongation to proceed. 
There may be the possibility that Ubp8p becomes over expressed in response to 
faulty translation, shifting the equilibrium of the transcriptional process towards 
the elongation phase. In the case of ubp8Δ tif1Δ double mutant, cellular death 
may occur as in the absence of Tif1p and Ubp8p contributions, the cell lacks the 
intercommunication that enables it to adjust the transcriptional process quickly 
enough. Given the physical interaction (affinity capture MS) annotated for Tif1p 
and Ubp8p (Lee, 2011), a “direct” communication between Tif1p and Ubp8p 
might be proposed. Although TIF1 and TIF2 genes encode an identical protein 
product (Tifp), no physical interaction has been reported for Tif2p-Ubp8p. A 
modest importance, however, should be given to this observation, in 
consideration of the promiscuity of protein-protein interactions. This thesis 
additionally postulates that Ubp8p might be required for actioning some of the 
changes required by loss of Tif1p. Furthermore, without Upb8p, there is a 
cellular shortage of ubiquitin, and this cannot be replenished in the situation of 
decreased Tifp.   
 Moreover, UBP8 has been linked to mRNA export, for example it has been 
shown that loss of SGF73, the gene that activates Ubp8p-deubiquination activity, 
results in a defected export of GAL1 mRNA. The cell could try to overcome this 
fault in the mRNA export system by increasing translation, for example of 
specific mRNAs that are kept in reserve for occasions in which the export of new 
mRNAs cannot function at full range. 
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Factors that influence H2B ubiquitination have been identified and point 
to a series of events involved in H2B during transcription. In this scenario Bre1p 
and Rad6p (this latter gene is not among this study’s SGA hits) have been 
proposed to first recruit to their promoters and then associate RNA Pol II as it 
begins the process of transcription. It may be possible that the deletion of TIF2 is 
received by the system as a signal of a decrease in protein synthesis and BRE1 
could over express in response to this stimulus inducing methylation and 
consequentially transcription initiation. When translation struggles, Bre1p (and 
perhaps Rad6p) take action and ubiquitinate more H2B ultimately augmenting 
gene activation and so transcription initiation activity. In the absence of Bre1p 
activity, a great amount of H2B may undergo RNA Pol II-mediated elongation. 
This could imply will be more expression from the histone genes HTB1 and/or 2 
and possibly elongation of HTB1 or 2 beyond the normal termination. As a result, 
an increased amount of H2B would go through elongation. The resultant 
anomalous number of transcripts, which are unrelated to the transcription 
signalling, may be deleterious for the cell (Figure 2-28). However, it appears 
that Bre1p role remains to be fully elucidated as, for example, Rad6p requires 
Bre1p for its recruitment independently from H2B ubiquitination status (Kao, 
2004). 
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Figure 2-28. SAGA-related mechanisms of transcription. Genes interacting with TIF2 (this study) 
are borded in orange.  
 
 
Altogether, all these considerations assert the importance of 
Bre1p/Ubp8p control on chromatin status and ultimately suggest different levels 
of intervention on the dialogue between transcription and translation initiation. 
It is concluded from this research study that when translation initiation needs to 
be modulated, a way to control transcription concurrently is to have a regulatory 
network surrounding the most powerful genes in affecting the histone status.  
 
Ubiquitination and histone methylation play complementary roles in the 
regulation of transcription, operating under different timescales. Although a so-
called cross-talk between H2B ubiquitination and other histone modifications 
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has been established, studies indicated that in the case of H3 methylation, the 
connection is unidirectional as mutations affecting H2B affect H3 methylation 
but not vice versa (Briggs, 2002). This organization is confirmed in our data 
through the paucity of genes involved in the H3 methylation process genetically 
associated to the translation initiation process Both UBP8 and BRE1 genes share 
the involvement in the regulation of histone H3 methylation, with yeast Ubp8p 
additionally annotated as part of the SLIK complex and its activity required for 
differentially regulating H3 methylation at some SAGA promoters. The cell 
benefits from the simplicity of an extended signalling regulation designed around 
the H2B histone as its status holds an indirect and efficient control on H3. 
Furthermore, whilst histone ubiquitination is rapidly reversed by DUB enzymes 
and allows quick control, histone methylation can remain stable long after 
transcription ends, maintaining the chromatin in a more readily accessible 
conformation for the transcription machinery (Ng, 2003).  
Deletions of UBP8 affects only TIF2 deletion, whilst deletion of BRE1 
produces suppressor-like phenotypes in both TIF1 and TIF2 KO screens. This 
difference suggests a differential and fine regulation on the ubiquitination and 
deubiquitination processes, which is not totally surprising given the different 
regulation associated to single enzymatic steps in the ubiquitination-
deubiquitination process. The observation that histone deubiquitination may be 
the result of an altered equilibrium in the ubiquitin cycle has been reported in a 
previous study, although the observation was confined to the stress caused by 
impairment of the proteasome structure (Dantuma, 2006).  
Strikingly, no genetic interaction was found among genes that encode for 
other de-ub H2B enzymes. An explanatory example may be the viable phenotype 
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associated with tif2Δ ubp10Δ strain. Although Ubp8p and Ubp10p perform the 
same post-translational modification, they work on different pools of ubH2B 
(Schulze, 2011); this result aligns with a proposed separated role for UBP10, 
likely in silencing and telomere maintenance.  
Structural studies also revealed as Ubp8p does not work alone but 
controlled by its associated factors. Induced allosteric changes within Ubp8p 
regulate its activity by binding to other partners, supposedly other components 
of the DUBm such the identified SL Sgf11p (Ingvarsdottir, 2005). This deduction 
is supported by the findings that, as an isolate recombinant protein, Ubp8p is 
inactive (Lee, 2005) and its ZnF-UBP domain -which is required to bind to SAGA- 
is unable to bind free ubiquitin (Ingvarsdottir, 2005). SAGA integrity is required 
for Ubp8 deubiquitination activity, as mutations disrupting the complex (for 
example sgf11Δ) increase the level of ubH2B (Powell, 2004). As a lethal 
phenotype has been reported for both SGF11 and UBP8 genes, Sgf11p may be 
accounted as one of the functionally interacting Ubp8p partners. Sgf11p is 
annotated as an integral subunit of SAGA histone acetyltransferase complex that 
allows regulation of transcription of a subset of genes. It has recently been 
identified as part of the SAGA DUBm (Lee, 2005) where it plays a role in the 
Ubp8p association with SAGA and H2B deubiquitination. As expected, strains 
lacking SGF11 encounter problems in the recruitment and association of Ubp8p 
with SAGA, which becomes difficult or impossible; the SL phenotype generated 
by combination of sgf11Δ and tif2Δ is not necessarily to be attributed to a direct 
interaction this specific pair of mutants as there is the possibility that this lethal 
phenotype is the result of an indirect effect of sgf11 preventing Ubp8p from 
interacting with SAGA properly. In this scenario Ubp8p is present and potentially 
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functional but it cannot be associated, showing how important Sgf11p 
contribution is in regulating the association of Ubp8p with SAGA complex, as it 
likely changes the conformation allowing the ubiquitin on.  
Work from independent groups reported higher eukaryote orthologues 
for both yeast UBP8 and SGF11. The human gene USP22 (yeast UBP8) is of 
particular interest since studies identified it as component of an 11-gene 
signature associated with prognosis of diverse types of cancer (Glinsky, 2005); 
more recent work done in McMahon’s laboratory further showed how USP22 
functions as a subunit of human SAGA (hSAGA) and it is required for cell-cycle 
progression, with its depletion leading to arrest of the cell cycle in G1 phase 
(Zhang, 2008). Supported by a convincing body of evidence (Liu, 2003; Kurabe, 
2007), Zhang’s results align with the hypothesis that hSAGA is linked 
mechanistically to human cancer and, in this scenario, USP22 could regulate 
tumorigenesis by inducing histone modification. It has been argued though, that 
being as USP22 is the only component of the hSAGA complex reported among the 
11 ORFs listed in the oncogenic signature, and this gene’s effect could be SAGA-
independent (Rodriguez-Navarro, 2009). 
Yeast SGF11 and UBP8 genes are believed to be part of the same DUBm 
that also includes SUS1. Whilst both SGF11 and UBP8 deletion strains were 
reported in this study as holding genetic interactions with TIF2, the deletion of 
SUS1 strain was unavailable in our yeast collection and consequentially 
participation of this particular module in translational control could not be 
tested.  Nevertheless, literature research revealed genetic interactions between 
SUS1 and TIF2 (Costanzo, 2010) and a physical interaction with Tif4631p 
(Cuenca Bono, 2010). Interestingly the association of this module is under the 
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competence of SGF73 deletion, however, with the dual tif2Δ sgf73Δ is viable. This 
result suggests that SGF73’s role is limited to the cooperation with other 
components of SAGA and their correct assembling, however, it may have little to 
do with regulation of protein synthesis.  
Elucidation on the exact correlation among SGF73, SUS1, UBP8 and TIF2 
may be worthwhile as it could potentially informative on the proposed UBP8 role 
in mRNA export. A direct role in mRNA export can be hypothesised for genes 
(e.g., GAL1) for which an mRNA export defect has been noted (Gwizdek, 2006) 
that are localized to the nuclear periphery. Loss of SGF73, the gene that activates 
Ubp8p deubiquination activity, results in a defect in the export of mRNA of GAL1. 
This may reflect the control actuated on translation via different directions, for 
example mRNA export. There could be a defect in translation that may be 
overcome by increasing the export of mRNAs or vice versa. There could be a 
defect in the export of mRNAs which is overcome by increasing translation of the 
remaining mRNAs, as it cannot export at full range; this is the case, for instance, 
for specific mRNAs that the cell has in reserve (“translation on demand”) 
(Brockmann, 2007). It may reflect a mechanism of regulation of protein synthesis 
for conditions under which mRNA export form the nucleus is compromised. 
Finally, although SAGA accounts for two enzymatic activities, only 
deletion of UBP8 resulted in a SL with tif2Δ, whilst the deletion of GCN5, gene 
through which SAGA controls acetylation, was not synthetically lethal with tif2Δ. 
This result endorses the versatility of SAGA as highly competent machinery in 
which different sub-modules can co-exist. Different modules of SAGA are 
required for different stages of gene activation, as such complex accounts for 
distinct units that collaborate to maintain structural integrity, genomic 
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recruitment and interaction with the transcription machinery (Koutelou, 2010). 
Genetic interactions between TIF2 and some of SAGA components reveal a dense 
specialized genetic network of SAGA elements surrounding the TIF2 gene, which 
ultimately has critical implications in translation initiation and protein synthesis. 
Modifications involving H2B chromatin, in particular its ubiquitination, 
appear to be part of a highly dynamic regulatory circuitry, as an alternating 
temporal cycle of H2B ubiquitination followed by deubiquitination is required 
for optimal gene activation. Gene control by DUBs may involve a wide range of 
distinct mechanisms, among them the control on the level of subcellular 
localization of key transcription factors in response to signalling. An emerging 
theory suggests that associated partner proteins control the activity and 
specificity of DUBs and selective DUBs can be targeted to specific genomic loci by 
transcription factors. This representation is in accordance with the discussed 
expanded role of DUBs as crucial regulators of chromatin dynamic and gene 
expression due to their counteracting ubiquitin enzymatic activity on specific 
targets. Results from this SGA screen suggest a strong control of transcription 
actuated through selected components of the SAGA complex only.  
 
Fuelling the interest on the relevance of SAGA transcriptional-regulated 
mechanisms is the finding that CHD1 gene -deletion of which is SL with TIF2 
query strain has been shown to be involved in chromatin remodelling, gene 
expression and transcriptional elongation. Pray-Grant and colleagues identified 
it in a mass spectrometry study as a component of SLIK (SAGA-like complex) 
(Pray-Grant, 2005) as Chd1p physically interacts with the SAGA and SLIK 
complexes and binds histone methylated tail peptides (Pray-Grant, 2005). Chd1p 
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is the only yeast member among the Chd family of proteins that contain two N-
terminal chromodomains, a central helicase/ATPase domain and a DNA binding 
domain at the C-terminus. More recently, an additional role for this gene was 
proposed (Biswas, 2008) in which Chd1p opposes to the function of the positive 
transcription factor yFACT (facilitates chromatin transcription) (Orphanides, 
1999). The yFACT complex promotes RNA Pol II transcription and plays a role in 
regulating transcription (Ausubel, 1987) and DNA replication (Wittmeyer, 1999), 
together with a regulatory role on TATA binding protein (TBP) during the 
initiation step of transcription (Biswas, 2005). Transcription initiation by RNA 
polymerase II is dependent on a set of transcription factors, including the TBP, 
which recognize the core promoter and facilitate initiation from the correct start 
site (Conaway, 1998) on which Chd1p and yFACTp have opposing roles in 
regulating TBP binding at promoters. Chd1p is thought to promote formation of 
inhibitory chromatin (Robinson & Schultz, 2003), in this way controlling 
chromatin assembly.  
This SGA screen also brought attention on the genetic surroundings of 
RTF1 and CHD1 genes, as both deletions resulted in SL phenotypes when paired 
with tif2Δ. S. cerevisiae Paf1 complex colocalizes with RNA Pol II during 
transcription elongation and it is required for the normal expression of a subset 
of genes (Krogan, 2002), Mutations in components of the Paf1 complex, including 
RNA polymerase II-associated protein Rtf1p, cause a loss of H2B ubiquitination 
(Ng, 2003). Noticeably, RTF1 was the only one among five components of the 
Paf1p complex to be identified as hit in this research SGA screens. The fact that 
RTF1 is annotated as the most significant contributor in regulating modifications 
such as H2B ubiquitination and H3 methylation (Mueller, 2004; Porter, 2005) 
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may give the reason for this finding. Furthermore, monoubiquitination of H2B by 
Rad6p-Bre1p (discussed previously in the text) is eliminated in strains lacking 
Rtf1p or the Paf1 complex; such modification appears of fundamental 
importance as it represents the pre-requisite for H3 methylation and suggests a 
control of H2B ubiquitination on H3. 
A physical interaction between Chd1p and Rtf1p has been described and 
it is ultimately thought to promote association with active ORFs (Simic, 2003). 
With Chd1p functioning as a component of SAGA and SILK complexes, the 
interaction between Rtf1p and Chd1p may serve to synchronize the activities of 
histone-modifying enzymes. Additionally, the involvement of Rtf1p in processes 
such as histone modification, recruitment of Chd1p and, to minor extent, 
telomeric silencing suggests that Rtf1p influences on transcription may be 
actuated via alteration of chromatin structure. Although yet not backed up by 
experimental evidence, the intriguing possibility that Rtf1p mediates effects on 
chromatin structure by recruiting Chd1p to active ORFs cannot be entirely ruled 
out: in this scenario Rtf1p would stabilize Chd1p association by promoting 
methylation of H3 histone. As both CHD1 and RTF1 hold a negative genetic 
interaction with TIF2, questions could be raised on the nature of the genes that 
could be regulated in this way and whether translation gets a say on which 
subsequent mRNAs are recruited. 
 
Three additional SL hits linked to RNA Pol II activity were also identified, 
suggesting an inter-control of the translational machinery on gene expression, 
possibly mediated via activity of the aforementioned enzyme. The first ORF, 
YGL024W, has been reported as dubious; however, it partially/completely 
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overlaps the verified gene (PolyGlutamine Domain) PGD1 (Fisk, 2006). Pgd1p, is 
a subunit of the RNA Pol II mediator complex, associated with core polymerase 
subunits to form the RNA Pol II holoenzyme and regarded as essential for basal 
and activated transcription (Guglielmi, 2004). Deletion of the PGD1 gene itself is 
not available in Boone’s YDS library and for this reason it could not be tested. 
YGL024W is a direct target of Cyc8p-Tup1p transcriptional corepressor, a duo of 
protein that functions in a complex to mediate repression of a certain subset of 
genes (for instance, those involved in osmotic stress and DNA response damage) 
(Lee, 2000). Such co-repression appears to be important as Cyc8p-Tup1p can 
suppress transcriptional activity by packing nucleosomes into repressive 
chromatin structures (Papamichos-Chronakis, 2000).  
A second gene, ASK10, encoding for a RNA Pol II holoenzyme component, 
was identified in this SGA. Ask10p becomes phosphorylated in response to 
oxidative stress in a MAP kinase-dependent fashion and it functions in activation 
of the aquaglyceroporin Fps1p, an aquaporine protein that regulates the plasma 
membrane permeability via its glycerol channel, upon changes in cellular 
osmolarity environment (Page, 1996). Ask10p-mediated function appears quite 
important as the MAP kinase pathway transmits an oxidative stress signal to the 
RNA Pol II holoenzyme through phosphorylation of Ask10p itself (Beese, 2009). 
Interesting in the context of duplicate genes is the observation that ASK10, also 
known as RGC2, has a paralog, RGC1 (Beese, 2009), which did not display any 
lethal or sick growth phenotype associated with its deletion, when paired with a 
deficient translation system.    
Finally, HAP5 encodes for a subunit of the heme-activated, glucose-
repressed Hap2/3/4/5 CCAAT-binding complex, a transcriptional activator and 
183 
 
global regulator of respiratory gene expression, also required for assembly and 
DNA binding activity of the complex (McNabb, 1995). It contributes to RNA Pol II 
sequence-specific DNA binding and is involved in positive regulation of the 
transcriptional process (McNabb, 1997). 
In summary, a number of genes reported in this study hold genetic 
interactions with TIF2 gene associated with the function of the RNA polymerase 
II enzyme. The described SL interactions are believed to arise from a lack of 
cellular ubiquitin that cannot be replenished in a faulty translational cellular 
background. Further evidence of cross-talk between transcription and 
translation are endorsed by observed genetic interactions between TIF2 and the 
SAGA complex: this latter acts as one the main mediators of histone 
modifications on gene promoters, ultimately enhancing the transcriptional 
activation and facilitating the elongation by deubiquitinating histones 
downstream of RNA Pol II. Furthermore, the ubiquitination-deubiquitination 
status of the H2B histone emerges as critical among transcriptional-related steps 
in addressing mechanism of gene expression that are required to be activated 
upon certain type of cellular challenges. 
 
TIF2 holds a negative genetic interaction with RIM101, a gene first 
identified in baker’s yeast as a positive regulator of early meiotic gene expression 
(Su & Mitchell, 1993) and lately shown to behave as a positive regulator of 
haploid invasive growth (Li & Mitchell, 1997). Annotated literature also 
describes RIM101 alkaline-pH-induced gene expression competence and its role 
in general ion homeostasis (Lamb, 2001). The ability of Rim101p to be 
proteolitically processed to its active form and to act as a repressor at the 
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negative regulatory element (NRE) depends on well characterized components 
of the Rim signalling pathway and requires DFG16, YGR122W and components of 
the ESCRT trafficking pathway (Rothfels, 2005). Supporting the idea that 
Rim101p signalling pathway has an important involvement, both DFG16 and 
YGR122W deletions appear along with RIM101 in the screen as ultra sensitive 
deletions SL associated with tif2 query strain. Ygr122wp, a non-ESCRT protein, is 
identified as contributor to Rim101 processing (Rothfels, 2005) and regulation 
(Xu & Mitchell, 2001); Dfg16p is a probable multiple transmembrane protein, 
involved in diploid invasive and pseudohyphal growth upon nitrogen starvation 
and it is required for accumulation of processed Rim101p. Since these genetic 
interactions are exclusive for tif2Δ, the intercommunication between translation 
initiation and Rim101 signalling pathway seems to be allocated to one of the TIF 
paralogs exclusively. Interestingly, deletions of genes involved in the proteolytic 
activation of Rim101p were identified as common between the two paralogs 
(further discussed in section 2.38). Lastly, the YEL057C ORF, deletion of which 
resulted in a SL phenotype, encodes for a protein of partially unknown function 
and it is annotated as involved in meiotic gene expression as target of 
(Unscheduled Meiotic gene Expression) UME6 (Williams, 2002), a key 
transcriptional regulator of early meiotic genes that supports coupling metabolic 
responses to nutritional cues with initiation and progression of meiosis. 
 
As it might be expected a gene directly involved in translation-related 
processes was also identified in tif2 SGA; surprisingly its annotation describes it 
as part of the translation initiation cap-independent process: GIS2 encodes for a 
translational activator for mRNAs with an IRES, cytoplasmic Gis2p associates 
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with the eukaryotic ribosome and acts as regulator of cap-independent 
translation. Gis2p functions are evolutionarily preserved in higher eukaryotes, as 
part of a conserved mechanism to control translation of specific mRNA molecules 
that contain an IRES (Tsvetanova, 2010). Its human ortholog gene, ZNF9, has 
been reported to be involved in myotonic dystrophy type 2 (Sammons, 2011). 
Although under certain conditions, inhibition of protein synthesis may 
seem a counterintuitive cellular choice, this choice could be explained by the 
differential regulation of mRNA, as reported under specific stress conditions 
(Spriggs, 2008). The fact that the translational process can be adjusted and its 
connections rewired allows translation of selective proteins and relies on 
upstream ORFs in the 5’ untranslated region of such mRNAs. Quite often 
encoding for protein products essential to cellular stress response are translated 
using alternative mechanisms of translation initiation, such as IRES (Bushell, 
2006). It is nowadays accepted that specific mRNAs are able to escape the overall 
inhibition of protein synthesis (Bushell, 2006) and a contingent of these mRNAs. 
A genome-wide study revealed the existence of a physical interaction 
between Gis2p and Sro9p (Tarassov, 2008). Sro9p, first discovered as multi copy 
suppressor of an RNA export defect, was later shown to associate with 
polysomes (Sobel & Wolin, 1999); in particular Sro9p associates with nascent 
transcripts and forms part of an mRNP complex that is exported to the 
cytoplasm, where it (Sro9p) then acts as a regulator of translation (Rother, 
2010). Although no genetic interaction was identified between TIF2 and SRO9 
genes, the physical interaction between Gis2p and Sro9p makes wonder whether 
a correlation between mRNA export and translation initiation may signal 
through this interaction, possibly through GIS2. Integration of a signal between 
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translation initiation and mRNA transport from GIS2 to SRO9 may be essential as, 
in absence of Gis2p, Sro9p struggles to counteract the mRNA export defect with 
the amount of mRNAs shuttled to the cytoplasm dramatically decreased; 
translation initiation is enhanced to make the most of the mRNAs already 
present.  In a strain missing the TIF2 gene, translation initiation cannot be 
augmented sufficiently, either because this signal is dealt with by TIF2 only and 
TIF1 is unspecialized to perform this type of signal processing as it misses the 
network of interactions of its counterpart gene and/or because more protein 
product is encoded by TIF2 transcripts and although Tif1p production may be 
enhanced, it is still not satisfactory. 
 
Finally, this screen identified that deletion of the SIT1 gene, encoding for a 
ferrioxamine B (FOB) transporter member of the ARN family of proteins 
(Lesuisse, 1998), as phenotypically suppressor when paired with tif2Δ query 
strain. All organisms require iron as it is essential in diverse biological processes, 
for instance respiration and oxidation-reduction pathways. At physiological pH, 
the majority of this element is presented in an insoluble ferric form (Fe3+) and 
accessible for cellular use. Excess of iron inside the cell promotes the formation 
of (reactive oxygen species) ROS, with potential damage to DNA, lipids, and 
proteins. Organisms have developed different mechanism to take up and 
transport iron; S. cerevisiae has two different pathways functioning in the 
absorption of this element: the first one is the reductive iron up taking pathway 
(see Philpott, 2006 for more detailed reading); the second one relies on 
sidephore-iron complexes, ion chelators that bind ferric ion with strong affinity 
(de Freitas, 2003). Among these latter, the Arnp family of transporters -Arn1p, 
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Arn2p, Arn3p (alias Sit1p) and Arn4p- functions in the uptake of the sidephore-
iron complexes; each of the Arn proteins is specialized for conveying different 
kinds of sidephores. In particular, Sit1p exhibits specificity for both ferroamine, 
including FOB and ferricrocin, and cells deleted of SIT1 gene become unable to 
take up FOB. Sit1p is potentially phosphorylated by Cdc28p and physically 
interacts with Ubi4p (Erpapazoglou, 2008) while SIT1 holds a negative genetic 
interaction with VPS27 (Aguilar, 2010), deletions of which both appeared as SL in 
this thesis screens.  
Functional trafficking of membrane-bound metal transporters is not only 
essential for protein function in order to maintain cellular ion homeostasis but, it 
also represents a notable feature of post-translational regulation. Aft1p, a major 
regulator of the so-called iron regulon, is located in the nucleus in the absence of 
iron, where it induces transcription of certain genes but, as soon as the metal 
concentration is sufficient for the cellular needs, Aft1p is exported to the 
cytosolic compartment with associated reduction of expression of the previously 
induced target genes. Sit1p domains have been suggested to interact with Aft1p, 
holding thus an effect on ubiquitination of specific sites and  guiding  this way the 
intracellular trafficking and degradation of Sit1p (Jeong, 2009). Interestingly 
Aft1p is also one of the “documented” transcription factors for the TIF3 gene 
(Harbison, 2004). Deletion of SIT1 could lead to some level of iron deficiency and 
this could result in upregulation of genes sharing the Aft1p transcription factor, 
TIF3 among them. As a result, TIF3 (eIF4B) expression increases and the 
phenotype of eIF4A deficiency is suppressed.   
Noticeably, Aft1p is also one of the “documented” transcription factors for 
the TIF3 gene (Harbison, 2004). Given that, as a siderophore-dependent 
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facilitator, Sit1p functions in what is considered a high affinity iron uptake 
pathway (Kosman, 2003), its participation might be particularly important for 
ensuring the physiological iron uptake. Such iron deficiency caused by the loss of 
Sit1p contribution could result in upregulation of genes sharing the Aft1p 
transcription factor, TIF3 among them. As a result, TIF3 (eIF4B) expression 
increases and enhances Tifp activity (as introduced in section 1.8): in this case, 
the phenotype expected from an inefficient translation, is suppressed. As no 
genetic interaction was observed for SIT1-TIF1 combination, the different 
phenotypes observed may reflect the different regulation of the two paralogs and 
could be dictated by a preferential relationship between TIF3 and TIF2 genes, 
through which the cell finds more beneficial to upregulate TIF2 in combination 
with this type of event. 
Recent studies have link UPR activation with cellular iron metabolism, as 
suggested by the modulation of ferroportin and ferritin H expression resulting 
from ER insults (Olivera, 2009). Data from the above publication suggest that the 
mRNA enrichment observed for both ferroportin and ferritin encoding genes in 
cells affected by ER stress could represent an attempt to bypass the intracellular 
deposition of free iron, either through its sequestration or export, respectively. 
The functional intersection between ER stress and iron homeostasis has been 
excellently reviewed by Olivera and colleagues (2010): dysregulation of iron 
metabolism emerged from studies into hereditary hemochromatosis (HH) type 1, 
one of the most common genetic disorders in northern European populations. 
(Pietrangelo, 2004) that evolves from a defective regulation of iron absorption. 
The hypothesis that diverse factors could modify this genetically determined 
disease was hinted by the outstanding phenotypic heterogeneity reported among 
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patients (Olynyk, 1999). Modifiers of the clinical traits of HH disorder have been 
investigated (Cruz, 2008), and the UPR appears to be a potential candidate, 
which could be probed in further studies. 
 
2.38. TIF1 and TIF2 genes functional profiling 
 
This research study revealed a number of common synthetic sick/lethal 
interactions between TIF1 and TIF2 genes, underlying functional competences 
shared by the duplicate pairs. Evidence is given for functional redundancy 
between the two paralogs with their full co-participation prominently 
represented in processes such as response to alkaline pH, whilst cellular 
responsiveness associated with processes such as vesicular trafficking and 
precise segments of transcription appear to be rather exclusive for each 
duplicate. 
 
As reported for both tif1Δ and tif2Δ SGAs separately, few deletions of 
genes involved in chromatin-related processing were also identified as SL hits 
mutual to the two paralogs. Among them, the SGF29 gene has been only recently 
properly annotated thanks to work done by Bian and colleagues (2011), which 
showed through an extensive crystallography/in vivo/in vitro approach how 
Sgf29p recognizes methylated H3 histone to recruit SAGA to its targets sites and 
intervening in this way in acetylation of H3. Both genetic and physical 
interactions are annotated in the literature for SGF29/Sgf29p and CHD1, SGF11, 
and UBP8 (all reported as SL in tif2Δ SGA) and their protein products. As 
previously discussed for the SAGA-related hit sgf11Δ, the functional connection 
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suggested by this genetic interaction, could find its explanation in an inter-talk 
between translation initiation and transcription mediated via SAGA components.  
Additional control on non-histonic chromatin is also suggested by lethal 
phenotypic outcomes that arise from combination of TIF1 and TIF2 KO with 
nhp10Δ and ies5Δ strains. NHP10 encodes for a protein related to mammalian 
high mobility group proteins and is annotated as a likely component of the 
chromatin-remodelling INO80 complex (Ino80-C).  It is also believed to hold a 
role in DNA repair as Nhp10p preferentially binds DNA ends, protecting them 
from exonucleatic cleavage. The second gene, IES5, encodes for a protein that 
associates with the Ino80-C under low-salt conditions. Although the role of 
chromatin remodelling in the context of translational control has been discussed 
in the previous chapter, a reflection should be made on the nature of chromatin-
related processes that involve the duplicate pairs together rather than alone. It 
appears that the competence shared by both duplicates in the matter of 
chromatin remodelling is limited to stress responses such as DNA repair 
(NHP10) and low-salt conditions (IES5), whit no hints to genetic connections 
between translation and histone ubiquitination status, as observed for TIF2 
genetic profile. Although Ino80-C shares a common core of conserved subunits in 
yeast and higher eukaryotes, where it contributes to a general variety of 
chromatin-dependent related processes including DNA repair and DNA 
replication and transcription (Conaway & Conaway, 2009), studies suggest that 
this complex diverged substantially during evolution acquiring new subunits 
with apparently species-specific functions. 
Interestingly, Ino80-C interacts with the early NER damage recognition 
complex Rad4-Rad23 (previously encountered in section 2.36) and is recruited 
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to chromatin by Rad4 in a UV damage-dependent fashion; a modulation of 
chromatin structure is believed to happen during excision repair, although the 
exact mechanism is still unknown. Recent publication from McHugh‘s laboratory 
showed that INO80 functions in the same genetic pathway as the NER machinery 
(Sarkar, 2010) and is required for the restoration of chromatin structure after 
repair. Chromatin becomes a target of extensive disruption to allow efficient 
NER, however, its structure is restored soon after the repairing stage –the 
”access–repair–restore model”- (Dinant, 2008), possibly as a result of targeted 
translation of selective mRNAs that cause the synthesis of chromatin remodelling 
proteins to increase (Bushell, 2006). 
 
Of particular interest, given the considerations made regarding the 
equilibrium of the lysosome compartment as previously discussed for the tif1Δ 
SGA, is the SL reported for both TIF1 and TIF2  KO strains when paired with 
ydr455cΔ, a dubious ORF which overlaps with YDR456w (alias VPS44). Vps44p is 
a Na+/H+ and K+/H+ exchanger, required for intracellular sequestration of Na+ 
and K+ and located in the vacuole and late endosome compartments, where it is 
needed for osmotolerance to hypertonic shock and vacuolar fusion.  
The lysosome represents an important compartment for Ca2+ signalling 
(Galione & Churchill, 2002) and is characterized by concentrations of this cation 
comparable to those in the ER (Miyawaki, 1997). This degradative structure is 
filled with Ca2+ via the action of not completely understood ion transporting 
ATPase and/or solute channels. Ca2+ transport could be directed against the 
proton gradient or involve a mechanism in which Ca2+ and Na+ transports are 
coupled (Na+/H+ and Na+/Ca2+ transporters). Given Vps44p role in vacuolar 
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function, its ion exchanging nature, and also considering that the mechanism for 
which Ca2+ enters the lysosome is proton-dependent (Christensen, 2002), it is 
tempting to propose Ydr455cp as one of the channels coupled with Ca2+ 
transport into lysosomes. 
Ca2+ accumulation in late endosomal and lysosomal structures is critical 
for the cell functioning as normal endocytic function is coupled with lysosomal 
Ca2+ homeostasis; Ca2+ release, on the other hand, represents both requirement 
and trigger for the final step in the fusion between docked endosomes and 
lysosomes complex assembly (Pfeffer, 1999). The majority of Ca2+ is released 
into the cytosol compartment from early endosomes in response to the initiation 
of acidification of the endolysosomal system.  
 
Deletions of three genes (RIM13, RIM20, and RIM8) belonging to the RIM 
family of genes were reported as SL in combination with both TIF1 and TIF2 KOs: 
these ORFs all share an involvement in the signalling pathway in the response to 
alkaline pH via their participation to the proteolytic activation of Rim101p. Two 
of three deletions also display interactions with components of the ESCRT 
pathway: Rim20p cooperates with ESCRT-III subunit Snf7p while Rim8p 
interrelates with ESCRT-I subunits Stp22p and Vps28p. The third hit, Rim13p, is 
a calpain-like cysteine protease involved in proteolytic activation of Rim101p in 
response to alkaline pH. This subset of genes suggests an affiliation between pH 
response and MVBs formation that could further enrich the network of 
interactions revealed so far for TIF1 paralog in concern to vesicular damage.  
Environmental pH impacts cellular growth, differentiation, and viability. 
For this reason an evolutionary development that generates a response system 
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that intervenes to counteract the effects of external alkalinity should be favoured, 
given the debilitating nature of disruption of membrane proton gradients for the 
cell. Such gradients normally supply energy for nutrient and ion transport (Van 
der Rest, 1995). It is quite remarkable that both paralogs conserved an 
interaction with alkaline response genes as, this particular subset of ORFs 
exhibits unique attributes that distinguishes it from other growth limitation 
conditions. This group does not correspond entirely to other sets of starvation or 
stress-induced genes; furthermore, alkaline response genes are not consistently 
induced by ordinary physiological triggers such as stationary phase, heat shock, 
or lack of calcineurin.  In other words, the response to alkaline pH may be due to 
a combination of stress and starvation response, which shares essential 
functional implications with TIF1 and TIF2 pair of duplicates. 
 
The genetic interactions between mitochondrial-related genes and TIF1 
paralog has been commented on in section 2.36: whilst interaction of MMM1, 
the gene encoding for the ER-resident Mmm1p component of the ERMES, seems 
to be mediated via TIF1 gene only, both duplicates show a functional connection 
with the MDM34 (Mitochondrial distribution and morphology, alias MMM2) gene, 
the product of which is an outer membrane protein that is also a component of 
the ERMES, which is discussed in the paragraph below. While it is arguable that 
the sensitivity of the revelation system may be marginally inexact when dealing 
with petite or slow growing strains and, there is thus the possibility that the 
observed genetic interaction is not exclusive for TIF1 and TIF2 genes, it is 
encouraging to find the deletion of YGL218W, an ORF overlapping to MDM34 as 
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SL in the paralogs screens, although it needs to be noticed that ygl218wΔ itself 
has been annotated as petite. 
Differently from the majority of the organelles, mitochondria do not 
exchange phospholipids via vesicular transport: an association between ER and 
mitochondria is necessary for the exchange to take place (Achleitner, 1999). 
Recently, a complex named ERMES -ER-mitochondria encounter structure- has 
been described: it consists of proteins located both at the mitochondrial and ER 
sides and acts as a molecular connector between these two cellular 
compartments, where is required for efficient inter-organelle phospholipid 
exchange. Given the extent degree of lipid trafficking between ER and 
mitochondria outer membrane, the location of the ERMES appears critical; this 
exchange has been suggested to be mediated by the synaptotagmin-like, 
mitochondrial and lipid-binding protein (SMP) domains of the ERMES subunits 
themselves (Kopec, 2010), which are capable to assemble into structurally well-
defined complexes, establishing this way a lipophillic, tubular path between the 
two membranes. Kornmann and colleagues (2009) showed through genome-
wide mapping of genetic interactions that the components of the ESCRT complex 
(Mmm1p/Mdm10p/Mdm12p/Mdm34p) are functionally connected to 
phospholipid biosynthesis and Ca2+-signalling genes. Their work satisfactorily 
showed that phospholipid biosynthesis is impaired in mutant cells, where the 
ESCRT complex localized into foci, thus suggesting that distinct sites of intimate 
contact between ER and mitochondria help the exchange of both Ca2+ and 
phospholipids in between the organelles (Kornmann, 2009). Such a connection 
between ER and mitochondria might have relevance in buffering and controlling 
of both cytosolic and mitochondrial Ca2+ concentrations (Pinton, 2008). In virtue 
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of ERMES tether function in connecting the ER and mitochondria and allowing 
transport of phospholipids between these compartments, the disruption of the 
complex, which likely takes place in the tested ERMES deficient KO strains would 
cause some components of the complex to partition with the ER, whilst others 
would end up on the mitochondrial side. The Ca2+ deposited in the ER is depleted 
following grave stress conditions, and the cellular response upon perturbation of 
ER Ca2+ homeostasis involves, among the others, the suppression at the initiation 
step of protein synthesis. At the same time, serious stresses recall an enormous 
amount of Ca2+ into mitochondria, increasing the influx of the bivalent cation into 
the respiratory organelles; this latter physiological response is believed to 
trigger the production of free radicals, the opening of the mitochondrial 
permeability transition (MPT) pore -identified as an inducer of cell death 
(Matstumoto, 1999)-, and perturbations of energy required for cellular 
metabolism. Deletions of MDM10 and MDM12 are annotated as ‘wild-type SL’ in 
Boone’s SGA set and for this reason not highly informative, as these types of 
deletion strains, although being viable on their own, are prone to SL with the 
majority of the other deletions present in the array.  
Another identified interaction was with CEM1, a gene encoding for a 
mitochondrial β-keto-acyl synthase that holds a possible role in fatty acid 
synthesis and it is required for mitochondrial respiration. The fact that no 
corroborating deletions were reported as sensitive in this study, along with the 
‘petite’ annotation which labelled this strain, make us wondering whether the SL 
observed may be caused or augmented by a respiratory system impaired in the 
first place. 
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As previously identified in both tif1Δ and tif2Δ screens separately, some 
translation-related processes appear as SL in both duplicates’ SGAs: TEF4 
encodes for Tef4p, a gamma subunit of translational elongation factor eEF1B, 
that stimulates the binding of aminoacyl-tRNA to ribosomes by releasing eEF1A 
(Tef1p/Tef2p) from the ribosomal complex. RPL9a gene encodes for a protein 
component of the large (60S) ribosomal subunit.  
 
One SL hit that seems to not find placement into the functional groups 
annotated so far is reported below is VRP1, which encodes for actin-associated 
Vrp1, a protein involved in cytoskeletal organization and cytokinesis. Loss of 
Vrp1p leads to a partial loss of cortical actin patch polarization during the cell 
cycle (Donnelly, 1993) and it has been related to mammalian Wiskott-Aldrich 
syndrome protein interacting protein. 
Although the actin cytoskeleton and the translation machinery are 
considered to be separate cellular complexes, growing evidence supports 
overlapping regulation of the two systems. In fact, the eukaryotic translation 
elongation factor 1A (eEF1A), other actin binding proteins, and actin mutants 
affect translation initiation through the actin cytoskeleton.  A model has emerged 
in which actin and the cytoskeleton may play important regulatory functions in 
protein synthesis, providing a scaffold for translational components including 
mRNAs, polyribosomes, and translation factors. The report of TIF1 and TIF2 
interaction with VPR1 could be interpreted as a direct supporting evidence of the 
regulation of protein synthesis by actin cytoskeleton components, Perturbations 
of the actin cytoskeleton in mammalian cells have been shown to induce 
profound effects on protein synthesis (Gross & Kinzy, 2007) and cases in which 
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the inhibition of translation initiation is accompanied by the depolymerization of 
the actin cytoskeletons of yeast cells in vivo systems following glucose 
deprivation have also been reported (Uesono, 2004). Although the actin 
cytoskeleton is believed to provide a scaffold for the translational apparatus, it is 
rather mysterious how such depolymerization would result in a reduction of the 
translational process. The fact that different constituents of the translation 
machinery interact with the actin cytoskeleton hints to an effect potentially 
mediated by steric inhibition. Translation initiation factors such as eIF2, eIF3, 
eIF4A (Tif1/2p), and eIF4B have been shown to associate with the cytoskeleton 
(Howe & Hershey, 1984). It is therefore conceivable that, upon actin 
depolymerization, one or more of these constituents lose their spatial 
arrangements and cannot properly interact with the ribosomal structure (Gross 
& Kinzy, 2007).  
Cytokinesis, the process in which Vrp1p is annotated to participate, 
requires protein synthesis to complete cell separation (Thanabalu & Munn, 
2001). Indeed, protein synthesis is required to complete a number of regulatory 
steps in the cell cycle, for instance after G1 (Burke, & Church, 1991) and to 
complete the G2 phase and enter mitosis (Goebi & Byers, 1988). Furthermore, 
initiation of DNA synthesis and mitosis are particularly sensitive to protein 
synthesis inhibitors (Schvartzman & Van’t Hof, 1982). 
 
2.39. Summary 
Translation can be regulated at different levels and via diverse 
procedures (Sonenber & Dever, 2003): some of them involve general responses, 
whilst others rely on specific mechanisms of translational regulation. The cell 
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may select from several processes to adjust protein synthesis accordingly to the 
cellular status, these include: mRNA abundance, translational rate through 
regulation of ribosome density/occupancy and protein specific degradation. As 
emerged from this research, mRNA concentration and export, ribosome 
assembling, degradation of selective proteins, and levels of transcription are, to 
different extents, role-players in regulation of translation initiation. Different 
cellular contexts and environments may require quite different, and sometimes 
apparently convoluted, mechanisms of translational regulation. 
An intimate connection between transcription and translation has long 
been suspected for a long time (Hinnebusch, 2005; Topisirovic, 2011). This is 
despite the unambiguous compartmentalisation of the two processes, as 
transcription of DNA into mRNA takes place in the nucleus, while translation of 
the mRNA occurs in the cytoplasm, where the transcript is also ultimately 
degraded. In prokaryotes, coupling of these two fundamental cellular processes 
has been acknowledged (Chen & Zubay, 1983); nevertheless the existence of a 
tied mechanism in eukaryotes has only recently been demonstrated in S. 
cerevisiae (Harel-Sharvitl, 2010). Transcription and translation become unveiled 
as inter-communicative through a sophisticated network of physical interactions, 
as extensively shown in annotated literature (Keene, 2001; Halbeisen, 2008) 
along with the wealth of genetic interactions described in this study. 
Interestingly, the functional competences relate to the two members of the 
duplicates on the duplicate pair separately. The tif1Δ genetic profile highlights a 
connection with transcription mediated via the direct formation of the TFIIA 
transcription subunit, a nuclear protein required for all RNA Pol II-dependent 
transcription events. A major finding of this work, however, is that the majority 
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of transcription-translation inter-talk is allocated to TIF2 duplicate: the 
translational initiation process appears tightly connected to control of gene 
expression via RNA Pol II assembly and functionality, along with a dense 
network of genetic interactions surrounding the SAGA complex. TIF2 also 
appears unequivocally the only paralog devoted to interactions with a 
substantial group of functionally related genes involved in early meiotic gene 
expression.  Altogether the genetic portrait of TIF1 and TIF2 genes speaks for a 
mutual control between transcription and translation aimed to reinforce the 
control of the two processes singularly. 
During cellular stresses, however, some genes can be efficiently 
transcribed whilst translation is suppressed or the translation products are 
rapidly degraded. In either case, the cell explores alternative ways to establish 
higher protein concentrations bypassing the need for transcribing additional 
mRNAs. It is possible then, that for proteins with little post-transcriptional 
regulation inside a certain compartment or functional module, their protein level 
will be more likely to be correlated to the corresponding mRNA concentrations. 
Changes in the translational state and stability may affect a quite broad range of 
mRNAs, as a positive correlation between mRNA high expression levels and its 
tendency to be highly translated has been reported (Beyer, 2004). When 
environmental signals require a quick cellular response, protein expression, 
regulation via altering transcription may occasionally be too slow. Prepared for 
such events, the cell constitutively maintains a sufficient level of mRNA, but it 
blocks translation, until the protein product is effectively required (Hinnebush & 
Natharajan, 2002). Under this scenario, ribosomal components could bind mRNA 
without actively translating the message (Khun, 2001). Stalling of the ribosome 
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at internal sites in an mRNA will also induce cleavage and degradation (Doma & 
Parker, 2006). For a given mRNA species there is a negative correlation between 
translation activity and degradation, suggesting that a way to decrease 
translation is to diminish mRNA abundance.  
The correlation between mRNA and protein abundance is profoundly 
affected by protein turnover (Pratt, 2002), as degradation of proteins in the 
global control of protein synthesis represents a fundamental process and it 
accounts for diverse points of potential control, as also suggested by this study’s  
SGAs data. Ubiquitin appears as a common denominator in degradative 
processes taking place in both the proteasome and MVBs vesicles, by generation 
of poly- and mono-ubiquitin tagged aggregates, respectively.  Both degradative 
pathways are represented in this study’s genetic investigation of translation. 
The interplay between a functional vesicular system and rate of protein 
synthesis for appropriate cellular up-keep during changes in cellular metabolism 
has also been reiterate by this study’s findings, whether this implies delivery of 
components to subcellular organelles or trafficking directed towards the 
degradative pathway. In particular this latter pathway seems to be playing an 
important role, with the kinetics of lysosomal degradation of a particular 
membrane protein tightly correlated with the extent of its ubiquitination (Hicke 
& Dunn, 2003). Although ubiquitination can itself initiate a sorting pathway 
directed to proteolytic structures at a variety of compartments, multiple rounds 
of ubiquitination must be undertaken for a competent delivery of a given cargo 
protein to be delivered to MVBs/lysosomal degradative structures from the 
ESCRT. An articulated regulation of MVBs should, however, not come as a 
surprise, given the conspicuous number of fundamental biological processes this 
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pathway is required for, such as developmental signalling, antigen presentation, 
cell growth control, and even the budding of certain viruses (reviewed in 
Katzmann, 2002). Such coordination of MVBs is likely to reflect its need to 
respond to cellular changes quickly. In consideration of the subdivision of roles 
required for the different ESCRT complexes, results of this study hint at the 
coordination of the ubiquitination grouping process, performed by ESCRT-0, as 
the most relevant step in terms of interconnections with the translational 
system. Contrarily, the ESCRT-I and -II complexes that respectively promote 
budding of the vesicles from the plasma membrane and finalize the scission of 
the vesicles do not seem to interact directly with translation. 
The mRNA surveillance mechanism NMD was represented in this study, 
although not prominently; this connection could be expected in consideration of  
the role of NMD and the fact that it has already been linked to other stages of 
translation, for example through the Ubf proteins, which are involved in the 
process of translation (Czaplinki, 1995).  
Finally, it is critically important to comment on the relative paucity of 
interactions reported for genes involved in ribosome biosynthesis/biogenesis in 
the tif1Δ and tif2Δ SGAs. This result seems to fall in with work from Linder’s 
laboratory which showed how rapid repression of translation is not governed by 
repression of ribosome biosynthesis, at least in secretory-deficient pathways 
(Deloche, 2004).  
Interpretation of data associated with transcription-related subsets of 
genes provides evidence in support of an expanded role for the DUB enzymes as 
crucial regulators of chromatin dynamic sand gene expression, likely due to their 
counteracting ubiquitinating enzymatic activity on specific targets. In this 
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scenario DUBs assist in the inter-talk between transcription and protein 
synthesis, with the recruitment of modules that involve selected components of 
the SAGA complex. Functional turnover of proteins is, to a certain extent, 
regulated by the balance between post-translational modifications, in particular 
ubiquitination/deubiquitination, indicating that this latter could be a general and 
predominant mechanism to regulate the stability of cellular proteins. In 
particular H2B histone ubiquitination may be of particular relevance; behind its 
requirement in early steps of transcription initiation and RNA Pol II-mediated 
elongation (Xiao, 2005), this modification appears to embody a prominent task in 
the ubiquitin balance, which ultimately has repercussions on the whole cell. In 
other words, modifications of H2B status may imply further consequences in 
modulation of chromatin dynamics and gene transcription. As optimal 
transcription of some genes requires complete cycles of H2B ubiquitination and 
deubiquitination. H2B ubiquitination takes place in the early stage of the 
transcriptional event; it becomes clear that the context of ubiquitination within 
the nucleosome is critical in arbitrating the outcome mediated by this 
modification.  
Free ubiquitin is present is very small quantities and there is a 
physiological requirement for it to be restocked continually, as ubiquitin is used 
in both cytoplasmic and nuclear processes. Under certain conditions of stress, 
there is a cellular demand for more free ubiquitin to be incorporated in poly-
ubiquitinated substrates, which will then be directed to the proteasome 
structure: this happens at the cost of mono-ubiquitinated histones resulting in 
chromatin remodelling and altered transcription (reviewed in Groothuis, 2006).  
The choice of targeting histone ubiquitin seems very intuitive in consideration of 
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the fact that  H2A and H2B histones represent the sites where major pools of 
ubiquitin are conjugated in physiological conditions (Zhang, 2003), whilst less 
significant amounts are employed in processes such as endocytosis and MVBs 
formation. The change in the ubiquitin pools must be sensed by the nucleus by 
affecting the histone-ubiquitin status in a concerted mechanism that directs the 
redistribution of ubiquitin from the nuclear compartment to the cytosolic one.  
This study has given an insight on the dynamics of translation regulation, 
which emerges as highly interconnected, this is understandable given the 
importance of protein synthesis as a cellular process. Supported by a previous 
hypothesis which suggest that eIF4Ap function is necessary even when no 
melting activity of secondary structures is required (Linder, 2003), this research 
thesis suggests that helicase activity may not be the only mechanism eIF4A 
protein participates, some of which still not clearly resolved in the literature. 
In certain circumstances the challenge may be overcome by allocating 
new competences to genes to achieve this remodelling. This seems to be 
reflected in the variety of genes identified in these SGA screens, where the 
observed genetic interactions are to be attributed to either their direct 
involvement in the function, such as the production of a protein or an 
intermediate or indirectly, through regulation of a common function.   
 
2.40. Redundancy  in genetic networks 
 
Although use of ORF deletions is a well-established way to investigate a 
system of connected genes (Tong, 2001), the interpretation of the resultant 
networks can often be far from simple. Redundancy represents a severe 
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complication in interpreting genetic networks; nonetheless it is a phenomenon 
which requires greater understanding, as its functional significance cannot be 
disengaged from the cellular system’s organism. As introduced in section 1.5, 
redundancy is often associated with robustness but, what do we really mean 
when we refer to robustness of living systems? The term tends to be rather 
context-specific in biology and its use should be accompanied by a precise 
indication as robustness of the state, robustness of the adaptability, etc…. 
Functional and systemic robustness is a feature of systematic gene deletion 
experiments, such as the SGAs in this research, where a combination of mutants 
shows the absence of a phenotype due, for instance, to the presence of a counter-
part duplicate gene. Both functional and systemic robustness are described in 
TIF1 and TIF2 genetic networks, with references of physical interactions but also 
regulatory connections. The goal of the research presented here was to 
investigate the networks associated with translation initiation. It soon became 
evident that the network displayed a relatively limited level of redundancy. 
Erosion of backup capacities has been described as an unavoidable process (Li, 
2010); the extent to which their ancestral genes managed to conserve the 
ancestral functional redundancy of the TIF1 and TIF2 genes has been conserved 
appears rather limited. This observation can be explained by the theory that 
duplicate pairs exhibit a functional backup ability which is limited to certain 
conditions and environments (Flintoft, 2007) and full functional redundancy 
between duplicate pairs is generally not mandatory. Indeed, the TIF1 and TIF2 
paralogous still share an essential subset of functions to achieve genetic 
buffering. It may be informative to consider GLG1 (neighbouring gene to TIF1) 
and GLG2 (neighbouring gene to TIF2) a duplicate pair which share 43% identity 
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between duplicates. Given neighbouring relationship of TIF1/2 and GLG1/2 has 
been preserved, these pairs of paralogs went through the same duplication 
event, suggesting that although there has been opportunity to diverge for TIF1 
and TIF2, they have resisted change. 
 
The average number of interactions per query strain has been reported to 
be thirty-four per screen and except for very few examples, the majority of the 
strains place around this value (VanderSluis, 2010). The genetic network 
surrounding TIF1 and TIF2 genes KO presents a more limited number of genetic 
interactions: the absence of phenotypic consequences could indicate robustness 
of the genetic network supported by gene redundancy and/or regulatory 
mechanisms able to reprogram the activity of the network nodes (Lesne, 2008) 
in the attempt to dynamically adapt to that specific condition.  
It is concluded that reliability of a cellular network is not necessarily due 
to the physical duplication of its components as it appears to be dependent on 
how well-coordinated the duplicate genes are between each other, along with the 
extent of connections within their own networks. This research shows how 
specific the interactions of singular paralogs are within their neighbourhoods of 
interacting genes and it strongly suggests that for some functional processes, the 
contribution of a specific paralog in controlling an essential function cannot be 
substituted as the responsiveness of the two duplicates is not interchangeable.  
 
2.41. SGA as a tool for evolutionary studies  
This investigation shed light on the evolutionary benefit to retain the 
duplicate nature of TIF1 and TIF2 paralogs. Apart from what can be considered a 
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relatively limited overlap, the two genes appear to have developed different 
cellular roles; remnants of their ancestral interactions have been preserved 
along their evolutionary paths, however, and range from response to alkaline pH 
to chromatin remodelling-related processes.  
The different genetic surroundings discovered for TIF1 and TIF2 paralogs 
showed how, within the same function, different competences can be developed 
and maintained in terms of interactions with particular subsets of genes. This 
appears true in the merged genetic network of the investigated pair of duplicates 
for the processes of translation and transcription. Although it is difficult to state 
with confidence whether TIF1 and TIF2 genes are exclusively retained for 
functional compensation or the presence of both help in fulfilling the 
requirement for dosage balance, data arising from this study suggests that 
functional compensation exists for these WGD duplicate pair, at least under 
certain conditions. It is conceivable that in some cases gene duplication could 
merely serve to increase the number of gene copies and thus the quantity of 
protein product produced, as seen in previous studies (Hughes & Friedman, 
2007). This feature of genetic profiles will be further investigated in the next 
chapter through an experimental approach that challenges the pair of paralogs in 
diverse environmental conditions.  
Genetic interactions identified as common for the pair of duplicates, 
strongly suggests that the duplicates’ functions used to be allocated in a single 
ancestral gene and it was only after duplication that the roles have been split. 
Although it appears less likely, one or more functions may have been performed 
by a different gene that was replaced or such function/s did not existed. (Wolfe & 
Shields 1997). It remains arduous to determine which evolutionary pathway 
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TIF1 and TIF2 genes have endured, however, because of the prominence of 
transcription-related hits in tif2 SGA, it would be tempting to speculate that ORF 
YJL138C, also known as TIF2, is in fact the ancestral TIF gene. In the cellular 
interest, it seems conceivable that the majority of the expertise for transcription 
is to be preserved in the original gene copy. Endorsing this hypothesis is the 
finding that genetic connections with a subset of ORFs involved in the early 
meiotic gene expression are univocally allocated to TIF2 gene. This latter result 
further infers that, in terms of regulation, the duplicates can respond to different 
types of circuits. On the other side, under the rationale that adaptation is the new 
copy’s key for survival, the opposite hypothesis is as much intriguing and 
envisions the possibility that, being gifted the transcriptional system, the new 
copy could have directly adjusted the level of transcription, in a way that 
possibly eased its evolutionary survival. As for others paralogs, in the case of 
TIF1 and TIF2, uncertainty remains on whether the fate of duplicate pairs could, 
to some extent, be influenced by their own gene interactions. 
A surprising outcome of studying tif1Δ and tif2Δ query strains was the 
wealth of information not found in the reported genetic interactions, including 
the ESCRT-0 complex, DUB modules, and ribosomal proteins, to cite some. 
Investigation on the modality through which the paralogs have split their 
functions may highlight a specialization of their roles not only between the 
paralogs but also regarding other genes that genetically interact with at least one 
of the duplicates.  
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2.42. Validation of the SGA study 
2.42.1. Small scale SGA 
This experiment was aimed to be an independent evaluation of the 
previously performed SGA. In this screen the mutants indicated by SESA as 
genetically interacting with one or both duplicates were manually arrayed from 
the Open Biosystems collection to generate an ad hoc YDS. This validation was 
expected to reproduce the combinations of double mutants highlighted by the 
SESA analysis in a more selective setting, where the number of “false positive” 
should be decreased. In this more thoughtfully selection wild type SL and 
frequent flyers strains were removed. 
Whilst the outcome of this experiment was at first glance surprising as 
very limited overlap between the results of the two SGA analyses was observed, 
this finding may be ascribed to a technical practicality. Whilst Boone’s set is used 
regularly and so thrown several times, the Open Biosystems library is not in such 
regular use and for this reason better conserved. Several consecutive 
thawing/re-freezing procedures may had influenced the viability of cells in the 
Boone’s array; the more robust set of strains in the Open Biosystems library may 
be less prone to synthetic sickness, giving a different profile to the potentially 
more fragile Boone’s array. It is our laboratory’s procedure to utilize daughter 
libraries of the Boone’s array with the aim of minimizing the described effect, 
this occurrence is not entirely to be ruled out. Although coherent with 
observation of linkage analysis and annotated literature, weak, the genetic 
interactions observed with the Open Biosystems were weak and this study will 
consider the results obtained with the Boone’s array only, as the yeast show 
better growth characteristics. 
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2.42.2. Tetrad analysis 
With the aim to confirm genes identified in the Boone’s SGA, RSA was 
used to ascertain the genotype of meiotic products, however, the indications 
obtained from the RSA were extremely ambiguous (section 2.31.1.1).  This may 
be in some measure ascribed to the nature of S. cerevisiae spores to stick to one 
other, characteristic that makes dispersion of the spores and the assessment of 
their growth, quite devious in comparison to S. pombe (Lundblad & Struhl, 2010). 
Seeking for a more rigorous verification, the genes of interest were tested 
through tetrad dissection. Not all the selected strains returned the SL suggested 
by the primary screen, a fraction of them due to low sporulation efficiency, an 
essential factor for the successful accomplishment of tetrad dissection and/or 
inviability of the spores.  
 
2.42.3. Potential and limitation of an SGA approach  
The SGA approach has proven useful in characterizing the function of the 
two duplicate genes TIF1 and TIF2 and also for uncovering interactions between 
the genes of interest and others (Tong & Boone, 2006). The use of SGA 
methodology in the investigation of the genetic surrounding of a gene holding a 
duplicate counterpart can be enormously informative; however it still 
encounters a number of limitations and problems.  As in a “singleton” gene SGA 
screen, the phenotype revealed for the KO of interest is likely to portray not 
merely the absence of the query gene but also the response of the whole cell 
system to the lack of that gene. Mechanisms associated with such a response 
have been suggested to engage in altered regulation of other genes and re-
allocation of metabolic fluxes (Fischer, 2003a; Kafri, 2005). A study on plasticity 
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of genetic interactions, conducted by a joint effort in between the Universities of 
Manchester and Oxford, revealed how numerous S. cerevisiae genes contribute to 
fitness under some but not all lab-reproducible environmental conditions, 
leading to speculation on the number of genes that still remain to be linked to a 
particular function or pathway due to the non-appearance of a detectable 
phenotype under certain environmental circumstances (Harrison, 2007). 
Moreover, in duplicate gene deletion screens the occurrence of compensation 
mechanisms (e.g., functional redundancy, gene-dosage effect) cannot be excluded 
and results should be considered only partially informative of the array of 
interactions characterizing the query gene network. As humorously stated by A. 
Meyer in his Duplication, duplication view assay (Meyer, 2003), ‘such genetic 
redundancy is a headache for researchers’ as while trying to determine the 
effects of a missing gene, the system faces the issue of other genes (and 
pathways) buffering the genome against such adverse conditions. Not the entire 
set of possible lethal interactions will be represented, with the biological system 
functionally backed up by other interacting genes possibly involved in 
alternative pathways. Peculiarly, the genetic panorama neighbouring TIF1 and 
TIF2 genes is even more intricate as a result of their common protein product 
(Tifp): removing one gene leaves the system with the contribution given by the 
other.  
Furthermore, there are indeed some genes whose deletions suffer in the 
first place: if a yeast deletion strain presents a “weak” phenotype to start with, 
combination with another such strain could arise synthetic sick or lethal double 
mutants. In other words, the eventual no growth phenotype could be ascribed to 
an inability to tolerate further insult which may, or may not, have an 
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underpinning functional relationship. Despite having many advantages, such as 
large-scale and high throughput identification of synthetic lethal interactions, 
SGA also has several downsides. The percentage of false negatives (Tong, 2004) 
is estimated to be approximately 17%. A further way of confirming the 
interactions highlighted by SGA is advised. Tetrad analysis is often conducted in 
order to confirm the interactions by looking at the segregation patterns of the 
genes. Overall, successful outcome of our and others’ studies (Tong, 2001; 2004) 
reinforce the concept that studying of mutant phenotypes is a fundamental 
method for understanding gene function.  
Given the problems associated with the SGA technique identified above 
(e.g., false positives, pathway compensation to mask true interactions and 
sickness or lethality arising without underlying functional relationships), it is 
advisable to design complementary experiments that can compensate and/or 
integrate SGA-derived results, adding pieces of information to our network of 
interactions. Experiments might include, over expression constructs, 
environmental challenges, and the use of chemicals and consideration of 
promoter systems.  This latter approach is described below. 
 
2.43. Significance of the promoter regions 
As previously mentioned, the TIF1 and TIF2 genes present essentially the 
same ORF, with the exception of very few substitutions; this particular feature 
suggests that differences in their genetic interactions are likely to be derived 
from their regulation. The promoter for a gene whose protein product is involved 
in an essential cellular process, such as eIF4A, will have to be able to respond to a 
diverse range of cellular requirements. It is possible that a single promoter 
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sequence would be unable to carry effectively a full range of transcriptional 
controls. In these circumstances, the retention of identical duplicates bearing 
differential promoter or terminator sequences becomes evolutionarily 
advantageous. This highlights the importance of the promoter regions and 
associated transcription factors. In this context, Kafri (2005) showed that 
dispensable paralogs have highly correlated expression in a few conditions but 
not in most (Kafri, 2005). This it is not important whether two genes are co-
expressed under normal conditions but rather that at least one of the paralogs is 
expressed at an adequate level under a diverse array of conditions, which could 
include the loss of functionality of one of the paralogous genes (Kafri, 2005).  
 
2.43.1. Tet-titratable promoter 
Outcomes of this experiment, even if limited, underline the relevance of 
the promoter regions in TIF1 and TIF2 pair of duplicates. Whilst insertion of a 
promoter cassette into a strain bearing a deletion for one of TIF genes is 
technically achievable, insertion of the tetO2-“off” cassette in the region upstream 
the coding region of either resulted in slowly growing mutants that were 
therefore reliable for undergoing SGA analysis. This implies that the promoter 
regions of TIF1 and TIF2 are very delicate and highly important for the cellular 
well-being. A salient result is the finding that repression by doxycycline is 
different depending on whether rich (YPD) or minimal (SD) medium was used. 
This observation recalls an effect previously observed in Hillenmeyer’s study 
(2008) in which tif1Δ and tif2Δ strains scored, which growth in drug-free SC 
media among the top 10 conditions inducing sensitivity (for fairness it needs to 
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be pointed out that this phenomenon was observed utilizing an homozygous 
YDS). 
In this study, the small number of tetO2-off strains in which repression of 
the promoter worked properly was quite low. It remains interesting to observe 
how different clones showed different degrees of repression in presence of 
doxycycline.  As the regulation of this system is dependent on two elements -the 
inducible promoter and the transactivator- there is the possibility that the 
regulation is troubled by interferences relating these two elements, a fault that 
could become exacerbated in a translationally impaired tifΔ background.  
Although the concentration of doxycycline required for partially 
repressing the transformed strain was higher than the one utilized in the original 
paper, this would not represent a major issue. It is widely accepted that 
doxycycline is innocuous to yeast as not only are there no obvious phenotypic 
effects observed when it is added to growth media to control promoter 
expression but also this drug has no significant effect on global transcription 
levels (Wishart, 2005). 
Although the issue of the promoter possibly being refractory to 
recombination should have been fixed with attent design of the flanking regions, 
there is still the possibility that the insertion of the promoter cassette itself leads 
to lethality, for instance by mis-expressing the gene when the tetO2 promoter is 
“on”. Furthermore, there is the possibility that the insertion of the tetO2 cassette 
may be sterically problematic. 
 
2.43.2. Galactose over-expression promoter 
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Insertion of the GAL overexpressing cassette in place of the native 
promoter resulted in the disruption of the activity and regulation of the “wild-
type” TIF1 and TIF2 genes promoters. This experiment did not lead to the 
generation of viable constructs as explained in section 2.33. 
 
It is well understood that isolated studies on system single components 
have a limited investigative value and are uninformative on the complexity 
surrounding biological systems, whilst more valuable information is revealed by 
investigating the connections between constituents of the system that will 
ultimately display the phenotype associated with a particular deletion or 
condition. This study contributes to the understanding of the mechanisms of 
duplication and attempts to elucidate evolutionary processes acting on the S. 
cerevisiae genome. Future studies of systems biology, such as population 
genomics and genome evolution, are likely to see the budding yeast as the 
organism of choice. The genetic profiles generated in this research may provide 
even greater value when integrated with other experimental outcomes, 
contributing this way to the reconstruction and assembly of connection patterns 
among networks. Integration of non-essential genome SL results with protein-
protein interaction analyses, and microarray mRNA profiling could enable 
construction of a highly wired network, which would be advantageous not only 
for evolutionary studies but also for the understanding of higher eukaryotes’ 
biology and genetic diseases traits. 
Further investigations into the robustness of the translation initiation 
process with respect to a given class of perturbations will be discussed in the 
next chapter. 
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3. Chapter 3  
 
This chapter describes the use of the chemical and environmental 
perturbation, primarily treatment with the lithium ions, to complement the TIF1 
and TIF2 genome-wide screen results presented in Chapter 2.  In addition to 
furthering our understanding of the TIF1 and TIF2 networks, it was hoped that 
the study might formulate an explanation on how augmented translation 
initiation overcomes lithium toxicity.  Finally, a global interpretative picture of 
wide-scale information is assembled in a network context, where the duplicate 
nature of TIF1 and TIF2 genes is analysed to unveil the evolutionary path they 
have gone through as paralogs. 
 
3.1. Introduction 
Discussion on the significance of the genetic interactions considered in 
the previous chapter has shed light on the differences and similarities between 
the pair of duplicate genes TIF1 and TIF2.  Due to these paralogs’ essential 
nature, an exhaustive understanding of their genetic connections is difficult to 
resolve by exclusively genetic means, as the double mutant is not viable. A set of 
complementary studies is required to augment the knowledge generated 
through the SGA screen and this was partially addressed in the previous chapter 
with the use of promoter-modulable constructs and by testing the pair of 
duplicates through a range of chemical and environmental challenges. This third 
chapter will focus on the exploration of Tifp function in consideration of the 
interactions highlighted by chemical perturbation with the lithium ion. Although 
it was not the first intended focus of this research, the study described in the 
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current chapter has the potential to provide information relating to the mode-of-
action and toxicity of the lithium ion itself.  
The essentiality of translation initiation is reflected in the genetic 
networks of TIF1 and TIF2, which encompass many and distant cellular 
processes. The extent of these connections is so vast that, for some of the cellular 
events described in the literature in which initiation of translation has been 
established to be involved, the exact mechanisms remain to be elucidated. Still 
enigmatic, for instance, is the finding that the translation process is inhibited by 
the chemical LiCl at the initiation step (Montero-Lomeli, 2002). In yeast this 
appears to be true only when galactose is the sole carbon source, as revealed by a 
polysome analysis showing an accumulation of 80S monosomes for yeast cells 
incubated with 6 mM LiCl in galactose (Montero-Lomeli, 2002); immunoblot 
analysis data from the same study also showed Tifp did not sediment with the 
ribosomal subunits. Over-expression of the TIF2 gene, however, was shown to 
overcome protein synthesis inhibition and restore Tifp sedimentation with the 
initiation complex, in this way conferring lithium tolerance in a galactose 
containing medium (Montero-Lomeli, 2002). The same research group had 
previously shown that, in S. cerevisiae, lithium toxicity is highly dependent on the 
carbohydrate source utilized to ensure growth (Masuda, 2001): when glucose is 
the carbon source of choice, the IC50 for lithium is 100 mM, whilst it lowers to 6 
mM, if galactose is utilized instead. To elucidate whether the inhibition of protein 
synthesis in cells grown in media containing lithium and galactose takes place 
through the same mechanism established for glucose starvation (Martinez-
Pastor & Estruch, 1996), Masuda’s group studied whether both experimental 
conditions lead to the dissociation of Tifp from the preinitiation complexes. 
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Interestingly, glucose starvation still leads to a loss of polysomes but not to 
dissociation of Tifp from the preinitiation complexes, strongly suggesting that 
the translational response to lithium treatment in galactose-grown cells is 
different from the response to glucose starvation; this statement is further 
validated by the observation that overexpression of Tifp does not reverse the 
inhibition on initiation of translation under glucose starvation (Montero-Lomeli, 
2002). 
 
3.2. Galactose and the Leloir pathway 
The utilization of galactose, a simple hexose sugar and the carbon source 
of choice for this study, is more complicated than glycolysis. The galactose 
metabolic pathway was revealed by the biochemist L. Leloir (1906-1987), whose 
studies on carbohydrate metabolism gained him the Nobel Prize in Chemistry in 
1970, in part for his significant contribution to the elucidation of the genetic 
disease galactosemia. 
The process Leloir helped elucidate is named after him and occurs 
through several steps (Figure 3-1) which ultimately allow galactose to enter 
glycolysis by its conversion to glucose-1-phosphate (Glu-1-P).  
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               Figure 3-1. Galactose pathway. Adapted from Masuda (2001). 
 
 
Initially, galactose is phosphorylated by the ATP-dependent galactokinase 
enzyme (GK) (encoded in yeast by the GAL1 gene) to produce galactose-1-
phosphate (Gal-1-P); this is then processed by galactose-1-phosphate 
uridylyltransferase (GALT) (encoded in yeast by the GAL7 gene) which catalyses 
the exchange of the phosphate of Gal-1-P and the UDP-group of UDP-glucose, 
leading to concurrent production of glucose-1-phosphate and UDP-galactose. The 
Glu-1-P produced by the transferase reaction is a substrate for the 
phosphoglucomutase (PGM) enzyme (encoded in yeast by the yeast genes PGM1 
and PGM2) which reversibly converts it into glucose-6-phosphate (Glu-6-P), 
while the other transferase product, UDP-galactose, is epimerized to UDP-
glucose by UDP-glucose-4-epimerase (GALE) (encoded in yeast by the GAL10 
gene). 
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The importance of the PGM-catalyzed step is crucial as it ultimately allows 
the transformed galactose to be utilized in the generation of cellular energy and 
consequently PGM is an essential enzyme for galactose metabolism (Boles, 
1994). It is at this step along the Leloir pathway that the action of lithium affects 
the cellular system: the ion is toxic to yeast when grown in galactose medium, 
mainly due to the inhibition of PGM (Figure 3-1) an enzyme which lithium 
inhibits in yeast (IC50 about 0.2 mM) and also in human (IC50 about 1.5 mM) 
(Masuda, 2001). The yeast paralogous genes PGM1 and PGM2 are responsible for 
encoding these key isoform enzymes, Pgm1p and Pgm2p, with Pgm2p accounting 
for 90% of the total PGM activity (Oh & Hopper, 1990). A third isoform of Pgmp 
has recently been named: following experimental evidence which suggests that 
YMR278W ORF encodes a protein product with phosphoglucomutase activity 
that takes part in the interconversion of Glu-1-P and Glu-6-P, the aforementioned 
ORF was named Pgm3p (Tiwari, 2008). In general, lithium inhibits the activity of 
enzymes by competitively displacing magnesium from its binding site (Ray, 
1978): this is also the case with the inositol phosphatases and fructose 1,6-
bisphosphatase enzymes, that all share a magnesium-binding domain (York, 
1995). Although, the magnesium-binding domain of both Pgm1p and Pgm2p 
(collectively referred as Pgmp) differ from these enzymes, lithium still 
competitively displaces the bivalent cation from its binding site on Pgmp, thus 
reducing its enzymatic activity (Masuda, 2001). 
Galactose toxicity is found in humans as an autosomal, recessive genetic 
disorder named galactosemia. S. cerevisiae is an appropriate model system for 
studying galactose toxicity (Metha, 1999) and galactosemia (Riehman, 2001), 
and an increased understanding of galactose metabolism may further lead to a 
220 
 
better comprehension of the metabolic events resulting in galactose-induced 
toxicity, an effect observed both in yeast strains and galactosemic patients. 
Several forms of this disease exist, all sharing an impairment of the normal 
processing of galactose; the most common and severe of which is caused by cells 
with genetic defects in the Gal-1-P uridiltransferase GALT (yeast GAL7) and is 
known as classic galactosemia (type I). Mutations in the galactokinase GALK1 
(yeast GAL1) and the epimerase GALE (yeast GAL10) encoding genes lead to 
galactosemia types II and III respectively. The clinical outcomes of this disease 
range in severity and it can lead to poor growth, hepatomegaly and/or jaundice; 
symptoms which disappear if the patient is kept on a galactose-free diet. 
However, there is the possibility that these individuals will suffer life-threatening 
neurological disturbances and possibly premature ovarian failure. For long time 
Gal-1-P was believed to be the only toxic intermediated (de Jongh, 2008) but 
evidence has been collected and it seems that Pgmp inhibition by Gal-1-P has a 
role in toxicity, however, the ratio between the concentration of Gal-1-P and 
galactitol together with the accumulation of galactitol could be the cause of the 
toxic effects instead, at least according to a study undertaken in mice (Ning, 
2001). 
 Yeast strains lacking the major isoform of phosphoglucomutase (PGM2) 
accumulates a high level of Glu-1-P and this mimics phenotypes resulting from 
an altered Ca2+ homeostasis, when galactose is utilized as the carbon source (Fu, 
2000), such as an increase in Ca2+ uptake and accumulation and sensitivity to 
high environmental Ca2+ levels. Unlike in mammals, a Glu-6-P transporter able to 
stimulate Ca2+ sequestrating into ER or Golgi has not yet been identified in yeast; 
Glu-1-P, however, has been shown to plays a role in yeast Ca2+ homeostasis (Fu, 
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2000). An extensive work done by Aiello and colleagues showed convincing 
evidence for a coupling mechanism between the cellular Ca2+ homeostasis and 
the levels of Glu-6-P and Glu-1-P in S. cerevisiae (Aiello, 2002). This 
demonstrated that Ca2+ homeostasis defects arising in the pgm2Δ strain are 
specific to accumulated Glu-1-P; furthermore, it was shown that an increased 
synthesis of Glu-1-P and not the sugar nucleotides derived, UDP-Glu, influences 
Ca2+ homeostasis and that although Glu-6-P has an effect on this process, it is 
distinct from the one involving Glu-1-P (Aiello, 2002). 
 
3.3. Calcium homeostasis  
Calcium homeostasis in eukaryotic cells is a complex process involving 
the regulated internalization and sequestration of calcium ions into a variety of 
locales. The basic mechanisms that mammals and yeast use to carry out this 
process are similar, and the cytosolic Ca2+ concentration in both types of cells is 
normally in the range of 50-200 nM (Iida, 1990; Miseta, 1999). In yeast, 90% of 
Ca2+ is stored in the vacuole (Halachmi & Eilam, 1989) where Ca2+ is complexed 
with vacuolar polyphosphate in a relatively stable form referred to as the non-
exchangeable Ca2+ pool. This name is derived from the fact that vacuolar Ca2+ 
exchanges with the environment more slowly than Ca2+ located in either the cytosol 
or other intracellular compartments (Cunningham & Fink, 1994b). Along with the 
vacuole, the ER and Golgi are also important for maintaining proper intracellular 
Ca2+ homeostasis in yeast. In these organelles the concentration of Ca2+ is 
carefully maintained to ensure the proper folding and processing of proteins 
transported through the secretory pathway. In mammals, the ER serves as a 
store for a readily mobilized source of Ca2+ for use in Ca2+ signalling. Upon 
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stimulus, ER Ca2+ stores can be released to generate a momentary increase in the 
cytosolic Ca2+ concentration which will then activate various signalling pathways 
(Putney, 1992). In non-excitable cells, the release of Ca2+ from the ER has been 
proposed to lead to a store depletion signal and consequential influx of Ca2+ 
cations across the plasma membrane in a process known as capacitative Ca2+ 
entry (CCE). CCE amplifies the transitory increase in cytosolic Ca2+, initiated by 
its release from the ER, and ultimately serves as a source of cytosolic Ca2+ for 
refilling the depleted ER Ca2+ store (Parekh & Penner, 1997). The variation in the 
Ca2+ concentration in the cytosol generated upon a stimulus activates a variety of 
Ca2+-sensing proteins such as calmodulin and calcineurin, which ultimately leads 
to the induction of various downstream signal transduction pathways (Putney, 
1992).  
Loss of PGM2, the gene that contributes most to the phosphoglucomutase 
activity in S. cerevisiae (see section 3.2), results in a significant increase in the 
cellular Glu-1-P:Glu-6-P ratio when cells are grown in a medium containing 
galactose as the carbon source. Importantly, this imbalance in metabolites was 
shown to also cause a six- to nine-fold increase in cellular Ca2+ accumulation. 
Lithium inhibition of Pmgp causes a similar elevation of cellular Ca2+ in medium 
containing galactose, but not glucose, as sole carbon source (Csutora, 2005); this 
lithium-induced Ca2+ over-accumulation has been shown to be significantly 
reduced in a yeast strain lacking the vacuolar Ca2+-ATPase Pmc1p,  suggesting 
that lithium inhibition of Pgmp results in an increased Glu-1-P:Glu-6-P ratio, 
which is associated with an accelerated rate of Ca2+ uptake by the vacuolar 
compartment,  mediated by the Ca2+-ATPase Pmc1p (Csutora, 2005) . 
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3.4. The TOR pathway  
Sit4p, a putative Ser-Thr phosphatase, was successfully cloned and, as 
shown for Tifp, when over-expressed confers lithium tolerance in galactose 
medium (Masuda, 2001) and it also appears to have a protective effect on 
translation initiation from lithium-induced inhibition (Montero-Lomeli, 2002). 
Although both inhibition of glycolysis by lithium and glucose deprivation lead to 
inhibition of protein synthesis (Ashe, 2000; Montero-Lomeli, 2002), only the first 
mechanism seems to be associated with SIT4, as overexpression induces 
recovery of protein synthesis when cells are cultured in galactose in the presence 
of lithium but not in a glucose-deprived environment (Montero-Lomeli, 2002). 
These results suggest that each treatment could be responsible for inducing a 
separate mechanism of inhibition of protein synthesis. 
 In baker’s yeast, the type 2A-like protein phosphatase catalytic subunit of 
Sit4p functions together with its regulatory subunit Tap42p downstream of the 
rapamycin-sensitive TOR (Target Of Rapamycin) complex 1 (TORC1) to mediate 
several Tor signalling events and to control mechanisms of responses to nutrient 
levels and events required for the physiological G1 to S phase cell cycle transition 
and budding (Fernandez-Sarabia, 1992). Sit4p-mediated TOR signalling 
functions via Sap-Sit4 complexes and helps in coordinating both transcription 
and translation mechanisms that connect cellular growth to the availability of 
amino acids (Rohde, 2004). The TOR pathway is known to have overall effects on 
the translation machinery of both mammalian and yeast cells, as amino acid 
starvation or use of the TOR inhibitor rapamycin (Rap) quickly inhibits the 
synthesis of the ribosomal components.  
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A link between TOR-mediated signalling and lithium sensitivity has also 
been established by studies on both S. cerevisiae and C. albicans, where deletion 
of one of the components of the TORC1 complex, Tco89p, induces sensitivity to 
both lithium and Rap (Zheng, 2007); this latter drug has been shown to inhibit 
translation initiation indirectly by inhibiting TOR. This results in the 
phosphorylation of numerous translation initiation factors, which ultimately 
prevents cap-dependant translation initiation in an indirect way (Crespo & Hall, 
2002). This particular aspect of inhibition of the translation initiation process 
has been recently regarded with increasing interest in the use of specific cap-
dependant translation inhibitors as anti-neoplastic drugs, given the over-
expression of numerous eIF4F components revealed in a number of cancer 
conditions (Lindqvist & Pelletier, 2009), and the role of translation initiation as 
the major point of translational control (Sonenberg & Hinnebusch, 2009). One of 
the hypothesised mechanisms of translational regulation goes through the 
phosphorylation of the cap binding protein eIF4E which plays an important role 
in regulating its affinity for the cap. On the other hand, eIF4E binding proteins 
(4E-BPs, which are Eap1p and Caf20p in yeast) bind to eIF4E and thereby abolish 
the interactions between eIF4E and eIF4G thus blocking ribosome recruitment to 
the mRNA (Poulin, 1998). In mammalian systems, the binding of 4E-BPs to eIF4E 
is regulated by phosphorylation: hypophosphorylated 4E-BPs bind to eIF4E 
whilst hyperphosphorylation blocks their binding to eIF4E. Many different 
extracellular signals have been shown to influence the hyperphosphorylated 
status of 4E-BPs (Gingras, 1999) such as hormones, growth factors and mitogens, 
nutrient deprivation and certain types of stresses such as treatment with the 
immunosuppressant Rapamycin. The conserved TOR signalling pathway appears 
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central to the regulation of 4E-BP phosphorylation (Teleman, 2005) as TOR is 
activated in response to a variety of stimuli that eventually lead to 
phosphorylation of 4E-BPs and other factors promoting cap-depend translation 
(see sections 1.8.1 and 2.4 for an overview of translation initiation). 
 
 
3.5. Lithium  
Lithium was discovered in 1817 by Swedish chemist J. Arfwedson, during 
analysis of the mineral petalite he was conducing in J. Berzelius’ lab; it was 
Berzelius who gave the mineral its name after the Greek word 'lithos' which 
means ‘stone’, as it was found to be quite abundant in a large number of igneous 
rocks and many mineral springs. 
Although we cannot state with accuracy when lithium was first used for 
medical purposes, historical evidence suggests that between the 5th and 2nd 
centuries B.C. Roman and Greek physicians would treat manic patients with 
alkaline waters available in loco, waters which are now known to contain very 
high levels of lithium salts (Kline, 1969). It was the Australian psychiatrist J. Cade 
in the mid-20th century who first discovered the role of lithium in controlling 
bipolar disorder, while running experiments with a compound he believed was 
the cause of manic behaviours: the uric acid. To prove his theory, Cade injected 
this substance into guinea pigs and chose lithium urate for its high solubility. 
Surprisingly, administration of lithium had a calming effect on the animals, 
instead of the expected increased excitation. Following experiments on both 
guinea pigs and humans proved that lithium had an effect on mania-depressive 
(or bipolar) disorder. Cade published the results of his work in the landmark 
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paper, Lithium salts in the treatment of psychotic excitement (1949) and shortly 
after, the psychopharmacologist R. Fieve was pioneering lithium clinical trials in 
the United States. By the late 1960s, the interest in this medication for bipolar 
disorders treatment among the world medical community was very solid and by 
the 1970s the FDA had approved lithium as a prescription medication. 
Bipolar disorder is a severe psychiatric condition with a strong genetic 
component and unknown pathophysiology with clinical manifestations afflicting 
5% of the general population (Sümegi, 2008). It results in heavy social and 
economical costs on society. Current medications used for its treatment are 
associated with variable rates of efficacy and often intolerable side effects. 
Although lithium is nowadays the oldest mood stabilizer available on the 
pharmaceutical market and its exact mechanism(s) remain(s) unknown, it is still 
commonly used clinically either alone or in combination with valproic acid or 
carbamazepine. Lithium is efficacious in the maintenance phase treatment of 
bipolar disorder, with evidence supporting an additional beneficial effect which 
prevents recurrence of mania; it is however less clear, if lithium prevents 
depressive episodes in bipolar disorder (Young, 2006). Lithium use has also been 
proposed for treatment of other neurodegenerative conditions by virtue of its 
stabilizing neuroprotective effect (Csutora, 2005), confirmed by evidence in the 
literature that links lithium and other mood stabilizers to an enhancement of the 
expression of the antiapoptotic gene BCL-2 (Zarate, 2006), suggesting a likely 
neuro-protective role for this medication. Its antimanic, antidepressive, and 
potentially anti-suicidal effects could make it suitable for the treatment of an 
expanded set of neurological and neurodegenerative diseases (Yu, 2012). This 
approach is endorsed by the encouraging finding that lithium exploits a 
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protective effect on neurons against β-amyloid-induced neurodegeneration by 
preventing the enhanced phosphorylation of tau proteins (Alvarez, 1999), and 
thus it could find an application in the Alzheimer’s disease treatment strategy. 
Furthermore, lithium may be applicable to Huntington’s disease therapy as it has 
been shown that it robustly protects neurons in the striatum (Chung, 1999). As 
lithium hits several targets, an extensive understanding of how this drug 
interacts with them is urgently needed to successfully integrate current 
knowledge on lithium’s mode of action; this would also be beneficial to address 
issues like combinatorial therapies, development of strategic lithium-alternative 
medications, the role of BCL-2 in lithium’s effects and amelioration of the side 
effects.  
 
3.6. Yeast as a model for neurodegenerative disorders 
The study of neurodegenerative disorders relied for a long time on post-
mortem neuropathologic observations until findings of mutations and misfolded 
proteins responsible for diseases encouraged molecular genetic probes, 
promoting the development of cellular and animal models. The high degree of 
conservation in cellular processes between yeast and higher eukaryotes has lead 
to the use of this simple organism as a reliable system for studying basic 
mechanisms underlying human diseases (section 2.3). The possibility of 
modelling neurodegenerative conditions has also been explored, unveiling the 
enormous potential of S. cerevisiae to provide insights into cellular pathways 
underlying such pathologies and their mode of action, along with elucidation of 
the toxicity of the drugs utilized in their treatments. Limitations exist in the use 
of yeast for such studies. The most obvious among all is the investigation of 
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aspects of multicellularity and cell-cell interactions, such as immuno-
inflammatory responses and diverse kinds of transmissions as synaptic signals 
and glia-neuron connections. Even though molecular processes may appear 
distant between human and S cerevisiae, and it can be argued that some 
mammalian functions have diversified or indeed never had a yeast counterpart, 
this monocellular organism is still representative of the majority of cellular 
mechanisms possessed by neuronal cells. This is particularly true for yeast cells 
in stationary phase that are not dividing and therefore experience a similar 
context to the brain neurons (Chen, 2005). Neuronal cells cannot attenuate 
cellular insults (for instance, the accumulation of damaged proteins, oxidative 
stress, proteasome impairment and the build-up of mutations) and neither can 
yeast; the effects of a challenge cannot be diluted out via cellular division by 
either organism. 
 
3.7. Further therapeutic  and commercial benefits 
Great advancement in the understanding of the genetic and biochemical 
pathways underlying neurodegenerative disorders has been achieved (reviewed 
in Bertram & Tanzi, 2005), however, in certain cases the treatments for these 
pathologies are still not satisfactory and the side effects associated with the 
therapies are highly undesirable. The identification of specific mechanisms 
involving a drug of interest is of extreme importance to resolve whether side 
effects are caused as a consequence of interactions with the primary target(s) or 
arise from off-target interactions. Elucidation of this extremely complicated 
scenario would consequently make any attempt of modifying and improving the 
performance of a drug more feasible.  
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Although there are many pathways held in common between all yeast 
strains, and indeed between yeast and other eukaryotes, there are metabolic 
differences in the production and utilization of the substrates between different 
strains and organisms. For example, elucidation of the regulatory underlying 
mechanisms underlying energy metabolism is crucial for understanding the 
general principles of carbohydrate regulation but also it is of valuable for the 
biotechnology industry, where capabilities of specific yeast strains could be 
taken advantage of. Insights into galactose metabolism in S. cerevisiae may open 
opportunities for designing strains that have improved galactose uptake, which 
is relevant for the industrial uses that need to enhance growth in galactose 
containing medium (Ha, 2011) and increase yields to ultimately optimize large 
scale processes.  
 
3.8. Chemical genetic screening 
There is diversity in the way in which a biological phenomenon is 
investigated using genetic approaches and the choice of a particular screen will 
determine the perspective from which the cellular process of interest will be 
explored. With the purpose of achieving a global understanding of a complex 
biological process, such as translation initiation, a set of complementary 
approaches has been used along with a genome-wide screen on genes KO 
(chapter 2). Chemicals and environmental conditions have been used as 
modulators of gene activity (Parson, 2004, 2006; Hillenmeyer, 2008). Budding 
yeast is particularly suitable for applications such chemical genetic probes on a 
genome-wide scale, where targeting of the gene at the protein level is achieved 
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by using small molecules to induce phenotypic changes in organisms (section 
2.5). 
The field of chemical genetics is based on the principle that small 
molecules can mimic the effects of genetic mutations: for example, a loss-of-
function mutation in the gene encoding a compound target may be mimicked by 
an inhibitory compound and vice versa. Deletion strains identified in a chemical 
genetic screen as sensitising to a compound will correspond to loss of genes 
encoding proteins which function in pathways that buffer the cell from the 
growth inhibitory effect of the compound. This information about pathways that 
are required to buffer an inhibitory effect may be especially useful when the 
specific target(s) of the compound are unknown (Parsons, 2004, 2006). This 
comparison is not, however, an aim of this research as, TIF1 and TIF2, the genes 
investigated through the SGA (chapter 2) are not known targets of lithium.  
Interactions between lithium and particular cellular processes revealed 
through a chemical genetic screen should help to elucidate the relationship 
between this drug’s mode-of-action, toxicity and translation initiation. The 
fundamental principle assumed in the study of chemical genetics (Parsons, 2004; 
2006; Hillenmeyer, 2008) is that a small perturbagen molecule can specifically 
bind to a gene product and disturb its function(s), mimicking a mutation in the 
corresponding gene. In other words, interactions of an epistatic nature between 
a mutant and a small molecule can be defined and further utilized to characterize 
genetic interaction networks. 
Although the TIF1 and TIF2 genes are not targets of lithium, over-
expression of the TIF2 gene has been shown to protect yeast cells from this 
drug’s toxic effect, as introduced in section 3.1.  Lithium was thus the compound 
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of choice to investigate the processes associated with the Tifp proteins, as the 
lithium ion is known to interact with translation initiation. It would have been 
difficult to obtain such a level of understanding of Tifp function by limiting our 
investigation to a gene-based perturbation only as presented in chapter 2. A side 
benefit from use of lithium to probe the Tifp is that additional meaningful 
information could emerge from this experimental approach in regards to the 
mechanism and toxicity of lithium. 
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3.9. Aim and objectives 
The aim of the work presented in this chapter is to improve further our 
understanding of the evolutionary benefits underlying conservation of a single 
protein product eIF4A (referred to below as Tifp, the protein product of the TIF1 
and TIF2 genes) through chemical and environmental perturbation, 
complementing the genetic approaches presented in chapter 2.   
In addition, as the lithium ion was selected as a key perturbant, it was 
hoped that the study might formulate an explanation on how augmented 
translation initiation overcomes lithium toxicity and provide information on the 
detailed mechanism of action of lithium ion treatment. Finally, a global 
interpretative picture of wide-scale information is assembled in a network 
context, where the duplicate nature of TIF1 and TIF2 genes is analysed to unveil 
the evolutionary path they have gone through as paralogs. 
 
To achieve these aims, a set of experiments will be undertaken: 
 Assess a concentration of the lithium ion that provides a 
modest growth defect in wild type strains with galactose as 
carbon source. 
 In a high throughput assay, treat the YDS with lithium ions 
in galactose at chosen concentrations, and identify sensitive 
and resistant deletion mutants. 
 Validate the high throughput assay results of selected 
deletion mutants, and thereby reveal pathways associated 
with lithium/galactose activity. 
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 Undertake a pilot study of to identify perturbating 
conditions that may be useful in evaluating the differences 
in use and regulation of the TIF1 and TIF2 genes.   
 Compare the functional redundancy and robustness of TIF1 
and TIF2 paralogs, emphasizing any similarity or specificity 
in their regulation. 
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3.10. Methods 
This section reports materials and methods for a first set of experimental 
procedures involving the use of lithium to assess mechanisms of translation 
initiation involved in resistance to this drug and a second investigation into 
diverse environmental and chemical challenges, aimed to test the robustness of 
the duplicate genes of interest. 
 
3.11. Yeast strains 
 
3.11.1. Lithium experiment 
Two sets of non-essential S. cerevisiae deletion strains were utilized in 
this investigation: the first set was kindly gifted by C. Boone’s laboratory 
(method 2.9.1), while the second one was purchased from Thermo Scientific-
Open Biosystems (Huntsville, AL, USA) as a part of the YKO MATa homozygous 
diploid strain collection (Winzeler, 1999). Each deletion strain holds a MATa 
mating type in a BY4741 background and a genotype of his3Δ1 leu2Δ0 met15Δ0 
ura3Δ0. The wild-type surrogate strain for this study is the his3Δ::kanR strain, 
which is used as replacement of the HIS3 gene with the kanamycin resistance 
cassette has no significant effect on the fitness since BY4741 is auxotrophic, but 
provides a suitable control for experiments in which all deletion strains have a 
gene of interest replaced by a KanR.  
pTIF2tif1Δ strain carries TIF2 gene driven by an over-expression GAL11 2 
micron plasmid promoter in a tifΔ::URA background (this study) and was kindly 
donated by Dr J. Matthews, Chemical Genetics laboratory, Victoria University of 
Wellington. 
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3.11.2. Different environmental and chemical challenges 
The deletion strains tested under a range of experimental conditions 
include MATα tif1Δ::natR and MATα tif2Δ::natR (both generated in this study) 
and wild type MATα Y8025 (method 2.9.1). 
 
3.12. Growth media  
Yeast strains utilized in this experimental section were grown in one of 
the following media: YPD, SD and SC (method 2.9.4.2); YPGal and SGal media 
were also prepared following the same procedure but replacing the glucose 
carbon source with the same concentration of galactose. 
 
3.12.1. Stock solutions 
Lithium chloride 1 M stock solution was prepared dissolving lithium 
chloride powder in an appropriate amount of dd water, autoclaved and stored at 
room temperature. 
 Rapamycin (LC Laboratories) 0.1 mM, tunicamycin (Merck) 12 mM, 
cycloheximide (Sigma) 35 mM, DTT (Merck, Whitehouse Station, NJ, USA) 1 M, 
and caffeine (Sigma) 100 mM stock solutions were prepared by dissolving the 
drug in an appropriate amount of dd water (rapamycin, cycloheximide, DTT, and 
caffeine) or DMSO (tunicamycin) and then filter sterilizing and storing at -4 °C. 
ClonNAT and G418 were prepared and stored as described in method 2.9.3; 
acetic acid 1 M, hydrochloric acid 1 M, hydrogen peroxide 1 M, sodium hydroxide 
1 M, magnesium chloride 1 M and ethanol 90 % were stored at room 
temperature. 
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3.12.2. Solid growth  
3.12.2.1.  Lithium experiment 
The two sets of deletion strains utilized for the lithium chemical genetic 
screen and further spot assays were grown and maintained according to method 
2.18.8 i-b. 
After autoclaving, agar was cooled to 50 °C and LiCl was added from stock 
to both YPGal and YPD plates at final concentrations of 7, 15, and 30 mM. 
Lithium-free YPD and YPGal control plates were also prepared. 
Magnesium chloride was added to media as for lithium at a final 
concentration of 7, 15 and 30 mM. 
3.12.2.2. Different environmental and chemical challenges 
After autoclaving, agar was cooled to 50 °C and the drug of choice was 
added from stock at the concentration listed in method 3.14. 
 
3.12.3. Liquid growth 
All the strains utilized in these experiments were grown in YPD, YPGal, 
SD, or SGal medium supplemented with 200 µg/ml of G418 or 100 µg/ml of 
clonNAT, if required. 
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3.13. Lithium investigation 
 
3.13.1. Preliminary experiments 
 
3.13.1.1. Pilot study 
A pilot test to determine a window of working concentrations was 
undertaken. A few plates from Boone’s KO collection were pinned on YPGal 
medium containing LiCl at the final concentration of 7 mM, 15 mM, and 30 mM. 
Pinned colonies were incubated for 5 d during which photographic records were 
taken to assess the concentration of drug that inhibits colony growth. 
 
3.13.2. Chemical genetic screen 
Boone’s KO collection was pinned on PlusPlates (Singer Instruments, 
Somerset, UK) containing YPGal and LiCl at final concentrations of 7, 15, and 30 
mM. The same array was also pinned onto drug-free YPGal plates acting as 
controls.  
 
3.13.3. Data analysis  
Following a 48-h incubation at 30 °C, the sensitivity or enhancement of 
growth of each deletion strain featured in the Boone’s array was assayed by 
comparison to controls using Colony HT and SESA software (method 2.19). The 
program SESA generated a list of gene deletions strains whose growth was 
perturbed by lithium treatment in presence of galactose as sole carbon source 
compared to their control lithium-free medium.  Outcome includes a degree of 
statistical confidence grouped for simplicity under headings in “definitive”, 
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“probable”, and “possible” hits; visual assessment was also carried on plates to 
confirm the results generated by the software.  
 
3.13.4. Spot Assay  
Sensitive and suppressor deletion strains indicated by SESA as “probable” 
and “definite” hits underwent further testing through spot assays along with a 
set of additional selected deletions strains. These additional strains were 
selected on the basis of: i) Ambiguity in the original screen relating to the visual 
assessment of the plate image  and/or results reported by the software SESA; ii) 
a functional association with other deletions highlighted by the primary screen 
supported by literature; iii) a functional interaction held by one or more genes 
outlined in the first screen, for example genes which are part of the same 
complex; and vi) visual assessment identifying a phenotypic change in a deletion 
listed as “possible” hit (generally not considered in data analysis due to its low 
statistical significance).  
Selected yeast strains were individually grown at 30 °C into 96-well plates 
containing YPGal liquid medium supplemented with G418. Saturated cultures 
were diluted in a 96-well plate containing YPGal medium using a BioTek robotic 
liquid handler (Winooski, VT, USA). The liquid-to-solid phase transfer of the 
diluted strains was robotically achieved utilizing a Singer RoToR (Somerset, UK) 
that spots strains from the 96-well plates onto an YPGal agar plates 
supplemented with concentrations of LiCl of 7, 15 or 30 mM and onto 
corresponding lithium-free YPGal control plates. The plates were incubated for 
five days; during this time photographic records were taken to assess growth 
variations according to scoring system described below (section 3.13.4.1). 
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Each plate contained the following as control strains: sensitive strain 
(cnb1Δ::kan), suppressor-like strain (bre5Δ::kan), over-expression strain 
(pTIF2tif1Δ), and “wild- type” surrogate strain (his3Δ::kan). The assay was 
routinely performed twice for each KO strain of interest, however, a subset of 
deletion strains underwent a further third test, as later explained in method 
3.13.5. 
3.13.4.1. Scoring system 
Deletion strains showing growth impairment or enhanced growth were 
scored for sensitivity or resistance according to the following scoring system. 
The number of the 4 dilution spots growing at each concentration was visually 
determined and scored according to the table below. This allowed deletion 
strains to be characterized into lithium “ultra-sensitive” (score 0-1.5) and 
“sensitive” (score 2-3.5). Strains with enhanced growth on lithium treatment had 
scores ranging from 5 to 8 (Table 3-1). 
 
 
Table 3-1. Scoring of sensitivity to lithium/galactose.  represents growth of a spot equivalently 
to control,  represents an absence of a dilution spot where growth was observed in the control.  
Partial growth of a dilution spot was interpolated to the nearest 0.5, such that less than 0.25 
growth for a spot gained no score, 0.25-0.75 added a score of 0.5 and greater than 0.75 growth 
was scored as an additional 1. 
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3.13.5. Dealing with incongruences 
A limited number of strains were selected for re-testing due to one of the 
following: i) the spot assay outcome was in contrast with the result obtained 
from the primary screen, ii) contrasting outcomes existed between the first and 
the second spot assay (e.g., strains showing sensitivity in one assay whilst being 
associated with resistance or unaltered phenotype in the other), iii) strains did 
not grow due to technical issues (e.g., missed pinning). These strains were re-
streaked from frozen stock following repetition of method 3.13.4; the results 
were analyzed as for method 3.13.4.1 and merged with the previously 
generated set.  
 
3.13.6. Analysis 
The overall resulting interactions were grouped according to the 
molecular function description gene ontology (method 2.19.1), along with a 
manually curated functional classification. 
 
 
3.14. Environmental challenges 
Single colonies of yeast strains listed in method 3.11.2 were inoculated 
into 10 ml of liquid YPD and SD media supplemented with 200 µg/ml G418 or 
100 µg/ml of clonNAT when required and grown overnight with shaking at 30 
°C. The following morning the overnight cultures were diluted to an OD600 of 
approximately 0.05, returned to the shaking incubator and grown to an OD600 of 
1. Serial dilutions were used to spot the cultures according to the following 
protocols: 
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3.14.1. 24-well plate sensitivity assessment spot assay 
Diluted cultures were spotted on 24-well plates containing YPD, SD, 
YPGal, and SGal solid media supplemented with drugs and relevant controls 
(DMSO or dd water) to identify a window of sensitivity for each compound, as 
follows: i) caffeine, from 1 µM to 100 mM; ii) cycloheximide, from 50 nM to 200 
nM; iii) DTT, from 3 mM to 7.5 mM; iv) rapamycin, from 1.5 nM  to 250 nM; and 
v)  tunicamycin, from 0.6 mM to 1.2 mM over 5 dilution spots. 
 The plates were incubated at 30 °C and photographic records taken every 
day for 5 d. Growth was assessed comparing the deletion strains with the 
appropriate control strain. 
 
3.14.2. Serial spot dilution assay 
3.14.2.1. Rapamycin 
If a change was observed upon the treatment performed according to 
method 3.14.1, the condition was further tested through a spot assay over a 
more focussed concentration range. Diluted cultures were spotted following 
method 2.17 on YPD or SD agar plates containing rapamycin at the final 
concentrations of 3 nM and 5 nM. 
3.14.2.2. Environmental challenges 
Supplementary environmental challenges were also tested specifically: i) 
2.5% acetic acid in YPD, SD, YPGal, SGal and SC media;  ii) 2% and 4% glycerol in 
YP and SC media,  iii) 2.5% ethanol in YP and SC media; iv) 1 M sorbitol in YPD, 
SD, YPGal, and SGal media; v) medium adjusted to pH 3 with hydrochloric acid in 
YPD, SD, YPGal, and SGal media; vi), medium adjusted to pH 10 with sodium 
242 
 
hydroxide in YPD, SD, YPGal, and SGal media; vii) Growth in minimal medium (SC 
medium); viii) Growth at non-optimal temperature (37°C) in YPD, SD, YPGal, and 
SGal media. With the exception of condition viii), the plates were incubated at 
30 °C and photographic records taken every day for 5 d. 
 
3.15. Results 
 
3.15.1. Chemical genetic profile of lithium 
In order to achieve a comprehensive analysis on the role of the 
translational initiation process in the relief of lithium toxicity in S. cerevisiae, the 
non-essential homozygous diploid gene knock-out collection was screened in 
rich media containing lithium at different concentrations, utilizing galactose as 
the only carbon source.  
The primary assay consisted of screening Boone’s YDS of ~4,480 strains 
grown on YPGal supplemented with 7, 15, and 30 mM LiCl. SESA, the software 
utilized for an analysis of growth and the previously described SGA (method 
2.30) releases results with a degree of statistical confidence and groups them as 
“definitive”, “probable”, and “possible” hits. As a general trend, deletions that 
showed phenotypic changes in medium supplemented with 30 mM LiCl also 
showed concordant phenotypes when the concentration of drug was halved. In 
the 15 mM screen, 29 out of the 29 sensitive definitive interactions indicated by 
SESA were also accounted in the higher concentration screen. Only 2 deletions 
were identified as suppressors in the 15 mM screen: one of them (ypt7Δ) was 
also noted in the 30 mM LiCl screen results, while the other (mub1Δ) was a 
unique hit for the 15 mM screen. For this latter working concentration, SESA also 
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generated a “probable” results list of 107 sensitive deletion strains: whilst 92 of 
them were correspondently reported as sensitive in the 30 mM experiment. No 
suppressor-like hits were reported for “probable” results under 15 mM LiCl 
treatment. On the basis of these observations this study intends to refer to the 30 
mM data, utilizing the 15 mM and 7 mM generated datasets as further elements 
of comparison, particularly in cases of uncertainty. 
This first experiment identified 138 “definitive” hits, i.e., strains with gene 
deletions that cause yeast cells to become sensitive to 30 mM of LiCl in YPGal 
medium. In this set, 81 deletions displayed a growth defect (sensitive), while the 
remaining 57 were described as suppressor phenotypes. A second subset of 172 
deletions was also reported by the software as “probable” and accounted for 154 
sensitive and 18 suppressor phenotypes. 
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Figure 3-2. An example of lithium/galactose assay plate. An example of assay plate highlighting 
an example of sensitive strain chs5Δ::kanR (red circle) and suppressor strain gal2Δ::kanR (green 
circle) represented as a quartet of identical deletions in YPGal medium supplemented with 30 
mM LiCl. 
 
 
 
3.15.2. Spot Assay 
Among the “definite” hits, 78 out of the 81 sensitives were further tested 
through a spot assay and so were 48 out of the 57 suppressors. In the “probable” 
group, 135 out of the 154 sensitive hits underwent spot assay, along with 12 out 
of 18 suppressor deletion strains. Spot assay confirmed 25 out of the 78 sensitive 
definite hits and 34 out of the 135 sensitive probable tested. For the suppressors, 
the spot assay recapitulated 19 out of the 48 “definitive” and 4 out of the 12 
”probable” hits tested. The spot assay was also done on 154 deletion strains, 
which were manually selected on the basis of principles described in method 
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3.13.4. The spot assay confirmed 25 out of the 154 manually inserted strains as 
sensitive. 
 
 
Figure 3-3. An example of spot assay plate containing 30 mM LiCl. An example of spot assay plate 
showing the basic array set up, comprising control strains included on each plate, namely: a) 
over-expression plasmid pTIF2tif1Δ, b) rcn1Δ::kanR sensitive strain, c) bre5Δ::kanR suppressor 
strain, and d) his3Δ::kanR wild-type surrogate strain Examples of strains scored as sensitive 
(snf5Δ::kanR) in red, e) suppressor (hur1Δ::kanR) in green, and f) dismissed as no phenotypic 
change observed (pex11Δ::kanR) in blue are also indicated.  
 
As described in method 3.13.5, following the two spot assays, a small 
subset of 49 strains was selected for re-testing. This third spot assay confirmed a 
further 24 sensitive and 2 suppressor hits and these results were merged with 
the previously generated ones. Two strains (gal80Δ and snf5Δ) still gave 
conflicting results after this assay, and were no further evaluated.  
The complete lists of deletion strains indicated by SESA as sensitive or 
suppressor upon lithium/galactose which were confirmed through the spot 
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assay are reported in sections 5.6 and 5.7 of the appendix. Altogether, the final 
number of interactions reported in the experimental condition of 30 mM LiCl in 
YPGal was of 108 for sensitives and 25 for resistants, as reported below. 
 
Phenotype Primary assay Spot dilution assay 
Total 
confirmed 
Sensitive 
81/4,480 (1.8%) 
definitive 
 
154/4,480 (3.4%) 
probable 
25/78 (32%) definitive 
 
34/135 (25%) probable 
 
Plus 
24/49 (49%) re-test 
25/154 (16%) selected 
108 
Suppressor 
57/4,480 (1.3%) 
definitive 
 
18/4,480 (0.4%) 
probable 
19/48 (40%) definitive 
 
4/12 (33%) probable 
 
Plus 
2/49 (4.1%) re-test 
25 
 
Table 3-2. Interactions reported by this study upon 30 mM LiCl/galactose treatment.  
 
 
3.16. Gene Ontology Analysis 
A GO terms analysis, as previously described in method 2.19.1 was used. 
When molecular function was used as a classification criterion, SGD mapper 
results (Error! Reference source not found.) reveal that sensitivity to 
ithium/galactose treatment is engendered by deletion of genes that are 
significantly (p-value <0.05) enriched for phosphotransferase/kinase activities.  
These are subclassified as follows: phosphotransferase activity and alcohol 
group as acceptor (15), kinase activity (15), transferase activity, transferring 
phosphorus-containing groups (15), a subset of the above genes’ group (12) 
functioning in protein kinase activity and protein serine/threonine kinase 
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activity (8). This subset was further divided into protein threonine/tyrosine 
kinase activity (4) and MAP kinase kinase (3). 
 
 
Function p-value ORF 
phosphotransferase activity, 
alcohol group as acceptor 
6.45E-05 
YJL187C, YOR231W, YPL140C, 
YJL155C, YNL307C, YHL007C, 
YIL035C, YJR049C, YHR030C, 
YJL128C, YJL095W, YGR092W, 
YLR113W, YHR025W, YHR079C 
kinase activity 2.4E-04 
YJL187C, YOR231W, YPL140C, 
YJL155C, YNL307C, YHL007C, 
YIL035C, YJR049C, YHR030C, 
YJL128C, YJL095W, YGR092W, 
YLR113W, YHR025W, YHR079C 
protein threonine/tyrosine 
kinase activity 
3.4E-04 
YOR231W, YPL140C, YNL307C, 
YJL128C 
protein kinase activity 6.8E-04 
YJL187C, YOR231W, YPL140C, 
YNL307C, YHL007C, YIL035C, 
YHR030C, YJL128C, YJL095W, 
YGR092W, YLR113W, YHR079C 
protein serine/threonine 
kinase activity 
0.008 
YNL307C, YHL007C, YIL035C, 
YHR030C, YJL095W, YGR092W, 
YLR113W, YHR079C 
transferase activity, 
transferring phosphorus-
containing groups 
0.009 
YJL187C, YOR231W, YPL140C, 
YJL155C, YNL307C, YHL007C, 
YIL035C, YJR049C, YHR030C, 
YJL128C, YJL095W, YGR092W, 
YLR113W, YHR025W, YHR079C 
MAP kinase kinase activity 0.011 YOR231W, YPL140C, YJL128C 
Table 3-3. GO term function over-represented for deletion strains sensitive to 
lithium/galactose treatment.  
 
 
Additionally, SGD mapper process results showed statistically significant 
(p-value <0.005)  over-representation for deletions sensitive to the same 
experimental conditions in the following, often overlapping, terms:  response to 
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stimulus (34), cell communication (18), signal transduction (17), 
phosphorylation (13), protein amino acid phosphorylation (12), response to 
stress (23), response to abiotic stimulus (11), response to osmotic stress (9). 
Further GO process terms associated to a lower level of significance (p-value 
<0.05) were response to acid (4), cellular carbohydrate metabolic process (14), 
phosphate metabolic process (13), phosphorus metabolic process (13), and 
carbohydrate metabolic process (14). As is clear in Error! Reference source not 
ound. many of these GO process terms are interconnected, often with one term 
being a subset of another, and their appearance in the ontological list presented 
in the table is often driven by the same set of genes.  For example, some 
processes all appear as separate terms in the process output, despite being clear 
subsets of each other, and with only minor differences between them.  Clearly 
the generic GO processes such as these are less informative than the more deeply 
nested terms such as endoplasmic reticulum unfolded protein response. It is 
these more informative terms that prove most useful in disentangling the basis 
of the interactions between lithium/galactose treatment and yeast cell survival. 
It is these terms which will be considered in the discussion below.  
 
Process p-value ORF 
response to 
stimulus 
3.52E-05 
YKL190W, YML057W, YLR332W, YOL109W, 
YHL027W, YDR388W, YIL017C, YLL043W, 
YNL080C, YJL101C, YNL307C, YDR359C, YNL136W, 
YHL007C, YIL035C, YHR030C, YJL128C, YJL095W, 
YER177W, YLR113W, YER118C, YCL032W, 
YPL089C, YER117W, YMR037C, YDR074W, 
YDR001C, YHR104W, YOL089C, YCR009C, YIL101C, 
YJL201W, YHR079C, YFL031W 
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cell 
communication 
6.31E-05 
YKL190W, YKL159C, YML057W, YOR231W, 
YPL140C, YHL007C, YHR030C, YJL128C, YJL095W, 
YER177W, YER118C, YCL032W, YOL081W, 
YPL089C, YMR037C, YPR040W, YHR079C, 
YFL031W 
signal 
transduction 
8.62E-05 
YKL190W, YKL159C, YML057W, YOR231W, 
YPL140C, YHL007C, YHR030C, YJL128C, YJL095W, 
YER177W, YER118C, YCL032W, YOL081W, 
YPL089C, YPR040W, YHR079C, YFL031W 
phosphorylation 1.9E-04  
YOR231W, YPL140C, YNL307C, YHL007C, YIL035C, 
YHR030C, YJL128C, YJL095W, YNL052W, YIL111W, 
YGR092W, YLR113W, YHR079C 
protein amino 
acid 
phosphorylation 
3.4E-04 
YOR231W, YPL140C, YNL307C, YHL007C, YIL035C, 
YHR030C, YJL128C, YJL095W, YGR092W, 
YLR113W, YHR079C 
response to 
stress 
0.002 
YLR332W, YOL109W, YDR388W, YNL080C, 
YJL101C, YNL307C, YDR359C, YNL136W, YIL035C, 
YJL128C, YER177W, YLR113W, YER118C, 
YCL032W, YMR037C, YDR074W, YDR001C, 
YHR104W, YOL089C, YCR009C, YIL101C, YHR079C, 
YFL031W 
response to 
abiotic stimulus 
0.003 
YLR332W, YHL027W, YDR388W, YJL101C, 
YJL128C, YLR113W, YER118C, YCL032W, 
YMR037C, YOL089C, YCR009C 
response to 
osmotic stress 
0.005 
YLR332W, YDR388W, YJL128C, YLR113W, 
YER118C, YCL032W, YMR037C, YOL089C, YCR009C 
response to acid 0.007 YLR332W, YHR030C, YJL095W, YPL089C 
cellular 
carbohydrate 
metabolic 
process 
0.01 
YNL233W, YBR023C, YLR330W, YIL017C, YJL155C, 
YKL127W, YMR105C, YER177W, YOR136W, 
YIL125W, YDR074W, YDR001C, YHR104W, 
YHR079C 
phosphate 
metabolic 
process 
0.012 
YOR231W, YPL140C, YNL307C, YHL007C, YIL035C, 
YHR030C, YJL128C, YJL095W, YNL052W, YIL111W, 
YGR092W, YLR113W, YHR079C 
phosphorus 
metabolic 
process 
0.012 
YOR231W, YPL140C, YNL307C, YHL007C, YIL035C, 
YHR030C, YJL128C, YJL095W, YNL052W, YIL111W, 
YGR092W, YLR113W, YHR079C 
carbohydrate 
metabolic 
process 
0.032 
YNL233W, YBR023C, YLR330W, YIL017C, YJL155C, 
YKL127W, YMR105C, YER177W, YOR136W, 
YIL125W, YDR074W, YDR001C, YHR104W, 
YHR079C 
Table 3-4. GO term process over-represented for deletion strains sensitive to 
lithium/galactose treatment. 
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Protein products of genes corresponding to deletion sensitive to 
lithium/galactose treatment displayed a cellular localization significantly (p-
value <0.05,) enriched for the calcineurin complex (YKL190W, YKL159C, and 
YML057W) and the site of polarized growth (YJL187C, YOR231W, YNL233W, 
YBR023C, YHL007C, YHR030C, YGR238C, YGR092W, YER118C, and YBL047C). 
 
For what concerns the resistant strains, GO analysis conducted on the 
basis of functional and localization similarities did not return significant 
enrichment. According to the same source, galactose metabolic process (3) is 
significantly (p-value <0.005) over-represented among strains identified as 
suppressor for the lithium/galactose treatment, along with galactose transport 
(2) and glycosylation related processes (4), as shown in Table 3-5. 
 
Biological process p-value ORF 
primary metabolic 
process 
3.5E-04 
YGL168W, YGL167C, YBR020W, YLR081W, 
YPL248C, YML048W, YOR002W, YOR067C, 
YGR078C, YNR051C, YER151C, YDR092W, 
YNL323W, YNL123W, YAL023C, YMR263W, 
YHR041C, YMR039C, YOR304W, YLR372W, 
YER111C 
galactose metabolic 
process 
0.002 YBR020W, YLR081W, YPL248C 
metabolic process 0.003 
YGL168W, YGL167C, YBR020W, YLR081W, 
YPL248C, YML048W, YOR002W, YOR067C, 
YGR078C, YNR051C, YER151C, YDR092W, 
YNL323W, YNL123W, YAL023C, YMR263W, 
YHR041C, YMR039C, YOR304W, YLR372W, 
YER111C 
galactose transport 0.006 YBR020W, YLR081W 
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cellular metabolic process 0.01 
YGL168W, YGL167C, YBR020W, YLR081W, 
YPL248C, YML048W, YOR002W, YOR067C, 
YGR078C, YNR051C, YER151C, YDR092W, 
YNL323W, YAL023C, YMR263W, YHR041C, 
YMR039C, YOR304W, YLR372W, YER111C 
macromolecule metabolic 
process 
0.017 
YGL168W, YGL167C, YBR020W, YLR081W, 
YPL248C, YML048W, YOR002W, YOR067C, 
YGR078C, YNR051C, YER151C, YDR092W, 
YAL023C, YMR263W, YHR041C, YMR039C, 
YOR304W 
biopolymer glycosylation 0.022 YGL167C, YOR002W, YOR067C, YAL023C 
protein amino acid 
glycosylation 
0.022 YGL167C, YOR002W, YOR067C, YAL023C 
glycoprotein biosynthetic 
process 
0.026 YGL167C, YOR002W, YOR067C, YAL023C 
glycoprotein metabolic 
process 
0.028 YGL167C, YOR002W, YOR067C, YAL023C 
Table 3-5. GO process terms over-represented for deletion strains resistant to 
lithium/galactose treatment. 
 
 
3.17. BiNGO Analysis 
Both sensitive and resistant strains datasets generated through methods 
3.13 were further analysed using BiNGO, as described in section 2.29; over-
representation of GO terms is reported with associated statistical significance 
generated according to the hypergeometric test.  
A main cluster among deletions sensitive to lithium/galactose treatment 
emerged for genes which protein products functionally serve as part of the 
oxido-reductase activity, particularly if acting on the heme group of donors, with 
oxygen as acceptor (p-value 2.0E-03) and heme-copper terminal oxidase activity 
(p-value 0.002) both which activities converge in the cytochrome c oxidase 
activity (p-value 2.0E-03). Furthermore, phosphoglucomutase enzymatic activity 
(p-value 5.20E-06) was also found to be effected, as shown in Fig 3-4.  
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Fig 3-4. BiNGO-generated illustration of over-represented GO function terms for sensitive strains 
upon lithium/galactose treatment. 
 
 
 
An over-representation was as well observed for kinase activity with 
serine/threonine (1.43E-07 p-value) and serine/threonine/tyrosine specificity 
(p-value 2.97E-06), and for MAPK kinase (p-value 2.05E-05) and MAP kinase 
activity (p-value 3.0E-03) (Fig 3-5). 
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Fig 3-5. BiNGO-generated illustration of over-represented GO function terms for sensitive strains 
upon lithium/galactose treatment. 
 
 
 
The processes shown to be the most affected by lithium treatment in 
galactose as sole carbon source is cell wall organization and biogenesis (p-value 
8.07E-08), although this latter function is considerably less represented. In 
addition, cytokinetic (p-value 6.11E-04), barrier septum formation (p-value 
5.76E-06), and external encapsulating structure organization (p-value 1.44E-06) 
functional cluster were also highlighted (Fig 3-6). 
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Fig 3-6. BiNGO-generated illustration of over-represented GO process terms for sensitive strains 
upon lithium/galactose treatment. 
 
Again, in line with the GO term analysis described above, a convincing 
subnetwork of related processes can be described for genes associated to the 
signalling pathway (p-value 1.84E-09): signal transmission (p-value 1.60E-04) in 
particular if mediated by signal transmission via phosphorylation event (p-value 
7.15E-05), and transduction (p-value 1.42E-04) eventually converge into the 
intracellular protein kinase (p-value 7.15E-05) which operates via the MAPKKK 
cascade (p-value 0.004). An extended network branch showed that response to 
ER stress (p-value 1.68E-07) and consequent driven UPR (p-value 2.06E-08) 
processes are  negatively affected by lithium/galactose treatment; in particular, 
among the intracellular signalling pathways, the ER nucleus signalling pathway 
(p-value 1.87E-10) was characterized by an high enrichment (Fig 3-7). This 
illustrates the value of the BiNGO analysis in highlighting the relatedness 
between terms, particularly their sub-dependency on each other, which is not 
presented within the crude GO analysis, as discussed above. 
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Fig 3-7. BiNGO-generated illustration of over-represented GO process terms for sensitive strains 
upon lithium/galactose treatment. 
 
 
A last cluster was noticed for lithium sensitive hits: the protein amino acid 
phosphorylation (p-value 9.44E-07) process appeared over-represented along 
with the converging branches of phosphorus (p-value 4.53E-05) and phosphate 
(p-value 3.68E-05) metabolic processes which  contribute to phosphorylation 
(7.93E-07) on one side and the protein modification processes, in particular 
post-translational protein modification (p-value 6.87E-05) on the other (Fig 
3-8). 
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Fig 3-8. BiNGO-generated representation of over-represented GO process terms for sensitive 
strains upon lithium/galactose treatment. 
 
 
 
For what concerns deletion strains that showed tolerance to lithium, the 
function-based classification was not particularly informative on specific 
categories, with the exception of a small cluster indicating transferase activity of 
hexosyl and glycosyl groups (p-value 2.13E-04). 
 
The process-based categorization, however, returned a wealth of 
information on the processes in whose genes’ deletion resistance in to 
lithium/galactose are involved: the most represented correspond to galactose 
metabolic process (p-value 9.32E-06), a number of nested terms relating to 
glycosylation (p-value 1.66E-04), protein amino acid N-linked glycosylation (p-
value 8.85E-04), glycoprotein (p-value 2.16E-04) and oligosaccharides (p-value 
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2.0E-03) biosynthetic processes, along with a significant contribution from 
protein modification, in particular deubiquination (p-value 3.0E-03) and 
ribophagy (not shown, p-value 4.66E-05 ), as represented in Fig 3-9. 
 
 
Fig 3-9. BiNGO-generated illustration of over-represented GO process terms for resistant strains 
upon lithium/galactose treatment. 
 
 
Over-representation of RNA-related processes and regulation of 
transcription were reported again offered in nested terms, these being regulation 
of RNA metabolic processes (p-value 2.28E-02), regulation of gene-specific 
258 
 
transcription (p-value 5.24E-05) and of gene expression (p-value 8.52E-05), 
regulation of gene-specific transcription through RNA Pol II (p-value 6.85E-04), 
and positive regulation of gene-specific transcription through RNA Pol III (p-
value 8.0E-03). These results are complemented by clusters linked to cellular 
response to stimulus (p-value 7.0E-03) and to nutrient (p-value 2.0E-03) and 
illustrated in Fig 3-10. An extended, but not significantly enriched response to 
stress was also detected (data not shown). 
 
 
Fig 3-10. BiNGO-generated illustration of over-represented GO process terms for resistant 
strains upon lithium/galactose treatment. 
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3.18. Different environmental conditions 
Among the vast set of environmental and chemical challenges against 
which TIF1 and TIF2 deletion strains have been tested (method 3.14), only one 
condition returned an appreciable phenotypic change. MATa tif1Δ::kanR 
displayed sensitivity to Rap treatment at both 3 nM and 5 nM in both rich (YPD) 
and minimal (SD) media but this was not the case for the same strain of opposite 
mating type nor the same strain carrying a different antibiotic cassette, as shown 
in Figure 3-11. 
 
 
 
Figure 3-11. Rapamycin spot assay. Spot assay showing from the top: MATa Δtif1:: kanR, MATa 
Δtif2:: kanR, MATa  Δhis3::kanR (WT surrogate strain), MATα Δtif1:: natR, MATα Δtif2:: natR, MATα 
Y7092 (WT) on YPD supplemented with RapA 5nM (right) and DMSO control (left) showing 
sensitivity to RapA for MATa tif1Δ::kanR exclusively. 
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3.19. Discussion 
 
Although SGA is a very powerful technique, a downside of it is that each 
mutant is forced to adapt to the loss of a particular gene, and compensatory 
events that can obscure the true effect of the original gene knockout cannot be 
ruled out. A way to attempt a resolution of this issue is to design complementary 
experiments that can integrate with the data from the SGA and thereby add 
pieces of information to the network of interactions, such as the use of promoter 
systems (chapter 2), chemicals, and environmental challenges (current chapter).  
 
3.20. Cell signaling   
Cell signaling functions as part of a complex system of communication 
that governs and synchronizes basic cellular activities; its associated GO term 
process was considerably over-represented among lithium sensitive strains and, 
as described in sections 3.16 and 3.17, contributions from different regulatory 
proteins’ mechanisms were observed. The high number of hits is indicative of the 
ubiquitous nature, importance and interconnections of these signalling 
pathways. Phosphorylation-mediated signalling governs the convincing cluster 
of related processes described for genes associated with signal transmission and 
transduction. Phosphorylation of proteins by kinase enzymes is important in 
signal transduction and regulation of cellular activity, such as cell division.  
 
3.20.1. Kinases  
Considered the key regulators of cell function, a substantial number of 
protein kinases have been reported to be effected by lithium action. Because 
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kinases instigate sweeping effects on cells, their activity is often regulated via 
phosphorylation, by binding of activator or inhibitor proteins, and/or small 
molecules. Different kinases mediate different signals and, according to GO term 
classification (sections 3.16 and 3.17) the enzymes affected by lithium 
treatment are to be identified in a substantial group of protein serine/threonine 
kinases. 
As many kinases use Mg2+ as a cofactor, it is likely that lithium interferes 
with the activity of these enzymes due to its competitive nature in occupying 
magnesium binding sites. As introduced in section 3.2, lithium binds to one of its 
targets, the enzyme Pgmp, by virtue of its ability to displace magnesium and 
compete in this way for the binding site; the same rationale could apply to the 
hypersensitivity observed upon lithium/galactose treatment in strains bearing a 
deletion of a kinase, and so the importance of one or more other kinases has 
been increased. 
 
One very important group of protein kinases are the mitogen-activated 
protein kinases (MAPK), which are activated by extracellular ligands that in turn 
activate cognate transmembrane receptors and/or proteins associated with 
them, whilst their inactivation is usually due to signals that inactivate the 
phosphatase controlling a given MAP kinase. Although the sensitivity of strains 
lacking kinase activity in this study has been rationalized with a general 
mechanism based on substrate competition, the consistent group of deletions 
which has been highlighted by the screens suggests that something more may 
need to be said about the Pck1p kinase pathway,  its signalling along the cell wall 
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integrity (CWI) route and the MAPK cascade which it initiates; this topic will be 
discussed in section 3.21. 
Kinase-mediated cell signalling is also a main regulatory component of 
stress response pathways, such as the High Osmolarity Glycerol (HOG) response 
pathway, which mediates cellular adaptation to hyperosmotic stress. Roles and 
activities of kinases involved in these routes will be discussed in section 3.25. 
 
3.21. Cell wall organization and biogenesis 
When confronting stressors of different natures, yeast cells face 
challenges that impact on their ability to adapt and ultimately survive and ensure 
growth. Changes at a cellular level are achieved through regulation of gene 
expression of selected genes, enabling the cell to endure unfavourable 
environments; this mechanism requires a coordinated effort from several 
pathways, the most significant of which is undertaken by the cell wall. As yeast is 
a unicellular organism, its cell wall is the primary means through which the cell 
defends itself from environmental adversities, assisted by stress sensors that 
advertise any damage inflicted and coordinate the repair process by activating 
the appropriate signalling pathway(s). Among eukaryotes the cell wall is a 
cellular structure exclusive to fungi. Knowledge of the organization of signalling 
proteins involved in cell wall-related response mechanisms is valuable for 
understanding the intricate signalling and pathways’ inter-talk in S. cerevisiae. 
Among several signalling pathways contributing to the cell wall maintenance, the 
cell wall integrity (CWI) pathway is primarily accountable for addressing the 
response to insults and coordinating changes to the wall structure. A precise 
implication of the CWI pathway in responding to lithium/galactose treatment 
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has been revealed by this research study, identifying the majority of the 
components of the pathway, from the cell surface sensor (Mid2p) which triggers 
CWI activation, through the MAPKs (Bck1p, Mkk1p, Mkk2p, and Slt2p) that 
propagate the signal to the ultimate transcription factor (Rlm1p), as shown in 
Figure 3-12. 
 
 
Figure 3-12. Diagram of the CWI cascade. The Mid2p sensor binds Rom2p that activates Rho1p; 
this latter initiates the PKC pathway following activation of Pkc1p. The PKC pathway includes the 
MAPK cascade (Bck1p, Mkk1p/2p, Slt2p, and Slt2p) which ultimately leads to the activation of 
the transcription factor Rlm1p. Zeo1p, a peripheral membrane protein acting as a regulator of the 
CWI cascade is also shown. The genes affected by lithium/galactose treatment are indicated with 
a red thick. Additional stress sensors exist and are capable of activating the CWI pathway, 
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although not represented in this diagram; for a detailed review on this topic the reader is 
referred to Fuchs & Mylonakis, 2009. 
 
 
A family of cell surface sensors is responsible for detecting the status of 
the cell wall and initiating a signalling response in the event of any compromise 
of cell wall integrity, this includes Wsc1p, Wsc2p and Wsc3p (Verna, 1997) and 
Mid2p and Mtl1p (Levin, 2005). Interestingly, this research screen identified 
only the mid2Δ strain as sensitive to lithium/galactose treatment and, although 
the deletions of Wsc family strains were all tested in the primary screen, none of 
them returned appreciable changes in phenotype. The mtl1Δ was brought to 
attention by the primary screen but spot assay results did not confirm its 
sensitivity to the drug/carbon source treatment. Among the aforementioned cell 
wall stress sensors, Wsc1p and Mid2p are considered the most important and 
serve with partially overlapping roles in CWI signalling; in this study, however, 
different phenotypes were displayed by their KO strains. This result finds 
correspondence with published data showing how MID2 and WSC1 genes 
respond differently to different stimuli (Rodicio & Heinisch, 2010).  The finding 
that only one of the sensors was impaired emphasizes the existence of a sharp 
specificity among cellular membrane sensors, although co-existing with an 
extensive and robust redundancy. In contrast, the failure to find sensitivity in 
either the wsc2Δ or sensitivity in either the wsc2Δ or wsc3Δ strains presumably 
arises from the ability of these partially redundant sensor transducers to cover 
for each other’s absence. 
The O-mannosylation of Mid2p and Wsc1p is regarded as important to 
their own stability (Philip &. Levin, 2001), in fact, reduced O-mannosylation 
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leads to incorrect proteolytic processing of these proteins, which in turn results 
in impaired activation of the PKC pathway and finally causes cell death in the 
absence of osmotic stabilization (Lommel, 2004). More recently, an N-glycan of 
Mid2p was found to be specifically and directly involved in Mid2p sensing, both 
the extent of the N-linked glycan and its distance from the plasma membrane 
affect Mid2p function. In line with this, Mid2p lacking N-glycosylation fails to 
perceive cell wall challenges (Hutzler, 2008). These observations demonstrate 
the importance of glycosylation for CWI sensing and in turn, its contribution to 
cell wall biogenesis and polarized growth, at least in yeast.  In consideration of 
the fact that the concentration of lithium tested in this screen it is not high 
enough to be considered a strong stress inducer, this study suggests an 
alternative proposition in which the reason for finding hits related to the CWI 
pathway may not lie in cell wall stress but rather in a glycosylation issue, which 
gives some form of feedback in accordance with minor cell wall stress. 
The cell surface stress sensor Mid2p, a verified hit in the screen, is 
responsible for detecting the cell wall status and communicating to Rom2p, a 
small G-protein which triggers a set of effectors, Rho1p among them. The 
chemical genetic technique used here is unable to provide an assessment of 
phenotypic changes for KO of genes encoding components of the so-called 
“upstream region” of the CWI pathway as both RHO1 and PKC1 are essential 
genes, so their deletion strains are not available in the homozygous deletion set.  
Furthermore, ROM2 has a duplicate, ROM1, which has at least partially 
overlapping functions, so its deletion generates an unreliable weakly sensitive 
phenotype. Rho1p consequently turns on the Pkc1-mediated pathway through 
the phosphorylation of Pkc1p, which transmits the signal via the MAPK cascade. 
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Pkc1p transmits the signal through the MAPK cascade, components of which all 
display indisputable sensitivity to lithium/galactose treatment. The target of 
Pkc1p phosphorylation is Bck1p, a MAPK kinase kinase (MAPKKK), that 
functions in the regulation of the MAPK kinases (MAPKKs) Mkk1p and Mkk2p. 
Differently from other yeast species in which only one enzyme isoform has been 
described, the baker’s yeast accounts for two kinases (Mkk1p and Mkk2p), and 
strains bearing deletions of either were adversely affected by lithium/galactose 
treatment. This result can be rationalized given the high degree of functional 
redundancy these protein share, although it implies that deletion of either gene 
leads to a situation where insufficient Mkk1/2 protein is available to provide the 
level of signalling required under lithium/galactose stress. The signal from 
Mkk1p and Mkk2p is received by the MAPK Slt2p, a kinase that in S. cerevisiae is 
activated by an extensive subset of stimuli (Torres, 1991; Costigan & Snyder, 
1994). Slt2p phosphorylation activity ultimately activates the transcription 
factor Rlm1p. Altogether these results emphasize the importance of the CWI 
pathway in budding yeast and align with emerging literature that proposes a 
more significant involvement of CWI for the S. cerevisiae species compared to 
other yeasts.  
This study concludes that all expected components of the Pkc1-mediated 
CWI pathway display sensitivity to lithium treatment when galactose is used as 
sole carbon source, suggesting that an involvement of this pathway in supporting 
the response. This latter may be correlated to TOR2, which is known to interact 
with elements of the CWI such as Rho1p and in this fashion modulate Pkc1p 
(Nonaka, 1995).  
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Furthermore, results indicated that deletion of ZEO1, the protein product 
of which is a regulator of the CWI (Green, 2003), also leads to sensitivity under 
lithium/galactose treatment. ZEO1 is a gene that encodes a peripheral membrane 
protein that interacts with the cytoplasmatic domain of the previously described 
Mid2p. This result allows speculation on whether Zeo1p, could also play an 
active role in the response mechanism activated by lithium in the outer cellular 
membrane, possibly through a conformational change imposed on Mid2p, which 
would activate the cascade of CWI response. Findings from the screens reported 
here hint to a scenario in which Zeo1p acts as a sensor for lithium, forwarding 
the message down the CWI pathway and possibly integrating this message to be 
addressed to other pathways as well.   
A better characterization of CWI pathway represents a steady 
improvement in consideration of the relevant roles the pathway retains to have 
in fungi pathogenic for humans, such as C. albicans, and its application in design 
of antifungal drugs.  
 
3.22. Endocytosis  
 
As extensively discussed in section 2.36, sorting and internalization of 
cell surface cargo into vesicles budding from the plasma membrane is achieved 
via endocytosis and is characterized by a complex network of highly connected 
proteins. Two deletion strains relevant to this process have been identified 
among the sensitive hits: RVS161 and RVS167 genes encode for actin-associated 
proteins with roles in endocytosis and actin cytoskeleton organization. Rvs161p 
and Rvs167p are recruited to the bud tip during polarized growth (Bon, 2000) 
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and are collectively referred to as the RVS genes or Rvs proteins (Rvsps) below. 
These genes are homologs of mammalian amphiphysins, a protein family that has 
been postulated to play a key role in clathrin-mediated endocytosis of synaptic 
vesicles. Amphiphysins play important roles in mammals and insects, having 
pleiotropic functions in clathrin-mediated endocytosis and the regulation of 
membrane dynamics, perhaps through the actin cytoskeleton (reviewed in Zhang 
& Zelhof, 2002).  
In S. cerevisiae, the endocytic defects discovered in Rvsp mutants have 
been interpreted as supporting evidence for a role of amphiphysins in clathrin-
mediated endocytosis; however, the role for Rvsps in endocytosis may present 
differences from that proposed for vertebrates. To further complicate the matter, 
remarkable differences exist in the clathrin-mediated endocytosis in yeast 
compared to other multicellular organisms (Baggett & Wendland, 2001) where 
clathrin is absolutely required for receptor-mediated endocytosis and cellular 
viability, whereas deletion of the homolog proteins in budding yeast only 
moderately reduces them. These observations suggest that the endocytotic 
defects caused by deletion of RVS genes may be the result of a different 
mechanism, rather than directly assisting vesicle fission. Congruent results 
support the model in which Rvs167p and Rvs161p are required for normal 
cortical actin cytoskeleton organization which, in turn, is coupled to endocytosis 
and membrane dynamics through signalling (Schafer, 2002). A correct 
stoichiometry of cytoskeletal components has long time been suspected as a 
crucial requirement for cell viability, at least in yeast (Drubin, 1988; Magdolen, 
1993); it was only recently, however, that a connection was uncovered between 
the actin cytoskeleton and the translational machinery (Gross & Kinzy, 2007). 
269 
 
Although these two cellular processes appear very distant, a total reduction of 
translation, eventually accompanied by accumulation of the 80S ribosome, was 
observed in strains carrying a mutation or a null allele of genes encoding actin or 
actin-regulating proteins. Both Rvs161p and Rvs167p proteins show a 
considerable number of physical interactions (97 and 312 respectively) strongly 
limiting the relevance of speculations. However in the context of this overall 
study, it is interesting to note that among the Rvs161p annotated physical 
interactions, the most relevant to be recognized is with Cdc33p the cytoplasmic 
mRNA cap binding protein and translation initiation factor eIF4E, the RNA 
helicase Ded1p (introduced in section 2.4), and Met4p, a transcription factor for 
several translation related genes, including TIF1, TIF2, TIF3, and TIF4631, along 
with a number of ribosomal proteins and few ubiquitin/de-ubiquitin proteins. 
For what concerns Rvs161p, which has 97 physical interactions, among them 
Tor1p, Tor2p, and Psb2p (sensitive deletion identified in this screen). The 
finding of this pair of genes may also be considered in the light of the impairment 
of the phosphorylation events observed (section 3.20). Phosphorylation also 
acts as a regulator of interactions between endocytic proteins as such 
modification allows disassembling of  endocytic complexes to prepare for the 
next round of cargo sorting and vesicle formation (Smythe & Ayscough, 2003).  
The TOR pathway acts an important signalling component by linking 
external signals to the cytoskeletal machinery in a variety of cell types and 
organisms. A connection between Tor2p and the CWI pathway (section 3.21) 
also suggests a link to actin/cytoskeleton related processes, with the 
serine/threonine kinase Pkc1p being the Rho1p effector which mediates Tor2p 
signalling to the actin cytoskeleton (Helliwell, 1998). 
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Strengthening the connection with the Rvsps proteins is the suppressor 
phenotype exhibited by deletion of the SUR4 gene upon lithium/galactose 
treatment; this is supported by the positive genetic interaction in combination 
with pgm2Δ observed by an independent group (Szappanos, 2011). Sur4p is 
involved in sphingolipid biosynthesis (Schneiter, 1999) and is annotated as 
suppressor of rvs161 and rvs167, both of them identified in this study as sensitive 
deletions. As RVS161 and RVS167 genes code actin patch components, this 
suppression is likely to be mediated by an effect on the sphingolipid synthesis 
(Desfarges, 1993; Young, 2002).  
 
3.23. Chitin 
The polysaccharide chitin is an important structural component of many 
fungi; in particular the yeast cell wall is mainly composed of glucan and mannan, 
together with a minor content (about 2%) of chitin and proteins; the majority of 
chitin is however found at the site of bud formation and bud scars (Tkacz & 
Lampent, 1972). 
When stress conditions cause alterations to the wall structure, the cell 
activates several responses as part of the so-called “compensatory mechanism” 
(Popolo, 2001), among these is an increase in chitin content. In S. cerevisiae, 
chitin content has been found to increase greatly as a compensatory stress 
mechanism in response to mutations that lead to a weakening of the cell wall, 
such as in mannoprotein, β-1,3-glucan and β-1,6-glucan synthesis KO mutants 
(Popolo, 1997; Valdivieso, 2000). Other changes in the structure and/or 
composition are known to be borne by the cell wall by virtue of its dynamic 
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nature; these amendments co-operate in the repair of the damaged cell wall and 
ultimately allow the cell to cope with a variety of environmental stresses.  
 Given the importance of chitin in surviving environmental stress, it is no 
surprise that loss of chitin leads to sensitivity to lithium treatment. The synthesis 
of this long-chain polymer of N-acetylglucosamine is directly controlled by three 
distinct chitin synthases (CS) I, II, and III, each characterized by different 
enzymatic activity (reviewed in Henar Valdivieso, 1999). CSIII provides the 
majority of cell wall chitin, whilst CSI and II are produced as zymogens that are 
presumably activated only at need. For this reason, loss of functionality within 
the CSIII system leads the sensitivity profile found in this study. 
As reported in section 3.16, strains bearing deletions of genes encoding 
for members of the CSIII subfamily (bni4Δ, chs3Δ, and chs5Δ) are debilitated in 
their growth in lithium/galactose medium. The BNI4 gene encodes a bud neck 
localized scaffold protein, which is required for localization of CSIII by 
interacting with septin neck filaments and Chs4p, a regulatory subunit of CSIII. 
The same Bni4p protein is also involved in targeting protein phosphatase 1 
(Glc7p) to the bud neck before bud emergence and its tasks also account for the 
assembly of the chitin ring, the septum formation and the maintenance of bud 
neck integrity. Bni4p localization is regulated during the cell cycle, with the 
protein located on the exterior of the septin ring before budding and on the 
mother side of the collar after budding (Kozubowski, 2005). CHS3 encodes the 
CSIII catalytic subunit, which promotes the transfer of N-acetylglucosamine to 
chitin and it is required for synthesis of the majority of cell wall chitin, the chitin 
ring during bud emergence, and spore wall chitosan. Exporting of Chs3p from the 
Golgi structure to the plasma membrane is under the expertise of Chs5p, a 
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component of the exomer complex encoded by CHS5. Although this is not 
applicable to the whole set of chitin-related deletions, it is interesting to note 
that CHS5 has also been reported to share a negative genetic interaction with 
PGM1 (Costanzo, 2010). In line with the above results, deletion of SHE1, whose 
corresponding protein localizes to the bud neck in a ring-shaped structure 
(Wong, 2007), also leads to sensitivity. 
Although data from this research show the involvement of chitin in the 
response to lithium treatment as uncontroversial, it remains to elucidate 
whether the impact on chitin is because of a role of chitin in lithium exclusion or 
whether lithium inhibits a different component of the cell wall, in which case 
chitin’s contribution would be required to compensate for the damage caused. In 
this context, chitin’s function would become essential. A similar instance has 
been previously verified for the antifungal agent echinocandin, an inhibitor of 
β(1,3)-glucan synthesis in C. albicans (Onishi, 2000) in which treatments 
increasing the chitin content of the cell wall reduced the efficacy of 
echinocandins. Although the mechanism is not fully understood, this supposition 
has been endorsed by previous work done by Walker and colleagues (2008) that 
proposed that it is likely to occur either by selection of a sub-population of 
naturally occurring chitin-rich cells, and/or by induction of the cell wall 
compensatory mechanisms that activate chitin synthesis. 
As extensively elucidated in C. albicans, the Ca2+-calcineurin route plays a 
key role in activating CS enzymes as part of the compensatory mechanism -at 
least of CaChs3p (Class IV), which corresponds to S. cerevisiae Chs3p (Class IV) 
(Munro, 2007)- as one of the signal transduction pathways that function in this 
response, along with  HOG and PKC routes. CaMkc1, corresponds to yeast Slt2p 
273 
 
(a sensitive hit discussed in section 3.21) is among the proteins that take part in 
this mechanism. In consideration of the wealth of lithium sensitive Ca2+-
calcineurin-related hits identified in this study (sections 3.24 and 3.31), 
parallels could be drawn between C. albicans and S. cerevisiae with respect to 
signalling pathways regulation. 
Although purely speculative, the possibility that the reason for finding this 
pathway may not lie as much in cell wall stress as in a problem with 
glycosylation may be considered. This event could provide some form of 
feedback inducing minor cell wall stress. A study undertaken in the fungus A. 
fumigatus, on the complex mechanisms of cell wall biosynthesis, recently 
revealed that the major compensatory mechanism induced by repression of N-
glycosylation causes an activation of the UPR, which may subsequently trigger an 
up-regulation in the expression of cell wall protein and chitin (Li, 2011).  
In summary, under lithium/galactose stress, the yeast cell responds by 
activating several mechanisms, among these the increase in chitin synthesis rate 
and content is one of the most significant. It is important to consider the role of 
chitin not only as a minor component of the cell wall but also as component of 
support for neck and cellular budding which may be crucial for cell surviving in 
certain situations. How Ca2+ signalling influences this and what extent of 
connection it holds with other processes remains to be elucidated. 
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3.24. Cell cycle 
 
Complicated mechanisms of Ca2+-dependent regulation are known to take 
place during the cell cycle, in which a Ca2+ signalling pathway inactivates the cell-
cycle at the G2 phase through two different route branches, one of them involving 
calcineurin, the other acting on the Slt2p MAPK cascade. Interestingly, SLT2, 
deletion of which was identified as leading to sensitivity to lithium/galactose in 
this screen (section 3.21), is also reported to share a negative genetic 
interaction with PGM1 (Costanzo, 2010), endorsing the rationale that any 
deletion that is SL with PGM1/2 deletion could hold the same type of genetic 
interaction with the “Pgmp inhibition” condition. 
Genetic and molecular analysis of the Ca2+-dependent cell cycle regulation 
has revealed an elaborate mechanism for the calcineurin-dependent regulation 
of the G2/M transition, in which calcineurin activates the protein kinase Swe1p. 
SWE1 gene deletion resulted in sensitivity to lithium/galactose treatment. 
Calcineurin elevates SWE1 expression at the transcriptional level and this is 
important for its activation leading to G2 cell cycle inhibition and polarized bud 
growth (Mizunuma, 2004). Interestingly, Ca2+-induced phenotypes were also 
reverted by deletion of Bck1p kinase (section 3.21) (Mizunuma, 1998), 
suggesting that calcineurin and the MAPK Bck1p function together in the Ca2+-
dependent regulation of the cell cycle and morphogenesis. Swe1p is regulated by 
calcineurin in the cell cycle G2/M transition and at several levels such 
transcription, post-translational modifications and degradation. The 
physiological importance for cell cycle regulation by Ca2+-dependent Swe1p 
activation is not completely understood, but this mechanism seems to be 
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required for the yeast response to an altered membrane since Ca2+-dependent G2 
cell cycle inhibition is induced in response to a membrane stretching stress that 
appears to trigger the activation of a Ca2+ signal (Mizunuma, 2004). Upon 
activation of the morphogenesis checkpoint that monitors the actin cytoskeleton 
and the septin ring in the G1 and early S phases, G2 cell cycle inhibition is induced 
by activation of Swe1p (Lew & Reed, 1995). However Ca2+-dependent Swe1p 
activation seems to take place by a mechanism that is distinctive from the 
morphogenesis checkpoint (McMillan, 1999).  
Interestingly, deletion of XBP1, a gene coding for a transcriptional 
repressor that binds to promoter sequences of the cyclin genes, was identified in 
this screen, raising the number of hits related to repression of cell cycle 
progression. Strikingly, among the very limited number of physical interactions 
(9) annotated for Xbp1p, one of them (protein-RNA; Colomina, 2008) is with the 
RNA binding protein Whi3p. The progression of cell cycle upon lithium/galactose 
treatment may then also be regulated by processes related to Whi3p, whose 
corresponding gene deletion was identified as sensitive in the screen. Although 
this finding is coherent with other hits identified in this study, it needs to be 
remarked that a conspicuous number of genetic/physical interactions are 
annotated for WHI3/Whi3p. This protein plays a role in monitoring of cellular 
fate and dose-dependent regulation of the critical cell size required for passage 
through START. This form of control is achieved by Whi3p RNA binding protein 
activity sequestering the mRNA of a G1 cyclin involved in cell cycle progression 
(Cln3p) in foci structures localized in the cytoplasm.   
Whilst the discovery that both XBP1 and WHI3 deletions sensitise to the 
lithium/galactose condition, this may be coincidental.  Xbp1 is a transcription 
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factor that the YEASTRACT (Yeast Search for Transcriptional Regulators And 
Consensus Tracking) database records to regulate more than 400 genes 
supported by documented, direct evidence.  Loss of any of these interactions 
could explain the sensitivity of the XBP1 deletion strain. The WHI3 deletion strain 
sensitivity could also have an alternative explanation:  Whi3p is an RNA binding 
protein and a study by Colomina et al (2008) shows that Whi3p targets a 
preponderance of mRNAs associated with membrane and exocytic proteins.  It is 
salient to note that this group highlighted genetic interactions between WHI3 
and the CWI pathway, commenting that “cell wall integrity is compromised in 
Whi3-deficient cells” (Colomina, 2008).  
 
3.25. Response to stress 
Whilst the cell has to face a broad range of environmental and chemical 
insults, the elements which function in the pathways related to these responses 
are present in a limited number. For this reason, when coping with 
environmental adversities specific cellular mechanisms can enable the same 
genes to participate in more than one response pathway. It is then not surprising 
to find a number of sensitising deletions correspond to genes (EOS1, GRE3, GSH1, 
HOG1, MID2, MSN2, PBS2, SHO1, STE20, and STE50) that operate in responding to 
diverse stress conditions, as chemical stimuli, osmotic stress, oxidative stress 
and response to heat among the lithium/galactose sensitive hits; a substantial 
subset of these genes co-participate in regulating the response to more than one 
challenge. This scenario simply reflects the cellular organization in adjusting the 
system after insults: the ability of certain genes to be modulated by an 
appropriately tuned signal enables these gene products to multifunction in 
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different pathways. This needs to be borne in mind when interpreting results 
generated through GO term analysis as data of this nature does not necessarily 
mean that lithium is involved in all these particular routes, as in the case of 
response to heat stress. 
Although the set of genes reported in the mechanisms of response to 
stress will not be extensively discussed, it is interesting to mention the sensitive 
phenotype observed for deletion of MSN2, which encodes for Msn2p, a zinc 
finger transcriptional activator required for transcriptional induction mediated 
through the stress response element (STRE) (Martinez-Pastor, 1996). The 
transcription factor activity of Msn2p, together with the related Msn4p, controls 
the general stress response in budding yeast (Martinez-Pastor, 1996) via 
regulation of the expression of more than a thousand genes. The result that 
deletion of MSN4 was not identified in the screen could find its rationale in what 
it is currently known about these two ORFs: MSN4 gene expression is itself 
Msn2p/Msn4p-dependent and is induced by stress, while MSN2 expression 
appears constitutive (Gasch, 2000). Msn2p and Msn4p share 41% identity and 
are similar in size (Estruch & Carlson, 1993); they are largely, but not completely, 
functionally redundant and there is increasing awareness that the individual 
regulatory contributions of these transcription factors could differ for specific 
genes and under particular stress conditions (Estruch, 2000 for review). Several 
genes have their expression regulated by Msn2p (and Msn4p) in response to 
diverse stresses, including heat shock, osmotic shock, oxidative stress, low pH, 
glucose starvation, sorbic acid, and high ethanol concentrations by binding to the 
STRE element, located in the promoters of these genes (Martinez-Pastor, 1996). 
Interestingly, proteomics (Boy-Marcotte, 1998) and microarray (Chua, 2006) 
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evidence show that PGM2 and PGM3 are amongst the genes targeted by 
Msn2p/4p. Under non-stress conditions, Msn2p and Msn4p are localized in the 
cytoplasm (Gorner, 1998); the regulation behind this localization is in some 
measure regulated by TOR signalling through the 14-3-3 protein (accounting for 
Bmh1p and Bmh2p, in S. cerevisiae), which acts as a cytoplasmic anchoring 
partner for both Msn2/4p (Beck & Hall, 1999). Upon stress, however, they 
display a periodic nucleocytoplasmic shuttling behaviour, as both Msn2p and 
Msn4p become hyperphosphorylated and relocalized to the nucleus (Jacquet, 
2003). There is also evidence that Bmh1p/2p may suppress growth inhibition by 
rapamycin (Bertram, 1998). This screen reports deletion of BMH1, but not BMH2, 
as a verified lithium/galactose sensitive hit: Bmh1p is the major isoform, so it is 
possible that the extent of its contribution is reflected in the deletion strain’s 
ability to grow under the condition tested. 
 
Deletions of key genes in the osmoregulation system, which is responsible 
for active control of the cellular water balance, lead to enhanced sensitivity in the 
presence of by LiCl. Although the molarity value utilized in this study is not high 
enough to invoke an osmotic stress (Brewster, 1993) a number of stress-related 
annotated hits were reported and speculation could be made about lithium being 
able to induce an ion stress at lower concentrations than other ions. The 
osmoregulatory system in the yeast S. cerevisiae has been extensively 
investigated and the crucial contribution to its osmoregulation is the production 
and accumulation of glycerol, a mechanism which is partly controlled by the high 
osmolarity glycerol (HOG) signalling system (reviewed in O’Rourke, 2002). 
Deletion of HOG1 gene, which encodes a MAPK with mammalian homolog p38 
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involved in inflammatory and stress responses (Raingeaud, 1995), was observed 
as sensitive to lithium/galactose in this study. Hog1p kinase activity is integral to 
the osmoregulatory signal transduction cascade, which ultimately affects gene 
expression, progression through G1 and G2 phases of the cell cycle, and cellular 
ion levels in response to hyperosmotic stress (reviewed in Correia, 2010). Whilst 
a conspicuous number of interactions records are annotated for HOG1/Hog1p 
making the interpretation of this hit rather difficult, the lithium sensitive 
interaction (this study) reported for PBS2 may provide the ground for more solid 
speculation. The MAPKK Pbs2p (Brewster, 1993) phosphorylates Hog1p, that 
once activated translocates to the nucleus with following induction of a specific 
transcriptional program. Distinct pathways are known to function in the Hog 
mediated adaptation response that leads to the activation of several MAPK 
cascades mediated by three distinct osmosensors (Alepuz, 2001): the first, 
Sho1p, was identified as sensitive hit in the screen and principally functions in 
the adaptation to high salt conditions by activating the Hog signalling pathway. 
Although functioning in a Sho1p-mediated parallel pathway, deletion of the 
Msb2p osmosensor did not result in a strain sensitive to lithium/galactose 
treatment, while deletion of the third osmosensor Sln1p could not be tested as it 
is an essential gene and therefore not available in the YDS. The fact that both 
deletion of HOG1 and PBS2 were identified supports the extent of their known 
relationship: Pbs2p serves both as a scaffold and a kinase in the Hog pathway, in 
order to prevent “crosstalk” activation between pathways, scaffold molecules 
and indeed the kinases themselves, coordinate a set of interactions that ensure 
the fidelity of each signalling cascade.  
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Phosphorylation of target proteins by Hog1p can lead to the recruitment 
of other transcription factors that recruit the transcription machinery; however 
Hog1p has also been shown to directly recruit RNA Pol II (Alepuz, 2003). 
Interaction between Hog1p and the histone deacetylase Rpd3p targets the 
Rpd3p/Sin3p/Sap30p (this last deletion was identified as a suppressor in this 
study) complex to the promoters of osmotic stress genes, resulting in chromatin 
modification and transcription initiation (De Nadal, 2004). 
In summary, deletion of genes MSN2, BMH1, HOG1, and SHO1, all lead to 
sensitivity to lithium/galactose; contrarily deletion of SAP30 lead to enhanced 
growth.  These genes work in concert in the response to stress pathway, and 
implicate it in yeast’s ability tolerate these conditions.  Although the working 
concentrations of LiCl employed in this study do not justify a full osmostress 
response, a branch of this highly connected network and this pathway partly 
seems to assist cellular survival under these conditions. 
 
3.26. Chromatin organization , histone , transcription 
 
A great variety of stresses are sensed by specific conserved signal 
transduction pathways, which usually conclude in the modulation of protein 
kinase activities, such as the previously described MAPKs (Gustin, 1998) and 
TOR (Martin & Hall, 2005). Independent studies have elucidated the complexity 
behind the mechanism through which these signalling kinases function, showing 
the requirement not only for the modulation of specific transcription factors but 
also for the steady association that takes place between the kinase and the 
chromatin of the regulated gene (Chow & Davis, 2006). Once tied to the 
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chromatin of inducible genes, Hog1p (section 3.25) undergoes activation and 
can favour transcription by recruiting chromatin complexes (De Nadal, 2004).  
Deletions of genes encoding for subunits of the histone acetyltransferase 
(EAF1/VID21 and EAF7), deacetylase (RCO1) and methyltransferase (SET2) 
enzymes were reported among the lithium sensitive hits, along with a subset of  
KOs corresponding to genes encoding for proteins functioning in chromatin 
remodelling (ARP8, IES5, and SWP82). Transcriptional-related processes are also 
represented with transcription factors (HAL9 and SEF1) and repressors (XBP1) 
and a component of the SAGA complex (SGF29). Although there is one gene hit 
(NNF2) that interacts with Rpb8p, a subunit shared by yeast RNA Pol I, II, and III 
(Briand, 2001), the majority of the connections links to RNA Pol II only, 
suggesting it as the most influential subunit to support re-programmed 
transcription, following post-stress adjustment to lithium/galactose treatment. 
The findings of genes involved in chromatin remodelling are thus explainable in 
terms of re-programming transcription after an environmental challenge, 
mechanism that is under the influence of the extensive action of Hog1p and other 
pathways. The direct recruitment of Hog1p to osmoresponsive promoters by 
specific transcription factors, such as the previously discussed Msn2p (section 
3.25), seems to be stimulating the recruitment of RNA Pol II (Alepuz, 2003). 
Furthermore, it is understood that proper transcription is also promoted by 
recruitment of the Rpd3S, a complex with histone deacetylase function; deletions 
of one of the genes (RCO1) encoding for an essential subunit of this complex 
appears among the sensitive hits. Once again it is through Hog1p that Rpd3S 
complex gets recruited to specific promoters (Proft, 2006) and following Hog1p-
mediated chromatin modification, it can properly initiate transcription (de 
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Nadal, 2004), suggesting a form of regulation of initiation of transcription by 
Hog1p through chromatin modification. Altogether the finding of genes involved 
in chromatin remodelling sensitive to lithium/galactose treatment falls in line 
with the model of a more complex and intimate role for the regulation of 
transcription initiation by signalling kinases. 
A possible explanation for the observed interactions could lie in the 
ability of lithium to fill some of the binding sites destined to different metals. The 
roles of metal ion cofactors are not interchangeable and may be accompanied by 
a loss in the enzyme’s activity (an example in Job, 1988). Even a partial 
substitution/lack of the required metal could be enough to impair the proper 
transcriptional rate and efficiency: this is because certain coactivators enhance 
transcription initiation by stabilizing the formation of the RNA polymerase 
holoenzyme, thus enabling faster clearance of the promoter and/or certain ions 
are required for optimal DNA binding of certain transcription factors (Zhang, 
2003). 
 
3.27. Mitochondria  
The use of S. cerevisiae growing in the fermentative state allows for the 
analysis of mitochondrial defects otherwise lethal in mammalian cells.  
 
3.27.1. Calcium 
The mechanisms of signalling and uptake for Ca2+ in the respiratory 
compartment have attracted interest since scientists intuited that Ca2+ trafficking 
not only has to do with processes in the cytoplasmatic compartment (section 
3.31), but with mitochondrial functions as well. Work done by Campanella and 
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colleagues (2004) revealed that mitochondrial Ca2+ uptake influences the kinetic 
properties of the cytoplasmic Ca2+ concentration and that, within the respiratory 
organelles, a Ca2+-mediated signal can trigger crucial and diverse effects, among 
them the induction of apoptosis (Campanella, 2004).  
The ability to accumulate, retain and promptly release Ca2+ is a 
fundamental function of mitochondria, which also able to handle the high 
amount of Ca2+ found in the cytosolic compartment upon certain stress 
conditions. For the exogenous Ca2+ to be accumulated inside the mitochondria, 
an electrogenic carrier that facilitates the cation transport across the inner 
mitochondrial membrane (IM) into the matrix is required. This mechanism takes 
place via a co-transport that leads to the accumulation of inorganic phosphates, 
which can form precipitate-like formations in the matrix of mitochondria 
(reviewed in Chalmers & Nicholls, 2004). Reduction in the ability to transport 
phosphate in the mitochondria would also lead to a reduction in Ca2+ cation 
storage: this may explain the sensitivity to lithium/galactose treatment that 
arises from deletion of the mitochondrial phosphate carrier gene MIR1.  
A functionally redundant protein has been identified for Mir1p, at least in 
S. cerevisiae and A. thaliana (Hamel, 2004): phosphate carrier isoform 2 (Pic2p) 
is constitutively less abundant than Mir1p under normal conditions, but it still 
participates in the delivery of phosphate to the mitochondria. The pic2Δ strain 
does not appear among the screen hits: this may be simply explained by the fact 
that Pic2p expression has been so far shown to be induced at high temperature 
(Hamel, 2004) only, and this protein may be required under specific stress 
conditions, which presumably not include lithium induced stress. 
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Deletion of MMM1, a gene previously encountered in the SGA study 
(section 2.36), also lead to sensitivity to lithium/galactose treatment. Its 
encoded product, Mmm1p, an ER integral membrane protein, is considered a 
component of ERMES (previously discussed in section 2.38), a complex with 
putative roles in the promotion of inter-organellar Ca2+ and phospholipid 
exchange. Ca2+ released from the ER storage passes through the membrane into 
the mitochondria where elevated intramitochondrial concentrations of Ca2+ can 
stimulate the activity of the TCA cycle, thereby boosting energy production in the 
mitochondria, as discussed in the next section. 
Extensive studies have shown that in the mitochondrial matrix Ca2+ 
promotes the activity of NADH production by pyruvate dehydrogenase (PDH), 
isocitrate dehydrogenase (ICDH), and α-ketoglutarate dehydrogenase (α-KGDH) 
(reviewed in McCormack, 1990), thus enhancing the electron flow through the 
electron transport chain (ETC) and increasing ATP production (Jouaville, 1999). 
More than one gene usually encodes for proteins functioning in these three 
enzymatic activities, two of them corresponding to KOs (idh1Δ and kgd1Δ) were 
reported as lithium sensitive in this screen, and will be discussed in the next 
section. 
 
3.27.2. The TCA cycle 
As discussed in the previous section, Ca2+ uptake can impact on 
mitochondrial functions as well as cytoplasmic ones. The major targets of the 
mitochondrial Ca2+ import pathway are the dehydrogenases of the tricarboxylic 
acid (TCA) cycle, enzymes which are rate limiting to the cycle and are all 
upregulated by Ca2+-dependent processes (Maechler & Wollheim, 2000).  
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The first dehydrogenase functioning in the Krebs’ cycle, Idhp, is part of 
the isocitrate dehydrogenase system, provided by IDH1 and IDH2 genes (this 
latter is a sensitive hit in this screen) and catalyzes the first NADH-yielding 
reaction of the cycle through the oxidation of isocitrate to α-ketoglutarate. The 
following step of the TCA cycle involves the oxidative decarboxylation of α-
ketoglutarate to form succinyl-CoA, accompanied by a production of NADH 
(Figure 3-14). This metabolic step is catalyzed by α-KGDH enzyme, whose 
components are encoded by the genes KGD1, KGD2, and LPD1. A very recent 
metabolomics investigation, aimed to elucidate a carbon source dependent 
model of transcriptional regulation in respiration, was undertaken (Fendt & 
Sauer 2010). While it is known that S. cerevisiae displays various degrees of 
respiration depending on the carbon source, the aforementioned study showed 
that a specific respiratory contribution to cellular energy production exists: this 
was almost absent on glucose and mannose supplemented media, intermediate 
in the presence of galactose, and rather high in pyruvate containing medium 
(Fendt & Sauer, 2010). What was observed for the galactose containing medium 
condition aligns with previous assertions that carbon sources such as galactose 
permit yeast to undergo simultaneous respiration and fermentation (Herrero, 
1985). In galactose supplemented medium, a 2.7-fold increase was reported for 
Kgd1p, whilst no change was observed for Kgd2p. In the same way, Idh2p 
showed an increment of 2.5-fold versus an only slightly augmented Idh1p (Fendt 
& Sauer, 2010). These findings may give the reason for the results presented in 
this investigation, where only loss of one gene for each duplicate pair was found 
to lead to sensitivity, reflecting their importance in response to galactose. In 
particular, it should be noticed that of the genes mentioned in Fendt & Sauer’s 
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study, only the kgd1Δ strain exhibited a growth defect upon lithium/galactose 
treatment in the study presented here, as shown in Figure 3-13.  
 
Figure 3-13. The TCA cycle. Genes encoding proteins functioning in the TCA, indicated in red are 
lithium sensitive hits, whilst in green were not tested as not present in the YDS, although not 
essential. 
 
The TCA cycle is required for the provision of bio-precursors, 
independent of the carbon source. Yeast is able to interplay the TCA and the 
glyoxylate cycles (Figure 3-14) in a way that, if one of the pathways is 
malfunctioning, the other can be utilized as a back up (Kolkman, 2005). In the 
glyoxylate cycle, two molecules of acetyl-CoA are converted into oxaloacetate, 
bypassing in this way the TCA cycle reactions in which CO2 is released. The 
glyoxylate cycle is essential during growth on C2 compounds for the synthesis of 
all cellular compounds with three or more carbon atoms, for example for the 
biosynthesis of amino acids and nucleotides (Cozzone, 1998).  
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Figure 3-14. Interplay of the TCA and glyoxylate cycles (Kolkman, 2005). 
 
 
The identified hits (KGD1 and IDH2) are associated to the process of 
conversion of isocitrate (from both glyoxylate and TCA pathways) to alpha-
ketoglutarate (in TCA cycle) and on to succinyl-CoA (in TCA cycle), as shown in 
the figure aboveError! Reference source not found. This could imply a 
alfunctioning, or even a block, of the glyoxylate cycle, presumably after the 
isocitrate-yielding step (since the conversion oxaloacetate to citrate to isocitrate 
is common to both pathways). The metal-activate enzyme isocitrate lyase 
(encoded by ICL1/2 genes) catalyzes the reversible cleavage of isocitrate into 
succinate and glyoxylate. This enzyme has been suggested to require Mg2+ at 
determined concentrations, at least in Pinus pinea (Giacchetti, 1988). There is no 
conclusive evidence in the literature regarding S. cerevisiae which describes 
whether the true substrate of Iclp is the free isocitrate or the Mg-isocitrate 
complex. In saying so, if what observed in other organisms is conserved to yeast, 
the possibility of a block of the glyoxylate pathway should be considered, a 
scenario which would explain the finding of any sensitive hits in the TCA cycle. 
The lack of a sensitive hit from MDH1 deletion may come down to the ability of 
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the cell to extricate itself with a functional Mdh2p as perhaps, albeit cytosolic, it 
may obtain malate from mitochondria to cytoplasm. The lack of appearance of 
some gene deletions in this screen might find its rationale in the fact that the 
protein products encoded by these genes are not required for survival by the 
organism, at least under this carbon source condition. It seems a reasonable 
assumption that formation of succinate could be essential for the cell, for 
instance in the formation of amino acids. The enzymes shared among the TCA 
and glyoxylate cycles are not dramatically down-regulated under glucose 
repression and/or anaerobic repression (Wales, 1980), while the Sdhp’s 
succinate dehydrogenase (Sdh1p/2p/3p/4p) and fumarase (Fum1p) are indeed 
repressed. In this particular case, under anaerobic/fermentative conditions, the 
organism is able to tolerate the loss of these proteins’ contributions as, cultured 
in galactose medium, yeast is able to successfully combine fermentation and 
respiration (Fendt & Sauer, 2010). 
Under normal conditions of anaerobic or glucose repression, which 
exhausts Kgdp’s enzymatic activity (Wales, 1980), the cell can still obtain 
succinate via the glyoxylate pathway, supporting the notion that the biological 
system does seem to be focussed on acquisition of succinate. It is conceivable 
that, if the glyoxylate cycle is not functioning properly (for instance due to the 
inhibition of lithium/galactose somewhere along this pathway, like isocitrate 
lyase), then the cell will require the TCA cycle to obtain succinate.  When the TCA 
cycle’s output is compromised by deletions, the cell has no chance to survive, a 
fate that is reflected in the impaired growth of these mutants. This hypothesis 
could be easily addressed in future studies by adding succinate to the medium, 
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with the expectation that addition of extra substrate will lead to rescue of the 
lethal phenotype observed.  
As discussed in the previous section, Ca2+ mobilization across cellular 
compartments appears crucial for the cell to store, deploy or dispose of any 
surplus Ca2+. Elevated intramitochondrial concentrations of Ca2+ can stimulate 
the activity of the TCA cycle, thereby boosting energy production in the 
respiratory organelles. In consideration of the described interplay between the 
TCA and the glyoxylate cycles, it is conceivable that any weakening of TCA-
generated contribution could potentially result in a lethal phenotype. This 
includes the hits related to NADH contribution, which is critical for the 
mitochondrial respiratory chain functioning and to boost energy. Interestingly, 
the genes corresponding to the sensitive deletions observed in this study share a 
common Ca2+ signalling regulation. Along with Idhp and Kgdp, the TCA cycle also 
relies on the contribution of a third dehydrogenase for accomplishing the 
production of NADH: the malate dehydrogenase Mdh1p. Further studies may 
elucidate whether there is a Ca2+-connection with the regulation of TCA cycle, 
which is partially dependent on local energy demands and where ATP and NADH 
function as regulators. Hypotheses could be drawn, although of purely 
speculative nature, on the consequences of an imprecise regulation as a result of 
dysfunctional Ca2+ signals; this latter directly or indirectly affected by lithium 
may be responsible for the generation of conflicting signals. This could perhaps 
be the case for the TCA cycle, whose functions may run too slowly relative, for 
instance, to the β-oxidation process. 
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Results discussed in this section offer an example of cellular benefits 
acquired via genome duplication. Due to its outstanding importance for the cell’s 
survival, the TCA cycle is one of the central pathways of metabolism, and it is not 
surprising that so many partially redundant genes have not been swept away by 
selection, should the yeast’s adaptive strategies be to provide robustness and 
adaptability for its central metabolism. This is true in general for the central 
carbon metabolism, as shown by the high number of retained duplicates 
associated to the same enzymatic activity (Kuepfer, 2005; Maltsev, 2005). 
Uninterrupted flow of energy, precursor metabolites and utilizable energy traffic 
along the metabolic pathways of central metabolism via glycolysis and the TCA 
cycle is essential, the proper functioning is ensured by a variety of adaptive 
mechanisms. One of the most significant mechanisms appears to be gene 
duplication, an event which has produced a number of isozymes which 
functioning under variable environmental and physiological conditions.  
 
3.27.3. Cytochrome c oxidase  
Cytochrome c oxidase is a large mitochondrial transmembrane protein 
that provides the proton motive force to drive synthesis of ATP and other 
fundamental cellular functions. As the last enzyme of the respiratory ETC, 
cytochrome c oxidase is located in the inner mitochondrial membrane where it 
accepts an electron from each of four cytochrome c molecules, and then transfers 
them to a single oxygen molecule to finally convert molecular oxygen into water. 
In the process, cytochrome c oxidase additionally translocates four protons 
across the membrane, helping to establish an electrochemical potential 
difference which leads to a transmembrane proton gradient utilized by ATP 
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synthase to synthesize ATP. Deletions of genes that encode for proteins with 
roles in the structure (COX5A and COX5B) and assembly (COX14) of this enzyme 
resulted in strains that were sensitive to lithium/galactose treatment. COX5A and 
COX5B genes encode for subunit Va and Vb of cytochrome c oxidase respectively. 
Cox5Ap, which is predominantly expressed during aerobic growth, is the 
terminal member of the ETC placed on the mitochondrial inner membrane, while 
its isoform Vb (Cox5Bp) is expressed during anaerobic growth. These are the 
only two of eight cytochrome oxidase c subunits encoded by nuclear genes that 
becomes differently expressed according to aerobic/anaerobic conditions of the 
surrounding environment. It may appear unusual that deletions of other Coxp 
were not affected as any of the genes encoding cytochrome c oxidase subunits 
(with exception of cox14Δ, discussed below), and any of the multiple genes 
required for expression or assembly of the subunits is associated with a decrease 
(in the most severe cases even a block) in respiratory growth (yeastgenome). 
This apparently odd result could be explained by consideration of the fact that, in 
addition to catalytic cofactors, the matrix portion-associated peripheral subunit 
Cox5b contains a bound Zn2+ ion, while an Mg2+ ion is found at the interface of 
Cox1p and Cox2p subunits (Stiburek, 2006).  Given the similarity between 
Cox5ap and Cox5bp proteins, which share a 63% identity, it is conceivable that if 
Cox5bp binds Zn2+, so could/should Cox5ap; this consideration appears well 
justified by the size of the Zn2+ ionic radius (88 pm, c.f. Li+ at 90 and Mg2+ at 86).  
This study hypothesizes that lithium may be causing a mild functional disruption 
of Cox5p, such that loss of either Cox5ap or Cox5bp could lead to the observed 
growth defect. COX14 encodes a mitochondrial membrane protein involved in 
assembling cytochrome c oxidase, and the cox14Δ strain was found to be lithium 
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sensitive. This protein is also involved in the translational regulation of Cox1p 
and in the association with complex IV assembly intermediates and complex 
III/complex IV supercomplexes. The impairment displayed by both assembling 
process and functionality of the complex IV upon lithium/galactose treatment 
echoes the notion that a paucity of cytochrome c oxidase is likely to occur as a 
consequence of the long term lithium pharmacological treatment. In fact, recent 
research from Hroudova and colleagues (2010) regarding the in vitro effects of 
some antidepressants and mood stabilizers showed those medications inhibit 
the activities of respiratory ETC complexes, with complexes I (NADH 
hydrogenase) and IV (cytochrome c oxidase) being the most affected (Hroudova, 
2011).  
 
3.27.4. Additional mitochondrial gene deletions 
Mitochondria possess a residual genome which heavily depends on 
factors encoded by the nuclear genome for both their maintenance and 
expression. A number of deletion strains whose genes encode proteins involved 
in up-holding the mitochondrial genome were reported as lithium sensitive: 
HMI1 whose product is the mitochondrial inner membrane localized ATP-
dependent DNA helicase Hmi1p (Lee, 1999), RIM1, which encodes for the single-
stranded DNA-binding protein Rim1p (Van Dyck, 1992), and PET130 whose 
corresponding protein has been suggested to have a role in respiratory growth 
(Reinders, 2006). 
Loss of GCV2 leads to sensitivity under lithium/galactose treatment. This 
gene encodes the P subunit of the mitochondrial glycine decarboxylase complex 
(GDC) (Sinclair, 1996), a multienzyme complex that catalyses the reversible 
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oxidative cleavage of glycine into carbon dioxide and ammonia. Thanks to the 
GDC, budding yeast can grow on glycine as sole nitrogen source and is also able 
to convert glycine to serine via a reaction catalyzed by the same complex 
(Sinclair & Dawes, 1995). The GDC has three additional subunits known as H-, L-, 
and T-proteins: but deletion of genes responsible for these proteins were either 
not available in the YDS (GCV3) or did not lead to sensitivity to lithium/galactose 
(GCV1 and LPD1) Gcv2p has been shown to be regulated by levels of 5,10-
methylene-THF (substrate) in the cytoplasmic compartment; as this enzyme acts 
together with several co-enzymes, which rely on Mg2+ as a cofactor which lithium 
competes with, this may explains this interaction. 
Furthermore, POT1, the gene coding the Pot1p thiolase enzyme catalyzing 
the last step of the β-oxidation (the cleavage of 3-ketoacyl-CoA into acyl-CoA and 
acetyl-CoA); is a lithium sensitive hit. β-Oxidation is the process by which fatty 
acids, in the form of acyl-CoA molecules, are broken down in mitochondria 
and/or in peroxisomes with generation of acetyl-CoA, which is then principally 
fed into the TCA cycle (discussed in section 3.27.2). It is extremely difficult to 
comment on the sensitivity of pot1Δ strain, in consideration of the fact that POT1 
shares around 50 negative genetic interactions and appears as the only hit in its 
pathway. 
An additional interaction was reported for CBR1, which encodes a 
microsomal cytochrome b reductase; mutation in a conserved NADH binding 
domain of the human ortholog results in type I methemoglobinemia 
(Nussenzveig, 2006). Only two genes have been manually curate in SGD as being 
SL with CBR1 (Tiedje, 2007). These are NCP1 (a P450 reductase) and CLA4 
(Cdc42p-activated signal transducing kinase of the PAK family).  Lithium could 
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lead to loss of Cla4p kinase function as discussed in section 3.20.1 which, from a 
cellular prospective, is equivalent to CLA4 deletion. This could underlie the 
sensitivity of the CBR1 strain upon lithium treatment.  
Three further genes (AIM34, YBL059W, and YGL057C) were additionally 
identified. Although their corresponding protein products have no annotated 
function, they all share a common mitochondrial localization. In particular AIM34 
holds a negative genetic interaction (Costanzo, 2010) with MCK1, a protein 
kinase involved in regulating entry into meiosis, which has been found sensitive 
in this screen and discussed in section 3.33.  YBL059W holds a negative genetic 
interaction with the TOR2 gene, while YGL057C encodes a protein of unknown 
function and null mutants exhibit a respiratory growth defect and synthetic 
interactions with one of the prohibitin encoding genes (PHB1). Although the 
precise molecular function of the Phb complex is not clear, a role as chaperone 
for respiratory chain proteins or as a general scaffold required for optimal 
mitochondrial morphology and function are suspected (Nijtmans, 2000). 
Noticeably, none of the discussed mitochondria-related hits seem to be 
associated with a diauxic shift effect, in fact no common hit can be found when 
comparing the hits revealed by this study to the ones reported by a proteomics 
study on diauxic shift (Ohlmeier, 2004). Furthermore, no correspondence has 
been noted between hits presented in this study and the proteins found in 
increased or decreased abundance in Kolkman’s proteomic study (2005). 
This study indicates mitochondrial activities as critical in responding to 
lithium treatment in medium containing galactose as sole-carbon-source. 
Important contributions have been identified from diverse processes, these 
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being: mitochondrial Ca2+ traffic, Krebs’ cycle, and ETC, along with additional 
activities, as reported in section 3.27.4. 
 
 
3.28. Trehalose 
 
This screen also reported sensitivity for deletion strains lacking 
production of proteins related to trehalose, a reserve disaccharide found in yeast 
(reviewed in Gancedo, 2004) and a wide variety of organisms including bacteria, 
insects, and plants. In S. cerevisiae, trehalose (α,α-1,1-diglucose), is among the 
major storage carbohydrates available to the cell upon stresses triggered by heat, 
ethanol, osmotic, and oxidative stresses (Pereira, 2001). Trehalose biosynthesis 
takes place through a two-step process in which glucose 6-phosphate and UDP-
glucose are first converted by trehalose-6-phosphate synthase (TPS), encoded by 
TPS1, into α,α-trehalose-6-phosphate, which is then converted with water into 
trehalose and phosphate by trehalose-6-phosphate phosphatase (TPP), encoded 
by TPS2 (Francois & Parrou, 2001), this latter a sensitive deletion in this study 
(Figure 3-15). Tps1p and Tps2p are part of the α,α-trehalose-phosphate 
synthase complex (Pereira, 2001) together with the regulatory proteins Tps3p 
and Tsl1p, and all four of proteins are co-induced under stress conditions, and 
corepressed by the Ras-cAMP pathway (Winderickx, 1996). Dysfunctions in 
strains carrying a full deletion of either TPS1 or TPS2 have been investigated: 
both KOs result in a growth defect on fermentable carbon sources, specifically 
tps1Δ resulted in loss of both TPS activity and trehalose biosynthesis (Bell, 
1992), whereas tps2Δ displayed temperature sensitivity and loss of TPP activity 
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(De Virgilio, 1993). A plausible explanation is that most strains build a trehalose 
reserve from before their final pinning onto lithium/galactose.  This reserve may 
help them through the initial response to the new lithium/galactose 
environment and provide a boost to cell numbers.  Strains that cannot use 
trehalose become disadvantaged, and so are seen as sensitive.  
 
 
 
Figure 3-15. Trehalose pathway. Gene deletions sensitive to lithium/galactose treatment are 
indicated with a red box. 
 
Although the trehalose biosynthetic pathway may appear distant and 
little related to the main utilized pathways, in fact it can affect glycolysis as one of 
its intermediates, trehalose-6-phosphate, inhibits hexokinase activity, which 
restricts the influx of sugars to glycolysis during the switch to fermentative 
metabolism (Hohmann, 1996).  Trehalose is a storage carbohydrate that can 
either be synthesized by the cell itself or obtained from the external 
environment, and then converted by trehalase enzymes with the use of water to 
obtain two glucose molecules (Francois & Parrou, 2001). S. cerevisiae has two 
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trehalase enzymes, an acid trehalase encoded by ATH1 (Alizadeh & Klionsky, 
1996) and a neutral trehalase encoded by NTH1 (Kopp, 1993). NTH1 is a 
sensitive hit in this screen and is induced by various stresses including exposure 
to heat, hydrogen peroxide, or cycloheximide (Zahringer, 1997) and its protein 
product is a cytoplasmic homodimer required for the hydrolysis of intracellular 
trehalose (Kopp, 1993). Deletion of NTH1 results in complete loss of neutral 
trehalase activity, accumulation of internal trehalose (Figure 3-15). The 
rationale reasoned for tps2Δ, could be applied to this interaction as well. 
Interestingly, Nth1p shares a physical interaction (Gavin, 2002) with Bmh2p, the 
14-3-3 protein already encountered in section 3.25; this leads to the suspicion 
that this interaction might underlie the same cellular connection and thus be 
under TOR signalling regulation.  
 
3.29. Gluconeogenesis 
Gluconeogenesis is a highly regulated cellular process by which yeast can 
produce glucose from alternative nutrient sources such as acetate, amino acids, 
lactate, and glycerol. S. cerevisiae senses and adapts to nutrient changes in its 
environment by altering the transcriptional profile and undertaking 
modifications of the protein complement within the cell.  
For example, when glucose repression is lifted, galactose can be imported 
and metabolised to produce glucose and derivatives for glycolysis, the TCA cycle 
and pentose phosphate pathway, as shown in Figure 3-16. D-Galactose is 
imported into the cell via Gal2p and the pathway begins with the production of 
α-D-galactose-1-phosphate (Gal-1P), catalysed by Gal1p. Gal-1P is converted to 
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UDP-Gal which is isomerised by Gal10p to UDP-glucose (UDP-Glc), which under 
the action of Gal7p forms α-D-glucose-1-phosphate (Glc-1P).  Glc-1P is 
isomerised to Glc-6P by the phosphoglucomutase enzymes (Pgm1p, 2p and 3p; 
collectively Pgmp) which are known targets of lithium as previously discussed. 
Phosphoglucose isomerase (Pgi1p) interconverts Glc-6P and β-D-fructose-6-
phosphate (F-6P), which in turn is converted to its 1,6-bisphosphate (F-1,6P2) 
and on to glyceraldehyde-3-phosphate. F-6P and glyceraldehyde-3P are key 
metabolites, ultimately providing for entry to key parts of the pentose phosphate 
pathway (e.g., the synthesis of ribose, purine and pyrimidine metabolism) and 
the TCA cycle respectively. Under lithium inhibition of Pgmp, levels of these 
metabolites will be reduced, and any deletion that exacerbates this situation is 
likely to lead to a growth defect. 
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Figure 3-16. Galactose utilization in gluconeogenesis. 
 
Enzymes that would be most expected to have an effect the balance of F-
6P and glyceraldehyde-3P are those in the surrounding equilibria.  However, 
Pgi1p and Fba1p are encoded for by essential genes, so were not assessed in this 
study. For example, deletion of FBP26, the gene coding for F-2,6-bisphosphatase, 
an enzyme required for glucose metabolism resulted in a sensitive strain in this 
screen. The product of its enzymatic reaction is F-2,6P, a metabolite that 
allosterically affects the activity of the enzymes phosphofructokinase 1 (PFK-1) 
(encoded by PFK1 and PFK2) and F-1,6-bisphosphatase (FBPase-1) (encoded by 
FBP1) to regulate glycolysis and gluconeogenesis (Figure 3-16), however the 
major effect of this deletion might be that regulatory branch to F-2,6P is now a 
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one-way siphon and there is a resultant loss of the key metabolites, F-6P and 
glyceraldehyde-3P. 
An additional pair of genes involved with degradation of F-1,6 
biphosphate was scored as sensitive in the assay: VID22 and VID28. These two 
genes produce proteins that are recognised as being important in the 
degradation of F-1,6-biphosphatase (Fbp1p, FBPase). In particular, the Vid 
proteins are major mediators of the degradation of FBPase on long term growth 
in glucose deficient media (Hung, 2004). FBPase is important in the 
gluconeogenesis pathway, where it converts F-1,6-biphosphate into F-6-P. In this 
sense, the loss of these Vid proteins enhances the lithium mediated reduction in 
the flux through the glycolysis pathway, leading to higher levels of FBPase 
activity or lowering the forward flux through the pathway. This leads to further 
reduction in the production of key metabolites such as glyceraldehyde-3-
phosphate and pyruvate and a reduced flux into the TCA cycle and subsequent 
inhibition of growth. Finally, it is not completely to be ruled out that the 
organism may utilize its stock of F-6-P too rapidly, depleting in this way the 
cellular reserve. 
 
3.30. Suppression of lithium/galactose toxicity  
 
In order to explain the suppression of lithium/galactose toxicity, it is 
helpful to understand the underlying mechanisms of suppression. Depending on 
the allele and gene specificity associated with suppressors, diverse mechanisms 
have been inferred for what is known as “second-site suppressors” (Prelich, 
1999): i. Dosage suppression where a protein product that stabilizes the mutant 
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phenotypes is expressed at high levels. This was elegantly shown by Chew et al 
(2010) in the stabilization of a Tbp1E186D mutant protein and suppression of 
the TBP1E186D mutant strain defect, following the overexpression of the 
deubiquitinating enzyme Ubp3p. ii. Interaction suppression where deleterious 
effects of a mutation in one protein causes a loss of a key interaction with a 
partner.  A suppressing mutation in the partner can restore the interaction. This 
form of suppression is not observed with deletion mutants.  The analogous 
situation for deletion set screens is where a second deletion relieves a stress 
induced by a first deletion as described below. iii. A bypass suppressor activates 
an alternative pathway to the wild-type pathway (an example in Hardy, 1997). It 
is pathway-specific and rescues null allele (Figure 3-17). 
 
 
 
 
Figure 3-17. Bypass suppressor mechanism. A bypass suppressor activates an alternative 
pathway to the wild type pathway. Adapted from Forsburg (2001). 
 
 
The “dosage suppression” mechanism does not seem likely to describe the 
outcome of this study, however there is a limited potential for dosage 
suppression via loss of regulatory proteins (such as those associated with 
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ubiquitination), which could lead to enhanced abundance of their target proteins. 
The second mechanism describes the so-called “interaction suppressor”. This 
mechanism appears even less likely than dosage suppression, given our study 
partner lithium/galactose condition (intended as the first mutation) with gene 
deletions. By far the most likely source of suppressor deletion mutants are those 
which fall into the third category above: “interaction suppression”. In this 
scenario, deletion mutants may force the yeast cell to shift metabolic flux away 
from pathways that are problematic in the presence of lithium/galactose and 
towards others which permit enhanced growth or survival. 
It has to be pointed out that the study of suppressor strains has 
limitations: as reflected by the small number of interactions reported, not all the 
KOs will be tractable for suppression as in certain cases the strains simply revert 
the phenotype back to a wild type level, rather than leading to enhanced growth. 
The deletion strains leading to suppression of lithium/galactose toxicity, and 
indeed to enhanced growth on this medium, initially appear to fall into two main 
categories:  those associated with de-ubiquitination and those associated with 
galactose metabolism.  However, they appear to coalesce on the single process – 
galactose metabolism – as discussed below. 
 
3.30.1. Ubiquitination 
Ubiquitination is an important process which impacts or is involved in a 
vast variety of cellular events. As previously discussed in section 2.37, together 
with enzymes functioning in ubiquitination, there is much current interest in 
deubiquination mechanisms, as they appear to be as important in the 
contribution of the homeostasis of the cell as the original ubiquitination event. 
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The data generated in this study indicated functional correlations for lithium 
sensitive genes separately involved in both ubiquitination and its reverse 
process: the sensitive deletion strain (bul1Δ) is a component of an ubiquitin 
ligase complex, whereas the two strong suppressor strains (bre5Δ and ubp3Δ) 
are part of a deubiquination complex. The opposite phenotypes exhibited by 
these deletions under lithium/galactose treatment reflect the opposite functions 
of their corresponding genes.  
As indicated in section 3.21, two deubiquitination-related hits were 
identified in the screen: BRE5 and UBP3 genes, the protein products from which 
function in a deubiquination complex where the ubiquitin protease, Ubp3p 
requires the presence of its cofactor Bre5p to cleave ubiquitin tags from their 
substrates (Cohen, 2003). The proteins and processes that are controlled by the 
Ubp3/Bre5p complex are only now becoming clear and include the processes of: 
ribophagy (autophagy specifically of ribosomes, where the de-ubiquitination 
actually destabilises ribosomes)(Beau, 2008); telomeric silencing; maintenance 
of the cell wall; global transcriptional regulation (Bilsland, 2007); and validated 
protein regulation of: Sec23p (a component of the COPII complex essential for 
the anterograde transport between the ER and Golgi (Cohen, 2003)) and Tbp1p 
(also known as Spt15p, a TATA binding protein and component of the general 
transcription factor, TFIID (Chew, 2010)).  Activity against Sec23p appears to be 
also under the control of Cdc48p (Ossareh-Nazari, 2010).  Unfortunately both 
SEC23 and CDC48 are essential genes and so their involvement in 
lithium/galactose sensitivity could not be probed by this analysis.   
Despite this range of target proteins and processes, it is reasonable to 
presume that the regulation of Tbp1p is especially important in the context of 
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growth of lithium/galactose. Chew et al (2010) have elegantly shown that 
Ubp3p-mediated stabilisation of Tbp1p is required for activation of GAL1 by 
Gal4p and indeed Tbp1p is recruited to the GAL1 promoter upon galactose 
induction.  This level of control of the galactose response is sufficiently profound 
that the ubp3Δ strain was shown to have a 20-fold reduction in the activation of 
GAL1 and is unable to grow on galactose under anaerobic conditions. This points 
to an expectation of reduced viability in response to disruption of the 
Upb3p/Bre5p-mediated de-ubiquitination pathway, however the reverse is in 
fact true under the conditions of this screen – the individual deletions are 
recorded as suppressors in the lithium/galactose experiment.  Unexpected as 
this may be at first glance, it is noticeable that deletion of GAL1 and GAL4 also 
lead to a suppressor phenotype, so loss of Tbp1p regulation, removal of Gal4p 
and deletion of the GAL1 gene all lead to the same result, as would be expected, 
as discussed below. 
 
3.30.2. Galactose metabolism 
Carbohydrate metabolism makes nutrients available for the cell via 
anabolic processes that in yeast, as for other organisms, are also mediated by 
enzymes that act in regulated metabolic pathways. Genes coding for enzymes 
functioning in carbohydrate metabolic processes are extensively represented in 
the lithium screen results, as shown in section 3.16. 
Metabolism of galactose, which is not the ideal or usual carbon source for 
yeast, is under the competence of enzymes encoded by a family of GAL genes that 
are repressed under growth in glucose while their expression is 1000-fold 
increased when glucose is absent (Johnston, 1987). As reported in section 3.16, 
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a cohesive group of GAL genes (GAL1, GAL2, and GAL4) were among those 
deletion strains which express a suppressor phenotype upon lithium/galactose 
treatment.  
The gene GAL1 encodes for Gal1p, a galactokinase, that phosphorylates α-
D-galactose to α-D-galactose-1-phosphate in the first step of galactose catabolism 
(Schell & Wilson, 1977); the same protein is also required for inducible high-
affinity galactose uptake (Ramos, 1989), and can function as a weak 
transcriptional regulator in the absence of Gal3p (Schell & Wilson, 1977). 
Deletions of both GAL1 and GAL3 genes were identified by SESA software as 
suppressor hits but, whilst gal1Δ was confirmed in all the further screens, gal3Δ 
failed to reproduce a similar phenotype in the spot dilution assays. Although it is 
commonly found that deletions identified in the first high-throughput primary 
assay are the results of experimental noise, it is possible that loss of sensitivity in 
the spot dilution assay with GAL3 deletion is an artefact. This possibility is raised 
because GAL1 and GAL3 share 90% amino acid similarity, the protein products 
Gal1p and Gal3p are not completely functionally redundant. In the context of 
gene duplication, the GAL1 and GAL3 pair deserves mention as not only it 
presents evidence of an intimate evolutionary relationship, but it also represents 
an exemplar case of gene duplication followed by sub-neo-functionalization. It is 
likely that a pre-duplication bifunctional protein held two activities that then 
became separated and through this process the loss of galactokinase activity 
made it possible for Gal3p to acquire specialized regulatory activity, as hinted at 
the finding that the re-insertion of only two amino acids was sufficient to confer 
galactokinase activity to the transcriptional regulator Gal3p (Platt, 2000). In the 
closely related yeast K. lactis there is no trace of a GAL3-equivalent gene and 
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Gal1p acts as both galactokinase and regulator of its own activity (Meyer, 1991). 
Differently, in S. cerevisiae, there have been reported cases of mutants lacking 
GAL3 expression in which Gal1p seemed to take over the regulatory role of Gal3p 
(reviewed in Dittmar, 2010) and the circuit through which this pair of GAL 
paralogs respond to lithium mechanism/s could possibly be among them. 
However, given the interaction with Upb3p/Bre5p and the lack of validation on 
spot dilution assay, it is safest to assume that the action on lithium is directed 
towards pathways associated to the galactokinase activity, which is a function 
specific to Gal1p. The Gal1p galactokinase enzyme is conserved from bacteria to 
humans and mutations in the hGALK1, the human functional ortholog of yeast 
GAL1, is known to lead to galactokinase deficiency (also known as galactosemia 
type II), an hereditary metabolic disease introduced in section 3.2. Although this 
form of the disorder is less common and is not associated with life-threatening 
conditions compared to galactosemia type I, it still causes cataract formation in 
infants due to galactitol accumulation (reviewed in Holden, 2004).  
The gene GAL2 encodes a high affinity galactose permease (Tschopp, 
1986): Gal2p is an integral plasma membrane protein belonging to a superfamily 
of sugar transporters functionally and is structurally similar to sugar 
transporters identified in humans (Nehlin, 1989). When cells are grown on 
glucose-containing media, GAL2 is negatively regulated at both the 
transcriptional level and protein degradation, this latter occurring through 
ubiquitination, followed by endocytosis and vacuolar proteolysis (Horak & Wolf, 
1997). The secretion of certain hexose transporters, including Gal2p is promoted 
by the ER localized integral membrane protein Gsf2p. Importantly, deletion of 
GSF2 was verified as leading to suppression in this study. 
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The GAL genes, including the above discussed GAL1 and GAL2, are 
regulated in a coordinate fashion in the absence of glucose at the level of 
transcription in response to galactose by the combined engagement of Gal3p, 
Gal4p, and Gal80p (Platt & Reece, 1998). Although these proteins’ action is 
believed to be concerted, results of this study results argue that a level of 
regulation via Gal4p exclusively, as the gal3 and gal80 deletions did not return 
enhanced growth when combined with a lithium/galactose treatment as shown 
by converging studies (Masuda, 2008 and this study). GAL4 encodes for a DNA-
binding transcriptional regulator required for the activation of the majority of 
GAL genes in response to galactose induction and it also functions in the 
activation of GAL1 expression (Griggs & Johnston, 1991). When cells are grown in 
the presence of galactose, Gal3p senses the carbon source and enters the nucleus 
where it binds to transcriptional repressor Gal80p, blocking any further 
interactions between this protein and Gal4p (Wightman, 2008). Active Gal4p can 
then recruit several RNA polymerase II related complexes, such as SAGA 
(extensively discussed in section 2.37) and the Mediator complex, which is 
required for the regulated transcription of nearly all RNA polymerase II-
dependent genes in baker’s yeast (reviewed in Björklund & Gustafsson, 2005). 
Activation by Gal4p relies on an acidic C-terminal region that both stimulates 
transcription and also binds Gal80p (Ma & Ptashne, 1987); in addition, this acidic 
activating domain interacts with subunits of the 19S regulatory particle of the 
26S proteasome (reviewed in Traven, 2006) and is a site of monoubiquitination 
(Archer, 2008). Mechanisms of inhibition and relief of this inhibitory effect on 
Gal4p differ according to the carbon source; the reader is directed to Peng & 
Hopper (2002) and Lohr (1995) for more detailed reading.  
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Assessment of the phenotype associated with deletion of GAL80 upon 
lithium/galactose treatment has given mixed results (as reported in section 
3.15.2) and therefore it remains difficult to state the phenotype associated with 
it and comment further on this type of mechanism, however it is worth noticing 
that Masuda (2008) did not observe a reversion of toxicity in the gal80Δ strain. 
Although initially surprising, the finding that some of the GAL mutant 
strains tested were associated with enhanced growth in galactose as the primary 
carbon source has a reasonably obvious explanation. It is essential to remember 
that to be noted as a suppressor, a deletion strain has to grow better in 
lithium/galactose than the parental strain does.  However, impaired growth may 
be observed relative to growth on galactose without lithium, for example.  It has 
been noted in the literature that a small number of intermediary metabolites that 
lie between galactose import and the step catalysed by phosphoglucomutase 
(Pgm1p and Pgm2p), an enzyme that is known to be inhibited by lithium, are 
deleterious to growth.  Thus, as discussed below, Pgm1/2p inhibition leads to a 
reduced flux through the Leloir pathway and a build up of these metabolites (de 
Jongh, 2008; Masuda, 2008).  Loss of galactose import or processing means that 
these toxic metabolites are not formed, and the yeast can grow satisfactorily (if 
not particularly well) on the basis of other carbon sources in the YPGal media 
and/or on internal trehalose stores. Work undertaken in S. cerevisiae shows that 
lithium mimics a “galactosemia-like” phenotype, almost certainly as a 
consequence of its inhibitory effect on Pgmp, a key enzyme in galactose 
metabolism (Masuda, 2001) This thesis study’s results strongly endorse this 
model.  
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A congruent body of evidence demonstrates that the GAL genes are 
essential in galactose metabolism: for example, gal1Δ mutant strains are are 
usually defective in galactose growth (Bhat, 1990) and Gal2p permease activity is 
required for galactose catabolism, and its loss renders cells unable to utilize 
galactose as a sole carbon source (Douglas & Condie, 1954). Despite this, these 
GAL deletions grew unequivocally better than relative controls in 
lithium/galactose media and consistently reproduced the same suppressor-like 
phenotypes, in primary and spot dilution spot assays. That the effect observed is 
not an artefact is further evidences by the congruent set of genes discussed 
(GAL1, GAL2, GAL4, UBP3, BRE5, and potentially GAL3).   
These findings assume that Gal-1-P, a phosphorylated intermediate of the 
Leloir pathway, is one of the toxic compounds and are also consistent with the 
direct correlation showed between the severity of lithium-induced impairment 
of growth and the galactose concentration in the medium (Masuda, 2008). 
Overall, there is unanimity of results on the phenotypes exhibited by the 
majority of the gal mutants tested in this study and Masuda (2008): deletions of 
GAL1 and GAL4 were suppressors and GAL7, GAL10 were not, unfortunately we 
cannot further speculate on gal80Δ related phenotype for reasons discussed 
above. The same publication, however, informed that deletion of GAL2 was 
unable to reverse the galactosemic-like phenotype; in disagreement with this 
observation, the gal2Δ was found to be a suppressor strain in this study. In a 
lithium-free environment, the deletion of this gene, reduces, but does not inhibit 
galactose uptake entirely, suggesting a reason why its removal fails to revert the 
galactosemic-like phenotype in the previously discussed paper. Clearly under 
conditions used here, the deletion of GAL2 was sufficient to lower the amount of 
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growth inhibitory metabolites to the point where a suppressor phenotype was 
observed. The difference between the results presented here and these of 
Masuda (2008) may well lay in their inclusion of 2% glycerol in the growth 
media, with possible downstream consequences on pathways such as 
respiration. 
Alleviation of the toxic effect is also to be expected for any pathway that 
can stop galactose from entering into the Leloir pathway, as this will ultimately 
help cellular growth. This is proven by the same Masuda and colleagues (2008), 
who showed that over-expressing GRE3, an aldose reductase that transforms 
galactose into galactitol, also reverts the galactosemia-like phenotype. As more 
galactitol is accumulated, less Gal-1-P is formed, with benefit for cellular fitness. 
Astonishingly, in this study gre3Δ was a sensitizing deletion, suggesting that 
further investigation is required to explain this result. 
Independent studies on intracellular metabolite profiles of S. cerevisiae 
strains with improved or impaired growth on galactose, (de Jongh, 2008) suggest 
that other metabolites and/or unbalance of metabolic fluxes are also likely to 
cause cellular toxicity. According to de Jongh’s investigation, it is the combination 
of the ratio between Gal-1-P concentration and Pgmp activity, and the elevated 
intracellular galactitol concentration that is critical for galactose related toxicity. 
Although this latter study conceives that Gal-1-P might cause a negative effect 
through inhibition of Pgmp, the toxic intermediate Gal-1-P is not the sole cause of 
galactose induced toxicity, as suggested by further identified toxic metabolite in 
the pathway, UDP-Gal. 
The research presented in chapter 3 concludes that with PGM1/2 
inhibited by lithium/galactose treatment, Gal-1-P and UDP-Gal build up, leading 
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to slow growth.  Blockage in the production of those, either by stopping the GAL 
pathway engaging by GAL4 deletion, or by deletion of GAL1 and thereby stopping 
formation of Gal-1P or by indeed preventing galactose entering the cells (gal2Δ) 
implies that no toxic metabolite is produced. 
 
 
3.30.3. Glycosylation 
During N-linked glycosylation of proteins, two molecules of N-
acetylglucosamine, nine molecules of mannose, and three of glucose are 
sequentially assembled on a lipid carrier molecule forming an oligosaccharide 
chain. A 14-residue oligosaccharide core is brought together and subsequently 
transferred to an asparagine residue on nascent polypeptide chains in the ER. As 
proteins progress through the Golgi apparatus, the oligosaccharide cores are 
shortened or extended to generate a diverse array of glycosylated proteins 
(reviewed in Herscovics & Orlean, 1993). In addition to those highlighted above 
relating, a further subset of suppressor-behaving deletion strains was identified 
in this screen upon lithium/galactose treatment; those involved in N-
glycosylation. These were as the duplicate pair ALG6 and ALG8, and the OST5 
gene, which bridges connections with the secretory pathway.  
In the lumen of the ER, the α-1,3-glucosyltransferase Alg6p catalyses the 
addition of the first molecule of glucose to the oligomannose core (Burda, 1999), 
followed by Alg8p (Stagljar, 1994) and Alg10p (Burda & Aebi, 1998) 
glucosyltransferase enzymes, that add the second and third glucoses, 
respectively, to the growing oligosaccharide chain. Deletion of ALG10 was 
identified in the primary screen as associated to the lowest range of statistic 
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significance (not shown) and it did not undergo spot assays; this deletion still 
showed a coherent, although statistically unreliable, suppressor phenotype at all 
of the tested concentrations of  lithium in galactose medium.  
Once the 14-sugar branched oligosaccharide is assembled, the 
oligosaccharyl transferase complex (OST complex) relocates it from the lipid 
carrier to the consensus glycosylation acceptor site, an asparagine residue. The 
complex includes nine protein subunits: Ost1p, Ost2p, Ost3p, Ost4p, Ost5p, 
Ost6p, Stt3p, Swp1p, and Wbp1p, all of which are integral membrane proteins of 
the ER (reviewed in Herscovics & Orlean, 1993), as mentioned above, ost5Δ was 
associated to a suppressor phenotype in this screen. Ost5p, along with other OST 
components, is not essential for the viability of the cell; however it is still 
required for the optimal activity of the complex both in vivo and in vitro (Knauer 
& Lehle, 1999b; Yan & Lennarz, 2005). Because more than 70% of all proteins 
processed by this pathway are N-glycosylated (Dempski & Imperiali, 2002), the 
OST complex plays a critical role at the initial step of the secretory pathway; this 
is because the addition and subsequent processing of the carbohydrate chains is 
crucial for the folding, stability, and maturation of several glycoproteins. 
Significantly, the OST complex has been described as the “gatekeeper” of the 
secretory pathway (Dempski & Imperiali, 2002) and interacts with the Sec61p 
pore complex (Chavan, 2005) involved in protein import into the ER.  
At first glance, it appears strikingly odd that only one (Ost5p) out of the 9 
complex subunit was identified in the screen; primarily this is likely to be due to 
the nature of the other members of the complex.  OST1, OST2, STT3, SWP1, and 
WBP1 are essential, and were therefore not available for screening in this 
experiment.  OST3 and OST6 are noted to produce proteins that have overlapping 
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function, such that the individual gene deletions have little associated phenotype 
(Karaoglu, 1995).  
 Ost5p was initially identified in a synthetic lethal screen in alg5 mutant 
cells (Reiss, 1997). Individually, deletions of either OST5 or ALG5 genes have only 
mild phenotypes, but deletion of both confers a synthetic temperature-sensitive 
glycosylation defect at 30° C (Reiss, 1997). A congruent genetic relationship of SL 
nature has been described for this pair of genes (Schuldiner, 2005; Costanzo, 
2010). A potential cause for the identification of OST5 in this screen could be 
that, whilst the loss of individual functionality is insufficient to cause a growth 
defect, it is sufficient to cause a growth benefit under lithium/galactose 
treatment. In the context of the other suppressor strains observed, this option 
seems rather parsimonious. In this model, a reduction in glycosylation leads to a 
corresponding loss of active cell surface glycosylated transporters. In the 
lithium/galactose context, any reduction in the transport of Li+ (relieving its 
intracellular effects including Pgmp inhibition) or of galactose (nothing the 
suppressing effects from deletion of GAL2) would lead to enhanced growth. S. 
cerevisiae sugar carriers of glucose, galactose, and maltose have been identified 
as glycoproteins (Lagunas, 1986), although glycosylation of Gal2p has not been 
established beyond all reasonable doubt (Tschopp, 1986; Ramos, 1989). A 
number of ion channels (Shi & Trimmer, 1999) and nuclear pore complexes 
(Belanger, 2005) are also glycosylated. In this model, complete ablation of 
glycosylation and the secretory pathway may be unnecessary (and indeed may 
be deleterious), all that would be required is a reduction in lithium import (so as 
to relieve Pgmp inhibition) and/or of galactose import (to ensure that levels of 
proposed toxic metabolites discussed in section 3.30.2 do not accumulate). If 
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Gal2p is glycosylated, than loss of glycosylation could lead to less galactose to be 
available, then reversing the toxic effect and leading to the suppressor phenotype 
observed.  
Although this study concludes that the reduction of lithium or galactose 
transport leads to enhanced growth and the observed suppressor phenotype is 
the most likely underpinning of the effect, an additional rather speculative 
proposition could be explored. Numerous cell surface proteins are modified by 
N-linked glycosylation, including a number of receptors important for growth 
regulation. The extent of their glycosylation affects their surface expression and 
cellular growth or differentiation (Lau, 2007; Fang, 2010). In an algΔ background 
strain, in the presence of lithium/galactose, the signalling pathway may be faulty, 
following its strict requirement for glucose-containing oligosaccharides, as 
indicators of N-glycosylation performance. Under the glucose-limiting conditions 
of this screen, it is possible that a signalling defect of this kind would lead to 
improper TOR regulation, and a resultant inability to modulate cellular 
processes, including protein synthesis. 
 
3.31. Calcium homeostasis  
In S. cerevisiae the majority of the cellular responses to hyper-osmotic 
stress is regulated by two interconnected pathways involving the MAPK Hog1p, 
discussed in section 3.25, and calcineurin, a Ca2+/calmodulin-regulated protein 
and a major player in Ca2+-dependent eukaryotic signal transduction pathways. 
Following a stimulus there is variation in the Ca2+ concentration in the cytosol. 
This activates a variety of Ca2+ sensing proteins such as calmodulin and 
calcineurin, which ultimately leads to the induction of various downstream 
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signal transduction pathways (reviewed in Kraus & Heitman, 2003).  The 
extended regulation of calcineurin-mediated route has extensively been exposed 
in this study by its regulation of specific components of the cell cycle (section 
3.24) and by playing a key role in activating CS enzymes as part of the 
compensatory mechanism (section 3.23). As several of the SL-like phenotypes 
observed upon lithium/galactose treatment have been linked to the competitive 
nature of the lithium ion, it has to be mentioned that, in yeast cells, a Mg2+ 
depletion leads to enhanced cellular Ca2+ concentration, which will then activate 
the Crz1p/calcineurin pathway, crucial for this organism to cope with the Mg2+ 
depletion stress (Wiesenberger, 2007). It is conceivable that, if the loss of Mg2+ 
ion is recognised in response to loss of activity of an Mg2+-dependent protein, 
then lithium could block that activity and generate an Mg2+-deficient response. 
Calcineurin type 2B phosphatase consists of a catalytic subunit, 
calcineurin A, and a regulatory subunit, calcineurin B; all eukaryotic organisms 
possess one or more genes for each subunit, which have been identified in yeast, 
insects, and mammals (Guerini & Klee, 1989). In budding yeast, the catalytic 
subunit of calcineurin is encoded by two genes (CNA1/CMP1 and CNA2/CMP2), 
whilst only one gene (CNB1) is accountable for the B subunit. Interestingly, this 
study’s screen identified only one of the two genes encoding the catalytic subunit 
of calcineurin A, CMP2, along with CNB1, which encodes for the regulatory Ca2+ -
binding subunit calcineurin B, but no interaction was found for the isoform 
encoded by CNA1/CMP1. cmp1Δ was part of the manually picked set of genes that 
went into the follow-up spot dilution assays, and was confirmed as not sensitive, 
suggesting it was not simply lost through noise in the more high-throughput 
screening approach. A further calcineurin-related sensitive hit was reported:  
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RCN1 encodes a protein whose levels are believed to fine tune calcineurin 
signalling in yeast and for this Rcn1p is involved in calcineurin regulation during 
Ca2+ signalling. Increasing interest has arisen around the RCN1 gene, following 
the discovery that it has conserved structural and functional similarities to H. 
sapiens DSCR1, and it is therefore likely that the mammalian Rcn1p-related 
proteins, calcipressins, could modulate calcineurin signalling in humans, 
potentially contributing to disorders such as Down syndrome (Kingsbury & 
Cunningham, 2000).  
In order to maintain Ca2+ homeostasis, the contribution of proteins found 
in different cellular compartments varies little, however the contribution to 
surveillance and maintenance of this cation balance may be more variable, as 
emerged in this screen. Ca2+ homeostasis affects vacuole, Golgi and ER 
compartments, which are subjected to calcineurin regulation via the stress-
response transcription factor Crz1p (Figure 3-18), required for the induction of 
genes encoding the vacuolar Pmc1p and secretory Pmr1p Ca2+-pumps 
(Cunningham & Fink 1994; Stathopoulos & Cyert, 1997). This latter deletion was 
identified as a suppressor in this screen.  There is the possibility that deletion is 
causing a reduction in the secretory pathway activity as discussed for the ALG 
and OST deletions, hence the suppressor effect. 
Along with Pmc1p, Ca2+ vacuolar intake also happens via Vcx1p (not 
shown), whose activity is still under calcineurin regulation, although in a Crz1p-
independent manner: The functional relationship between these two vacuolar 
Ca2+ transporters is rather complex: calcineurin activation stimulates Pmc1p 
function, whilst it inhibits Vcx1p’s through a post-translational mechanism 
(Cunningham & Fink, 1996). 
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Figure 3-18. Calcineurin-mediated regulation of ion homeostasis in budding yeast. 
 
The high affinity Ca2+/Mn2+ P-type ATPase encoded by PMR1 and localized 
on the plasma membrane, is required for both cations’ transport into the Golgi 
(Miseta, 1999), and it was identified as a suppressor in this study. Pmr1p belongs 
to family of transporters known as Secretory Pathway Ca2+-ATPases, which are 
found in C. elegans, D. melanogaster, and mammals (Culotta, 2005) and plays a 
role in maintaining the Ca2+ luminal concentration required for proper 
glycosylation and processing of proteins in the Golgi compartment (Antebi & 
Flink, 1992). Both Ca2+ and Mn2+ are necessary for proper processing and 
trafficking of polypeptides through the secretory pathway, but each with a 
different role: whilst Ca2+ is required to sustain protein sorting, Mn2+ is needed 
for protein glycosylation, a process represented in this screen (section 3.30.3). 
In this context it is possible that the PMR1 deletion leads to loss of efficient 
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glycosylation and secretion of key cell surface proteins, which might include 
Gal2p and pumps which might import lithium. As previously discussed, this 
might allow reduced galactose import and/or lower intracellular concentrations 
of lithium which would then lead to the suppressor phenotype observed with 
other strains working in this pathway.  
Deletion of the gene HUR1 also resulted in a suppressor phenotype. This 
gene codes a protein of unknown function; however, its appearance in this 
screen is likely to be due to its overlap with the suppressor PMR1 gene. The 
deletion of these two genes causes suppression, so the inability to transport Ca2+ 
into the Golgi leads to enhanced growth in lithium/galactose environment.  
  
PMR1 and PMC1 undergo a regulation driven by calcineurin (Figure 
3-18) so the observed phenotype may have something to do with the specific 
compartment where the Ca2+ in excess is accumulated. It is likely to be a 
response driven from the Golgi compartment, as hinted at by the wild-type like 
phenotype observed for deletion of vacuolar Ca2+ pumps genes PMC1 and VCX1. 
Lithium-induced Ca2+ over-accumulation is reduced in yeast strains 
lacking the vacuolar Ca2+-ATPase contribution of Pmc1p (Kellermayer, 2003), a 
result that lead the authors to conclude that lithium inhibition of Pgmp  results in 
an increased Glu-1-P to Glu-6-P ratio, which consequently translates into an 
augmented rate of vacuolar Ca2+ uptake mediated by the Ca2+-ATPase Pmc1p. 
This led us to expect a change in sensitivity on PMC1 deletion, the pmc1Δ was 
selected to undergo spot assay. Contrary to our expectations, it still did not 
return a change in growth and we are left to conclude that the difference in the 
strains’ backgrounds or the specific lithium/galactose treatment used in this 
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study. It is worth recognising that other cellular compartments can compensate 
for the reduced capability to uptake Ca2+ by the vacuole (Miseta, 1999). The 
diverse contributions of cellular compartments are possibly dictated by their 
own ability to take up this cation. 
A depletion of secretory pathway Ca2+ stores is caused by the mutation or 
deletion in PMR1 region and subsequently leads to improper folding and 
processing of proteins that transit through ER and Golgi (Antebi & Fink, 1992). 
Possibly as a result of feedback from this outcome, elevated cellular Ca2+ uptake 
is observed in pmr1Δ strain. This is mediated by Cch1p and Mid1p and recalls the 
mammalian capacitative Ca2+ entry (CCE) response introduced in section 3.3. 
CCH1 encodes a high-affinity Ca2+ channel with homology to mammalian voltage-
gated Ca2+ channels (Diriong, 1995). Both cch1Δ and mid1Δ mutants display 
reduced tolerance to monovalent cations such as lithium, suggesting a role for 
Ca2+ uptake in the calcineurin-dependent ion stress response, providing further 
support for the hypothesis that Mid1p and Cch1p function in the same Ca2+ 
uptake process (Paidhungat & Garrett, 1997). Cch1p functions together with the 
stretch-activated cation channel Mid1p (identified in the primary screen but not 
confirmed by the spot dilution assays) to form a channel for Ca2+ influx at the 
plasma membrane level (Locke, 2000). Along with the transporters Pmr1p 
(discussed above), Pmc1p, and the vacuolar ion exchanger Vcx1p, Cch1p and 
Mid1p are involved in the regulation of cellular Ca2+ levels and mediate Ca2+ 
signalling. Strains lacking either CCH1 or MID1 show hypersensitivity to ER 
stress including accumulation of misfolded proteins in the ER (Bonilla, 2002), 
alkaline (Viladevall, 2004), and iron stress (Peiter, 2005); upon 
lithium/galactose treatment, however, the loss of Cch1p seems to be more 
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debilitating than Mid1p.  In a similar fashion, the hit ECM7 encodes for a non-
essential putative integral membrane protein and its transcription is induced 
under conditions of zinc deficiency. Ecm7p has a role in Ca2+ uptake and ecm7Δ 
mutants have cell wall defects and Ca2+ uptake deficiencies which could explain 
the sensitivity observed for this deletion strain. 
When relating the results of this study to mammals, a mention should be 
made of the higher number of hits identified in this study for Ca2+ related 
processes happening in the Golgi compared to ER. This finding might relate to 
the fact that yeast Golgi plays a role functionally similar to that of mammalian ER, 
in its potential to mediate a temporary increase in cytosolic Ca2+, which will then 
be amplified by a CCE-like mechanism (Aiello, 2002). Endorsing this explanation 
is the knowledge that the yeast ER appears to play a lesser role in cellular Ca2+ 
storage supported by the finding that the free Ca2+ concentration in this 
compartment has been reported to be only about 10 µM (Strayle, 1999) 
compared to the mM concentration reported for the Golgi apparatus (Fasolato, 
1991). 
Studies have demonstrated that some misfolded luminal proteins are 
exported from the ER into the cytosol for ubiquitination and subsequent 
degradation by the proteasomal structure (reviewed in Brodsky & McCracken, 
1997). If this process is impaired by the action of lithium in competing with  Ca2+ 
interactions, it would be expected that overexpression of a translational 
encoding gene with the intent of enhancing protein synthesis could overcome the 
toxicity the effect of a poor recycling could be overcome, as shown for TIF2 
(Montero-Lomeli, 2002). Adjunctive evidence that points to a loss of 
glycosylation is also suggested by observations reported in section 3.30.3. 
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3.32. The TOR pathway 
S. cerevisiae adapts to changing nutrient conditions by regulating its 
transcription profile and complementing cellular protein requirements in 
correlation with the nutrient conditions. The TOR signalling pathway is one of 
the major control mechanisms within the cell that facilitates these changes, 
which actuates, among others, the transcription, intracellular trafficking, and 
protein turnover of nutrient transporters which are regulated in response to 
nutrient conditions, as highlighted in section 3.17 for the “generation of 
precursor metabolites and energy” GO term. 
The relevance of TOR as an important signalling component in the 
regulation of cellular responses is reflected in the wealth and variety of cellular 
processes indicated by this screen in assisting the cell to tolerate and overcome 
the lithium/galactose toxicity, many of which share TOR-mediated regulation. 
Indeed, a link between TOR signalling and lithium sensitivity has already been 
established by studies on both baker’s yeast and C. albicans, where deletion of 
one of the components of the TOR complex TORC1, Tco89p , induces sensitivity 
to both lithium and rapamycin (Zheng, 2007). 
Under nutrient-rich conditions, the TOR complex 1 (TORC1) prevents 
general autophagy and promotes ribosome biosynthesis and protein translation, 
however, nutrient limitation or the addition of rapamycin leads to TORC1 
inhibition and consequent autophagy. Ubiquitin-mediated degradation could be 
involved in the mechanisms of regulation of autophagy and ribophagy (section 
3.30.1). It is still unclear whether and to what extend TOR regulates autophagy 
and ribophagy. Similarly, it is not clear whether TOR signalling regulates a 
connection between the targeted disposal of stalling ribosomes and the 
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translation of specific mRNAs. TOR regulation extends to the CWI pathway 
(section 3.21), where the signal is mediated via Rho1p; this latter interacts with 
Pkc1p activating the MAP kinase pathway cascade, which is essential for 
regulating cell wall integrity and actin cytoskeleton (Helliwell, 1998) (section 
3.22). The inter-communication which allows the adjustment of the two 
important processes of glycosylation and protein synthesis could be, in some 
measure, TOR-mediated (section 3.30.3). 
 
3.33. Targets of lithium 
This study recapitulated the majority of the long-time agreed targets of 
lithium. These include glycogen synthase kinase 3β (GSK-3β), 
phosphoglucomutase, and FBPase as discussed below. 
 
i. Glycogen synthase kinase 3β 
The adverse effects observed upon lithium treatment in the 
developmental processes of many different organisms are thought to have a 
common cause. One possibility is that this occurs through inhibition of the GSK-
3β (Klein, 1996), since loss of function of this enzyme produces the same 
phenotypes in organisms as different as the social amoeba Dictyostelium 
discoideum (Harwood, 1995) and the frog Xenopus laevis (He, 1995). Some of 
lithium effects could be easily explained by a negative regulation of GSK-3β 
proteins and other proteins by competitively displacing Mg2+ from its binding 
site. 
Four homologs of GSK-3β are present in yeast: RIM11, MCK1, MRK1, and 
YGK3. Among them, RIM11 and MCK1 are homologs with a highly probability that 
323 
 
they arose from a recent genome duplication followed by a rapid divergence, as 
shown by the ability of the two homologs to phosphorylate different specific 
substrates (Puziss, 1994). Rim11p is essential for entry into meiosis, whereas 
Mck1p is required for growth at elevated and low temperatures. While both 
kinases transmit nutrient signals, Mck1p transmits additional signals including 
stress signals such those related to temperature and osmotic shock. The other 
two paralogs (MRK1 and YGK3) show redundant roles, though believed to be less 
important. Among the four GSK-3β yeast homologs, only one was reported in this 
study:  MCK1; the fact that MCK1 deletion leads to lithium sensitivity indicates 
that the protein product of this gene is not a prime candidate as a target.  
However, it is notable that MCK1 shows both a synthetic growth defect (Hirata, 
2003) and negative genetic interaction (Fiedler, 2009; Costanzo, 2010) with 
RIM11, amongst other genes.  It would be plausible, therefore, that lithium leads 
to inhibition of Rim11p, which in combination with MCK1 deletion leads to a 
growth defect analogous to the growth defect observed in the dual deletion.  
 
ii. Phosphoglucomutase (PGM).  
Lithium has been previously shown to inhibit the PGM enzymes as 
extensively discussed in section 3.2. The contribution of the different PGM genes 
to Pgmp activity is reflected in the sensitivity observed in the relative deletions 
under lithium/galactose treatment. Abolition of Pgm2p, the major isoform lead 
to a more severe growth defect than loss of Pgm1p; concordantly, pgm3Δ strain 
is only associated to a mild sensitivity upon lithium/galactose treatment, as 
expected from its relatively minor contribution. Lithium-induced inhibition of 
Pgmp has been noted to impact on Ca2+ regulation, as discussed in section 3.3. 
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iii. FBPase  
The FBPase enzyme is also a verified target of lithium; the mechanisms 
through which this drug inhibits enzymatic activity has been previously 
established and extensively discussed in section 3.29. Under the 
lithium/galactose dual treatment, a depletion of the F-6P reserves is observed 
leading to severe cellular consequences, likely triggered by the unavailability of 
carbohydrate necessary for the synthesis of fundamental building blocks of 
nucleic acids (e. g., ribose). 
iv. Inositol Monophosphate (IMP).   
According to the “inositol depletion hypothesis” (Berridge & Irvine, 1989), 
lithium inhibits the inositol monophosphatases (IMPases) (Hallcher & Sherman, 
1980) and inositol polyphosphate 1-phosphatases (IPPases) enzymes (Inhorn & 
Majerus, 1988) ultimately leading to the impairment of the inositol 1,4,5-
triphosphate-dependent signal transduction pathway (Berridge & Irvine, 1989). 
Despite literature reports of inhibition of inositol monophosphatases, deletions 
of IMPase encoding yeast genes INM1 and INM2, did not appear to be sensitive in 
this study, possibly masked by other more highly sensitive deletions under the 
dual lithium/galactose treatment. 
 
3.34. Implications for lithium’s mode of action and 
neuroprotective agents 
Several features associated with neurodegenerative diseases, such as 
cellular toxicity mediated by misfolded proteins and oxidative stress have been 
partially recapitulated by findings highlighted by this study, providing 
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information on conserved mechanisms that may be further utilized to gain 
mechanistic and genetic insights into candidate drugs. 
Impairment of mitochondrial energy metabolism has been clearly 
recognized as one of the mechanisms crucial in many neurodegenerative 
disorders. A growing set of evidence relates reduced energy production and 
mitochondrial dysregulation to bipolar disorder and indications of mitochondrial 
dysfunction in other neurodegenerative conditions are supported by studies on 
the molecular pharmacology of mood stabilizers pointing at the respiratory 
organelles as one of the drugs targets (Zarate, 2006). Results presented in this 
thesis could help to better define the current model, in which the mitochondrial 
ETC emerges as a major source for the generation of reactive oxygen species; 
findings of alterations in the expression patterns of genes associated with 
mitochondrial activity in the respiratory chain have been reported, for example 
in brain samples from patients treated for bipolar disorder (Konradi, 2004). This 
study indicates several mitochondria-localized processes (e.g., TCA, ETC, and 
partially the beta oxidation of fatty acids) as critical in supporting the cell under 
the tested treatment and altogether reinforces the current awareness that the 
etiology of neurodegenerative diseases has to be sought in the abnormality of the 
aforementioned related biological processes (Calabrese, 2001 for review; Schon 
& Manfredi, 2003).  
The number of pathways reported in this study with ubiquitin-related 
links demonstrates convincingly the importance of regulated proteolysis for 
cellular metabolism and how relevant and ubiquitous this process is, with a 
highly connected net of interactions that impinge on fundamental and far off 
pathways. The selective degradation of ribosomes by autophagy (ribophagy) is 
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mediated by hits from this screen - ubiquitin-specific protease 3 (Ubp3p) and 
Ubp3p-associated cofactor, Bre5p. This result strengthens the connections 
between the autophagy-like degradation mechanisms and neurodegenerative 
disorders, given the established role of ubiquitin as a key regulator of neuronal 
biology and the notion that dysfunction in ubiquitin metabolism may contribute 
to their pathogenesis (Layfield, 2005). 
Furthermore, the proposal of this study that FBPase is inhibited by 
lithium may be useful for other investigations. FBPase has a structural fold 
similar to that of inositol-1-phosphatase (I-1-Pase) (Zhang, 1993), and both are 
members of the sugar phosphatase superfamily which has been shown to be 
subjected to lithium action (section 3.29). Inhibition of mammalian I-1-Pase by 
lithium is of particular interest, since this enzyme is expressed in brain tissue 
and forms the main target in medical treatment of manic-depression (Pollack, 
1994). The mechanisms of the lithium inhibition of FBPases and IMPases are 
believed to be essentially the same: lithium binds at one of the metal binding 
sites, thereby retarding turnover or phosphate release (Johnson, 2001). The 
residues that constitute this metal binding site are conserved in lithium-sensitive 
I-1-Pase and in FBPase (Verhees, 2002).  
The discrete number of deletion strains corresponding to genes encoding 
for a functional protein of unknown function reported in this study is challenging 
and encouraging. It emphasizes the concept that several targets exist for this 
drug and it may mean that there is more investigation to be undertaken into 
lithium toxicity and mechanism(s), and that alternative pathways could be 
targeted. Current rresearch is directing its efforts towards identification of 
alternative medications that could be used in combination with lithium or alone 
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as a replacement for it, as already established for medications such as 
carbamazepine and valproate. The existence of compensatory pathways is 
indeed endorsed by this study which found the MAP kinase cascade, HOG and 
Ca2+/calcineurin-mediated signalling processes over-represented amongst the 
screen hits. Phosphorylation-mediated signalling dominates the cluster of 
related processes described for genes associated to signal transmission and 
transduction achieved via phosphorylation of proteins by kinases. As anticipated, 
the extensiveness of its targets makes the therapeutic path of lithium difficult to 
disentangle, and while more insights are sought for the neurobiology of mood 
disorders and antidepressants’ mechanisms of action, a shift in emphasis has 
been registered. Research earlier orientated towards investigations of the 
changes in neurotransmitters’ release and metabolism has been overtaken by the 
study of the regulation of gene expression and neuroprotection. This current 
approach is supported by evidence from animal studies suggesting that drug 
therapy may act on specific transcription factors and target genes that regulate 
processes such as neuroprotection and neuronal survival.  
 
3.35. This study screen versus Zhao’s and Hillenmeyer’s 
Analogous lithium genome-scale genetic screens were conducted by 
independent groups (Hillenmeyer, 2008; Zhao, 2010) utilizing rich medium (YP) 
and glucose as a carbon source. Those two studies can be compared to this 
investigation, as the same diploid BY4743 deletion sets were employed; the 
concentrations of lithium chloride tested in the two aforementioned studies 
were, however, higher than the one used in this study. 
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This latter study identified 114 lithium-sensitive and 6 lithium-tolerant 
gene mutations in S. cerevisiae, with the majority of the sensitive mutations being 
genes annotated to a function in the VPS pathway (discussed in section 2.36), 
sporulation and meiosis, mainly operating in membrane docking and fusion. This 
led the authors to conclude that the integrity of the VPS pathway is critical for 
the ion homeostasis, at least in yeast cells (Zhao, 2010). Results presented here 
do not mirror Zhao’s in terms of most represented functional categories, 
although sharing 14 common lithium sensitive strains and two suppressors. This 
incongruity between the generated data sets reflects the effect of different 
carbon sources on cell metabolism, with different mechanisms characterizing 
glucose versus galactose-related hits. A higher drug working concentration (0.1 
M, 0.2 M, and 0.4 M) could also have played a role, as adaptation to low-to-mid 
molarities can engage different mechanisms. This lack of overlapping between 
sensitive and suppressor hits under lithium treatment reinforces the notion that 
many targets exist for this drug. 
Data from the lithium/galactose screen presented in this study can be 
compared to those generated from Hillenmeyer’s study (2008). The working 
concentrations utilized in the two assays were different: LiCl treatment was done 
at 150 mM in the cited study, while 30 mM was the highest concentration tested 
in this study, reflecting the differences in growth in inhibition in the galactose 
and YPD contexts. All the ORFs identified in this screen at 30 mM are also found 
in Hillenmeyer’s study, with the ultra-sensitive gene deletions identified in this 
screen (e.g., CNB1, CRZ1, and RCN1) being among Hillenmeyer’s screens top hits. 
As the suppressor phenotypes associated with certain deletion strains are 
specific for the carbon source utilized (galactose in -this study- vs glucose in -
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Hillenmeyer’s-), deletions showing enhanced growth in this screen may be found 
annotated as sensitive in Hillenmeyer’s study. It should not pass unnoticed that, 
all the sensitive deletions reported in this screen are also annotated in screens 
undertaken for different inorganic salts, for instance NaCl (Hillenmeyer, 2008). 
This suggests that either screens need to be performed at sensible 
concentrations to be able to appreciate discrete drug specific effects, otherwise 
osmotic stress effect may overbear the specific processes involved in drug’s 
mechanisms and toxicity in a genome-wide assay. For this reason, although 
useful preliminary tools, chemical screens have to be complemented with 
different approaches, to further validate the results.  
 
 
3.36. Summary 
Under lithium/galactose stress, cell communication, the complex system 
that governs and synchronizes almost all basic cellular activities was 
considerably over-represented amongst the screen hits. Particularly convincing 
evidence is gained from finding of the key regulators as being protein kinases. 
Additionally, the finding of genes involved in chromatin remodelling resonates 
with the model of a complex and intimate role for the regulation of transcription 
initiation by signalling kinases. Transcriptional repressors that bind to promoter 
sequences of the cyclin genes were also reported, defining a subset of genes 
related to repression of cell cycle progression. 
 The maintenance of the cell wall under stress conditions was brought to 
attention, along with its regulation delivered by calcineurin signalling, the HOG, 
and TOR pathways. The involvement of this latter pathway, also acting as an 
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important component by linking external signals to the actin/cytoskeletal 
machinery, is supported by the activation of chitin synthase which ultimately 
leads to an increase in chitin synthesis rate and content. 
Defects in growth were observed in mitochondrial gene deletions, 
testifying to the interplay between the TCA and the glyoxylate cycle, particularly 
in a non- or weakly-fermentable environment. In this context, the extraordinary 
extent of duplicate genes’ contribution to metabolic pathways could also be 
appreciated. 
An interpretation of the result on the loss of FBP26 strongly suggests that 
this condition induces cell death as a result of the organism’s inability to proceed 
with the synthesis of fundamental bio-precursors such purines, pyrimidines, and 
histidine.  
The deletion strains leading to suppression of lithium/galactose toxicity 
appear to coalesce on the single process of galactose metabolism. Inhibition of 
the lithium target protein Pgmp leads to a reduced flux through the Leloir 
pathway and a build up of metabolites that impair growth. Reasonably, loss of 
galactose import or processing prevents the toxic metabolites from being 
formed, resulting in a satisfactory cellular growth, by making use of other 
available carbon sources. A model where a reduction in glycosylation leads to a 
corresponding loss of active cell surface glycosylated transporters is also 
proposed as possible reason for the eased toxic effects observed with some 
suppressor strains. 
 
331 
 
Finally, although an extended Ca2+ regulation in several of the processes 
highlighted in this chapter discussion is strongly suspected, the degree of this 
contribution is not fully addressable from the results presented in this study. 
Broadly agreed upon targets of lithium have been recapitulated (FBPase, 
PGM, GSK-3) with exception of the IMPase/IPPase system. The yeast S. cerevisiae 
has proven once again that, despite being evolutionary distant from humans, it 
can be used as a model to study conserved cellular processes in higher 
eukaryotes. 
 
3.37. Different environmental challenges 
To determine the extent of similarity and divergence between the TIF1 
and TIF2 paralogs, growth of their individual deletion strains was assessed under 
different environmental conditions with the intent to explore the relative 
contributions of each paralog to response to environmental conditions, as 
reported in method 3.14. Inducing stresses used included high salt, alkaline pH, 
osmotic stress, carbon source switch, glucose starvation, and high temperature, 
etc…, however the pair of duplicates appeared convincingly robust in coping 
with these adversities in both rich and minimal media, as this study reported no 
differences for the majority of the experimental conditions tested (section 3.18). 
This result suggests a highly conserved, backed-up genetic network, strikingly 
even in the case of carbon source switch, where the appreciable growth delay 
expected was not observed.  
The paralogous genes’ network of interactions appears to confer 
robustness in almost any perturbed environment but still breaks down in 
response to a specific perturbation, as seen for the drug rapamycin. The basis for 
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this strain specificity in response to rapamycin requires further investigation, as 
discussed in chapter 4. 
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4. Chapter 4 
 
4.1. Summary 
Being one of the key steps in protein synthesis, the process of translation 
initiation is subjected to a multi-level regulation which is achieved via diverse 
mechanisms (Sonenber & Dever, 2003). The first part of this thesis focuses on 
identifying mechanisms of regulation in a translationally deficient system 
imparted by the loss of one or the other of the TIF1/2 genes. The cell is 
understood to select from several processes with the final purpose to adjust 
protein synthesis accordingly to the cellular status and environment. These 
include control of: mRNA abundance, translational rate through regulation of 
ribosome density/occupancy, and protein specific degradation. Results 
presented in this study faithfully reflect these well agreed arrangements, 
including sensitivity induced from loss of genes for proteins that function 
directly in, or regulation of mRNA concentration and export, ribosome assembly, 
degradation of selective proteins, and levels of transcription. These therefore all 
contribute to the regulation of translation initiation. The definition of the 
different degrees of contribution for any of the aforementioned routes can be 
inferred from the data presented in this study.  
Despite a quite neat compartmentalisation, coupling of the cellular 
processes of translation and transcription has been acknowledged (Hinnebusch, 
2005; Topisirovic, 2011); in fact, the existence of a tied mechanism in eukaryotes 
has recently been demonstrated in S. cerevisiae (Harel-Sharvitl, 2010). The 
interpretation of the results presented in this thesis indicates a sophisticated 
inter-communication between these two fundamental processes, which is 
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ultimately represented in the genetic networks of yeast translation initiation 
factor 4a encoding genes TIF1 and TIF2. Furthermore, such dense arrangement 
of connections is endorsed by the wealth of physical interactions annotated in 
the existent literature (Keene, 2001; Halbeisen, 2008). A major finding of this 
research is related to the functional competences associated to the two duplicate 
members of the gene pair, expertises that appear somewhat separate. The tif1Δ 
genetic profile highlights a connection with transcription mediated via the direct 
formation of the TFIIA transcription subunit, a nuclear protein required for all 
RNA polymerase II-dependent transcription events. The majority of 
transcription-translation inter-talk, however, is allocated to TIF2 duplicate. By 
virtue of the interactions held by this paralog, the translational initiation process 
has connections to control gene expression via RNA polymerase II assembly and 
functionality along with a dense network of genetic interactions surrounding the 
SAGA complex. TIF2 is also described unequivocally as the only paralog devoted 
to interactions with a substantial group of functionally related genes involved in 
early meiotic gene expression.  Altogether, the genetic portrait of TIF1 and TIF2 
genes speaks for a mutual control between transcription and translation aimed 
to reinforce the control of the two processes singularly. 
The correlation between mRNA and protein abundance is profoundly 
affected by protein turnover (Pratt, 2002): degradation of proteins in the global 
control of protein synthesis represents a fundamental process and accounts for 
diverse points of potential control, as also confirmed by this study’s SGA data. 
Ubiquitin appears as a common denominator in degradative processes taking 
place in both the proteasome and MVBs vesicles; both degradative pathways are 
represented in this study’s genetic investigation of translation. The interplay 
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between a functional vesicular system and the rate of protein synthesis for 
appropriate cellular up-keep during changes in cellular metabolism has also 
been reiterated. 
Interestingly, events like NMD which leads to stalling of the ribosome on 
mRNA, and thereby induce mRNA cleavage and degradation (Doma & Parker, 
2006), do not appear to play a major role in addressing cellular issues 
concerning the translational initiation process. Given the established link 
between the mRNA surveillance machinery and other stages of translation, there 
is the possibility that the NMD contribution may be concealed behind other 
connections, for instance those with reference to the ubiquitin pathway. 
Finally, it is critically important to comment on the relative paucity of 
interactions reported for genes involved in ribosome biosynthesis/biogenesis in 
the tif1Δ and tif2Δ SGAs. This result seems to fall in with existent work which 
showed how repression of ribosome biosynthesis does not rule the rapid 
repression of translation, at least in secretory-deficient pathways (Deloche, 
2004). For this condition, the same group also report no TOR-mediated 
regulation in the decrease of translation, as echoed by the data in the current 
study, where no immediate link to TOR was reported. 
This research testifies to the critical importance of translation-
transcription inter-talk among the several mechanisms put in place to amend 
protein synthesis according to cellular needs. This contribution is mastered 
through the intervention of the DUB enzymes via their counteracting 
ubiquitinating enzymatic activity on specific targets. These DUBs are crucial 
regulators of chromatin dynamics and gene expression, and assist with the 
recruitment of modules that involve selected components of the SAGA complex. 
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Functional turnover of proteins is, to a certain extent, regulated by the balance 
between post-translational modifications, in particular 
ubiquitination/deubiquitination. In particular H2B histone ubiquitination 
appears to be of particular relevance: a scenario is proposed in which changes in 
the ubiquitin pools could be sensed by the nucleus by affecting the histone-
ubiquitin status. Following this rationale, the proposed mechanism may lead to 
either a signal to recycle/degrade ubiquitin or to up/downregulate ubiquitin de 
novo synthesis.  
This research concludes that functional turnover of proteins and the 
translation/transcription inter-talk emerges as the most significant contributors 
to the sofisticatly regulated translational regulation, whilst the participation of 
NMD machinery or ribosome biogenesis to this process appear minor in this 
work. This study offers an insight on the dynamics of translation regulation, 
which emerges as highly interconnected and amendable process, which is to be 
expected given the importance of protein synthesis as a cellular process. Over 
evolutionary timescales, the challenge of regulating translation may be overcome 
by allocating new competences to genes to achieve this remodelling. This seems 
to be reflected in the variety of genes identified in these SGA screens. Supported 
by a previous hypothesis which suggested that eIF4Ap function is necessary even 
when no melting activity of secondary structures is required (Linder, 2003), this 
thesis suggests that RNA helicase activity may not be the only mechanism in 
which this protein participates, some of which still not clearly resolved in the 
literature.  
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The second part of this thesis describes the use of chemical and 
environmental perturbations, to complement the TIF1 and TIF2 genome-wide 
screen results. This is achieved by accommodating a variety of potential growth 
environment in which the robustness of the duplicate pair is challenged under 
disparate cellular contexts.  One of the primary treatments made use of lithium, 
condition which was hoped to help, along with furthering our understanding of 
the TIF1 and TIF2 networks, in formulating an explanation on how augmented 
translation initiation overcomes lithium toxicity.   
Although this approach did not return enlightening results that could be 
used to address this unresolved topic, it was highly instructive of mechanisms of 
response triggered upon lithium/galactose stress. Regulation and 
synchronization of basic cellular processes were affected: emphasis brought on 
aspects of cell communication highlighted mechanisms articulated by kinases 
enzymes as key regulators. This was also endorsed by the finding of genes 
involved in chromatin remodelling. In fact, this latter result was interpreted in 
line with the model of a complex and intimate role for the regulation of 
transcription initiation by signalling kinases. Additionally, transcriptional 
repressors able to bind to promoter sequences of the cyclin genes were also 
reported, emphasizing the importance of repression of cell cycle progression in 
control of protein synthesis. The maintenance of the cell wall under stress 
conditions was also underscored, along with its regulation delivered by 
calcineurin signalling, the HOG, and TOR pathways. The involvement of this latter 
pathway, also acting as an important component by linking external signals to 
the actin/cytoskeletal machinery, is supported by the activation of chitin 
synthase enzymes. These hits from the screen also indicated the stress that 
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combined lithium/galactose treatment places on central metabolic pathways, for 
instance those between the Leloir route and the gluconeogenesis and trehalose 
pathways. Interpretation of the results concluded growth defects are induced as 
a result of three major factors: 1) Impairment of gluconeogenesis and the TCA 2) 
the build-up of growth inhibitory intermediate metabolites, and 3) the 
organism’s inability to proceed with the synthesis of fundamental bio-precursors 
such purines, pyrimidines, and histidine, triggered by the inadequate amount of 
ribose available. Furthermore, the extraordinary extent of duplicate genes’ 
contribution to metabolic pathways could be appreciated, in the context of 
mitochondrial localized cycles. In regard to this, the interplay between the TCA 
and the glyoxylate routes in a weakly-fermentable carbon source environment 
was discussed in detail. 
Mechanisms of genetic suppression were observed for deletion strains in 
response to lithium/galactose toxicity: although they may have initially appeared 
related to the ubiquitination process and the metabolism of the carbon source 
galactose, they all ultimately coalesce on the single process of galactose 
metabolism. Inhibition of the lithium target protein Pgmp leads to a reduced flux 
through the Leloir pathway and a build up of metabolites that impair growth. 
Reasonably, loss of galactose import or processing prevents the toxic metabolites 
from being formed, resulting in a satisfactory cellular growth making use of 
other carbon sources. A model where a reduction in glycosylation leads to a 
corresponding loss of active cell surface glycosylated transporters is also 
proposed as possible reason for the eased toxic effect. Finally, although an 
extended Ca2+ regulation is strongly suspected in several of the processes 
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highlighted in this study, the underlying mechanisms of this cation’s contribution 
cannot be inferred from the results obtained. 
Finally, the lithium/galactose study recapitulated almost fully the broadly 
agreed upon targets of lithium, as suggested for its therapeutic action. Despite 
being quite far away from humans, the yeast S. cerevisiae has proven once again, 
to be a valuable model for the study of conserved cellular processes in higher 
eukaryotes. 
To determine the extent of similarity and divergence between the TIF1 
and TIF2 paralogs, growth of their individual deletion strains was challenged 
under different chemical and environmental conditions with the intent to 
explore the relative contributions of each paralog in response to an extend range 
of stresses. The pair of duplicates appeared convincingly robust in coping with 
these adversities, thus suggesting a highly conserved and backed-up genetic 
network. Although the paralogous genes’ network of interactions appears to 
confer robustness in almost any perturbed environment, it still breaks down in 
response to a specific perturbation, as observed for the drug rapamycin. The 
basis for this strain specificity in response to such chemical treatment requires 
further investigation, as discussed later in this chapter. 
 
4.2. Future directions 
Although several interesting discoveries have been achieved over the 
course of this research, there are still a number of areas that warrant future 
investigation and/or confirmation. Moreover, some results suggested findings 
that fell outside the remit of the current study but that would be particularly 
appealing for future investigations. 
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The interpretation of results obtained in the chapter 2 of this thesis 
provides a captivating visualization and a rather detailed understanding of the 
similarities and differences between TIF1 and TIF2 duplicate genes. Underlying 
the glimpse offered by this study of the mechanisms of robustness supporting 
the functions of TIF1 and TIF2 gene pair is a wealth of information that could 
ultimately assist in extrapolating from the laboratory to broader time scales. 
Evolutionary-based approaches are required to fully elucidate whether and 
through which modalities robustness may facilitate evolutionary innovation, not 
only for this pair of duplicates, but also with the attempt to augment our 
comprehension of WGD-derived paralogs. The type of approach utilized in this 
research encountered a limiting weakness, as only the study of evolutionary 
novelty arising from modest laboratory time scales could be uncovered. To what 
extent robustness promotes evolutionary innovations could be possibly achieved 
through comparative genomics studies. Some further investigations, although 
intended, were not achieved mainly as time did not permit and will be addressed 
shortly with the aid of Green Fluorescent Protein (GFP) microscopy, utilizing 
resources available in our laboratory. This is particularly applicable to cases in 
which the contribution of one or both duplicates to a particular process might be 
assessed. 
It also became apparent that limitations in the techniques used meant 
that this research was not able to prove some of the newly proposed and 
unconventional interpretations beyond reasonable doubt and auxiliary 
validations are needed to turn them in unambiguous assertions. This is the case 
of some findings highlighted in the second part of this thesis (chapter 3) that 
complemented and deepened the discoveries made in the previous chapter. 
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Potential links to the process of translation initiation and ultimately protein 
synthesis have been hinted at, linked to highly connected mechanisms of control 
at the cellular level (e.g., TOR, ubiquitination/deubiquitination, and Ca2+-
mediated regulation); for this reason further investigations are required to 
ascertain the level of their involvement with the translational initiation process. 
TOR, inactivation of initiation induces a well-established inhibitory effect on 
protein synthesis, was brought to attention over the course of this study analysis. 
It is hard to state with certainty whether TOR involvement is directly linked to its 
regulation on proteins synthesis rather than acting through its extended range of 
interactions. Furthermore, since the functional turnover of proteins is regulated 
to a certain extent by the balance between post-translational modifications, such 
ubiquitination/deubiquitination, further experiments should address whether 
this process represents the predominant mechanism to regulate Tif1/2p 
proteins’ stability. Cellular implications of Ca2+-mediated regulation have also 
been considered; however, given the complexity of this regulatory mechanism, 
specific experiments should be designed to indisputably address this topic.  
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5. Appendix 
 
5.1. Negative genetic interactions identified in tif1 SGA 
ORF Gene  Description 
YBR093C PHO5 Repressible acid phosphatase (1 of 3) that also 
mediates extracellular nucleotide-derived 
phosphate hydrolysis; secretory pathway 
derived cell surface glycoprotein; induced by 
phosphate starvation and coordinately 
regulated by PHO4 and PHO2 
YBR106W PHO88 Probable membrane protein, involved in 
phosphate transport; pho88 pho86 double null 
mutant exhibits enhanced synthesis of 
repressible acid phosphatase at high inorganic 
phosphate concentrations 
YCR063W BUD31 Protein involved in bud-site selection; analysis 
of integrated high-throughput datasets predicts 
an involvement in RNA splicing; diploid 
mutants display a random budding pattern 
instead of the wild-type bipolar pattern 
YCR081W SRB8 Subunit of the RNA polymerase II mediator 
complex; associates with core polymerase 
subunits to form the RNA polymerase II 
holoenzyme; essential for transcriptional 
regulation; involved in glucose repression 
YDL006W PTC1 Type 2C protein phosphatase (PP2C); 
inactivates the osmosensing MAPK cascade by 
dephosphorylating Hog1p; mutation delays 
mitochondrial inheritance; deletion reveals 
defects in precursor tRNA splicing, sporulation 
and cell separation 
YDL002C NHP10 Protein related to mammalian high mobility 
group proteins; likely component of the INO80 
complex, which is an ATP-dependent 
chromatin-remodeling complex 
YBR289W SNF5 Subunit of the SWI/SNF chromatin remodeling 
complex involved in transcriptional regulation; 
functions interdependently in transcriptional 
activation with Snf2p and Snf6p 
YCL010C SGF29 SaGa associated Factor 29kDa; Probable 
29kKDa Subunit of SAGA histone 
acetyltransferase complex 
YDR080W VPS41 Vacuolar membrane protein that is a subunit of 
the homotypic vacuole fusion and vacuole 
protein sorting (HOPS) complex; essential for 
membrane docking and fusion at the Golgi-to-
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ORF Gene  Description 
endosome and endosome-to-vacuole stages of 
protein transport 
YDL232W OST4 Subunit of the oligosaccharyltransferase 
complex of the ER lumen, which catalyzes 
protein asparagine-linked glycosylation; type I 
membrane protein required for incorporation 
of Ost3p or Ost6p into the OST complex 
YDR173C ARG82 Inositol polyphosphate multikinase (IPMK), 
sequentially phosphorylates Ins(1,4,5)P3 to 
form Ins(1,3,4,5,6)P5; also has 
diphosphoinositol polyphosphate synthase 
activity; regulates arginine-, phosphate-, and 
nitrogen-responsive genes 
YER061C CEM1 Mitochondrial beta-keto-acyl synthase with 
possible role in fatty acid synthesis; required 
for mitochondrial respiration 
YER162C RAD4 Protein that recognizes and binds damaged 
DNA (with Rad23p) during nucleotide excision 
repair; subunit of Nuclear Excision Repair 
Factor 2 (NEF2); homolog of human XPC 
protein 
YDR455C  Dubious open reading frame unlikely to encode 
a protein, based on available experimental and 
comparative sequence data; partially overlaps 
the verified gene YDR456W  
YER092W IES5 Protein that associates with the INO80 
chromatin remodeling complex under low-salt 
conditions 
YFL013W-A Dubious open reading frame unlikely to encode 
a protein, based on available experimental and 
comparative sequence data; overlaps the 
verified gene IES1/YFL013C 
 
YFL036W RPO41 Mitochondrial RNA polymerase; single subunit 
enzyme similar to those of T3 and T7 
bacteriophages; requires a specificity subunit 
encoded by MTF1 for promoter recognition 
YGL212W VAM7 Component of the vacuole SNARE complex 
involved in vacuolar morphogenesis; SNAP-25 
homolog; functions with a syntaxin homolog 
Vam3p in vacuolar protein trafficking 
YGL219C MDM34 Mitochondrial outer membrane protein, 
required for normal mitochondrial morphology 
and inheritance; localizes to dots on the 
mitochondrial surface near mtDNA nucleoids; 
interacts genetically with MDM31 and MDM32 
YGL218W  Dubious open reading frame, unlikely to 
encode a protein; not conserved in closely 
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ORF Gene  Description 
related Saccharomyces species; 93% of ORF 
overlaps the verified gene MDM34; deletion in 
cyr1 mutant results in loss of stress resistance 
YFR025C HIS2 Histidinolphosphatase, catalyzes the eighth 
step in histidine biosynthesis; mutations cause 
histidine auxotrophy and sensitivity to Cu, Co, 
and Ni salts; transcription is regulated by 
general amino acid control 
YGR092W DBF2 Ser/Thr kinase involved in transcription and 
stress response; functions as part of a network 
of genes in exit from mitosis; localization is cell 
cycle regulated; activated by Cdc15p during the 
exit from mitosis 
YGL253W HXK2 Hexokinase isoenzyme 2 that catalyzes 
phosphorylation of glucose in the cytosol; 
predominant hexokinase during growth on 
glucose; functions in the nucleus to repress 
expression of HXK1 and GLK1 and to induce 
expression of its own gene 
YGR105W VMA21 Integral membrane protein that is required for 
vacuolar H+-ATPase (V-ATPase) function, 
although not an actual component of the V-
ATPase complex; functions in the assembly of 
the V-ATPase; localized to the yeast 
endoplasmic reticulum (ER) 
YGL147C RPL9A Protein component of the large (60S) 
ribosomal subunit, nearly identical to Rpl9Bp 
and has similarity to E. coli L6 and rat L9 
ribosomal proteins 
YGR118W RPS23A Ribosomal protein 28 (rp28) of the small (40S) 
ribosomal subunit, required for translational 
accuracy; nearly identical to Rps23Bp and 
similar to E. coli S12 and rat S23 ribosomal 
proteins; deletion of both RPS23A and RPS23B 
is lethal 
YGL016W KAP122 Karyopherin beta, responsible for import of the 
Toa1p-Toa2p complex into the nucleus; binds 
to nucleoporins Nup1p and Nup2p; may play a 
role in regulation of pleiotropic drug resistance 
YGL154C LYS5 Phosphopantetheinyl transferase involved in 
lysine biosynthesis; converts inactive apo-form 
of Lys2p (alpha-aminoadipate reductase) into 
catalytically active holo-form by 
posttranslational addition of 
phosphopantetheine 
YGL168W HUR1 Protein required for hydroxyurea resistance; 
has possible roles in DNA replication and 
maintenance of proper telomere length 
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ORF Gene  Description 
YGL026C TRP5 Tryptophan synthase involved in tryptophan 
biosynthesis, regulated by the general control 
system of amino acid biosynthesis 
YGL046W  Merged open reading frame, does not encode a 
discrete protein; YGL046W was originally 
annotated as an independent ORF, but as a 
result of a sequence change, it was merged with 
an adjacent ORF into a single reading frame, 
designated YGL045W 
 
YGL045W RIM8 Protein of unknown function, involved in the 
proteolytic activation of Rim101p in response 
to alkaline pH; has similarity to A. nidulans PalF 
YHR067W HTD2 Mitochondrial 3-hydroxyacyl-thioester 
dehydratase involved in fatty acid biosynthesis, 
required for respiratory growth and for normal 
mitochondrial morphology 
YGR188C BUB1 Protein kinase that forms a complex with 
Mad1p and Bub3p that is crucial in the 
checkpoint mechanism required to prevent cell 
cycle progression into anaphase in the 
presence of spindle damage, associates with 
centromere DNA via Skp1p 
YHL007C STE20 Signal transducing kinase of the PAK (p21-
activated kinase) family, involved in 
pheromone response and 
pseudohyphal/invasive growth pathways, 
activated by Cdc42p; binds Ste4p at a GBB 
motif present in noncatalytic domains of PAK 
kinases 
YHL025W SNF6 Subunit of the SWI/SNF chromatin remodeling 
complex involved in transcriptional regulation; 
functions interdependently in transcriptional 
activation with Snf2p and Snf5p 
YHR025W THR1 Homoserine kinase, conserved protein 
required for threonine biosynthesis; expression 
is regulated by the GCN4-mediated general 
amino acid control pathway 
YJL204C RCY1 F-box protein involved in recycling plasma 
membrane proteins internalized by 
endocytosis; localized to sites of polarized 
growth 
YIR023W DAL81 Positive regulator of genes in multiple nitrogen 
degradation pathways; contains DNA binding 
domain but does not appear to bind the 
dodecanucleotide sequence present in the 
promoter region of many genes involved in 
allantoin catabolism 
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ORF Gene  Description 
YJL138C TIF2 Translation initiation factor eIF4A, identical to 
Tif1p; DEA(D/H)-box RNA helicase that couples 
ATPase activity to RNA binding and unwinding; 
forms a dumbbell structure of two compact 
domains connected by a linker; interacts with 
eIF4G 
YJL046W AIM22 Putative lipoate-protein ligase, required along 
with Lip2 and Lip5 for lipoylation of Lat1p and 
Kgd2p; similar to E. coli LplA; null mutant 
displays reduced frequency of mitochondrial 
genome loss 
YJR075W HOC1 Alpha-1,6-mannosyltransferase involved in cell 
wall mannan biosynthesis; subunit of a Golgi-
localized complex that also contains Anp1p, 
Mnn9p, Mnn11p, and Mnn10p; identified as a 
suppressor of a cell lysis sensitive pkc1-371 
allele 
YKR059W TIF1 Translation initiation factor eIF4A, identical to 
Tif2p; DEA(D/H)-box RNA helicase that couples 
ATPase activity to RNA binding and unwinding; 
forms a dumbbell structure of two compact 
domains connected by a linker; interacts with 
eIF4G 
YKR058W GLG1 Self-glucosylating initiator of glycogen 
synthesis, also glucosylates n-dodecyl-beta-D-
maltoside; similar to mammalian glycogenin 
YKR057W RPS21A Protein component of the small (40S) 
ribosomal subunit; nearly identical to Rps21Bp 
and has similarity to rat S21 ribosomal protein 
YKR056W TRM2 tRNA methyltransferase, 5-methylates the 
uridine residue at position 54 of tRNAs and 
may also have a role in tRNA stabilization or 
maturation; endo-exonuclease with a role in 
DNA repair 
YKR055W RHO4 Non-essential small GTPase of the Rho/Rac 
subfamily of Ras-like proteins, likely to be 
involved in the establishment of cell polarity 
YKR054C DYN1 Cytoplasmic heavy chain dynein, microtubule 
motor protein, required for anaphase spindle 
elongation; involved in spindle assembly, 
chromosome movement, and spindle 
orientation during cell division, targeted to 
microtubule tips by Pac1p 
YKR053C YSR3 Dihydrosphingosine 1-phosphate phosphatase, 
membrane protein involved in sphingolipid 
metabolism; has similarity to Lcb3p 
YKR052C MRS4 Mitochondrial iron transporter of the 
mitochondrial carrier family (MCF), very 
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ORF Gene  Description 
similar to and functionally redundant with 
Mrs3p; functions under low-iron conditions; 
may transport other cations in addition to iron 
YKR051W  Putative protein of unknown function 
YKR050W TRK2 Component of the Trk1p-Trk2p potassium 
transport system 
YJR109C CPA2 Large subunit of carbamoyl phosphate 
synthetase, which catalyzes a step in the 
synthesis of citrulline, an arginine precursor 
YKR070W  Putative protein of unknown function; the 
authentic, non-tagged protein is detected in 
highly purified mitochondria in high-
throughput studies 
YKR069W MET1 S-adenosyl-L-methionine uroporphyrinogen III 
transmethylase, involved in the biosynthesis of 
siroheme, a prosthetic group used by sulfite 
reductase; required for sulfate assimilation and 
methionine biosynthesis 
YKR067W GPT2 Glycerol-3-phosphate/dihydroxyacetone 
phosphate dual substrate-specific sn-1 
acyltransferase located in lipid particles and 
the ER; involved in the stepwise acylation of 
glycerol-3-phosphate and dihydroxyacetone in 
lipid biosynthesis 
YKR066C CCP1 Mitochondrial cytochrome-c peroxidase; 
degrades reactive oxygen species in 
mitochondria, involved in the response to 
oxidative stress 
YKR065C FMP18 Presequence translocase-associated motor 
subunit, required for stable complex formation 
between cochaperones Pam16p and Pam18p, 
promotes association of Pam16p-Pam18p with 
the presequence translocase 
YKR064W  Zinc cluster protein of unknown function; the 
authentic, non-tagged protein is detected in 
highly purified mitochondria in high-
throughput studies 
YKR061W KTR2 Mannosyltransferase involved in N-linked 
protein glycosylation; member of the 
KRE2/MNT1 mannosyltransferase family 
YKR060W UTP30 Possible U3 snoRNP protein involved in 
maturation of pre-18S rRNA, based on 
computational analysis of large-scale protein-
protein interaction data 
YKL081W TEF4 Translation elongation factor EF-1 gamma 
YKL212W SAC1 Lipid phosphoinositide phosphatase of the ER 
and Golgi, involved in protein trafficking and 
secretion 
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YKR084C HBS1 GTP binding protein with sequence similarity 
to the elongation factor class of G proteins, EF-
1alpha and Sup35p; associates with Dom34p, 
and shares a similar genetic relationship with 
genes that encode ribosomal protein 
components 
YKR082W NUP133 Subunit of the Nup84p subcomplex of the 
nuclear pore complex (NPC), localizes to both 
sides of the NPC, required to establish a normal 
nucleocytoplasmic concentration gradient of 
the GTPase Gsp1p 
YKR078W  Cytoplasmic protein of unknown function, has 
similarity to Vps5p; potential Cdc28p 
substrate; contains a Phox homology (PX) 
domain and specifically binds 
phosphatidylinositol 3-phosphate (PtdIns-3-P) 
YKR096W  Protein of unknown function that may interact 
with ribosomes, based on co-purification 
experiments; green fluorescent protein (GFP)-
fusion protein localizes to the nucleus and 
cytoplasm; predicted to contain a PINc domain 
YKR023W  Putative protein of unknown function; the 
authentic, non-tagged protein is detected in 
highly purified mitochondria in high-
throughput studies 
YLL006W MMM1 Mitochondrial outer membrane protein, 
component of the Mdm10-Mdm12-Mmm1 
complex involved in import and assembly of 
outer membrane beta-barrel proteins 
YKR034W DAL80 Negative regulator of genes in multiple 
nitrogen degradation pathways; expression is 
regulated by nitrogen levels and by Gln3p; 
member of the GATA-binding family, forms 
homodimers and heterodimers with Deh1p 
YKR033C  Dubious open reading frame unlikely to encode 
a protein, based on available experimental and 
comparative sequence data; partially overlaps 
the verified gene DAL80 
YKR028W SAP190 Protein that forms a complex with the Sit4p 
protein phosphatase and is required for its 
function; member of a family of similar 
proteins including Sap4p, Sap155p, and 
Sap185p 
YKR047W  Dubious open reading frame unlikely to encode 
a protein, based on available experimental and 
comparative sequence data; partially overlaps 
the verified gene NAP1 
YKR046C PET10 Protein of unknown function that co-purifies 
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with lipid particles; expression pattern 
suggests a role in respiratory growth; 
computational analysis of large-scale protein-
protein interaction data suggests a role in 
ATP/ADP exchange 
YKR043C SHB17 Sedoheptulose bisphosphatase involved in 
riboneogenesis; dephosphorylates 
sedoheptulose 1,7-bisphosphate, which is 
converted via the nonoxidative pentose 
phosphate pathway to ribose-5-phosphate; 
facilitates the conversion of glycolytic 
intermediates to pentose phosphate units; also 
has fructose 1,6-bisphosphatase activity but 
this is probably not biologically relevant, since 
deletion does not affect FBP levels; GFP-fusion 
protein localizes to the cytoplasm and nucleus 
YKR042W UTH1 Mitochondrial outer membrane and cell wall 
localized SUN family member required for 
mitochondrial autophagy; involved in the 
oxidative stress response, life span during 
starvation, mitochondrial biogenesis, and cell 
death 
YLL039C UBI4 Ubiquitin, becomes conjugated to proteins, 
marking them for selective degradation via the 
ubiquitin-26S proteasome system; essential for 
the cellular stress response; encoded as a 
polyubiquitin precursor comprised of 5 head-
to-tail repeats 
YLR337C VRP1 Proline-rich actin-associated protein involved 
in cytoskeletal organization and cytokinesis; 
related to mammalian Wiskott-Aldrich 
syndrome protein (WASP)-interacting protein 
(WIP) 
YLR039C RIC1 Protein involved in retrograde transport to the 
cis-Golgi network; forms heterodimer with 
Rgp1p that acts as a GTP exchange factor for 
Ypt6p; involved in transcription of rRNA and 
ribosomal protein genes 
YLR048W RPS0B Protein component of the small (40S) 
ribosomal subunit, nearly identical to Rps0Ap; 
required for maturation of 18S rRNA along 
with Rps0Ap; deletion of either RPS0 gene 
reduces growth rate, deletion of both genes is 
lethal 
YLR287C-
A 
RPS30A Protein component of the small (40S) 
ribosomal subunit; nearly identical to Rps30Bp 
and has similarity to rat S30 ribosomal protein 
YLR182W SWI6 Transcription cofactor, forms complexes with 
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DNA-binding proteins Swi4p and Mbp1p to 
regulate transcription at the G1/S transition; 
involved in meiotic gene expression; 
localization regulated by phosphorylation; 
potential Cdc28p substrate 
YLR062C BUD28 Dubious open reading frame, unlikely to 
encode a protein; not conserved in closely 
related Saccharomyces species; 98% of ORF 
overlaps the verified gene RPL22A; diploid 
mutant displays a weak budding pattern 
phenotype in a systematic assay 
YLR056W ERG3 C-5 sterol desaturase, catalyzes the 
introduction of a C-5(6) double bond into 
episterol, a precursor in ergosterol 
biosynthesis; mutants are viable, but cannot 
grow on non-fermentable carbon sources 
YMR154C RIM13 Calpain-like cysteine protease involved in 
proteolytic activation of Rim101p in response 
to alkaline pH; has similarity to A. nidulans 
palB 
YMR080C NAM7 ATP-dependent RNA helicase of the SFI 
superfamily, required for nonsense mediated 
mRNA decay and for efficient translation 
termination at nonsense codons; involved in 
telomere maintenance 
YLR448W RPL6B Protein component of the large (60S) 
ribosomal subunit, has similarity to Rpl6Ap and 
to rat L6 ribosomal protein; binds to 5.8S rRNA 
YNL294C RIM21 Component of the RIM101 pathway, has a role 
in cell wall construction and alkaline pH 
response; has similarity to A. nidulans PalH 
YNL106C INP52 Phosphatidylinositol 4,5-bisphosphate 5-
phosphatase, synaptojanin-like protein with an 
N-terminal Sac1 domain, plays a role in 
endocytosis; hyperosmotic stress causes 
translocation to actin patches 
YNR010W CSE2 Subunit of the RNA polymerase II mediator 
complex; associates with core polymerase 
subunits to form the RNA polymerase II 
holoenzyme; component of the Med9/10 
module; required for regulation of RNA 
polymerase II activity 
YNL236W SIN4 Subunit of the RNA polymerase II mediator 
complex; associates with core polymerase 
subunits to form the RNA polymerase II 
holoenzyme; contributes to both postive and 
negative transcriptional regulation; dispensible 
for basal transcription 
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YNR006W VPS27 Endosomal protein that forms a complex with 
Hse1p; required for recycling Golgi proteins, 
forming lumenal membranes and sorting 
ubiquitinated proteins destined for 
degradation; has Ubiquitin Interaction Motifs 
which bind ubiquitin (Ubi4p) 
YOL052C SPE2 S-adenosylmethionine decarboxylase, required 
for the biosynthesis of spermidine and 
spermine; cells lacking Spe2p require spermine 
or spermidine for growth in the presence of 
oxygen but not when grown anaerobically 
YOR026W BUB3 Kinetochore checkpoint WD40 repeat protein 
that localizes to kinetochores during prophase 
and metaphase, delays anaphase in the 
presence of unattached kinetochores; forms 
complexes with Mad1p-Bub1p and with 
Cdc20p, binds Mad2p and Mad3p 
YOR141C ARP8 Nuclear actin-related protein involved in 
chromatin remodeling, component of 
chromatin-remodeling enzyme complexes 
YOR196C LIP5 Protein involved in biosynthesis of the 
coenzyme lipoic acid, has similarity to E. coli 
lipoic acid synthase 
YOR221C MCT1 Predicted malonyl-CoA:ACP transferase, 
putative component of a type-II mitochondrial 
fatty acid synthase that produces intermediates 
for phospholipid remodeling 
YPL069C BTS1 Geranylgeranyl diphosphate synthase, 
increases the intracellular pool of 
geranylgeranyl diphosphate, suppressor of 
bet2 mutation that causes defective 
geranylgeranylation of small GTP-binding 
proteins that mediate vesicular traffic 
YPL090C RPS6A Protein component of the small (40S) 
ribosomal subunit; identical to Rps6Bp and has 
similarity to rat S6 ribosomal protein 
YOR355W GDS1 Protein of unknown function, required for 
growth on glycerol as a carbon source; the 
authentic, non-tagged protein is detected in 
highly purified mitochondria in high-
throughput studies 
YPL106C SSE1 ATPase that is a component of the heat shock 
protein Hsp90 chaperone complex; binds 
unfolded proteins; member of the heat shock 
protein 70 (HSP70) family; localized to the 
cytoplasm 
YOR275C RIM20 Protein involved in proteolytic activation of 
Rim101p in response to alkaline pH; 
352 
 
ORF Gene  Description 
PalA/AIP1/Alix family member; interaction 
with the ESCRT-III subunit Snf7p suggests a 
relationship between pH response and 
multivesicular body formation 
YPL239W YAR1 Cytoplasmic ankyrin-repeat containing protein 
of unknown function, proposed to link the 
processes of 40S ribosomal subunit biogenesis 
and adaptation to osmotic and oxidative stress; 
expression repressed by heat shock 
YOR293W RPS10A Protein component of the small (40S) 
ribosomal subunit; nearly identical to Rps10Bp 
and has similarity to rat ribosomal protein S10 
 
 
5.2. Positive genetic interactions identified in tif1 SGA 
ORF Gene  Description 
YGL029W CGR1 Protein involved in nucleolar integrity and 
processing of the pre-rRNA for the 60S 
ribosome subunit; transcript is induced in 
response to cytotoxic stress but not genotoxic 
stress 
YDL074C BRE1 E3 ubiquitin ligase for Rad6p, required for the 
ubiquitination of histone H2B, recruitment of 
Rad6p to promoter chromatin and subsequent 
methylation of histone H3 (on K4 and K79), 
contains RING finger domain 
YEL042W GDA1 Guanosine diphosphatase located in the Golgi, 
involved in the transport of GDP-mannose into 
the Golgi lumen by converting GDP to GMP 
after mannose is transferred its substrate 
YEL020C  Hypothetical protein with low sequence 
identity to Pdc1p 
YEL016C NPP2 Nucleotide 
pyrophosphatase/phosphodiesterase family 
member; mediates extracellular nucleotide 
phosphate hydrolysis along with Npp1p and 
Pho5p; activity and expression enhanced 
during conditions of phosphate starvation 
YEL028W  Dubious open reading frame unlikely to encode 
a protein, based on available experimental and 
comparative sequence data 
YEL023C  Putative protein of unknown function; 
expression is increased greatly during 
sporulation; YEL023C is not an essential gene 
YEL014C  Dubious open reading frame unlikely to encode 
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a functional protein, based on available 
experimental and comparative sequence data  
 
 
5.3. Negative genetic interactions identified in tif2 SGA 
ORF Gene  Description 
YBL027W RPL19B Protein component of the large (60S) 
ribosomal subunit, nearly identical to 
Rpl19Ap and has similarity to rat L19 
ribosomal protein; rpl19a and rpl19b 
single null mutations result in slow 
growth, while the double null mutation 
is lethal 
YBR106W PHO88 Probable membrane protein, involved 
in phosphate transport; pho88 pho86 
double null mutant exhibits enhanced 
synthesis of repressible acid 
phosphatase at high inorganic 
phosphate concentrations 
YCR063W BUD31 Protein involved in bud-site selection; 
analysis of integrated high-throughput 
datasets predicts an involvement in 
RNA splicing; diploid mutants display a 
random budding pattern instead of the 
wild-type bipolar pattern 
YCR081W SRB8 Subunit of the RNA polymerase II 
mediator complex; associates with core 
polymerase subunits to form the RNA 
polymerase II holoenzyme; essential 
for transcriptional regulation; involved 
in glucose repression 
YDL006W PTC1 Type 2C protein phosphatase (PP2C); 
inactivates the osmosensing MAPK 
cascade by dephosphorylating Hog1p; 
mutation delays mitochondrial 
inheritance; deletion reveals defects in 
precursor tRNA splicing, sporulation 
and cell separation 
YDL002C NHP10 Protein related to mammalian high 
mobility group proteins; likely 
component of the INO80 complex, 
which is an ATP-dependent chromatin-
remodeling complex 
YBR289W SNF5 Subunit of the SWI/SNF chromatin 
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remodeling complex involved in 
transcriptional regulation; functions 
interdependently in transcriptional 
activation with Snf2p and Snf6p 
YCL010C SGF29 SaGa associated Factor 29kDa; 
Probable 29kKDa Subunit of SAGA 
histone acetyltransferase complex 
YDR173C ARG82 Inositol polyphosphate multikinase 
(IPMK), sequentially phosphorylates 
Ins(1,4,5)P3 to form Ins(1,3,4,5,6)P5; 
also has diphosphoinositol 
polyphosphate synthase activity; 
regulates arginine-, phosphate-, and 
nitrogen-responsive genes 
YER061C CEM1 Mitochondrial beta-keto-acyl synthase 
with possible role in fatty acid 
synthesis; required for mitochondrial 
respiration 
YER164W CHD1 Nucleosome remodeling factor that 
functions in regulation of transcription 
elongation; contains a chromo domain, 
a helicase domain and a DNA-binding 
domain; component of both the SAGA 
and SILK complexes 
YDR455C    Dubious open reading frame unlikely 
to encode a protein, based on available 
experimental and comparative 
sequence data; partially overlaps the 
verified gene YDR456W 
YER092W IES5 Protein that associates with the INO80 
chromatin remodeling complex under 
low-salt conditions 
YEL057C    Protein of unknown function involved 
in telomere maintenance; target of 
UME6 regulation 
YEL068C    Dubious open reading frame unlikely 
to encode a functional protein, based 
on available experimental and 
comparative sequence data 
YGL212W VAM7 Component of the vacuole SNARE 
complex involved in vacuolar 
morphogenesis; SNAP-25 homolog; 
functions with a syntaxin homolog 
Vam3p in vacuolar protein trafficking 
YGL219C MDM34 Mitochondrial outer membrane 
protein, required for normal 
mitochondrial morphology and 
inheritance; localizes to dots on the 
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mitochondrial surface near mtDNA 
nucleoids; interacts genetically with 
MDM31 and MDM32 
YGL218W    Dubious open reading frame, unlikely 
to encode a protein; not conserved in 
closely related Saccharomyces species; 
93% of ORF overlaps the verified gene 
MDM34; deletion in cyr1 mutant 
results in loss of stress resistance 
YFR025C HIS2 Histidinolphosphatase, catalyzes the 
eighth step in histidine biosynthesis; 
mutations cause histidine auxotrophy 
and sensitivity to Cu, Co, and Ni salts; 
transcription is regulated by general 
amino acid control 
YGR097W ASK10 Component of the RNA polymerase II 
holoenzyme, phosphorylated in 
response to oxidative stress; has a role 
in destruction of Ssn8p, which relieves 
repression of stress-response genes 
YGL244W RTF1 Subunit of the RNA polymerase II-
associated Paf1 complex; directly or 
indirectly regulates DNA-binding 
properties of Spt15p and relative 
activities of different TATA elements; 
involved in telomere maintenance 
YGL147C RPL9A Protein component of the large (60S) 
ribosomal subunit, nearly identical to 
Rpl9Bp and has similarity to E. coli L6 
and rat L9 ribosomal proteins 
YGL154C LYS5 Phosphopantetheinyl transferase 
involved in lysine biosynthesis; 
converts inactive apo-form of Lys2p 
(alpha-aminoadipate reductase) into 
catalytically active holo-form by 
posttranslational addition of 
phosphopantetheine 
YGL026C TRP5 Tryptophan synthase involved in 
tryptophan biosynthesis, regulated by 
the general control system of amino 
acid biosynthesis 
YGL024W    Dubious open reading frame unlikely 
to encode a protein, based on available 
experimental and comparative 
sequence data; partially/completely 
overlaps the verified ORF 
PGD1/YGL025C 
YGL046W    Merged open reading frame, does not 
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encode a discrete protein; YGL046W 
was originally annotated as an 
independent ORF, but as a result of a 
sequence change, it was merged with 
an adjacent ORF into a single reading 
frame, designated YGL045W 
 
YGL045W RIM8 Protein of unknown function, involved 
in the proteolytic activation of 
Rim101p in response to alkaline pH; 
has similarity to A. nidulans PalF 
YHR067W HTD2 Mitochondrial 3-hydroxyacyl-thioester 
dehydratase involved in fatty acid 
biosynthesis, required for respiratory 
growth and for normal mitochondrial 
morphology 
YGR188C BUB1 Protein kinase that forms a complex 
with Mad1p and Bub3p that is crucial 
in the checkpoint mechanism required 
to prevent cell cycle progression into 
anaphase in the presence of spindle 
damage, associates with centromere 
DNA via Skp1p 
YHL007C STE20 Signal transducing kinase of the PAK 
(p21-activated kinase) family, involved 
in pheromone response and 
pseudohyphal/invasive growth 
pathways, activated by Cdc42p; binds 
Ste4p at a GBB motif present in 
noncatalytic domains of PAK kinases 
YHL027W RIM101 Transcriptional repressor involved in 
response to pH and in cell wall 
construction; required for alkaline pH-
stimulated haploid invasive growth and 
sporulation; activated by proteolytic 
processing; similar to A. nidulans PacC 
YHR025W THR1 Homoserine kinase, conserved protein 
required for threonine biosynthesis; 
expression is regulated by the GCN4-
mediated general amino acid control 
pathway 
YJL204C RCY1 F-box protein involved in recycling 
plasma membrane proteins 
internalized by endocytosis; localized 
to sites of polarized growth 
YJL130C URA2 Bifunctional carbamoylphosphate 
synthetase (CPSase)-aspartate 
transcarbamylase (ATCase), catalyzes 
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the first two enzymatic steps in the de 
novo biosynthesis of pyrimidines; both 
activities are subject to feedback 
inhibition by UTP 
YJL128C PBS2 MAP kinase kinase that plays a pivotal 
role in the osmosensing signal-
transduction pathway, activated under 
severe osmotic stress 
YJL126W NIT2 Nit protein, one of two proteins in S. 
cerevisiae with similarity to the Nit 
domain of NitFhit from fly and worm 
and to the mouse and human Nit 
protein which interacts with the Fhit 
tumor suppressor; nitrilase 
superfamily member 
YJL124C LSM1 Lsm (Like Sm) protein; forms 
heteroheptameric complex (with 
Lsm2p, Lsm3p, Lsm4p, Lsm5p, Lsm6p, 
and Lsm7p) involved in degradation of 
cytoplasmic mRNAs 
YJL123C  MCT1  Protein of unknown function that may 
interact with ribosomes; green 
fluorescent protein (GFP)-fusion 
protein localizes to the cytoplasm and 
to COPI-coated vesicles (early Golgi); 
mtc1 is synthetically lethal with cdc13-
1 
YJL122W ALB1 Shuttling pre-60S factor; involved in 
the biogenesis of ribosomal large 
subunit; interacts directly with Arx1p; 
responsible for Tif6p recycling defects 
in absence of Rei1p 
YJL116C NCA3 Protein that functions with Nca2p to 
regulate mitochondrial expression of 
subunits 6 (Atp6p) and 8 (Atp8p ) of 
the Fo-F1 ATP synthase; member of the 
SUN family 
YJL115W ASF1 Nucleosome assembly factor, involved 
in chromatin assembly and 
disassembly, anti-silencing protein that 
causes derepression of silent loci when 
overexpressed 
YIR023W DAL81 Positive regulator of genes in multiple 
nitrogen degradation pathways; 
contains DNA binding domain but does 
not appear to bind the 
dodecanucleotide sequence present in 
the promoter region of many genes 
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involved in allantoin catabolism 
YJL144W    Cytoplasmic hydrophilin with a role in 
dessication resistance; expression 
induced by osmotic stress, starvation 
and during stationary phase; GFP-
fusion protein is induced by the DNA-
damaging agent MMS 
YJL142C IRC9 Hypothetical protein; null mutant 
displays increased levels of 
spontaneous Rad52 foci 
YJL141C YAK1 Serine-threonine protein kinase that is 
part of a glucose-sensing system 
involved in growth control in response 
to glucose availability; translocates 
from the cytoplasm to the nucleus and 
phosphorylates Pop2p in response to a 
glucose signal 
YJL139C YUR1 Mannosyltransferase of the KTR1 
family, involved in protein N-
glycosylation; located in the Golgi 
apparatus 
YJL138C TIF2 Translation initiation factor eIF4A, 
identical to Tif1p; DEA(D/H)-box RNA 
helicase that couples ATPase activity to 
RNA binding and unwinding; forms a 
dumbbell structure of two compact 
domains connected by a linker; 
interacts with eIF4G 
YJL137C GLG2 Self-glucosylating initiator of glycogen 
synthesis, also glucosylates n-dodecyl-
beta-D-maltoside; similar to 
mammalian glycogenin 
YJL136C RPS21B Protein component of the small (40S) 
ribosomal subunit; nearly identical to 
Rps21Ap and has similarity to rat S21 
ribosomal protein 
YJL135W    Dubious open reading frame unlikely 
to encode a protein, based on available 
experimental and comparative 
sequence data; partially overlaps the 
verified genes YJL134W/LCB3 
YJL134W LCB3 Long-chain base-1-phosphate 
phosphatase with specificity for 
dihydrosphingosine-1-phosphate, 
regulates ceramide and long-chain base 
phosphates levels, involved in 
incorporation of exogenous long chain 
bases in sphingolipids 
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YJL133W MRS3 Mitochondrial iron transporter of the 
mitochondrial carrier family (MCF), 
very similar to and functionally 
redundant with Mrs4p; functions under 
low-iron conditions; may transport 
other cations in addition to iron 
YJL132W    Putative protein of unknown function; 
localizes to the membrane fraction; 
possible Zap1p-regulated target gene 
induced by zinc deficiency 
YJL154C VPS35 Endosomal subunit of membrane-
associated retromer complex required 
for retrograde transport; receptor that 
recognizes retrieval signals on cargo 
proteins, forms subcomplex with 
Vps26p and Vps29p that selects cargo 
proteins for retrieval 
YJL153C INO1 Inositol 1-phosphate synthase, involved 
in synthesis of inositol phosphates and 
inositol-containing phospholipids; 
transcription is coregulated with other 
phospholipid biosynthetic genes by 
Ino2p and Ino4p, which bind the 
UASINO DNA element 
YJL152W    Dubious ORF unlikely to encode a 
functional protein, based on available 
experimental and comparative 
sequence data 
YJL151C SNA3 Integral membrane protein localized to 
vacuolar intralumenal vesicles, 
computational analysis of large-scale 
protein-protein interaction data 
suggests a possible role in either cell 
wall synthesis or protein-vacuolar 
targeting 
YJL150W    Dubious open reading frame unlikely 
to encode a functional protein, based 
on available experimental and 
comparative sequence data 
YJL149W DAS1 Putative SCF ubiquitin ligase F-box 
protein; interacts physically with both 
Cdc53p and Skp1 and genetically with 
CDC34; similar to putative F-box 
protein YDR131C; null mutant 
suppresses dst1delta sensitivity for 6-
azauracil 
YJL148W RPA34 RNA polymerase I subunit A34.5 
YJL147C    Mitochondrial protein of unknown 
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function; homozygous diploid deletion 
strain has a sporulation defect 
characterized by elevated dityrosine in 
the soluble fraction; expression 
induced by Ca2+ shortage; YJL147W is 
a non-essential gene 
YJL146W IDS2 Protein involved in modulation of 
Ime2p activity during meiosis, appears 
to act indirectly to promote Ime2p-
mediated late meiotic functions; found 
in growing cells and degraded during 
sporulation 
YJL145W SFH5 Putative phosphatidylinositol transfer 
protein (PITP), exhibits 
phosphatidylinositol- but not 
phosphatidylcholine-transfer activity, 
localized to cytosol and microsomes, 
similar to Sec14p; may be PITP 
regulator rather than actual PITP 
YJL164C TPK1 cAMP-dependent protein kinase 
catalytic subunit; promotes vegetative 
growth in response to nutrients via the 
Ras-cAMP signaling pathway; inhibited 
by regulatory subunit Bcy1p in the 
absence of cAMP; partially redundant 
with Tpk2p and Tpk3p 
YJL162C JJJ2 Protein of unknown function, contains 
a J-domain, which is a region with 
homology to the E. coli DnaJ protein 
YJL160C    Putative protein of unknown function; 
member of the PIR (proteins with 
internal repeats) family of cell wall 
proteins; non-essential gene that is 
required for sporulation; mRNA is 
weakly cell cycle regulated, peaking in 
mitosis 
YJL159W HSP150 O-mannosylated heat shock protein 
that is secreted and covalently attached 
to the cell wall via beta-1,3-glucan and 
disulfide bridges; required for cell wall 
stability; induced by heat shock, 
oxidative stress, and nitrogen 
limitation 
YJL158C CIS3 Mannose-containing glycoprotein 
constituent of the cell wall; member of 
the PIR (proteins with internal repeats) 
family 
YJL157C FAR1 Cyclin-dependent kinase inhibitor that 
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mediates cell cycle arrest in response 
to pheromone; also forms a complex 
with Cdc24p, Ste4p, and Ste18p that 
may specify the direction of polarized 
growth during mating; potential 
Cdc28p substrate 
YJL175W    Dubious open reading frame unlikely 
to encode a functional protein; deletion 
confers resistance to cisplatin, 
hypersensitivity to 5-fluorouracil, and 
growth defect at high pH with high 
Ca2+; overlaps gene for SWI3 
transcription factor 
YJL172W CPS1 Vacuolar carboxypeptidase yscS; 
expression is induced under low-
nitrogen conditions 
YJL170C ASG7 Protein that regulates signaling from a 
G protein beta subunit Ste4p and its 
relocalization within the cell; specific to 
a-cells and induced by alpha-factor 
YKR059W TIF1 Translation initiation factor eIF4A, 
identical to Tif2p; DEA(D/H)-box RNA 
helicase that couples ATPase activity to 
RNA binding and unwinding; forms a 
dumbbell structure of two compact 
domains connected by a linker; 
interacts with eIF4G 
YJR109C CPA2 Large subunit of carbamoyl phosphate 
synthetase, which catalyzes a step in 
the synthesis of citrulline, an arginine 
precursor 
YKL081W TEF4 Translation elongation factor EF-1 
gamma 
YKL212W SAC1 Lipid phosphoinositide phosphatase of 
the ER and Golgi, involved in protein 
trafficking and secretion 
YKL041W VPS24 One of four subunits of the endosomal 
sorting complex required for transport 
III (ESCRT-III); forms an ESCRT-III 
subcomplex with Did4p; involved in the 
sorting of transmembrane proteins into 
the multivesicular body (MVB) 
pathway 
YLR337C VRP1 Proline-rich actin-associated protein 
involved in cytoskeletal organization 
and cytokinesis; related to mammalian 
Wiskott-Aldrich syndrome protein 
(WASP)-interacting protein (WIP) 
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YLR039C RIC1 Protein involved in retrograde 
transport to the cis-Golgi network; 
forms heterodimer with Rgp1p that 
acts as a GTP exchange factor for 
Ypt6p; involved in transcription of 
rRNA and ribosomal protein genes 
YLR182W SWI6 Transcription cofactor, forms 
complexes with DNA-binding proteins 
Swi4p and Mbp1p to regulate 
transcription at the G1/S transition; 
involved in meiotic gene expression; 
localization regulated by 
phosphorylation; potential Cdc28p 
substrate 
YMR154C RIM13 Calpain-like cysteine protease involved 
in proteolytic activation of Rim101p in 
response to alkaline pH; has similarity 
to A. nidulans palB 
YMR201C RAD14 Protein that recognizes and binds 
damaged DNA during nucleotide 
excision repair; subunit of Nucleotide 
Excision Repair Factor 1 (NEF1); 
contains zinc finger motif; homolog of 
human XPA protein 
YMR223W UBP8 Ubiquitin-specific protease that is a 
component of the SAGA (Spt-Ada-Gcn5-
Acetyltransferase) acetylation complex; 
required for SAGA-mediated 
deubiquitination of histone H2B 
YNL257C SIP3 Protein that activates transcription 
through interaction with DNA-bound 
Snf1p, C-terminal region has a putative 
leucine zipper motif; potential Cdc28p 
substrate 
YNL255C GIS2 Protein with seven cysteine-rich CCHC 
zinc-finger motifs, similar to human 
CNBP, proposed to be involved in the 
RAS/cAMP signaling pathway 
YNL294C RIM21 Component of the RIM101 pathway, 
has a role in cell wall construction and 
alkaline pH response; has similarity to 
A. nidulans PalH 
YOL052C SPE2 S-adenosylmethionine decarboxylase, 
required for the biosynthesis of 
spermidine and spermine; cells lacking 
Spe2p require spermine or spermidine 
for growth in the presence of oxygen 
but not when grown anaerobically 
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ORF Gene  Description 
YOR026W BUB3 Kinetochore checkpoint WD40 repeat 
protein that localizes to kinetochores 
during prophase and metaphase, delays 
anaphase in the presence of unattached 
kinetochores; forms complexes with 
Mad1p-Bub1p and with Cdc20p, binds 
Mad2p and Mad3p 
YOR141C ARP8 Nuclear actin-related protein involved 
in chromatin remodeling, component of 
chromatin-remodeling enzyme 
complexes 
YOR030W DFG16 Probable multiple transmembrane 
protein, involved in diploid invasive 
and pseudohyphal growth upon 
nitrogen starvation; required for 
accumulation of processed Rim101p 
YOR196C LIP5 Protein involved in biosynthesis of the 
coenzyme lipoic acid, has similarity to 
E. coli lipoic acid synthase 
YPL047W SGF11 Integral subunit of SAGA histone 
acetyltransferase complex, regulates 
transcription of a subset of SAGA-
regulated genes, required for the 
Ubp8p association with SAGA and for 
H2B deubiquitylation 
YPL069C BTS1 Geranylgeranyl diphosphate synthase, 
increases the intracellular pool of 
geranylgeranyl diphosphate, 
suppressor of bet2 mutation that 
causes defective geranylgeranylation of 
small GTP-binding proteins that 
mediate vesicular traffic 
YPL178W CBC2 Small subunit of the heterodimeric cap 
binding complex that also contains 
Sto1p, component of the spliceosomal 
commitment complex; interacts with 
Npl3p, possibly to package mRNA for 
export from the nucleus; contains an 
RNA-binding motif 
YPL090C RPS6A Protein component of the small (40S) 
ribosomal subunit; identical to Rps6Bp 
and has similarity to rat S6 ribosomal 
protein 
YOR358W HAP5 Subunit of the heme-activated, glucose-
repressed Hap2/3/4/5 CCAAT-binding 
complex, a transcriptional activator and 
global regulator of respiratory gene 
expression; required for assembly and 
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ORF Gene  Description 
DNA binding activity of the complex 
YOR275C RIM20 Protein involved in proteolytic 
activation of Rim101p in response to 
alkaline pH; PalA/AIP1/Alix family 
member; interaction with the ESCRT-III 
subunit Snf7p suggests a relationship 
between pH response and 
multivesicular body formation 
YGR122W    Probable ortholog of A. nidulans PalC, 
which is involved in pH regulation and 
binds to the ESCRT-III complex; null 
mutant does not properly process 
Rim101p and has decreased resistance 
to rapamycin; GFP-fusion protein is 
cytoplasmic 
YGL029W CGR1 Protein involved in nucleolar integrity 
and processing of the pre-rRNA for the 
60S ribosome subunit; transcript is 
induced in response to cytotoxic stress 
but not genotoxic stress 
YDL074C BRE1 E3 ubiquitin ligase for Rad6p, required 
for the ubiquitination of histone H2B, 
recruitment of Rad6p to promoter 
chromatin and subsequent methylation 
of histone H3 (on K4 and K79), 
contains RING finger domain 
    
    
    
 
5.4. Positive genetic interactions identified in tif2 SGA 
ORF Gene  Description 
YGL029W CGR1 Protein involved in nucleolar integrity and 
processing of the pre-rRNA for the 60S 
ribosome subunit; transcript is induced in 
response to cytotoxic stress but not 
genotoxic stress 
YDL074C BRE1 E3 ubiquitin ligase for Rad6p, required for 
the ubiquitination of histone H2B, 
recruitment of Rad6p to promoter chromatin 
and subsequent methylation of histone H3 
(on K4 and K79), contains RING finger 
domain 
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ORF Gene  Description 
YEL020C  Hypothetical protein with low sequence 
identity to Pdc1p 
YEL016C NPP2 Nucleotide 
pyrophosphatase/phosphodiesterase family 
member; mediates extracellular nucleotide 
phosphate hydrolysis along with Npp1p and 
Pho5p; activity and expression enhanced 
during conditions of phosphate starvation 
YEL028W  Dubious open reading frame unlikely to 
encode a protein, based on available 
experimental and comparative sequence 
data 
YEL023C  Putative protein of unknown function; 
expression is increased greatly during 
sporulation; YEL023C is not an essential 
gene 
YEL014C  Dubious open reading frame unlikely to 
encode a functional protein, based on 
available experimental and comparative 
sequence data  
YPR044C OPI11 Dubious open reading frame unlikely to 
encode a protein, based on available 
experimental and comparative sequence 
data; partially overlaps verified gene 
RPL43A/YPR043W; deletion confers 
sensitivity to GSAO 
YEL065W SIT1 Ferrioxamine B transporter, member of the 
ARN family of transporters that specifically 
recognize siderophore-iron chelates; 
transcription is induced during iron 
deprivation and diauxic shift; potentially 
phosphorylated by Cdc28p 
YLR200W YKE2 Subunit of the heterohexameric 
Gim/prefoldin protein complex involved in 
the folding of alpha-tubulin, beta-tubulin, 
and actin 
 
 
5.5. Primers 
 
 
Table A-1 
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Lab identification number Primer Sequence 
#26 
TIF1 1.5 confirmation 
forward GAATATACGCAGCCCTGACATTTGT 
#27 TIF1 1.3 confirmation reverse CCAATCTCTATTAGTAGGGCATCG 
#28 
TIF2 1.5 confirmation 
forward TCATCTCAAGGAGAAGGAAACAGC 
#29 TIF2 1.3 confirmation reverse GAAGGGGAAAGTGGTTATGTGGCAG 
#4 nat confirmation forward TACGAGACGACCACGAAGC 
#3 nat confirmation reverse TGGAACCGCCGGCTGACC 
 
Table A-2 
 
Laboratory identification 
number 
Primer Sequence 
#81 Tet-tif2 forward 
ATTCAACTAAACTACTACATAGT
ATACATTAGCTGTACAGTCGTCA
CATCAGACGGCCAGCTGAAGCTT
CGTACGC 
#82 Tet-tif2 reverse 
TGTCATAGTTGGTTTGAATTTGG
GATTCTTCAATATCAGTAATACC
TTCACAGACATATCCCCCGAATT
GATCCGGTAA 
#79 Tet-tif1 forward 
AAGGTTTATCAGCAACAACATCC
GATGCTTGCTGTTTATCTTTCTC
ACCTCACAGCCAGCTGAAGCTTC
GTACGC 
#80 Tet-tif1 reverse 
TGTCATAGTTGGTTTGAATTTGG
GATTCTTCAATATCAGTAATACC
TTCAGACATAT 
 
 
Table A-3 
 
Laboratory identification 
number 
Primer Sequence 
#40 TIF1 GAL forward 
CTTATTTTATAACAAATTCGTTA
AACGGCCTCCTTCTAATTATATAC
AAGATGCGTACGCTGCAGGTCGA
C 
#41 TIF1 GAL reverse 
CCTTGTCATAGTTGGTTTGAATT
TGGGATTCTTCAATATCAGTAAT
ACCTTCAGACATCGATGAATTCT
CTGTCG 
#42 TIF2 GAL forward 
AGGACTGGTGTGTACAAGAAACT
AATAAATAGTAATTGCAATATGC
GTACGCTGCAGGTCGAC 
#43 TIF2 GAL reverse 
AGTTGGTTTGAATTTGGGATTCT
TCAATATCAGTAAATACCTTCAG
ACATCGATGAATTCTCTGTCG 
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Table A-4 
 
Lab identification 
number 
Primer Sequence 
#83 MX4 forward  ACATGGAGGCCCAGATACCC 
#84 MX4 reverse CAGTATAGCGACCAGCATTCAC 
 
 
5.6. Lithium/galactose sensitive deletion strains 
 
ORF Gene Description 
YKL190W CNB1 Calcineurin B; the regulatory subunit of 
calcineurin, a Ca++/calmodulin-regulated 
type 2B protein phosphatase which 
regulates Crz1p (a stress-response 
transcription factor), the other calcineurin 
subunit is encoded by CNA1 and/or CMP1 
YKL159C RCN1 Protein involved in calcineurin regulation 
during calcium signaling; has similarity to 
H. sapiens DSCR1 which is found in the 
Down Syndrome candidate region 
YML057W CMP2 Calcineurin A; one isoform (the other is 
CNA1) of the catalytic subunit of 
calcineurin, a Ca++/calmodulin-regulated 
protein phosphatase which regulates 
Crz1p (a stress-response transcription 
factor), the other calcineurin subunit is 
CNB1 
YGR217W CCH1 Voltage-gated high-affinity calcium 
channel involved in calcium influx in 
response to some environmental stresses 
as well as exposure to mating pheromones; 
interacts and co-localizes with Mid1p, 
suggesting Cch1p and Mid1p function 
together 
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ORF Gene Description 
YLR443W ECM7 Non-essential putative integral membrane 
protein with a role in calcium uptake; 
mutant has cell wall defects and Ca+ 
uptake deficiencies; transcription is 
induced under conditions of zinc 
deficiency 
YLL006W MMM1 ER integral membrane protein, component 
of the ERMES complex that links the ER to 
mitochondria and may promote inter-
organellar calcium and phospholipid 
exchange as well as coordinating 
mitochondrial DNA replication and growth 
YJL187C SWE1 Protein kinase that regulates the G2/M 
transition by inhibition of Cdc28p kinase 
activity; localizes to the nucleus and to the 
daughter side of the mother-bud neck; 
homolog of S. pombe Wee1p; potential 
Cdc28p substrate 
YNL197C WHI3 RNA binding protein that sequesters CLN3 
mRNA in cytoplasmic foci; cytoplasmic 
retention factor for Cdc28p and associated 
cyclins; regulates cell fate and dose-
dependently regulates the critical cell size 
required for passage through Start 
YLR332W MID2 O-glycosylated plasma membrane protein 
that acts as a sensor for cell wall integrity 
signaling and activates the pathway; 
interacts with Rom2p, a guanine 
nucleotide exchange factor for Rho1p, and 
with cell integrity pathway protein Zeo1p 
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ORF Gene Description 
YIL011W TIR3 Cell wall mannoprotein of the Srp1p/Tip1p 
family of serine-alanine-rich proteins; 
expressed under anaerobic conditions and 
required for anaerobic growth 
YOL109W ZEO1 Peripheral membrane protein of the 
plasma membrane that interacts with 
Mid2p; regulates the cell integrity pathway 
mediated by Pkc1p and Slt2p; the 
authentic protein is detected in a 
phosphorylated state in highly purified 
mitochondria 
YOR231W MKK1 Mitogen-activated kinase kinase involved 
in protein kinase C signaling pathway that 
controls cell integrity; upon activation by 
Bck1p phosphorylates downstream target, 
Slt2p; functionally redundant with Mkk2p 
YHL027W RIM101 Transcriptional repressor involved in 
response to pH and in cell wall 
construction; required for alkaline pH-
stimulated haploid invasive growth and 
sporulation; activated by proteolytic 
processing; similar to A. nidulans PacC 
YPL140C MKK2 Mitogen-activated kinase kinase involved 
in protein kinase C signaling pathway that 
controls cell integrity; upon activation by 
Bck1p phosphorylates downstream target, 
Slt2p; functionally redundant with Mkk1p 
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ORF Gene Description 
YNL233W BNI4 Targeting subunit for Glc7p protein 
phosphatase, localized to the bud neck, 
required for localization of chitin synthase 
III to the bud neck via interaction with the 
chitin synthase III regulatory subunit 
Skt5p 
YBR023C CHS3 Chitin synthase III, catalyzes the transfer of 
N-acetylglucosamine (GlcNAc) to chitin; 
required for synthesis of the majority of 
cell wall chitin, the chitin ring during bud 
emergence, and spore wall chitosan 
YLR330W CHS5 Component of the exomer complex, which 
also contains Csh6p, Bch1p, Bch2p, and 
Bud7p and is involved in export of selected 
proteins, such as chitin synthase Chs3p, 
from the Golgi to the plasma membrane 
YOR141C ARP8 Nuclear actin-related protein involved in 
chromatin remodeling, component of 
chromatin-remodeling enzyme complexes; 
has mRNA binding activity 
YER092W IES5 Protein that associates with the INO80 
chromatin remodeling complex under low-
salt conditions 
YFL049W SWP82 Member of the SWI/SNF chromatin 
remodeling complex in which it plays an as 
yet unidentified role; has identifiable 
counterparts in closely related yeast 
species; abundantly expressed in many 
growth conditions; paralog of Npl6p 
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ORF Gene Description 
YEL043W YEL043W Predicted cytoskeleton protein involved in 
intracellular signalling based on 
quantitative analysis of protein-protein 
interaction maps; may interact with 
ribosomes, based on co-purification 
studies; contains fibronectin type III 
domain fold 
YDR388W RVS167 Actin-associated protein with roles in 
endocytosis and exocytosis; interacts with 
Rvs161p to regulate actin cytoskeleton, 
endocytosis, and viability following 
starvation or osmotic stress; recruited to 
bud tips by Gyl1p and Gyp5p during 
polarized growth; homolog of mammalian 
amphiphysin 
YIL017C VID28 Protein involved in proteasome-dependent 
catabolite degradation of fructose-1,6-
bisphosphatase (FBPase); localized to the 
nucleus and the cytoplasm 
YLR373C VID22 Glycosylated integral membrane protein 
localized to the plasma membrane; plays a 
role in fructose-1,6-bisphosphatase 
(FBPase) degradation; involved in FBPase 
transport from the cytosol to Vid (vacuole 
import and degradation) vesicles 
YJL155C FBP26 Fructose-2,6-bisphosphatase, required for 
glucose metabolism 
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ORF Gene Description 
YLL043W FPS1 Plasma membrane channel, member of 
major intrinsic protein (MIP) family; 
involved in efflux of glycerol and in uptake 
of acetic acid and the trivalent metalloids 
arsenite and antimonite; phosphorylated 
by Hog1p MAPK under acetate stress 
YNL080C EOS1 Protein involved in N-glycosylation; 
deletion mutation confers sensitivity to 
exidative stress and shows synthetic 
lethality with mutations in the spindle 
checkpoint genes BUB3 and MAD1; 
YNL080C is not an essential gene 
YJL101C GSH1 Gamma glutamylcysteine synthetase 
catalyzes the first step in glutathione (GSH) 
biosynthesis; expression induced by 
oxidants, cadmium, and mercury 
YNL307C MCK1 Protein serine/threonine/tyrosine (dual-
specificity) kinase involved in control of 
chromosome segregation and in regulating 
entry into meiosis; related to mammalian 
glycogen synthase kinases of the GSK-3 
family 
YKL127W PGM1 Phosphoglucomutase, minor isoform; 
catalyzes the conversion from glucose-1-
phosphate to glucose-6-phosphate, which 
is a key step in hexose metabolism 
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ORF Gene Description 
YMR105C PGM2 Phosphoglucomutase, catalyzes the 
conversion from glucose-1-phosphate to 
glucose-6-phosphate, which is a key step in 
hexose metabolism; functions as the 
acceptor for a Glc-phosphotransferase 
YMR278W PGM3 Phosphoglucomutase, catalyzes 
interconversion of glucose-1-phosphate 
and glucose-6-phospate; transcription 
induced in response to stress; green 
fluorescent protein (GFP)-fusion protein 
localizes to the cytoplasm and nucleus; 
non-essential 
YDR359C EAF1/VID21 Component of the NuA4 histone 
acetyltransferase complex; acts as a 
platform for assembly of NuA4 subunits 
into the native complex; required for 
initiation of pre-meiotic DNA replication, 
likely due to its requirement for expression 
of IME1 
YJL168C SET2 Histone methyltransferase with a role in 
transcriptional elongation, methylates a 
lysine residue of histone H3; associates 
with the C-terminal domain of Rpo21p; 
histone methylation activity is regulated 
by phosphorylation status of Rpo21p 
YNL136W EAF7 Subunit of the NuA4 histone 
acetyltransferase complex, which 
acetylates the N-terminal tails of histones 
H4 and H2A 
YMR075W RCO1 Essential subunit of the histone 
deacetylase Rpd3S complex; interacts with 
Eaf3p 
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ORF Gene Description 
YJR040W GEF1 Voltage-gated chloride channel localized to 
the golgi, the endosomal system, and 
plasma membrane, and involved in cation 
homeostasis; highly homologous to 
vertebrate voltage-gated chloride channels 
YHL007C STE20 Cdc42p-activated signal transducing 
kinase of the PAK (p21-activated kinase) 
family; involved in pheromone response, 
pseudohyphal/invasive growth, vacuole 
inheritance, down-regulation of sterol 
uptake; GBB motif binds Ste4p 
YIL035C CKA1 Alpha catalytic subunit of casein kinase 2 
(CK2), a Ser/Thr protein kinase with roles 
in cell growth and proliferation; CK2, 
comprised of CKA1, CKA2, CKB1 and CKB2, 
has many substrates including 
transcription factors and all RNA 
polymerases 
YJR049C UTR1 ATP-NADH kinase; phosphorylates both 
NAD and NADH; active as a hexamer; 
enhances the activity of ferric reductase 
(Fre1p) 
YHR030C SLT2 Serine/threonine MAP kinase; involved in 
regulating maintenance of cell wall 
integrity, progression through the cell 
cycle, and nuclear mRNA retention in heat 
shock; required for mitophagy and 
pexophagy; affects recruitment of 
mitochondria to the phagophore assembly 
site (PAS); regulated by the PKC1-
mediated signaling pathway 
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ORF Gene Description 
YJL128C PBS2 MAP kinase kinase of the HOG signaling 
pathway; activated under severe osmotic 
stress; mitophagy-specific regulator; plays 
a role in regulating Ty1 transposition 
YJL095W BCK1 Mitogen-activated protein (MAP) kinase 
kinase kinase acting in the protein kinase C 
signaling pathway, which controls cell 
integrity; upon activation by Pkc1p 
phosphorylates downstream kinases 
Mkk1p and Mkk2p 
YER177W BMH1 14-3-3 protein, major isoform; controls 
proteome at post-transcriptional level, 
binds proteins and DNA, involved in 
regulation of many processes including 
exocytosis, vesicle transport, Ras/MAPK 
signaling, and rapamycin-sensitive 
signaling 
YDR532C KRE28\YDR532C  Subunit of a kinetochore-microtubule 
binding complex with Spc105p that 
bridges centromeric heterochromatin and 
kinetochore MAPs and motors, and is also 
required for sister chromatid bi-
orientation and kinetochore binding of SAC 
components 
YML129C COX14 Mitochondrial membrane protein, involved 
in translational regulation of Cox1p and 
assembly of cytochrome c oxidase 
(complex IV); associates with complex IV 
assembly intermediates and complex 
III/complex IV supercomplexes 
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ORF Gene Description 
YJR077C MIR1 Mitochondrial phosphate carrier, imports 
inorganic phosphate into mitochondria; 
functionally redundant with Pic2p but 
more abundant than Pic2p under normal 
conditions; phosphorylated 
YCR028C-A RIM1 Single-stranded DNA-binding protein 
essential for mitochondrial genome 
maintenance; involved in mitochondrial 
DNA replication 
YNL052W COX5A Subunit Va of cytochrome c oxidase, which 
is the terminal member of the 
mitochondrial inner membrane electron 
transport chain; predominantly expressed 
during aerobic growth while its isoform Vb 
(Cox5Bp) is expressed during anaerobic 
growth 
YIL111W COX5B Subunit Vb of cytochrome c oxidase, which 
is the terminal member of the 
mitochondrial inner membrane electron 
transport chain; predominantly expressed 
during anaerobic growth while its isoform 
Va (Cox5Ap) is expressed during aerobic 
growth 
YOL095C HMI1 Mitochondrial inner membrane localized 
ATP-dependent DNA helicase, required for 
the maintenance of the mitochondrial 
genome; not required for mitochondrial 
transcription; has homology to E. coli 
helicase uvrD 
YOR136W IDH2 Subunit of mitochondrial NAD(+)-
dependent isocitrate dehydrogenase, 
which catalyzes the oxidation of isocitrate 
to alpha-ketoglutarate in the TCA cycle; 
phosphorylated 
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ORF Gene Description 
YIL125W KGD1 Component of the mitochondrial alpha-
ketoglutarate dehydrogenase complex, 
which catalyzes a key step in the 
tricarboxylic acid (TCA) cycle, the 
oxidative decarboxylation of alpha-
ketoglutarate to form succinyl-CoA 
YIL160C POT1 3-ketoacyl-CoA thiolase with broad chain 
length specificity, cleaves 3-ketoacyl-CoA 
into acyl-CoA and acetyl-CoA during beta-
oxidation of fatty acids 
YJL023C PET130 Protein required for respiratory growth; 
the authentic, non-tagged protein is 
detected in highly purified mitochondria in 
high-throughput studies 
YMR189W GCV2 P subunit of the mitochondrial glycine 
decarboxylase complex, required for the 
catabolism of glycine to 5,10-methylene-
THF; expression is regulated by levels of 
5,10-methylene-THF in the cytoplasm 
YGR238C KEL2 Protein that functions in a complex with 
Kel1p to negatively regulate mitotic exit, 
interacts with Tem1p and Lte1p; localizes 
to regions of polarized growth; potential 
Cdc28p substrate 
YGR092W DBF2 Ser/Thr kinase involved in transcription 
and stress response; functions as part of a 
network of genes in exit from mitosis; 
localization is cell cycle regulated; 
activated by Cdc15p during the exit from 
mitosis 
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ORF Gene Description 
YEL061C CIN8 Kinesin motor protein involved in mitotic 
spindle assembly and chromosome 
segregation 
YBL031W SHE1 Mitotic spindle protein that interacts with 
components of the Dam1 (DASH) complex, 
its effector Sli15p, and microtubule-
associated protein Bim1p; also localizes to 
nuclear microtubules and to the bud neck 
in a ring-shaped structure 
YDR436W PPZ2 Serine/threonine protein phosphatase Z, 
isoform of Ppz1p; involved in regulation of 
potassium transport, which affects osmotic 
stability, cell cycle progression, and 
halotolerance 
YLR113W HOG1 Mitogen-activated protein kinase involved 
in osmoregulation; acts via three 
independent osmosensors; mitophagy-
specific regulator; mediates the 
recruitment and activation of RNA Pol II at 
Hot1p-dependent promoters; localization 
regulated by Ptp2p and Ptp3p 
YER118C SHO1 Transmembrane osmosensor involved in 
activation of the Cdc42p- and MAP kinase-
dependent filamentous growth pathway 
and the high-osmolarity glycerol response 
pathway; phosphorylated by Hog1p; 
interacts with Pbs2p, Msb2p, Hkr1p, and 
Ste11p 
YCL032W STE50 Protein involved in mating response, 
invasive/filamentous growth, and 
osmotolerance, acts as an adaptor that 
links G protein-associated Cdc42p-Ste20p 
complex to the effector Ste11p to modulate 
signal transduction 
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ORF Gene Description 
YGL105W ARC1 Protein that binds tRNA and methionyl- 
and glutamyl-tRNA synthetases (Mes1p 
and Gus1p), delivering tRNA to them, 
stimulating catalysis, and ensuring their 
localization to the cytoplasm; also binds 
quadruplex nucleic acids 
YIL043C CBR1 Microsomal cytochrome b reductase, not 
essential for viability; also detected in 
mitochondria; mutation in conserved 
NADH binding domain of the human 
ortholog results in type I 
methemoglobinemia 
YIL123W SIM1 Protein of the SUN family (Sim1p, Uth1p, 
Nca3p, Sun4p) that may participate in DNA 
replication, promoter contains SCB 
regulation box at -300 bp indicating that 
expression may be cell cycle-regulated 
YPL157W TGS1 Trimethyl guanosine synthase, conserved 
nucleolar methyl transferase that converts 
the m(7)G cap structure of snRNAs, 
snoRNAs, and telomerase TLC1 RNA to 
m(2,2,7)G; also required for nucleolar 
assembly and splicing of meiotic pre-
mRNAs 
YPL213W LEA1 Component of U2 snRNP; disruption 
causes reduced U2 snRNP levels; 
physically interacts with Msl1p; putative 
homolog of human U2A' snRNP protein 
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ORF Gene Description 
YOL081W IRA2 GTPase-activating protein that negatively 
regulates RAS by converting it from the 
GTP- to the GDP-bound inactive form, 
required for reducing cAMP levels under 
nutrient limiting conditions, has similarity 
to Ira1p and human neurofibromin 
YPL089C RLM1 MADS-box transcription factor, component 
of the protein kinase C-mediated MAP 
kinase pathway involved in the 
maintenance of cell integrity; 
phosphorylated and activated by the MAP-
kinase Slt2p 
YDR363W-A SEM1 Component of the lid subcomplex of the 
regulatory subunit of the 26S proteasome; 
involved in mRNA export mediated by the 
TREX-2 complex (Sac3p-Thp1p); ortholog 
of human DSS1 
YER117W RPL23B Protein component of the large (60S) 
ribosomal subunit, identical to Rpl23Ap 
and has similarity to E. coli L14 and rat L23 
ribosomal proteins 
YBL027W RPL19B Protein component of the large (60S) 
ribosomal subunit, nearly identical to 
Rpl19Ap and has similarity to rat L19 
ribosomal protein; rpl19a and rpl19b 
single null mutations result in slow 
growth, while the double null mutation is 
lethal 
YKR057W RPS21A Protein component of the small (40S) 
ribosomal subunit; nearly identical to 
Rps21Bp and has similarity to rat S21 
ribosomal protein 
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ORF Gene Description 
YGR089W NNF2 Protein that exhibits physical and genetic 
interactions with Rpb8p, which is a 
subunit of RNA polymerases I, II, and III; 
computational analysis of large-scale 
protein-protein interaction data suggests a 
role in chromosome segregation 
YMR037C MSN2 Transcriptional activator related to Msn4p; 
activated in stress conditions, which 
results in translocation from the cytoplasm 
to the nucleus; binds DNA at stress 
response elements of responsive genes, 
inducing gene expression 
YDR074W TPS2 Phosphatase subunit of the trehalose-6-
phosphate synthase/phosphatase complex, 
which synthesizes the storage 
carbohydrate trehalose; expression is 
induced by stress conditions and repressed 
by the Ras-cAMP pathway 
YDR001C NTH1 Neutral trehalase, degrades trehalose; 
required for thermotolerance and may 
mediate resistance to other cellular 
stresses; may be phosphorylated by 
Cdc28p 
YPR040W TIP41 Protein that interacts physically and 
genetically with Tap42p, which regulates 
protein phosphatase 2A; component of the 
TOR (target of rapamycin) signaling 
pathway 
YHR025W THR1 Homoserine kinase, conserved protein 
required for threonine biosynthesis; 
expression is regulated by the GCN4-
mediated general amino acid control 
pathway 
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ORF Gene Description 
YHR104W GRE3 Aldose reductase involved in 
methylglyoxal, d-xylose, arabinose, and 
galactose metabolism; stress induced 
(osmotic, ionic, oxidative, heat shock, 
starvation and heavy metals); regulated by 
the HOG pathway 
YBL066C SEF1 Putative transcription factor, has homolog 
in Kluyveromyces lactis 
YOL089C HAL9 Putative transcription factor containing a 
zinc finger; overexpression increases salt 
tolerance through increased expression of 
the ENA1 (Na+/Li+ extrusion pump) gene 
while gene disruption decreases both salt 
tolerance and ENA1 expression 
YCR009C RVS161 Amphiphysin-like lipid raft protein; 
interacts with Rvs167p and regulates 
polarization of the actin cytoskeleton, 
endocytosis, cell polarity, cell fusion and 
viability following starvation or osmotic 
stress 
YCL010C SGF29 Component of the HAT/Core module of the 
SAGA, SLIK, and ADA complexes; 
HAT/Core module also contains Gcn5p, 
Ngg1p, and Ada2p; binds methylated 
histone H3K4; involved in transcriptional 
regulation through SAGA recruitment to 
target promoters and H3 acetylation 
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ORF Gene Description 
YIL101C XBP1 Transcriptional repressor that binds to 
promoter sequences of the cyclin genes, 
CYS3, and SMF2; expression is induced by 
stress or starvation during mitosis, and 
late in meiosis; member of the 
Swi4p/Mbp1p family; potential Cdc28p 
substrate 
YMR275C BUL1 Ubiquitin-binding component of the Rsp5p 
E3-ubiquitin ligase complex, functional 
homolog of Bul2p, disruption causes 
temperature-sensitive growth, 
overexpression causes missorting of amino 
acid permeases 
YBL047C EDE1 Key endocytic protein involved in a 
network of interactions with other 
endocytic proteins, binds membranes in a 
ubiquitin-dependent manner, may also 
bind ubiquitinated membrane-associated 
proteins 
YGL141W HUL5 Multiubiquitin chain assembly factor (E4); 
proteasome processivity factor that 
elongates polyUb chains on substrates, 
opposing Ubp6p, a branched polyubiquitin 
protease; required for retrograde 
transport of misfolded proteins during 
ERAD 
YLR262C-A TMA7/RBF7 Protein of unknown that associates with 
ribosomes; null mutant exhibits 
translation defects, altered polyribosome 
profiles, and resistance to the translation 
inhibitor anisomcyin 
YBL059W YBL059W Putative protein of unknown function; the 
authentic, non-tagged protein is detected 
in highly purified mitochondria in high-
throughput studies 
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ORF Gene Description 
YGL057C GEP7 Protein of unknown function; null mutant 
exhibits a respiratory growth defect and 
synthetic interactions with prohibitin 
(phb1) and gem1; authentic, non-tagged 
protein is detected in highly purified 
mitochondria in high-throughput studies 
YIL161W YIL161W Putative protein of unknown function; 
green fluorescent protein (GFP)-fusion 
protein localizes to the cytoplasm; mRNA 
is enriched in Scp160p-associated mRNPs; 
YIL161W is a non-essential gene 
YJR054W YJR054W Vacuolar protein of unknown function; 
potential Cdc28p substrate 
YMR003W AIM34 Protein of unknown function; GFP-fusion 
protein localizes to the mitochondria; null 
mutant is viable and displays reduced 
frequency of mitochondrial genome loss 
YMR196W YMR196W Putative protein of unknown function; 
green fluorescent protein (GFP)-fusion 
protein localizes to the cytoplasm; 
YMR196W is not an essential gene 
YNL011C YNL011C Putative protein of unknown function; 
YNL011C is not an essential gene 
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ORF Gene Description 
YOR052C YOR052C Nuclear protein of unknown function; 
expression induced by nitrogen limitation 
in a GLN3, GAT1-independent manner and 
by weak acid; transcriptionally regulated 
by Rpn4p along with proteasome subunit 
genes; putative ortholog of human AIRAP, 
which stimulates proteasome activity in 
response to arsenic 
YOR238W YOR238W Putative protein of unknown function; 
green fluorescent protein (GFP)-fusion 
protein localizes to the cytoplasm 
YJL201W ECM25 Non-essential protein of unknown 
function; promoter contains a consensus 
binding sequence for factor Abf1p 
YGL226W YGL226W Protein of unknown function; green 
fluorescent protein (GFP)-fusion protein 
localizes to the mitochondrion; mtc3 is 
synthetically sick with cdc13-1 
YJR120W YJR120W Protein of unknown function; essential for 
growth under anaerobic conditions; 
mutation causes decreased expression of 
ATP2, impaired respiration, defective 
sterol uptake, and altered 
levels/localization of ABC transporters 
Aus1p and Pdr11p 
YHR079C IRE1 Serine-threonine kinase and 
endoribonuclease; transmembrane protein 
that mediates the unfolded protein 
response (UPR) by regulating Hac1p 
synthesis through HAC1 mRNA splicing; 
Kar2p binds inactive Ire1p and releases 
from it upon ER stress 
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ORF Gene Description 
YFL031W HAC1 Basic leucine zipper (bZIP) transcription 
factor (ATF/CREB1 homolog) that 
regulates the unfolded protein response, 
via UPRE binding, and membrane 
biogenesis; ER stress-induced splicing 
pathway facilitates efficient Hac1p 
synthesis 
YGL212W VAM7 Vacuolar SNARE protein that functions 
with Vam3p in vacuolar protein trafficking; 
has an N-terminal PX domain 
(phosphoinositide-binding module) that 
binds PtdIns-3-P and mediates membrane 
binding; SNAP-25 homolog 
YDR080W VPS41 Vacuolar membrane protein that is a 
subunit of the homotypic vacuole fusion 
and vacuole protein sorting (HOPS) 
complex; essential for membrane docking 
and fusion at the Golgi-to-endosome and 
endosome-to-vacuole stages of protein 
transport 
YDL077C VAM6 Vacuolar protein that plays a critical role in 
the tethering steps of vacuolar membrane 
fusion by facilitating guanine nucleotide 
exchange on small guanosine 
triphosphatase Ypt7p 
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5.7. Lithium/galactose suppressor deletion strains 
 
ORF Gene Description 
YGL168W HUR1 Protein of unknown function; reported 
null mutant phenotype of hydroxyurea 
sensitivity may be due to effects on 
overlapping PMR1 gene. The PMR1  
gene encodes for High affinity 
Ca2+/Mn2+ P-type ATPase required 
for Ca2+ and Mn2+ transport into 
Golgi; involved in Ca2+ dependent 
protein sorting and processing; 
mutations in human homolog ATP2C1 
cause acantholytic skin condition 
Hailey-Hailey disease 
YGL167C PMR1 High affinity Ca2+/Mn2+ P-type 
ATPase required for Ca2+ and Mn2+ 
transport into Golgi; involved in Ca2+ 
dependent protein sorting and 
processing; mutations in human 
homolog ATP2C1 cause acantholytic 
skin condition Hailey-Hailey disease 
YBR020W GAL1 Galactokinase, phosphorylates alpha-
D-galactose to alpha-D-galactose-1-
phosphate in the first step of galactose 
catabolism; expression regulated by 
Gal4p 
YLR081W GAL2 Galactose permease, required for 
utilization of galactose; also able to 
transport glucose 
YPL248C GAL4 DNA-binding transcription factor 
required for the activation of the GAL 
genes in response to galactose; 
repressed by Gal80p and activated by 
Gal3p 
YML048W GSF2 ER localized integral membrane 
protein that may promote secretion of 
certain hexose transporters, including 
Gal2p; involved in glucose-dependent 
repression 
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ORF Gene Description 
YOR002W ALG6 Alpha 1,3 glucosyltransferase, involved 
in transfer of oligosaccharides from 
dolichyl pyrophosphate to asparagine 
residues of proteins during N-linked 
protein glycosylation; mutations in 
human ortholog are associated with 
disease 
YOR067C ALG8 Glucosyl transferase, involved in N-
linked glycosylation; adds glucose to 
the dolichol-linked oligosaccharide 
precursor prior to transfer to protein 
during lipid-linked oligosaccharide 
biosynthesis; similar to Alg6p 
YGR078C PAC10 Part of the heteromeric co-chaperone 
GimC/prefoldin complex, which 
promotes efficient protein folding. 
Protein required in the Absence of 
Cin8p 
YNR051C BRE5 Ubiquitin protease cofactor, forms 
deubiquitination complex with Ubp3p 
that coregulates anterograde and 
retrograde transport between the 
endoplasmic reticulum and Golgi 
compartments; null is sensitive to 
brefeldin A 
YER151C UBP3 Ubiquitin-specific protease that 
interacts with Bre5p to co-regulate 
anterograde and retrograde transport 
between the ER and Golgi; inhibitor of 
gene silencing; cleaves ubiquitin 
fusions but not polyubiquitin; also has 
mRNA binding activity 
YDR092W UBC13 Ubiquitin-conjugating enzyme 
involved in the error-free DNA 
postreplication repair pathway; 
interacts with Mms2p to assemble 
ubiquitin chains at the Ub Lys-63 
residue; DNA damage triggers 
redistribution from the cytoplasm to 
the nucleus 
YNL323W LEM3 Membrane protein of the plasma 
membrane and ER, interacts 
specifically in vivo with the 
phospholipid translocase (flippase) 
Dnf1p; involved in translocation of 
phospholipids and 
alkylphosphocholine drugs across the 
plasma membrane 
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ORF Gene Description 
YOL042W NGL1 Putative endonuclease, has a domain 
similar to a magnesium-dependent 
endonuclease motif in mRNA 
deadenylase Ccr4p; the authentic, non-
tagged protein is detected in highly 
purified mitochondria in high-
throughput studies 
YNL123W NMA111 Serine protease and general molecular 
chaperone; involved in response to 
heat stress and promotion of 
apoptosis; may contribute to lipid 
homeostasis; sequence similarity to 
the mammalian Omi/HtrA2 family of 
serine proteases 
YAL023C PMT2 Protein O-mannosyltransferase, 
transfers mannose residues from 
dolichyl phosphate-D-mannose to 
protein Ser/Thr residues; involved in 
ER quality control; acts in a complex 
with Pmt1p, can instead interact with 
Pmt5; target for new antifungal 
YMR263W SAP30 Subunit of a histone deacetylase 
complex, along with Rpd3p and Sin3p, 
that is involved in silencing at 
telomeres, rDNA, and silent mating-
type loci; involved in telomere 
maintenance 
YHR041C SRB2 Subunit of the RNA polymerase II 
mediator complex; associates with 
core polymerase subunits to form the 
RNA polymerase II holoenzyme; 
general transcription factor involved 
in telomere maintenance 
YMR039C SUB1 Transcriptional coactivator, facilitates 
elongation through factors that modify 
RNAP II; role in peroxide resistance 
involving Rad2p; role in the 
hyperosmotic stress response through 
polymerase recruitment at RNAP II 
and RNAP III genes 
YPL247C YPL247C Putative protein of unknown function; 
green fluorescent protein (GFP)-fusion 
protein localizes to the cytoplasm and 
nucleus; similar to the petunia WD 
repeat protein an11; overexpression 
causes a cell cycle delay or arrest 
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ORF Gene Description 
YBR162W-
A 
YSY6 Protein whose expression suppresses 
a secretory pathway mutation in E. 
coli; has similarity to the mammalian 
RAMP4 protein involved in secretion 
YOR304W ISW2 ATP-dependent DNA translocase 
involved in chromatin remodeling; 
ATPase component that, with Itc1p, 
forms a complex required for 
repression of a-specific genes, INO1, 
and early meiotic genes during mitotic 
growth 
YGL226C-
A 
OST5 Zeta subunit of the 
oligosaccharyltransferase complex of 
the ER lumen, which catalyzes 
asparagine-linked glycosylation of 
newly synthesized proteins 
YLR372W SUR4 Elongase, involved in fatty acid and 
sphingolipid biosynthesis; synthesizes 
very long chain 20-26-carbon fatty 
acids from C18-CoA primers; involved 
in regulation of sphingolipid 
biosynthesis. SUppressor of Rvs161 
and rvs167 mutations 
YER111C SWI4 DNA binding component of the SBF 
complex (Swi4p-Swi6p), a 
transcriptional activator that in 
concert with MBF (Mbp1-Swi6p) 
regulates late G1-specific transcription 
of targets including cyclins and genes 
required for DNA synthesis and repair 
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